data_2ns5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ns5 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.689 0.281 . . . . 0.0 110.877 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.02 120.6 1.0 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.04 0.448 . . . . 0.0 111.203 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 m -136.74 142.56 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -100.57 132.3 46.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.438 HG13 ' CE1' ' A' ' 24' ' ' PHE . 9.5 t -113.23 105.7 19.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 t -83.16 101.59 11.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.176 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.438 ' CE1' HG13 ' A' ' 22' ' ' VAL . 15.4 m-85 -83.45 100.65 10.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.397 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.48 -78.84 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.444 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 mtt180 -139.16 31.18 2.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.784 0.326 . . . . 0.0 110.973 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.4 m -140.92 122.59 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.17 125.39 38.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.148 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 p -125.41 124.73 67.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.038 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -79.03 140.0 38.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.61 92.64 26.7 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.64 116.75 4.11 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.076 2.517 . . . . 0.0 112.192 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.403 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -91.41 120.83 32.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.754 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.78 -53.89 33.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.971 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -106.04 -33.03 8.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.834 0.349 . . . . 0.0 111.067 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.22 -12.09 61.92 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.31 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 56.27 3.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.121 0.486 . . . . 0.0 110.812 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.5 ttp -122.38 114.48 20.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.607 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -53.07 147.59 9.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 44' ' ' ILE . 22.0 t -46.85 -43.43 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 10.6 t80 -50.19 -42.16 50.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.954 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -71.14 -31.73 68.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.182 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 tt -71.77 -38.82 70.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.748 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.4 mt -64.58 -48.66 83.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.745 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.21 -38.8 87.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -67.85 -43.24 79.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.51 69.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.3 t -54.37 -52.21 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 110.647 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.3 m -58.18 -47.23 84.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -29.8 70.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.955 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -62.07 -57.36 11.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.743 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 53' ' ' LYS . 9.5 ptt-85 -60.92 -36.34 79.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.838 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 11.4 tppt? -72.6 -27.74 62.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.145 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.96 -35.54 23.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.5 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.0 p -82.04 1.75 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.796 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 75.33 29.96 0.88 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.739 0.304 . . . . 0.0 111.626 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.44 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 7.4 mttt -99.24 -169.9 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.486 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.431 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -158.89 170.36 9.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.907 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 43.1 Cg_endo -68.14 61.8 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -124.01 -41.14 2.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.426 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.479 ' CE2' HG12 ' A' ' 63' ' ' ILE . 9.1 p90 -95.65 150.44 20.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.319 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.47 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -78.42 152.94 31.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.748 0.308 . . . . 0.0 110.94 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.479 HG12 ' CE2' ' A' ' 61' ' ' TYR . 73.0 mt -139.92 110.95 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.81 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.47 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -102.14 101.74 12.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.363 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.405 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 3.9 t -83.21 97.07 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.125 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -58.62 -77.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.88 -176.77 4.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.169 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.16 160.91 21.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.847 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -152.17 137.48 17.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -64.19 -30.47 71.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.83 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.24 -70.96 0.26 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.518 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.79 35.32 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.838 0.352 . . . . 0.0 111.021 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.51 64.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.49 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.12 60.94 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.436 HD13 HG23 ' A' ' 75' ' ' ILE . 12.6 mt -59.42 156.18 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 0.0 111.074 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mp -130.83 122.03 26.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.984 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -109.38 169.23 8.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.538 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 41' ' ' PHE . 0.5 OUTLIER -86.06 79.99 8.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.062 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.82 -38.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -77.08 131.07 38.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.061 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 28.4 mm -55.71 158.28 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.096 0.474 . . . . 0.0 111.546 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.439 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 2.2 tp -71.15 -54.58 10.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.094 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -26.45 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.484 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.12 -35.54 17.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 t -97.38 -67.09 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 111.675 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.97 174.29 3.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.291 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.43 154.9 41.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.781 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.46 117.03 1.98 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.67 60.81 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -122.87 142.94 50.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.6 mmm-85 -95.79 154.5 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.2 mt -148.87 138.25 21.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.025 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 m -90.15 121.95 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.651 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.44 121.79 43.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.061 0.457 . . . . 0.0 111.885 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.04 122.97 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.103 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.405 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 2.2 p90 -151.16 -174.35 4.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.192 0.52 . . . . 0.0 111.586 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -120.62 156.99 30.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.791 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.3 pt-20 -158.23 128.98 6.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.84 0.352 . . . . 0.0 111.224 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.466 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 1.3 tt0 -93.27 70.72 4.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.982 0.42 . . . . 0.0 110.746 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.886 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.73 120.82 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.015 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.68 142.49 37.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.1 m -97.67 121.88 40.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.74 111.49 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.6 t -86.46 101.82 13.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 47' ' ' ALA . 51.4 m-85 -85.46 100.26 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.766 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.16 -90.09 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.575 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.67 31.47 6.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.0 m -139.46 144.99 38.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.41 118.2 30.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.84 126.75 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.98 146.66 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.01 92.73 38.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.064 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -77.71 106.26 2.16 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.869 2.379 . . . . 0.0 112.244 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.67 137.53 36.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.608 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.57 -36.07 7.76 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.061 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -151.55 -45.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.39 13.52 4.75 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.777 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.619 ' CG ' ' O ' ' A' ' 37' ' ' ARG . 8.4 ttm-85 -99.57 29.73 3.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.654 0.74 . . . . 0.0 109.876 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 6.8 ttp -108.86 151.6 26.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.625 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.93 144.62 38.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.607 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 44' ' ' ILE . 58.4 t -48.11 -41.4 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.815 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -50.36 -43.01 54.04 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -33.64 72.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.177 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 tp -69.09 -39.41 79.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.654 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 40' ' ' VAL . 3.9 mt -63.18 -51.35 72.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.732 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -36.96 73.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -68.93 -48.05 64.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -66.6 -41.21 88.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.328 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 44' ' ' ILE . 97.0 t -58.45 -48.13 86.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 0.0 110.619 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.0 m -58.55 -46.98 85.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.596 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -64.39 -33.73 76.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.691 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' HB2' ' CD2' ' A' ' 24' ' ' PHE . 20.0 t80 -59.56 -57.16 14.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.683 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ttm105 -57.47 -40.37 78.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.841 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -72.11 -29.3 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.214 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.43 -30.91 26.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.221 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG1' ' HD2' ' A' ' 57' ' ' LYS . 14.9 p -85.3 -2.97 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.598 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.58 34.82 2.04 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.733 0.301 . . . . 0.0 111.288 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HE2' ' CZ ' ' A' ' 61' ' ' TYR . 13.6 mttt -102.93 -175.36 2.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.796 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.9 m-20 -149.69 175.92 2.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 25.3 Cg_exo -63.15 -11.12 23.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.745 2.297 . . . . 0.0 112.738 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -44.97 -33.17 1.91 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.596 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.443 ' CE2' HG12 ' A' ' 63' ' ' ILE . 2.7 p90 -116.1 145.29 43.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.76 0.315 . . . . 0.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -77.62 154.95 31.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.652 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.443 HG12 ' CE2' ' A' ' 61' ' ' TYR . 52.1 mt -141.64 110.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.001 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.503 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -105.88 108.6 20.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.754 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.413 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 2.2 t -80.05 100.09 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.407 ' CD2' ' HA ' ' A' ' 96' ' ' PHE . 97.8 m-70 -57.8 -63.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -176.77 -173.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.009 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.1 154.32 40.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.763 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -138.37 141.1 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.984 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -68.44 -46.74 69.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.47 -85.24 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.04 39.1 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.349 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.99 102.03 2.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.98 57.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.412 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.417 HD11 HG23 ' A' ' 75' ' ' ILE . 13.1 mt -59.22 157.12 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.188 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.76 123.83 19.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.44 -167.54 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.95 46.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.389 . . . . 0.0 110.826 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -157.45 27.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -142.86 134.37 26.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 24.0 mm -52.59 156.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.038 0.447 . . . . 0.0 111.461 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.406 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -73.13 -49.02 30.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.401 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.8 t -64.97 -14.53 60.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.608 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -91.0 -45.91 8.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.648 0.261 . . . . 0.0 111.615 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.2 m -95.73 -39.22 9.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.02 174.11 7.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.885 0.374 . . . . 0.0 111.28 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.03 144.46 48.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.37 132.55 48.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 tptt 61.66 57.69 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -130.0 164.37 24.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.029 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -111.22 151.06 28.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.75 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.6 mt -143.49 165.66 26.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.151 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.86 117.83 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.791 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.25 113.42 25.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.63 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.99 118.0 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.398 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.407 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . 17.0 p90 -144.01 174.5 10.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.068 0.461 . . . . 0.0 111.477 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -107.53 158.14 17.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.787 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 12.2 pt-20 -154.66 137.67 15.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.753 0.311 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.483 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 19.6 tt0 -105.46 60.74 0.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.807 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.0 p30 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.858 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.409 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.766 0.317 . . . . 0.0 110.807 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -153.73 120.39 5.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.4 m -140.4 142.96 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.069 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -107.29 118.67 37.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.76 109.29 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 101.63 14.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.061 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 26' ' ' ARG . 58.8 m-85 -85.62 102.82 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.504 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.03 -83.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.32 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -133.78 31.28 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.5 m -137.97 122.24 18.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.758 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -96.67 129.53 44.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.13 137.4 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.35 144.73 26.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.022 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.25 92.82 7.39 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.37 121.77 2.33 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.735 2.29 . . . . 0.0 112.518 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -94.28 123.29 37.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.785 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.56 -53.1 30.32 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.063 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.52 -33.6 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 111.081 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.1 6.19 61.86 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.684 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 31.86 2.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.864 0.364 . . . . 0.0 110.669 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.17 139.63 32.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.641 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -67.9 144.7 55.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.394 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -46.67 -54.3 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.818 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 78' ' ' LEU . 9.7 t80 -50.18 -29.81 10.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.216 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -73.15 -40.77 64.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.398 . . . . 0.0 110.3 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.85 -38.26 73.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.681 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 40' ' ' VAL . 6.3 mt -62.54 -48.99 85.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.713 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -59.13 -42.73 91.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.625 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -64.94 -43.43 92.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.591 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.52 87.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.914 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.17 -46.51 94.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.435 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.2 m -59.63 -43.52 93.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.287 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -34.98 79.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.628 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -59.29 -57.12 14.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.471 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -53.31 -47.41 69.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -29.88 67.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.947 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.37 -29.8 57.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.2 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.41 ' CG1' ' CD ' ' A' ' 57' ' ' LYS . 14.5 p -97.25 3.88 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.591 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.74 36.52 8.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HE2' ' CZ ' ' A' ' 61' ' ' TYR . 11.6 mttt -101.78 -174.75 2.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.893 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m-20 -152.54 176.92 2.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.687 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 24.6 Cg_exo -63.47 -10.56 22.13 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.58 2.187 . . . . 0.0 112.734 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -45.26 -37.72 4.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.661 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 63' ' ' ILE . 3.9 p90 -107.59 154.65 21.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.747 0.308 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HD1' ' CB ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.45 154.17 24.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.961 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 66.1 mt -143.44 111.21 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.101 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -104.01 102.42 12.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.75 98.58 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.075 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -60.53 -77.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.074 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -166.9 -174.22 2.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.656 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -120.16 160.49 22.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.46 129.73 23.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -59.65 -29.62 68.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.34 -68.94 0.22 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -158.07 39.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.909 0.385 . . . . 0.0 110.757 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.25 49.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.318 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.05 57.04 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.361 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 mt -59.61 146.51 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.403 . . . . 0.0 111.316 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 5.2 mp -113.53 111.15 21.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.176 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -152.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.092 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 41' ' ' PHE . 5.6 mt -117.75 27.38 9.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.6 0.238 . . . . 0.0 111.097 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 24.1 m-20 -137.65 -38.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.594 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -54.7 109.16 0.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.872 0.368 . . . . 0.0 111.615 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 27.8 mm -50.74 158.58 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.489 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 86' ' ' ALA . 3.4 mm? -54.88 -59.1 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.269 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 22.0 p -65.3 -14.81 61.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.452 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -80.99 -32.45 34.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.575 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 p -124.95 -45.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.805 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . -76.6 174.12 10.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.992 0.425 . . . . 0.0 111.427 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -143.85 155.16 44.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.7 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -52.82 119.14 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.6 tttp 61.68 71.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -139.62 136.5 34.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.018 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -87.57 147.86 25.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.796 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mt -136.72 153.03 50.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.027 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.3 117.13 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.704 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.25 119.26 37.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 111.702 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.15 123.6 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.47 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -151.32 -174.17 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.032 0.444 . . . . 0.0 111.491 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -125.91 159.06 33.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.962 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -157.18 137.5 12.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.782 0.325 . . . . 0.0 111.384 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.487 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 19.2 tt0 -117.89 59.17 0.79 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.073 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.942 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.029 0 CA-C-O 120.884 0.373 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.38 120.61 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.992 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.63 142.3 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.977 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.1 m -110.77 106.03 15.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 m -97.84 103.76 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.93 101.77 2.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.037 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.437 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 4.5 m-85 -78.52 101.88 7.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.425 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.18 -77.0 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.234 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . 6.2 ttt180 -143.89 30.92 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.889 0.375 . . . . 0.0 110.763 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.9 m -142.02 126.88 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -79.51 117.77 20.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.06 109.17 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -74.94 144.23 43.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.05 92.62 7.62 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.65 138.42 6.19 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.802 2.335 . . . . 0.0 112.599 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -113.02 146.39 39.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.61 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.19 -38.74 9.77 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.938 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -121.78 -43.93 2.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.58 10.87 18.55 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.547 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -97.97 35.11 1.77 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.605 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.41 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.5 OUTLIER -110.16 113.15 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.724 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -54.42 157.39 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 44' ' ' ILE . 48.7 t -51.88 -52.11 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.054 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -49.49 -29.73 7.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.077 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.41 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 50.5 m -76.11 -42.18 47.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.805 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.86 -37.66 73.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.606 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.3 mt -64.09 -50.02 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.528 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -57.09 -41.34 78.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.366 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -38.38 90.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.32 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.62 -39.62 73.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.755 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.5 t -58.14 -53.17 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.2 m -59.25 -41.56 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.341 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -27.14 64.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.671 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -68.28 -58.08 4.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.739 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -36.75 75.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.753 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -72.13 -26.06 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.825 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.15 -31.39 25.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.448 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.411 HG23 ' CD ' ' A' ' 57' ' ' LYS . 29.3 m -94.0 17.6 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.649 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 58.6 31.82 21.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.559 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 19.1 mttm -98.17 -177.19 3.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.799 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.27 175.34 2.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.97 -10.05 23.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.776 2.317 . . . . 0.0 112.815 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -47.65 -63.06 1.16 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.905 0.383 . . . . 0.0 111.283 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.438 ' CZ ' ' HD3' ' A' ' 57' ' ' LYS . 2.7 p90 -75.86 145.64 40.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.83 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.483 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.61 154.12 34.66 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.672 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' A' ' 61' ' ' TYR . 62.2 mt -141.4 111.11 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.874 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.483 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.6 OUTLIER -104.84 104.48 14.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.585 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 3.0 t -82.42 98.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -61.67 -68.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.067 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -174.87 -176.93 1.04 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.703 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.7 mt -121.86 160.94 23.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 111.063 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -141.26 136.31 31.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -59.8 -51.7 68.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.22 -31.87 0.95 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.565 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -151.8 75.42 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.32 . . . . 0.0 110.829 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.59 76.75 1.01 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.52 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.25 55.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.543 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 mt -64.47 153.81 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.57 121.77 35.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.832 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.45 -163.07 1.01 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.787 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.3 mt -109.0 42.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.083 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -157.06 32.3 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.4 ' O ' ' CG2' ' A' ' 40' ' ' VAL . 6.1 t0 -134.35 134.03 41.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.098 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 30.6 mm -61.83 158.37 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.399 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.426 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 55.1 tp -65.4 -54.19 32.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.533 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.3 p -72.01 -5.94 38.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.928 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -101.03 -24.66 14.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.518 0.199 . . . . 0.0 111.5 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.08 -34.21 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.771 0.319 . . . . 0.0 111.553 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.74 174.22 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.393 . . . . 0.0 111.275 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -136.08 156.26 48.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -52.59 127.05 21.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.032 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.59 70.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -129.78 134.82 47.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.039 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -99.2 113.42 25.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.798 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.02 167.13 11.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.08 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.44 141.83 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.736 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.437 ' CB ' ' CD1' ' A' ' 24' ' ' PHE . . . -113.18 119.86 39.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.411 . . . . 0.0 111.472 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.9 t -105.16 114.6 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.572 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.413 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 3.2 p90 -144.91 -177.23 5.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.04 0.448 . . . . 0.0 111.503 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -116.28 157.04 25.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.793 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -157.58 133.53 9.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 111.422 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.474 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 2.5 tt0 -101.55 67.41 1.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.745 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.895 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.43 ' CD1' HD23 ' A' ' 82' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.769 0.319 . . . . 0.0 110.858 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.73 120.88 1.48 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 111.201 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.51 156.13 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.881 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.4 m -117.39 119.47 35.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.903 0.382 . . . . 0.0 111.121 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.96 102.91 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.833 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.6 t -83.9 101.61 11.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.432 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 48.4 m-85 -83.57 99.84 10.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.521 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.86 -83.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.301 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -132.58 31.5 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.352 . . . . 0.0 110.761 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 m -138.35 118.71 13.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.76 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.22 120.51 32.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.086 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.5 138.41 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.986 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.75 142.49 27.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.01 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.61 93.78 7.62 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.83 160.39 27.58 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.624 2.216 . . . . 0.0 112.658 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -129.32 129.51 44.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.747 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.38 -41.06 21.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.018 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.11 -33.22 6.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.196 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.25 -0.04 63.6 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.566 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.54 44.68 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.036 0.446 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -114.87 107.75 15.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -53.28 159.25 1.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.055 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 44' ' ' ILE . 40.1 t -51.62 -52.71 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -49.39 -29.04 5.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 110.841 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.8 m -75.85 -45.0 38.08 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.398 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 4.2 pp -72.98 -34.75 66.65 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.896 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.1 mt -66.43 -48.06 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 110.431 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -57.95 -45.79 86.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -37.11 83.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.282 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.55 -37.18 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.829 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.403 HG22 ' CG2' ' A' ' 65' ' ' VAL . 60.9 t -59.41 -54.98 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.325 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -58.11 -44.11 87.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.355 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -35.84 78.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.582 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.413 ' O ' HG21 ' A' ' 55' ' ' VAL . 33.6 t80 -59.99 -57.96 10.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.255 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -49.26 -44.13 43.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.701 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -28.94 68.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.583 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.01 -29.76 43.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.008 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.427 HG22 ' CD ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -98.45 18.14 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.268 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.96 28.68 3.95 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.441 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.427 ' CD ' HG22 ' A' ' 55' ' ' VAL . 18.2 mttt -95.0 -172.46 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -151.9 172.33 5.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.432 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 36.7 Cg_endo -65.74 -8.09 18.49 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.205 1.937 . . . . 0.0 112.818 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -45.77 -42.92 12.61 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.742 0.306 . . . . 0.0 111.436 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.437 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 7.5 p90 -97.02 161.16 13.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.76 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.479 ' HD1' ' CB ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -87.27 154.34 20.77 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.694 0.283 . . . . 0.0 111.149 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.437 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 86.0 mt -143.11 111.47 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.788 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.476 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -99.25 102.01 13.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.682 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' CG2' HG22 ' A' ' 48' ' ' VAL . 9.9 t -81.43 95.42 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -56.18 -77.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.283 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.26 -177.61 4.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.875 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -115.58 147.91 40.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.94 132.58 42.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -58.33 -28.84 65.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.059 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.36 -59.77 0.53 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.567 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.59 32.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 0.0 110.848 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.53 78.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.44 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.11 62.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.409 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.455 HD13 HG22 ' A' ' 75' ' ' ILE . 11.7 mt -59.5 157.95 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 mp -131.87 121.17 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.22 -174.48 2.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.55 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -104.0 34.1 3.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.92 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -150.17 34.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.186 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.33 132.28 29.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.918 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.8 mm -56.38 154.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.086 0.47 . . . . 0.0 111.318 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.43 HD23 ' CD1' ' A' ' 18' ' ' PHE . 49.3 tp -63.0 -52.77 61.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.288 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 64.5 m -67.89 -11.36 58.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.738 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -97.9 -22.72 16.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 p -111.21 -44.04 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.638 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.33 174.18 6.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.322 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -129.31 149.65 51.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.673 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -51.81 126.43 17.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.151 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm 61.69 67.64 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -136.63 153.29 50.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.3 mtm105 -104.35 146.18 29.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.661 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.7 152.65 49.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.187 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 t -108.29 108.64 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.596 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.68 129.5 36.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.989 0.423 . . . . 0.0 111.809 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.8 t -110.8 126.65 68.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.436 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 24' ' ' PHE . 3.4 p90 -150.16 179.69 7.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.116 0.484 . . . . 0.0 111.432 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -116.13 162.35 17.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.721 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.2 pt-20 -161.58 134.76 6.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.8 0.333 . . . . 0.0 111.456 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.479 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 13.8 tt0 -102.88 72.74 1.22 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.623 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.902 -179.865 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.696 0.284 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -162.74 120.46 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 111.279 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.72 142.57 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.835 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.6 m -114.1 107.62 15.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.997 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.8 m -97.91 137.35 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.979 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.8 m -103.49 102.58 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.24 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 40.6 m-85 -77.13 95.47 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.442 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.9 -73.89 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.144 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' PHE . 1.6 mmt85 -143.54 29.09 1.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 110.565 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.8 m -136.31 114.82 11.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.757 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -87.11 127.38 35.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.23 140.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.114 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.27 149.5 21.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.076 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.81 96.03 10.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.39 127.72 6.74 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.609 2.206 . . . . 0.0 112.303 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.3 154.98 22.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.05 -69.4 1.38 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.576 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -109.15 -17.84 13.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 111.203 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.83 14.97 57.3 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.444 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -100.31 29.13 4.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 110.825 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 ttp -98.2 130.26 44.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -57.63 142.96 43.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.595 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.543 ' O ' HG13 ' A' ' 44' ' ' ILE . 92.7 t -48.46 -45.44 14.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.72 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -50.17 -35.18 25.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.111 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 m -74.57 -37.56 62.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.469 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.28 -39.02 75.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.683 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.1 mt -64.26 -49.4 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.654 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -38.92 80.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.63 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -42.95 84.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.507 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.26 -40.34 81.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.63 -52.09 58.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.118 0.485 . . . . 0.0 110.471 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -57.27 -43.73 83.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.422 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -38.81 80.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.573 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -58.66 -56.49 21.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.474 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.4 mtm-85 -48.88 -47.8 42.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -32.28 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.062 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 -26.71 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.042 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.432 ' CG1' ' HD2' ' A' ' 57' ' ' LYS . 14.1 p -99.13 1.86 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.53 30.89 6.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.765 0.317 . . . . 0.0 111.435 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.433 ' HE2' ' CE2' ' A' ' 61' ' ' TYR . 11.4 mttt -99.2 -175.14 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.736 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.1 m-20 -146.13 175.85 2.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 24.3 Cg_exo -64.15 -7.92 15.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.89 2.393 . . . . 0.0 112.932 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -48.02 -66.99 0.31 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.88 0.372 . . . . 0.0 110.99 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.47 ' CZ ' ' CD1' ' A' ' 63' ' ' ILE . 1.9 p90 -74.37 160.71 30.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.576 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.479 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -89.49 151.64 21.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.791 0.329 . . . . 0.0 111.258 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 35.0 mt -142.08 111.0 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.686 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.479 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -109.04 101.53 10.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.674 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 11.3 p -86.3 96.74 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.144 0.497 . . . . 0.0 111.032 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -54.29 -81.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.586 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.07 -167.08 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.802 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mt -127.66 164.99 20.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.847 0.356 . . . . 0.0 111.143 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.21 141.92 34.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.839 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -64.59 -35.82 82.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.993 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.54 -77.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.574 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.63 40.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.27 103.15 2.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.441 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.3 58.19 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.582 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 mt -68.32 158.44 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.297 . . . . 0.0 111.046 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -158.41 131.84 7.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.16 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -90.81 -156.61 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.802 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.26 84.92 2.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.85 0.357 . . . . 0.0 110.74 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -171.75 -40.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.09 142.5 41.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 27.6 mm -56.75 156.89 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.17 0.51 . . . . 0.0 111.474 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.429 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 64.6 tp -66.39 -56.7 9.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.293 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.83 -14.74 61.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.584 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -90.53 -28.21 18.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.586 0.231 . . . . 0.0 111.328 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 14.6 p -117.09 4.48 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.83 174.22 11.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.35 . . . . 0.0 111.212 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.77 152.85 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.817 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.54 135.95 54.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.993 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.55 58.1 3.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.769 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -120.78 157.86 28.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.066 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -116.39 137.06 52.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -142.89 154.39 44.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.069 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.62 117.76 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.66 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.83 122.74 34.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.694 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.3 126.37 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.271 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.463 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -155.33 169.72 23.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.239 0.542 . . . . 0.0 112.124 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.91 157.09 25.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.8 136.43 15.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 111.327 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.476 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 6.7 tt0 -105.23 63.96 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.801 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.721 0.295 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -152.25 120.66 6.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.983 0.42 . . . . 0.0 111.069 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.6 m -132.34 142.42 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.921 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -106.43 125.34 50.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.816 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.66 109.96 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.96 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.1 m -75.27 101.51 4.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 48' ' ' VAL . 7.4 m-85 -84.74 97.32 9.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.705 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.32 -92.87 0.01 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.509 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.34 31.72 6.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.876 0.37 . . . . 0.0 110.641 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.0 m -153.35 117.67 4.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 135.21 33.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.028 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.16 137.08 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.167 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.78 148.94 25.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.9 t -138.93 92.88 10.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.229 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.42 124.94 3.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.767 2.311 . . . . 0.0 112.493 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 m -103.62 136.96 42.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.784 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.38 -41.77 93.34 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.996 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -128.68 -46.53 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.878 0.37 . . . . 0.0 111.236 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.23 12.19 8.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.46 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 -93.85 35.61 1.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.923 0.392 . . . . 0.0 110.576 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.431 ' HG2' ' HB2' ' A' ' 42' ' ' SER . 8.9 ttm -111.17 114.19 27.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.702 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -49.7 144.36 6.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.215 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 44' ' ' ILE . 27.5 t -46.61 -44.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 111.146 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.407 ' CD1' ' HB3' ' A' ' 78' ' ' LEU . 6.0 t80 -50.64 -41.15 54.91 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.531 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.431 ' HB2' ' HG2' ' A' ' 38' ' ' MET . 2.9 m -71.98 -34.41 68.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 110.223 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 tp -66.98 -35.41 79.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.155 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.5 mt -65.88 -51.28 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.547 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -55.76 -36.66 67.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.485 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -67.19 -42.37 84.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.567 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.77 75.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.974 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.428 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 61.2 t -56.41 -52.89 46.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.723 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.1 m -58.31 -44.34 88.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.484 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -62.74 -36.92 84.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.697 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -58.16 -52.94 63.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.534 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -55.19 -49.09 72.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.863 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -70.49 -24.61 62.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.85 -41.41 62.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 0.0 111.28 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.4 p -93.06 9.69 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.668 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 62.8 37.68 12.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.758 0.313 . . . . 0.0 111.466 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.447 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 31.8 mttt -96.54 -174.36 3.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -144.86 172.27 5.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.43 -10.71 22.57 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.822 2.348 . . . . 0.0 112.797 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.21 -59.09 3.11 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.835 0.35 . . . . 0.0 111.45 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.453 ' CE2' HG12 ' A' ' 63' ' ' ILE . 3.6 p90 -79.58 141.24 36.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.71 156.18 32.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.621 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.453 HG12 ' CE2' ' A' ' 61' ' ' TYR . 57.9 mt -142.03 111.22 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.075 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -103.96 105.53 15.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.516 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.452 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 3.1 t -82.54 100.05 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.203 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -63.62 -70.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -168.42 -173.01 1.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.749 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -131.35 158.86 39.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.829 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -142.81 141.14 31.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -61.53 -45.19 95.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.81 -87.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.519 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -120.38 33.8 5.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.797 0.332 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.22 89.56 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.445 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.57 62.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.435 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 75' ' ' ILE . 14.2 mt -56.68 156.05 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.942 0.401 . . . . 0.0 111.104 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 2.6 mt -126.8 115.05 18.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.058 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.71 -163.13 1.01 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.794 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.407 ' HB3' ' CD1' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -117.38 77.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.867 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -174.61 -62.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.238 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -53.05 128.08 26.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.329 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.1 mm -54.12 146.6 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.479 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 tp -60.77 -39.72 89.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.373 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.02 -12.87 61.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.619 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.12 -29.86 12.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.646 0.26 . . . . 0.0 111.392 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.26 -44.7 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.864 0.364 . . . . 0.0 111.668 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.81 174.07 8.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.204 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -145.14 155.39 43.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.677 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -48.8 118.22 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.26 57.84 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -112.69 147.53 36.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.65 148.59 22.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.6 mt -146.2 169.09 19.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.05 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 t -127.7 114.4 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.12 122.68 36.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.44 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.42 112.01 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.415 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 20.2 p90 -141.22 174.46 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.011 0.434 . . . . 0.0 111.282 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -108.48 159.6 16.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.026 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.4 pt-20 -156.53 135.45 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 111.244 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.481 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 30.8 tt0 -107.23 69.52 0.76 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.967 0.413 . . . . 0.0 110.899 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.1 p30 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.957 -179.91 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.79 0.329 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.59 120.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.5 m -137.51 141.91 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.1 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.407 ' CG2' ' CG ' ' A' ' 28' ' ' ARG . 5.8 m -105.55 120.03 40.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.865 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.457 ' CG1' ' CE1' ' A' ' 24' ' ' PHE . 17.1 t -101.61 111.76 32.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -92.13 101.64 14.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CE1' ' CG1' ' A' ' 22' ' ' VAL . 65.9 m-85 -85.52 108.01 17.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.697 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.74 -87.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.377 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -131.55 31.63 4.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.364 . . . . 0.0 110.702 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.1 m -137.76 136.54 37.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.407 ' CG ' ' CG2' ' A' ' 21' ' ' THR . 10.3 ttm180 -101.14 137.5 39.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.48 126.67 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -86.96 144.45 26.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.797 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.0 t -142.29 92.64 7.41 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.196 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.62 122.57 2.74 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.788 2.325 . . . . 0.0 112.481 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -91.13 137.45 32.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.79 -53.53 44.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.685 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -117.27 -38.19 3.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.41 17.87 10.92 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.594 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 -104.61 32.6 4.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.707 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 7.8 ttp -101.83 168.91 9.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -100.25 151.05 21.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.695 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 44' ' ' ILE . 57.7 t -50.42 -47.23 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -49.97 -32.5 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.392 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -36.9 47.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.824 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.24 -38.27 68.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.567 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.9 mt -67.44 -45.86 84.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.552 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -59.35 -41.26 88.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.759 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -66.99 -45.83 76.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.46 91.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.134 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.419 HG22 ' CZ ' ' A' ' 24' ' ' PHE . 71.0 t -58.45 -50.71 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.573 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.1 m -57.38 -45.06 84.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.64 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -63.07 -36.69 84.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.77 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -58.39 -57.18 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -54.64 -48.73 71.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.261 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -72.05 -24.45 61.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.327 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.6 -35.07 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 111.267 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.24 9.35 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.537 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.56 52.92 1.67 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.006 0.432 . . . . 0.0 111.197 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 16.0 mttm -122.74 -175.41 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.99 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.2 m-20 -153.32 172.21 5.93 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.472 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 20.5 Cg_endo -61.07 -10.54 15.36 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.339 2.026 . . . . 0.0 112.932 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -43.68 -36.19 2.1 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.7 0.286 . . . . 0.0 111.691 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.458 ' CE2' HG12 ' A' ' 63' ' ' ILE . 4.7 p90 -108.96 159.88 16.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.698 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.476 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -87.06 151.89 22.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 111.196 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.458 HG12 ' CE2' ' A' ' 61' ' ' TYR . 57.2 mt -141.73 111.26 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.746 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.476 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -108.41 107.13 17.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.818 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.404 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 7.7 t -82.56 100.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -57.41 -75.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.51 -171.94 2.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -125.87 157.06 38.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.95 0.405 . . . . 0.0 110.847 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -142.54 161.13 38.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.76 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -79.93 -61.48 1.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.19 79.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.567 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 60.31 44.46 12.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.52 62.11 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.21 46.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.602 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 75' ' ' ILE . 12.3 mt -62.77 154.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.73 0.3 . . . . 0.0 111.001 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.42 144.79 21.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.963 0.411 . . . . 0.0 111.274 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -94.56 -160.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.73 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.58 86.45 2.29 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.764 0.316 . . . . 0.0 110.864 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -176.9 -39.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.83 128.25 35.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 30.9 mm -55.23 157.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.021 0.438 . . . . 0.0 111.638 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.429 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.7 OUTLIER -56.89 -57.0 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.632 -179.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.6 t -74.12 -3.64 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.885 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -95.5 -30.65 13.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.589 0.233 . . . . 0.0 111.4 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.447 HG11 ' N ' ' A' ' 86' ' ' ALA . 10.2 p -120.51 -30.37 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.447 ' N ' HG11 ' A' ' 85' ' ' VAL . . . -109.91 174.22 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 0.0 111.299 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -136.77 155.75 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.838 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.32 133.84 19.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.87 66.21 1.26 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.803 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -124.41 131.51 53.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.11 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -93.84 105.39 17.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.628 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.2 mt -101.12 145.78 28.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.341 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.04 121.36 44.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.592 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.56 122.84 42.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.997 0.427 . . . . 0.0 111.891 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 t -108.45 122.96 63.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.194 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 24' ' ' PHE . 1.8 p90 -149.4 -175.12 4.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.217 0.532 . . . . 0.0 111.615 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.02 154.95 36.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.952 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -155.54 132.73 10.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.738 0.304 . . . . 0.0 111.302 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.465 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -97.77 69.52 2.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.405 ' CE1' HD13 ' A' ' 82' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.756 0.313 . . . . 0.0 110.687 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.94 120.62 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.26 142.77 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.013 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 m -104.53 105.73 15.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.35 103.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.2 t -79.16 101.59 8.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 26' ' ' ARG . 8.4 m-85 -80.1 100.15 8.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.631 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 -79.12 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.319 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . 5.5 mmt85 -139.92 31.18 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.356 . . . . 0.0 110.771 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.7 m -140.92 122.23 14.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.886 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 122.74 29.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.834 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.78 107.5 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.317 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.94 147.99 40.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.723 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -141.29 103.47 6.06 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.339 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -85.5 140.35 7.26 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.731 2.287 . . . . 0.0 112.278 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.8 m -114.8 141.8 47.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.42 -50.28 60.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.743 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -112.63 -29.27 7.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.52 17.11 50.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -109.96 31.69 5.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.832 0.349 . . . . 0.0 110.7 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.9 ttp -93.78 127.34 39.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -58.14 144.8 39.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.586 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 44' ' ' ILE . 43.4 t -47.78 -45.48 11.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.837 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -50.2 -38.01 37.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.181 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.0 t -73.63 -33.0 64.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 110.235 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -72.17 -38.18 69.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.679 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.6 mt -66.51 -43.9 90.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -64.25 -39.5 94.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.605 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -67.44 -37.28 82.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.367 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.79 -37.3 59.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.034 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -60.54 -44.29 96.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.976 0.417 . . . . 0.0 110.585 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.422 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 86.3 m -68.6 -46.69 68.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.531 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.03 -32.73 74.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.705 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CE1' HG11 ' A' ' 55' ' ' VAL . 35.0 t80 -64.33 -57.67 8.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.651 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -52.61 -42.56 64.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -72.2 -30.96 65.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.96 -37.16 69.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.052 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.412 HG11 ' CE1' ' A' ' 51' ' ' TYR . 35.4 m -88.57 7.78 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.539 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 61.47 41.02 13.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 111.333 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 49.5 mttt -101.89 -174.62 2.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.8 OUTLIER -144.46 172.05 5.93 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.571 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 52.0 Cg_endo -69.3 -6.04 17.4 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.281 1.988 . . . . 0.0 112.875 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -49.42 -38.05 27.74 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.711 0.291 . . . . 0.0 111.283 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.471 ' CE2' HG12 ' A' ' 63' ' ' ILE . 3.1 p90 -104.61 149.32 25.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.487 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -80.74 153.66 27.69 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.842 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.471 HG12 ' CE2' ' A' ' 61' ' ' TYR . 48.9 mt -141.95 111.01 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.847 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.487 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.9 OUTLIER -108.94 109.43 20.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.673 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 2.2 t -82.13 102.6 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.247 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -57.45 -77.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -160.07 -179.36 7.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.021 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.87 159.93 20.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -145.52 140.2 27.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.781 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.401 ' CE1' HD22 ' A' ' 92' ' ' LEU . 6.6 m-70 -63.61 -54.91 28.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.28 -52.56 0.16 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.544 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -152.92 31.96 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.79 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.12 75.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.563 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.41 68.96 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.414 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.6 mm -65.18 157.13 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.906 0.384 . . . . 0.0 111.059 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.408 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 3.8 mp -132.65 119.35 20.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.039 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -98.07 173.24 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.68 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.26 76.6 6.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.92 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -176.06 -44.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.013 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.93 138.97 57.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.984 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 30.6 mm -61.05 158.94 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.507 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.44 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -58.01 -59.18 5.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.442 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.5 t -67.44 -12.83 61.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.783 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -90.85 -21.93 21.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.623 0.249 . . . . 0.0 111.485 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.9 -26.58 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.583 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.99 174.64 10.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.372 . . . . 0.0 111.442 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -127.08 159.66 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.477 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 11.7 p-10 -47.51 153.46 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.134 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 35.06 57.72 0.77 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.005 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -110.02 161.57 15.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.981 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -114.7 130.15 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.76 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.401 HD22 ' CE1' ' A' ' 70' ' ' HIS . 2.1 mp -144.55 160.84 40.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.109 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.23 138.62 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.775 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.04 133.47 54.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.423 . . . . 0.0 111.65 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.01 131.9 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.295 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.442 ' HB3' ' HA ' ' A' ' 65' ' ' VAL . 37.2 p90 -152.06 177.73 10.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.013 0.435 . . . . 0.0 111.632 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.61 157.36 22.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.021 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 8.7 pt-20 -154.34 139.32 17.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.686 0.279 . . . . 0.0 111.388 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.477 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 6.1 tt0 -109.72 63.34 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.914 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.943 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.417 ' CD1' HD21 ' A' ' 82' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.771 0.319 . . . . 0.0 110.738 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -157.85 120.57 3.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.051 0.453 . . . . 0.0 111.167 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 m -136.79 143.23 35.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.835 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.0 m -101.12 116.06 31.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.0 102.84 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.78 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -82.88 102.12 11.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.191 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.411 ' CD2' ' HB2' ' A' ' 51' ' ' TYR . 29.7 m-85 -84.58 98.83 10.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.28 -83.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.299 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -133.51 30.98 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.81 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.4 m -139.21 116.39 11.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -89.09 120.84 30.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.84 116.66 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.03 149.2 39.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.8 t -142.03 95.97 6.72 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.39 108.67 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.661 2.241 . . . . 0.0 112.337 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.404 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -79.23 140.76 37.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.818 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.77 -54.97 29.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.91 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.7 -40.85 2.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.98 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.38 13.51 8.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.647 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.5 mtm-85 -98.79 30.18 3.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.823 0.344 . . . . 0.0 110.724 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -102.53 114.04 27.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.704 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -49.74 148.71 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.71 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 44' ' ' ILE . 23.8 t -46.92 -48.44 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.938 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.428 ' CD2' ' HB3' ' A' ' 78' ' ' LEU . 1.2 t80 -50.81 -44.99 59.17 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.059 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.9 t -58.93 -42.44 89.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.997 0.427 . . . . 0.0 110.328 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.46 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.655 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 40' ' ' VAL . 7.5 mt -64.7 -48.21 85.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.877 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -60.99 -44.86 96.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -39.21 90.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.51 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.35 -34.01 67.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.071 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -63.79 -44.76 98.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.95 0.405 . . . . 0.0 110.721 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.411 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 89.2 m -65.96 -44.49 84.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.548 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -64.77 -27.39 68.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.411 ' HB2' ' CD2' ' A' ' 24' ' ' PHE . 52.5 t80 -69.13 -57.71 5.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.848 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -59.85 -39.29 84.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.055 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -72.27 -35.27 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.03 -29.94 43.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.43 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.403 HG12 ' CG ' ' A' ' 57' ' ' LYS . 14.4 p -87.96 7.74 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.701 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.76 36.2 10.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.798 0.332 . . . . 0.0 111.413 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 43.9 mttt -107.4 -176.61 3.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.842 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.4 m-20 -139.28 175.47 3.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.016 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 20.0 Cg_exo -66.05 -7.85 18.29 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.92 2.414 . . . . 0.0 112.877 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.08 -71.49 0.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.956 0.408 . . . . 0.0 111.113 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.47 ' CZ ' ' CD1' ' A' ' 63' ' ' ILE . 1.3 p90 -64.5 150.71 46.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.809 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.528 ' CZ3' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.18 152.99 25.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.777 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 18.4 mt -143.04 110.39 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.055 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.528 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -113.94 101.93 9.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.63 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.418 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 2.4 t -76.61 97.85 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.151 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -52.28 -70.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.155 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.47 -175.53 3.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 mt -127.56 161.47 28.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.998 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -143.69 159.62 42.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.783 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -77.85 -50.52 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.13 -88.73 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -96.19 41.32 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.814 0.34 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.25 98.18 1.68 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.19 61.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.435 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.1 mt -56.3 158.15 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 111.029 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mt -135.96 106.69 6.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.27 -164.92 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.533 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.428 ' HB3' ' CD2' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -115.96 74.56 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 0.0 110.794 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.48 -52.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.105 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.44 129.03 39.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.033 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.7 mm -54.25 152.97 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.025 0.44 . . . . 0.0 111.511 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.417 HD21 ' CD1' ' A' ' 18' ' ' PHE . 3.0 tp -61.01 -53.32 58.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.371 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.6 p -66.49 -12.17 56.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.687 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.85 -32.39 16.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.656 0.265 . . . . 0.0 111.567 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.23 -45.24 5.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.754 0.312 . . . . 0.0 111.691 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.06 174.09 9.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.384 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -135.58 155.37 50.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -56.37 126.37 26.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.048 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.8 tptt 60.7 69.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -139.7 138.5 36.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -85.9 146.02 26.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.785 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 mt -142.07 145.1 33.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.199 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.0 133.36 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.22 118.0 33.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.374 . . . . 0.0 111.639 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.3 t -104.13 122.71 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.418 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.418 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 1.6 p90 -149.5 -175.34 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.115 0.483 . . . . 0.0 111.709 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -131.55 127.97 38.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.177 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.1 pt-20 -128.46 138.83 52.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.824 0.345 . . . . 0.0 111.004 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -98.44 65.69 1.66 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.809 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.986 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.343 . . . . 0.0 110.878 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -164.59 120.45 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.034 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.5 m -138.84 141.97 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.127 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 m -101.17 116.11 32.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.659 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.415 HG13 ' CE1' ' A' ' 24' ' ' PHE . 10.7 t -101.83 111.77 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.085 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.52 101.52 13.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE1' HG13 ' A' ' 22' ' ' VAL . 15.1 m-85 -83.76 99.81 10.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.538 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.3 -85.97 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.432 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 24' ' ' PHE . 13.1 mtt-85 -130.18 31.23 4.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.893 0.377 . . . . 0.0 110.838 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.1 m -141.25 120.84 13.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.789 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -94.78 130.13 41.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 m -139.19 120.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.8 148.89 39.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.821 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.46 92.94 14.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.237 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.17 116.79 2.76 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.611 2.207 . . . . 0.0 112.312 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.19 150.98 22.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.78 -68.73 1.54 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.451 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.44 -32.43 9.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.38 3.18 41.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.824 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.9 35.84 1.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.2 ttp -100.57 142.21 32.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.23 146.39 52.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.701 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 44' ' ' ILE . 48.1 t -49.49 -44.78 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.861 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -50.17 -36.79 31.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 m -74.82 -34.62 62.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.154 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -41.98 75.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.528 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.0 mt -64.44 -45.65 95.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.846 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.26 -37.53 80.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.718 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -45.01 76.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.756 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.13 -44.19 76.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.232 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.9 t -54.59 -53.55 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 110.713 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 88.3 m -57.03 -42.57 80.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.383 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -34.53 78.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -60.2 -57.23 13.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.484 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -53.71 -44.96 70.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -32.8 69.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.018 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.65 -29.06 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -94.78 -3.76 10.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.611 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.31 36.26 1.84 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.788 0.328 . . . . 0.0 111.21 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 20.1 mttt -104.58 -176.04 2.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.881 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.6 m-20 -149.47 176.57 2.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.759 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 25.0 Cg_exo -63.42 -9.9 19.57 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.632 2.221 . . . . 0.0 112.869 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -44.7 -32.74 1.6 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.709 0.29 . . . . 0.0 111.73 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.454 ' CZ ' ' HD3' ' A' ' 57' ' ' LYS . 6.7 p90 -110.56 163.1 14.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.832 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.484 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -89.64 154.07 20.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.877 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.9 mt -143.58 110.75 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.157 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.484 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -106.71 101.93 11.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.262 179.244 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.4 t -79.32 94.79 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.007 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -53.37 -70.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.078 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -173.54 -177.68 1.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.834 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mt -116.14 159.92 21.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.962 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -137.23 144.72 42.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.963 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -66.53 -31.06 71.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.74 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.15 -38.56 1.1 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -172.33 35.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.829 0.347 . . . . 0.0 110.801 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.4 72.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.415 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.6 64.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.404 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.1 mt -65.87 158.01 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 111.266 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 mp -133.06 128.17 35.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.758 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -94.92 -166.24 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.36 43.93 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -156.56 26.52 0.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -137.13 144.39 42.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.824 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 29.1 mm -57.09 156.77 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.576 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.422 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 41.4 tp -74.8 -50.7 16.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.269 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.436 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 10.5 t -59.69 -20.26 55.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.361 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -85.54 -59.64 2.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.329 . . . . 0.0 111.377 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 m -76.56 -16.35 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.826 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.02 174.22 10.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 0.0 111.282 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.55 155.06 50.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.866 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -52.67 130.09 31.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.02 66.55 1.03 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -131.85 156.0 46.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.02 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.83 144.35 31.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 mt -144.13 145.34 32.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.004 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.41 119.8 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.53 121.41 37.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.54 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.3 120.27 60.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.762 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -148.23 171.36 16.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.054 0.454 . . . . 0.0 111.128 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -114.55 133.88 55.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.059 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.1 pt-20 -133.67 138.39 45.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.788 0.328 . . . . 0.0 111.212 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.435 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -101.37 69.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.4 t0 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.891 179.874 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.833 0.349 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.17 120.22 2.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.051 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.5 m -132.59 142.86 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.012 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.0 m -103.2 108.92 20.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.92 102.75 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.4 t -85.19 101.55 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.428 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 20.3 m-85 -79.99 99.93 7.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.529 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.92 -80.6 0.02 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.263 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . 2.7 mtt180 -137.08 30.82 2.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.935 0.398 . . . . 0.0 110.636 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 83.1 m -138.65 121.26 16.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.57 126.23 33.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.94 114.06 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -74.88 146.35 41.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.09 93.68 7.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.28 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.22 128.51 3.62 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.818 2.346 . . . . 0.0 112.329 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -98.59 136.94 37.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.858 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.54 77.43 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.77 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.25 -44.07 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.72 18.37 6.09 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.562 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -98.17 29.24 3.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.827 0.346 . . . . 0.0 110.701 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.402 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 6.0 ttp -108.09 133.9 51.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.754 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -70.84 148.42 47.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 44' ' ' ILE . 46.8 t -47.81 -40.76 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 14.5 t80 -50.71 -42.49 57.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.872 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.402 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.8 OUTLIER -72.49 -29.56 63.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.195 179.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.29 -39.85 71.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.525 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.7 mt -65.45 -48.65 82.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.775 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -60.86 -35.67 77.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.713 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -68.93 -42.99 76.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.43 -43.63 66.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -56.24 -48.28 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.5 m -61.17 -49.3 77.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.298 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -31.66 72.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.547 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -62.31 -57.69 10.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.451 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.7 ttm105 -52.42 -44.81 65.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -24.59 61.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.96 -30.17 26.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.222 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 55' ' ' VAL . 12.8 p -103.32 20.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.304 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 48.03 89.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.382 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -155.13 -172.2 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -162.2 177.7 1.86 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.698 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 32.3 Cg_exo -58.46 -13.56 17.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.698 2.265 . . . . 0.0 112.937 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -42.82 -36.73 1.57 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.668 0.271 . . . . 0.0 111.571 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 63' ' ' ILE . 2.1 p90 -115.49 153.02 31.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.697 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.89 154.66 24.49 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 111.194 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 79.6 mt -142.54 110.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.479 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.509 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.6 OUTLIER -105.39 106.3 16.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.061 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 8.7 t -82.49 100.46 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.428 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -61.22 -67.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -176.53 -178.29 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.8 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.1 mt -121.62 155.63 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.979 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -144.8 149.49 35.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -70.07 -43.21 71.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.62 -58.36 0.42 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.452 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.86 80.11 1.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.317 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.04 71.6 1.28 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.559 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.55 54.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.449 HD13 HG22 ' A' ' 75' ' ' ILE . 13.1 mt -58.59 155.37 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 0.0 111.199 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.67 114.13 11.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.088 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -96.19 -163.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.522 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -114.74 78.59 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.59 -46.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.33 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.2 136.53 48.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.084 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 24.6 mm -56.94 157.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.045 0.45 . . . . 0.0 111.467 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 3.2 tp -61.6 -57.6 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.088 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.1 t -57.9 -19.42 29.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.382 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -40.72 26.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.571 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.26 -47.21 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . -72.49 174.16 7.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.264 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -144.64 146.6 32.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.837 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.57 123.79 16.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.02 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.1 58.4 3.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.76 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -118.33 161.26 20.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -114.33 129.08 56.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.7 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.51 160.55 37.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.244 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.7 t -116.22 130.5 70.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.749 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.34 128.59 52.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.542 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.58 121.31 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -149.94 177.51 9.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.366 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.44 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . 0.3 OUTLIER -111.05 156.77 20.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.421 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -153.15 133.03 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.002 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.485 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 28.7 tt0 -98.97 70.19 1.81 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.971 0.415 . . . . 0.0 110.618 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.862 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.417 ' CE2' ' HA ' ' A' ' 83' ' ' CYS . 3.6 t80 . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.628 0.251 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -98.61 119.31 37.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 111.311 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.27 142.26 43.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.703 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -109.03 108.15 18.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.018 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.9 105.75 18.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 t -77.44 101.49 6.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -83.0 100.61 10.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.628 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.43 -87.35 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.325 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.09 31.1 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.708 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -145.47 120.32 9.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.689 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -87.72 125.73 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.9 t -126.76 119.41 53.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.206 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -81.71 149.01 28.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.09 98.85 8.29 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.16 85.51 1.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.767 2.311 . . . . 0.0 112.6 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.4 140.55 56.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.75 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.76 -24.53 19.2 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.954 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.29 -42.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.362 . . . . 0.0 110.99 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.98 11.51 6.94 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.615 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -96.44 30.55 2.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.763 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.6 ttp -109.26 144.01 37.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -67.71 143.46 55.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 44' ' ' ILE . 42.5 t -48.74 -41.78 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.839 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -50.37 -39.74 47.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -31.73 63.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.218 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.45 -39.33 71.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.774 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.2 mt -68.1 -42.17 84.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.855 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -36.86 85.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.514 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -38.29 83.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.319 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.91 -39.19 56.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.904 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -58.7 -43.55 87.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.418 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 90.9 m -68.81 -45.87 70.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.482 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -63.9 -30.52 71.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.682 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -65.55 -57.3 8.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.558 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -55.76 -39.17 70.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -72.13 -45.19 61.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.199 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.54 98.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.106 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' CG1' ' HD2' ' A' ' 57' ' ' LYS . 12.2 p -75.03 -7.15 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.559 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 71.92 35.28 1.36 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.83 0.348 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 8.8 mttt -99.71 -175.52 3.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.5 m-20 -151.09 177.14 1.97 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 34.0 Cg_exo -61.92 -12.3 25.22 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.712 2.275 . . . . 0.0 112.769 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -44.07 -33.0 1.33 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.713 0.292 . . . . 0.0 111.727 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.478 ' CE2' HG12 ' A' ' 63' ' ' ILE . 3.6 p90 -114.67 154.44 28.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.966 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.513 ' CD1' ' CB ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -84.35 151.6 24.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.08 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.478 HG12 ' CE2' ' A' ' 61' ' ' TYR . 54.1 mt -140.22 111.6 4.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.889 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.472 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -107.6 103.44 12.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 179.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.422 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 3.3 t -82.08 110.86 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -76.33 -70.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.096 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -171.21 -177.61 2.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.749 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.81 164.97 18.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -147.98 137.67 22.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -66.71 -60.1 2.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.7 73.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.523 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.4 t0 60.2 36.35 20.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.14 60.81 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.481 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.87 56.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 mt -58.57 152.12 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.832 0.349 . . . . 0.0 111.171 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.6 mp -126.76 111.71 14.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.937 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -94.88 -164.26 1.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.827 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mt -110.87 76.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.969 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.55 -58.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.115 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.41 135.02 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.233 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 27.4 mm -56.11 159.02 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.076 0.465 . . . . 0.0 111.431 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.455 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 15.9 tp -69.8 -54.8 11.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.332 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.417 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -52.94 -23.91 8.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.555 -179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.91 -60.52 2.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.532 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.6 m -73.99 -45.82 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.937 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.37 174.45 7.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.255 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -139.28 155.44 47.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.727 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 0.7 OUTLIER -55.65 143.56 29.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.85 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.9 OUTLIER 40.8 50.91 3.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.502 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -111.36 171.8 7.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.214 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.69 146.15 47.31 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.883 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.55 169.1 21.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.4 p -120.53 121.88 66.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -96.69 119.78 35.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.464 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.85 120.57 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.811 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.422 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 2.2 p90 -146.82 -178.12 6.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.159 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.81 158.91 23.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.32 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 1.8 pt-20 -159.57 136.49 9.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 111.258 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.513 ' CB ' ' CD1' ' A' ' 62' ' ' TRP . 8.9 tt0 -129.37 76.63 1.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.142 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.917 179.957 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.674 0.274 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 120.39 6.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.035 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.98 142.62 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.009 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -106.76 105.92 16.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 m -98.27 116.57 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.084 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.07 101.58 14.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' A' ' 47' ' ' ALA . 6.5 m-85 -79.29 100.14 7.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.688 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.67 -79.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.308 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . 1.4 ptm85 -138.07 31.64 2.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.872 0.368 . . . . 0.0 110.732 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.1 m -140.32 121.89 15.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.973 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.72 115.49 28.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.008 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.1 118.18 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.04 144.84 42.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.94 94.67 14.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.44 101.22 1.38 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.505 2.136 . . . . 0.0 112.301 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 149.63 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.34 -76.69 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.723 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.01 -39.45 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 111.05 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.92 11.76 7.48 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.607 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -97.5 29.77 3.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.838 0.352 . . . . 0.0 110.774 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -103.34 125.12 49.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.56 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -59.8 148.02 36.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.557 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 44' ' ' ILE . 48.4 t -47.79 -46.32 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -50.36 -41.86 52.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.4 t -65.14 -39.83 93.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.055 0.455 . . . . 0.0 109.825 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -66.91 -32.18 73.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.407 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.2 mt -64.11 -53.15 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -38.47 78.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -67.24 -45.12 77.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.424 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . . . -68.86 -43.75 74.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.316 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.0 t -55.84 -53.0 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -58.12 -43.76 87.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.724 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -63.65 -41.93 98.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -57.09 -55.32 36.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.733 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -51.86 -53.76 36.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -72.25 -18.68 61.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.371 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.43 -39.86 27.43 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.751 0.31 . . . . 0.0 111.137 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 p -87.04 6.07 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.512 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.13 49.74 0.61 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 13.4 mttm -116.56 -175.78 2.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.464 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.4 m-20 -145.11 171.25 6.79 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.793 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 31.9 Cg_endo -64.03 -8.8 17.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.455 2.104 . . . . 0.0 113.056 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -46.78 -58.25 4.08 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.904 0.383 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.459 ' CE2' HG12 ' A' ' 63' ' ' ILE . 3.5 p90 -80.1 155.56 27.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.872 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.461 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -84.93 153.58 22.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.852 0.358 . . . . 0.0 110.925 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.459 HG12 ' CE2' ' A' ' 61' ' ' TYR . 55.6 mt -142.54 111.0 2.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.836 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.461 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -110.95 116.24 30.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.854 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.408 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 2.1 t -83.45 101.55 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.954 0.407 . . . . 0.0 111.035 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -64.37 -69.18 0.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.509 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -171.43 166.77 6.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 5.5 mt -111.61 156.16 22.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.996 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -150.26 129.39 12.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.98 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.444 ' CE1' ' CD2' ' A' ' 92' ' ' LEU . 41.8 m-70 -56.91 -58.51 7.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.17 68.95 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.489 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.8 44.36 11.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.862 0.363 . . . . 0.0 110.852 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.73 45.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.43 53.56 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.9 mt -60.27 153.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.234 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 1.4 mp -135.92 124.0 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.715 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -94.58 -164.44 1.17 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.679 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.07 44.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.959 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -152.96 23.63 0.57 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.327 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.07 141.32 47.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.927 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 25.3 mm -59.6 156.11 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.013 0.435 . . . . 0.0 111.436 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 86' ' ' ALA . 2.3 tp -72.92 -51.33 18.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.413 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.8 p -59.98 -18.75 48.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.457 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -87.17 -46.25 9.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.706 0.289 . . . . 0.0 111.523 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.1 m -91.25 -46.2 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . -83.73 174.08 10.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.312 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.35 149.09 37.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.7 125.68 22.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.05 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.27 67.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.937 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -129.88 161.97 29.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.965 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.8 mtm-85 -120.52 105.99 11.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.807 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.444 ' CD2' ' CE1' ' A' ' 70' ' ' HIS . 0.8 OUTLIER -110.47 169.07 8.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.176 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.79 140.21 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.852 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.17 117.08 30.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.383 . . . . 0.0 111.683 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 t -90.09 128.26 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.025 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -163.85 171.43 15.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.504 . . . . 0.0 111.773 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.59 154.76 28.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.219 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.06 132.01 12.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.0 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.428 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 10.6 tt0 -92.1 66.96 5.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.413 . . . . 0.0 110.746 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.875 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.426 ' CD1' HD11 ' A' ' 82' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.729 0.299 . . . . 0.0 110.805 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.47 120.04 1.77 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.52 142.05 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.196 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -102.72 107.12 17.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.693 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.09 106.31 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.186 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.86 101.15 3.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.486 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.409 ' CE2' ' HA ' ' A' ' 48' ' ' VAL . 5.4 m-85 -81.86 96.82 7.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.689 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.61 -84.36 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.482 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.79 34.17 4.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.9 m -146.46 145.06 30.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.803 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -103.6 110.18 22.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.994 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 t -114.43 111.27 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.04 144.76 34.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.15 96.89 17.02 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.037 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.39 117.14 1.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.787 2.325 . . . . 0.0 112.506 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.418 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -92.6 131.69 37.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.753 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.45 -37.5 66.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.959 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -135.92 -46.39 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 111.136 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.88 16.56 4.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.602 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -97.04 29.85 2.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.906 0.384 . . . . 0.0 110.667 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.413 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.1 OUTLIER -109.6 122.33 47.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.679 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -58.84 157.58 9.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.68 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 44' ' ' ILE . 39.3 t -52.11 -53.44 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.24 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -49.66 -30.8 9.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.185 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.413 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 49.8 m -73.99 -40.91 62.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.051 0.453 . . . . 0.0 110.314 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.05 -37.46 75.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.539 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.5 mt -63.64 -46.72 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.726 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -59.71 -42.67 93.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.615 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.57 -39.81 94.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.638 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.15 -42.64 68.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 98.2 t -56.63 -54.2 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.721 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -58.82 -42.71 89.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.62 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -69.02 -27.34 65.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.784 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -67.41 -57.49 6.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.821 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -58.97 -38.06 78.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.724 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -29.89 64.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.14 -30.23 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.525 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.3 p -87.02 8.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.694 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.79 24.67 5.27 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.534 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -100.95 -176.39 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.323 . . . . 0.0 110.809 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -142.77 177.42 1.86 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.717 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 19.7 Cg_exo -66.27 -5.99 13.81 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.742 2.295 . . . . 0.0 112.84 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -51.55 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.81 0.338 . . . . 0.0 111.044 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.434 ' CE1' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.56 144.53 54.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.793 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.523 ' CZ3' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -76.81 155.62 32.91 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.672 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 66.5 mt -143.66 110.62 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 19.9 tt0 -104.94 107.27 18.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.285 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.435 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 2.7 t -82.45 101.29 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.403 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 96' ' ' PHE . 47.5 m-70 -64.56 -63.96 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.055 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.34 -176.98 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.661 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -127.46 154.4 45.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.971 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -136.05 146.96 47.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.757 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.448 ' CE1' ' CD2' ' A' ' 92' ' ' LEU . 10.7 m-70 -71.61 -44.8 63.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.2 -80.6 0.21 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.67 31.42 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.04 112.26 1.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.582 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.43 83.21 0.23 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.441 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.6 mm -82.05 157.47 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 0.0 111.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.41 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 1.2 mp -125.92 114.24 18.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -98.27 -164.35 1.13 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.828 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -112.68 47.92 1.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.956 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -164.64 30.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.236 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.403 ' O ' ' CG2' ' A' ' 40' ' ' VAL . 12.5 t70 -133.8 136.17 44.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.892 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 29.0 mm -62.1 158.55 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.106 0.479 . . . . 0.0 111.475 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -56.68 -61.16 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.334 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.4 t -66.34 -14.44 62.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.486 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.1 -36.14 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.687 0.28 . . . . 0.0 111.348 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 p -114.81 -44.68 4.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.634 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . -84.85 174.08 10.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.188 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -144.62 154.41 42.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.749 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -54.93 123.04 12.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.975 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.32 71.55 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.819 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -123.15 173.62 7.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -134.51 98.28 4.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.448 ' CD2' ' CE1' ' A' ' 70' ' ' HIS . 3.7 mt -101.63 169.13 9.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.988 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 t -119.51 121.27 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . . . -90.69 117.95 29.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.567 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.67 110.04 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.574 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.426 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 37.1 p90 -142.8 -179.28 6.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.039 0.447 . . . . 0.0 111.386 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -115.11 152.74 32.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.93 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -150.56 134.23 16.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 0.0 111.16 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.47 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 2.0 tt0 -99.46 68.96 1.63 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.938 0.399 . . . . 0.0 110.694 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.1 t0 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.997 179.936 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.842 0.353 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.36 120.33 2.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.119 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.2 m -138.04 141.86 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.986 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.4 m -100.05 116.38 31.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.81 109.14 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.974 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 73.2 m -84.62 101.17 11.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 94' ' ' ALA . 37.0 m-85 -88.03 102.36 14.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.589 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.6 -88.63 0.01 OUTLIER Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 24' ' ' PHE . 6.3 mtp180 -128.13 31.44 5.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 110.707 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.8 m -151.44 115.64 5.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.736 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.33 148.05 24.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.271 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 m -144.79 133.2 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.089 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.52 136.56 40.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -127.08 92.68 43.59 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.04 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -83.45 117.29 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.778 2.319 . . . . 0.0 112.358 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.0 t -87.54 136.79 32.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.88 -53.03 48.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.712 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -112.3 -31.57 6.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.726 0.298 . . . . 0.0 110.958 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.06 14.41 59.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.92 35.04 3.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -105.77 138.71 41.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.686 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -59.35 147.69 35.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.985 0.421 . . . . 0.0 111.168 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 44' ' ' ILE . 67.2 t -52.23 -40.2 30.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -49.82 -46.82 51.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.027 0.441 . . . . 0.0 110.649 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 7.0 t -66.14 -34.56 78.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.759 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 tp -67.52 -35.48 79.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.5 mt -65.44 -50.87 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.868 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 6.3 pt20 -60.3 -33.91 73.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.454 ' N ' ' HG3' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -70.18 -47.84 59.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.02 -45.41 77.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.6 t -56.09 -48.1 79.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.869 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.1 m -59.2 -45.61 90.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.23 -32.52 73.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -63.65 -57.43 10.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.7 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -54.95 -38.82 68.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.231 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -45.29 60.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.266 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.82 -48.17 80.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.142 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.43 ' CG2' ' HD2' ' A' ' 57' ' ' LYS . 29.0 m -64.96 -15.37 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.452 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 79.59 31.77 0.25 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.83 0.348 . . . . 0.0 111.312 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.494 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 17.4 mttt -93.97 -173.03 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.512 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.2 m-20 -150.35 170.1 8.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.709 0.29 . . . . 0.0 111.076 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.424 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 55.6 Cg_endo -70.12 57.26 1.63 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.636 2.224 . . . . 0.0 112.67 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -120.58 -23.32 6.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.768 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.494 ' CZ ' ' HD3' ' A' ' 57' ' ' LYS . 9.6 p90 -111.88 154.57 24.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.527 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.478 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -81.36 154.29 26.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.661 0.267 . . . . 0.0 110.753 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.472 HG12 ' CE2' ' A' ' 61' ' ' TYR . 85.6 mt -142.29 111.32 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.026 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.478 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -106.53 101.85 11.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.711 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.436 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 14.8 t -81.42 97.85 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.021 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -58.92 -67.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -177.14 -177.48 0.73 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 mt -123.63 152.11 42.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.28 143.61 31.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -66.28 -69.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.04 101.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.563 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 58.97 44.28 16.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.0 90.26 0.72 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.528 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.68 53.88 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.0 mt -59.34 158.08 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.378 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mt -138.71 117.19 12.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.84 -166.62 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.749 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.86 43.65 1.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.48 25.46 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.283 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -133.89 136.82 44.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 29.5 mm -58.69 155.85 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.063 0.459 . . . . 0.0 111.581 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.4 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -66.3 -52.72 44.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.438 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.8 m -63.92 -14.75 56.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.584 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -91.63 -32.19 15.57 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 m -107.08 -43.72 6.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.86 174.23 6.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.779 0.324 . . . . 0.0 111.253 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -138.41 153.99 48.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.803 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -51.49 124.65 12.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.947 0.403 . . . . 0.0 111.068 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.93 74.3 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.77 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -138.66 151.56 47.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -102.94 140.5 37.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.8 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.34 169.0 17.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.5 108.7 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.916 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . . . -88.5 121.16 30.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.705 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.81 118.03 55.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.598 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.436 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 2.1 p90 -148.73 -174.0 4.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.075 0.464 . . . . 0.0 111.414 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -122.21 155.74 35.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.958 179.15 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 10.0 pt-20 -156.93 130.94 8.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.701 0.286 . . . . 0.0 111.22 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.463 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 16.9 tt0 -97.78 66.73 1.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.732 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.946 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.419 ' CE1' ' HA ' ' A' ' 83' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.988 0.423 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.85 120.44 1.02 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.97 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.44 142.81 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.005 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.3 m -101.31 117.44 34.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -99.24 104.9 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 7.4 t -81.42 101.33 9.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 94' ' ' ALA . 43.3 m-85 -89.27 103.08 15.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.43 -93.5 0.01 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.736 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mpm_? -119.05 30.93 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 m -156.46 114.5 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.715 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 5.7 ppt_? -105.03 151.81 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.316 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -146.47 145.89 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.093 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -87.74 141.38 28.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.756 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.31 95.25 31.03 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.211 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.82 116.1 2.48 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.68 2.253 . . . . 0.0 112.369 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.4 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -90.62 158.35 16.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.929 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.87 -63.53 2.83 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.645 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.21 -47.62 3.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.958 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.65 7.5 8.83 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.741 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -96.74 39.39 1.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.5 ttp -111.0 123.9 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.862 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.56 145.64 18.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.546 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.538 ' O ' HG13 ' A' ' 44' ' ' ILE . 98.6 t -49.36 -41.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.738 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.429 ' CB ' ' HB3' ' A' ' 78' ' ' LEU . 1.7 t80 -50.24 -42.59 52.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m -70.85 -34.63 71.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.185 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -67.89 -38.91 83.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.512 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 40' ' ' VAL . 3.9 mt -65.1 -45.25 94.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.695 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -59.17 -39.82 83.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.728 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -65.79 -48.19 72.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.714 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.7 -48.65 73.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.1 t -54.03 -48.19 64.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.028 0.442 . . . . 0.0 110.765 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 83.9 m -57.12 -42.9 81.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.521 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.53 -33.05 74.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.779 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -60.5 -56.7 18.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.647 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -43.49 85.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -72.01 -27.35 62.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.39 -39.74 31.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.181 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.3 p -85.67 4.3 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.61 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.56 52.78 2.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.81 0.338 . . . . 0.0 111.257 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 72.3 mttt -116.71 -175.22 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.453 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.1 m-20 -145.86 171.0 7.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.73 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 34.2 Cg_endo -65.02 -7.43 15.29 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.425 2.083 . . . . 0.0 112.903 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -46.86 -37.43 8.79 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 111.446 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.453 ' CE2' HG12 ' A' ' 63' ' ' ILE . 5.9 p90 -104.56 152.59 22.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.478 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.09 154.24 25.69 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.827 0.346 . . . . 0.0 111.058 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.453 HG12 ' CE2' ' A' ' 61' ' ' TYR . 70.1 mt -142.78 111.0 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.849 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.478 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -106.95 107.18 18.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.42 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 4.2 t -83.44 98.89 5.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.011 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -55.26 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.264 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 ptt85 -163.54 -175.16 4.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.87 152.27 47.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 111.023 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -141.51 132.79 26.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.88 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.412 ' CE1' HD22 ' A' ' 92' ' ' LEU . 11.5 m-70 -58.13 -46.85 84.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.1 -61.58 0.21 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.507 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -151.65 77.61 1.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.951 0.405 . . . . 0.0 110.835 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.96 39.45 1.41 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.43 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.22 41.71 0.48 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mt -63.16 157.47 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 0.0 111.066 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 139.68 15.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 111.211 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -108.48 -163.12 0.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.731 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 41' ' ' PHE . 0.3 OUTLIER -98.75 71.61 1.94 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.827 0.346 . . . . 0.0 110.889 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.82 -43.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.4 ' O ' ' CG2' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -72.25 135.02 45.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.736 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 28.2 mm -53.1 155.94 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.158 0.504 . . . . 0.0 111.581 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.404 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 62.9 tp -70.88 -51.56 25.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.493 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.419 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 31.0 p -71.62 -8.15 52.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.73 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.6 -38.34 10.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.641 0.257 . . . . 0.0 111.291 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 p -101.02 -33.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.882 0.372 . . . . 0.0 111.599 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.42 174.23 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.378 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.23 154.85 50.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.51 130.64 36.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 56.37 68.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -132.55 149.17 52.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -97.32 143.62 27.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.412 HD22 ' CE1' ' A' ' 70' ' ' HIS . 12.0 mt -142.86 145.37 33.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.903 0.383 . . . . 0.0 111.202 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.81 116.18 35.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.766 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.433 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . . . -99.48 121.89 41.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.052 0.453 . . . . 0.0 111.716 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 t -109.03 126.79 66.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.34 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.409 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 1.6 p90 -151.41 -179.77 7.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.178 0.513 . . . . 0.0 111.611 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.66 156.66 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.077 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.93 134.38 11.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.466 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 5.0 tt0 -99.06 67.87 1.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.836 -179.953 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.738 0.304 . . . . 0.0 110.737 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.23 120.46 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.044 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.8 143.13 40.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -96.12 114.89 26.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.12 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.0 t -104.43 104.31 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.5 t -86.66 101.8 13.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.082 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 44.7 m-85 -85.06 98.47 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.778 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.9 -79.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.357 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -138.19 31.32 2.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.822 0.344 . . . . 0.0 110.791 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.4 m -139.61 112.34 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.812 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -88.65 123.19 32.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 m -135.27 116.74 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.062 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.9 145.58 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.66 103.12 14.8 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.243 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.61 130.13 4.35 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.649 2.233 . . . . 0.0 112.294 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.64 131.42 47.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.03 -48.86 57.6 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.97 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -120.98 -46.07 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.31 11.69 9.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.675 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -97.76 35.02 1.75 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 110.622 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.94 118.73 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.811 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -54.52 149.96 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.616 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 44' ' ' ILE . 48.9 t -48.05 -43.81 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.008 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 78' ' ' LEU . 1.8 t80 -50.38 -49.38 54.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.236 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.3 t -62.33 -35.96 80.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.397 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 tp -66.36 -33.99 76.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.568 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.3 mt -66.18 -51.18 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.814 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -35.11 72.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.002 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -68.67 -48.13 64.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.93 -47.08 69.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.366 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.432 HG23 ' CZ ' ' A' ' 24' ' ' PHE . 61.2 t -53.09 -53.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.842 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.5 m -56.96 -44.74 82.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -29.89 70.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.911 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -65.58 -57.4 8.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.772 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HA ' HG11 ' A' ' 55' ' ' VAL . 8.9 ptt180 -58.8 -35.19 72.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.887 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -72.6 -29.99 63.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.29 -33.66 25.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.426 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 52' ' ' ARG . 14.9 p -84.7 4.6 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.645 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.87 44.31 4.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 111.258 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -112.69 -174.76 2.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -147.59 176.29 2.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.742 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 18.7 Cg_exo -66.24 -9.29 23.15 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.826 2.35 . . . . 0.0 112.624 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -45.79 -39.4 8.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.714 0.292 . . . . 0.0 111.438 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.447 ' CE2' HG12 ' A' ' 63' ' ' ILE . 6.7 p90 -102.74 145.1 30.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.933 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.479 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.47 155.6 33.73 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.609 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.447 HG12 ' CE2' ' A' ' 61' ' ' TYR . 78.8 mt -142.95 110.97 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.887 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.479 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.2 OUTLIER -106.94 105.36 15.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.561 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.44 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 1.5 t -83.29 97.29 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.159 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -56.08 -74.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -167.66 178.12 5.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.786 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mt -119.45 156.84 29.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.957 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -138.66 147.01 42.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.962 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -68.14 -64.54 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.89 -53.02 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.474 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.74 34.13 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.24 69.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.44 56.37 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.438 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 mt -62.49 153.38 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 111.099 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.0 114.18 16.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.794 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -163.39 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.17 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -113.54 36.5 3.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 0.0 110.773 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -148.29 26.88 0.95 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 134.28 45.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.882 0.372 . . . . 0.0 110.946 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 29.1 mm -57.91 157.14 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.698 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.423 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -61.84 -56.13 22.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.626 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 34.7 m -71.19 -7.4 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.835 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.67 -37.46 15.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.574 0.226 . . . . 0.0 111.479 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 m -114.9 -31.34 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.69 174.1 6.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 0.0 111.226 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.16 153.96 45.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.7 125.97 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.99 71.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -134.34 157.48 46.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.15 130.85 50.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.533 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.2 mt -138.62 132.7 31.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.354 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.7 m -82.94 134.42 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.436 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -109.86 117.01 32.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.947 0.403 . . . . 0.0 111.768 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.03 127.12 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.344 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.44 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -160.75 174.77 13.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.122 0.487 . . . . 0.0 111.707 -179.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.17 157.95 25.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.242 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 9.7 pt-20 -155.23 135.0 12.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.046 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.47 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 2.3 tt0 -101.44 65.93 1.07 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.892 0.377 . . . . 0.0 111.008 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.956 179.895 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.775 0.321 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -164.53 120.5 1.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.77 142.56 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.046 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.9 m -95.3 119.68 34.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.97 107.55 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.022 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.86 101.59 14.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 43.6 m-85 -85.75 100.75 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.714 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.33 -78.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.294 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 tpm_? -141.84 31.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.729 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.0 m -137.66 125.48 22.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.43 130.42 42.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.7 m -135.35 127.11 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.043 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -74.98 143.22 43.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.986 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.72 92.62 8.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.145 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -84.65 123.03 2.8 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.757 2.305 . . . . 0.0 112.593 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.12 141.87 28.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.745 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.29 -81.79 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.881 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.24 -35.52 9.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 110.978 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.64 14.67 10.15 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 mtt-85 -98.6 28.46 4.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.941 0.4 . . . . 0.0 110.866 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.404 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 10.2 ttp -105.06 145.53 30.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.694 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.46 147.88 33.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 44' ' ' ILE . 59.1 t -48.83 -42.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.666 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -50.23 -38.8 42.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.4 OUTLIER -73.86 -34.58 64.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.278 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 tt -70.15 -38.66 75.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.673 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.1 mt -66.09 -45.83 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.634 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -59.06 -40.62 85.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.709 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -67.9 -44.79 76.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.782 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . . . -66.85 -37.77 85.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.64 -54.11 39.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.412 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -55.86 -42.72 76.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.599 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -37.87 86.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.703 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -58.98 -57.02 14.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.69 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -51.37 -47.74 62.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.96 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -72.28 -25.75 61.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.225 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.49 -38.56 55.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.197 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.6 p -92.28 12.74 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.617 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 57.54 56.86 4.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.905 0.383 . . . . 0.0 111.307 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 65.3 mttt -120.72 -175.39 3.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.6 m-20 -148.05 171.16 6.63 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.506 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 31.6 Cg_endo -64.19 -8.13 15.65 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.371 2.047 . . . . 0.0 112.916 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -46.35 -37.39 7.43 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.64 0.257 . . . . 0.0 111.521 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.447 ' CZ ' HD13 ' A' ' 63' ' ' ILE . 6.0 p90 -104.8 156.13 18.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -85.03 153.79 22.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.164 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.447 HD13 ' CZ ' ' A' ' 61' ' ' TYR . 76.6 mt -142.13 110.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.81 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -103.71 102.91 12.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.648 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 5.8 t -76.52 97.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -57.49 -78.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.0 -177.5 6.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.33 165.0 12.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -148.98 160.56 43.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -94.61 -43.47 8.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.66 -88.39 0.14 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.41 33.02 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.769 0.318 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.45 108.12 0.99 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.4 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.09 95.28 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.403 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mm -93.19 155.26 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 0.0 111.132 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 mp -133.54 118.02 17.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -95.17 -175.36 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.793 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.49 44.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.855 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.4 27.52 0.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.973 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -137.26 134.7 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 31.7 mm -58.78 158.56 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.121 0.486 . . . . 0.0 111.586 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.441 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -58.0 -56.76 17.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.444 -179.433 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 68.9 m -70.66 -7.55 45.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.789 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.22 -30.97 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.678 0.275 . . . . 0.0 111.586 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 m -120.06 -36.09 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.33 174.14 6.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.791 0.329 . . . . 0.0 111.338 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.55 150.52 47.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.752 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.61 132.72 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.01 60.32 2.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.732 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -138.97 134.85 33.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.38 151.2 26.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.763 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.7 mt -146.13 150.85 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.007 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.25 114.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.758 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.27 128.1 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.751 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.93 137.15 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.32 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -167.88 163.32 13.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.129 0.49 . . . . 0.0 111.901 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -104.79 156.81 17.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.11 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -155.27 128.9 8.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.014 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.443 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 20.6 tt0 -86.53 66.85 9.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.036 0.446 . . . . 0.0 110.533 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.89 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.421 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.763 0.315 . . . . 0.0 110.85 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -161.24 120.28 2.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.01 0.434 . . . . 0.0 111.061 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.9 142.9 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.926 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -100.43 118.59 36.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.4 t -97.75 109.59 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.758 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 t -88.3 101.68 14.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 47' ' ' ALA . 55.7 m-85 -84.71 98.51 10.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.395 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.97 -85.42 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.333 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 mmp_? -129.17 31.38 4.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.4 m -138.25 145.09 40.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -105.85 138.3 42.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.027 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.76 108.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.019 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -74.81 149.05 39.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.25 94.12 7.8 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.322 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.28 129.11 4.37 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.645 2.23 . . . . 0.0 112.391 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.6 m -99.66 140.04 34.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.768 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.69 -50.81 62.37 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.576 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -112.28 -29.91 7.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 111.066 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.68 14.24 53.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.523 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.81 35.91 2.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.731 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.2 ttp -104.17 137.61 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -69.77 150.14 47.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.53 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 44' ' ' ILE . 44.3 t -48.86 -42.08 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.968 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -50.17 -43.06 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.32 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -30.48 63.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.579 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 tp -71.38 -39.18 71.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.618 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.3 mt -67.81 -44.13 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.692 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.21 -38.43 86.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -68.79 -42.73 76.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.604 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.47 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . . . -69.46 -40.77 76.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.296 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.0 t -58.45 -51.84 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.72 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.9 m -58.18 -44.44 88.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.416 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -64.48 -29.93 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.423 ' HB2' ' CD2' ' A' ' 24' ' ' PHE . 7.5 t80 -64.13 -57.88 8.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.656 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -58.77 -32.66 69.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.641 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 11.2 mmtt -72.52 -27.91 62.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.52 26.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.34 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.42 HG22 ' HD2' ' A' ' 57' ' ' LYS . 2.8 m -93.99 18.98 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.583 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 55.16 28.97 11.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.562 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.42 ' HD2' HG22 ' A' ' 55' ' ' VAL . 10.0 mttt -94.54 -169.87 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.835 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m-20 -160.06 177.07 2.21 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.731 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 33.0 Cg_exo -61.49 -12.13 22.99 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.663 2.242 . . . . 0.0 112.767 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -45.02 -53.1 8.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.815 0.341 . . . . 0.0 111.346 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.446 ' CE2' HG12 ' A' ' 63' ' ' ILE . 3.7 p90 -90.44 148.68 22.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.479 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -79.71 155.49 27.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.79 0.328 . . . . 0.0 111.028 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.446 HG12 ' CE2' ' A' ' 61' ' ' TYR . 68.7 mt -142.46 111.02 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.759 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.479 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -104.65 105.33 15.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.651 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.425 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 1.4 t -83.02 97.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.133 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -53.56 -76.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -159.85 -176.97 6.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.991 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.0 mt -117.49 160.75 20.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.57 159.36 43.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -85.23 -30.78 23.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.773 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.95 -53.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.406 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -156.72 73.01 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 110.784 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.91 57.66 0.54 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.41 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.61 59.0 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.493 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.2 mt -71.66 158.36 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.824 0.345 . . . . 0.0 111.187 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.25 141.43 22.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.7 -162.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.707 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.01 43.49 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.886 0.374 . . . . 0.0 110.944 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.3 25.33 1.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -133.13 132.99 42.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 27.5 mm -56.02 158.38 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.038 0.447 . . . . 0.0 111.534 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.443 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -62.27 -57.55 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.625 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.3 t -67.76 -11.6 58.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.934 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.41 -47.28 11.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.586 0.231 . . . . 0.0 111.516 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.3 m -103.9 -32.75 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.55 173.99 6.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.901 0.381 . . . . 0.0 111.213 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.87 154.44 49.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.766 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -54.34 124.03 14.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.09 70.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -140.21 144.55 36.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.024 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -92.86 148.97 21.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.796 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.41 146.84 33.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.128 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.3 t -92.12 122.76 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.605 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.85 118.12 35.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.002 0.429 . . . . 0.0 111.822 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 t -103.31 128.18 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.149 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 24' ' ' PHE . 2.1 p90 -153.31 -177.65 6.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.277 0.56 . . . . 0.0 111.718 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -118.06 157.27 27.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.856 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.17 132.15 9.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 0.0 111.125 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.443 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 3.7 tt0 -92.05 73.42 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.05 0.452 . . . . 0.0 110.462 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 t70 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.927 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.82 0.343 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -85.78 -176.86 6.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -80.2 159.87 25.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.877 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.02 120.6 1.0 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.04 0.448 . . . . 0.0 111.203 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 m -136.74 142.56 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -100.57 132.3 46.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.438 HG13 ' CE1' ' A' ' 24' ' ' PHE . 9.5 t -113.23 105.7 19.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 t -83.16 101.59 11.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.176 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.438 ' CE1' HG13 ' A' ' 22' ' ' VAL . 15.4 m-85 -83.45 100.65 10.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.397 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.48 -78.84 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.444 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 mtt180 -139.16 31.18 2.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.784 0.326 . . . . 0.0 110.973 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.4 m -140.92 122.59 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.17 125.39 38.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.148 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 p -125.41 124.73 67.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.038 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -79.03 140.0 38.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.61 92.64 26.7 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.64 116.75 4.11 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.076 2.517 . . . . 0.0 112.192 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.403 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -91.41 120.83 32.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.754 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.78 -53.89 33.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.971 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -106.04 -33.03 8.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.834 0.349 . . . . 0.0 111.067 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.22 -12.09 61.92 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.31 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 56.27 3.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.121 0.486 . . . . 0.0 110.812 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.5 ttp -122.38 114.48 20.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.607 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -53.07 147.59 9.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 44' ' ' ILE . 22.0 t -46.85 -43.43 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 10.6 t80 -50.19 -42.16 50.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.954 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -71.14 -31.73 68.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.182 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 tt -71.77 -38.82 70.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.748 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.4 mt -64.58 -48.66 83.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.745 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.21 -38.8 87.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -67.85 -43.24 79.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.51 69.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.3 t -54.37 -52.21 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 110.647 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.3 m -58.18 -47.23 84.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -29.8 70.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.955 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -62.07 -57.36 11.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.743 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 53' ' ' LYS . 9.5 ptt-85 -60.92 -36.34 79.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.838 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 11.4 tppt? -72.6 -27.74 62.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.145 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.96 -35.54 23.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.5 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.0 p -82.04 1.75 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.796 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 75.33 29.96 0.88 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.739 0.304 . . . . 0.0 111.626 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.44 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 7.4 mttt -99.24 -169.9 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.486 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.431 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -158.89 170.36 9.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.907 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 43.1 Cg_endo -68.14 61.8 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -124.01 -41.14 2.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.426 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.479 ' CE2' HG12 ' A' ' 63' ' ' ILE . 9.1 p90 -95.65 150.44 20.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.319 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.47 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -78.42 152.94 31.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.748 0.308 . . . . 0.0 110.94 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.479 HG12 ' CE2' ' A' ' 61' ' ' TYR . 73.0 mt -139.92 110.95 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.81 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.47 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -102.14 101.74 12.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.363 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 3.9 t -83.21 97.07 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.125 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -58.62 -77.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.88 -176.77 4.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.169 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.16 160.91 21.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.847 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -152.17 137.48 17.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -64.19 -30.47 71.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.83 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.24 -70.96 0.26 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.518 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.79 35.32 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.838 0.352 . . . . 0.0 111.021 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.51 64.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.49 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.12 60.94 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.436 HD13 HG23 ' A' ' 75' ' ' ILE . 12.6 mt -59.42 156.18 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 0.0 111.074 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mp -130.83 122.03 26.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.984 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -109.38 169.23 8.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.538 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 41' ' ' PHE . 0.5 OUTLIER -86.06 79.99 8.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.062 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.82 -38.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -77.08 131.07 38.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.061 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 28.4 mm -55.71 158.28 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.096 0.474 . . . . 0.0 111.546 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.439 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 2.2 tp -71.15 -54.58 10.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.094 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -26.45 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.484 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.12 -35.54 17.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 t -97.38 -67.09 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 111.675 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.97 174.29 3.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.291 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.43 154.9 41.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.781 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.46 117.03 1.98 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.67 60.81 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -122.87 142.94 50.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.6 mmm-85 -95.79 154.5 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.2 mt -148.87 138.25 21.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.025 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 m -90.15 121.95 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.651 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.44 121.79 43.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.061 0.457 . . . . 0.0 111.885 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.04 122.97 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.103 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.405 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 2.2 p90 -151.16 -174.35 4.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.192 0.52 . . . . 0.0 111.586 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -120.62 156.99 30.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.791 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.3 pt-20 -158.23 128.98 6.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.84 0.352 . . . . 0.0 111.224 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.466 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 1.3 tt0 -93.27 70.72 4.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.982 0.42 . . . . 0.0 110.746 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.886 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.797 0.332 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.08 -164.79 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.812 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.21 158.32 15.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.73 120.82 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.015 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.68 142.49 37.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.1 m -97.67 121.88 40.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.74 111.49 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.6 t -86.46 101.82 13.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 47' ' ' ALA . 51.4 m-85 -85.46 100.26 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.766 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.16 -90.09 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.575 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.67 31.47 6.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.0 m -139.46 144.99 38.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.41 118.2 30.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.84 126.75 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.98 146.66 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.01 92.73 38.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.064 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -77.71 106.26 2.16 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.869 2.379 . . . . 0.0 112.244 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.67 137.53 36.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.608 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.57 -36.07 7.76 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.061 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -151.55 -45.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.39 13.52 4.75 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.777 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.619 ' CG ' ' O ' ' A' ' 37' ' ' ARG . 8.4 ttm-85 -99.57 29.73 3.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.654 0.74 . . . . 0.0 109.876 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 6.8 ttp -108.86 151.6 26.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.625 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.93 144.62 38.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.607 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 44' ' ' ILE . 58.4 t -48.11 -41.4 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.815 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -50.36 -43.01 54.04 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -33.64 72.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.177 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 tp -69.09 -39.41 79.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.654 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 40' ' ' VAL . 3.9 mt -63.18 -51.35 72.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.732 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -36.96 73.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -68.93 -48.05 64.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . . . -66.6 -41.21 88.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.328 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 44' ' ' ILE . 97.0 t -58.45 -48.13 86.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 0.0 110.619 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.0 m -58.55 -46.98 85.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.596 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -64.39 -33.73 76.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.691 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.412 ' HB2' ' CD2' ' A' ' 24' ' ' PHE . 20.0 t80 -59.56 -57.16 14.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.683 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ttm105 -57.47 -40.37 78.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.841 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -72.11 -29.3 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.214 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.43 -30.91 26.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.221 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG1' ' HD2' ' A' ' 57' ' ' LYS . 14.9 p -85.3 -2.97 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.598 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.58 34.82 2.04 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.733 0.301 . . . . 0.0 111.288 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HE2' ' CZ ' ' A' ' 61' ' ' TYR . 13.6 mttt -102.93 -175.36 2.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.796 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.9 m-20 -149.69 175.92 2.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 25.3 Cg_exo -63.15 -11.12 23.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.745 2.297 . . . . 0.0 112.738 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -44.97 -33.17 1.91 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.596 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.443 ' CE2' HG12 ' A' ' 63' ' ' ILE . 2.7 p90 -116.1 145.29 43.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.76 0.315 . . . . 0.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -77.62 154.95 31.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.652 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.443 HG12 ' CE2' ' A' ' 61' ' ' TYR . 52.1 mt -141.64 110.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.001 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.503 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -105.88 108.6 20.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.754 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 2.2 t -80.05 100.09 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.407 ' CD2' ' HA ' ' A' ' 96' ' ' PHE . 97.8 m-70 -57.8 -63.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -176.77 -173.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.009 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.1 154.32 40.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.763 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -138.37 141.1 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.984 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -68.44 -46.74 69.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.47 -85.24 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.04 39.1 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.349 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.99 102.03 2.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.98 57.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.412 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.417 HD11 HG23 ' A' ' 75' ' ' ILE . 13.1 mt -59.22 157.12 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.188 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.76 123.83 19.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.44 -167.54 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.95 46.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.389 . . . . 0.0 110.826 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -157.45 27.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -142.86 134.37 26.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 24.0 mm -52.59 156.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.038 0.447 . . . . 0.0 111.461 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.406 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -73.13 -49.02 30.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.401 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.8 t -64.97 -14.53 60.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.608 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -91.0 -45.91 8.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.648 0.261 . . . . 0.0 111.615 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.2 m -95.73 -39.22 9.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.02 174.11 7.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.885 0.374 . . . . 0.0 111.28 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.03 144.46 48.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.37 132.55 48.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 tptt 61.66 57.69 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -130.0 164.37 24.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.029 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -111.22 151.06 28.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.75 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.6 mt -143.49 165.66 26.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.151 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.86 117.83 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.791 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.25 113.42 25.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.63 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.99 118.0 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.398 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.407 ' HA ' ' CD2' ' A' ' 66' ' ' HIS . 17.0 p90 -144.01 174.5 10.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.068 0.461 . . . . 0.0 111.477 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -107.53 158.14 17.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.787 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 12.2 pt-20 -154.66 137.67 15.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.753 0.311 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.483 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 19.6 tt0 -105.46 60.74 0.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.807 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.0 p30 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.858 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.734 0.302 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 58.63 -175.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.409 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.6 OUTLIER -59.99 148.99 33.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.807 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -153.73 120.39 5.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.4 m -140.4 142.96 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.069 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -107.29 118.67 37.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.76 109.29 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 101.63 14.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.061 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 26' ' ' ARG . 58.8 m-85 -85.62 102.82 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.504 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.03 -83.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.32 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -133.78 31.28 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.5 m -137.97 122.24 18.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.758 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -96.67 129.53 44.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.13 137.4 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.35 144.73 26.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.022 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.25 92.82 7.39 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.37 121.77 2.33 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.735 2.29 . . . . 0.0 112.518 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -94.28 123.29 37.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.785 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.56 -53.1 30.32 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.063 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.52 -33.6 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 111.081 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.1 6.19 61.86 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.684 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 31.86 2.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.864 0.364 . . . . 0.0 110.669 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.17 139.63 32.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.641 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -67.9 144.7 55.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.394 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -46.67 -54.3 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.818 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 78' ' ' LEU . 9.7 t80 -50.18 -29.81 10.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.216 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -73.15 -40.77 64.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.398 . . . . 0.0 110.3 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.85 -38.26 73.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.681 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 40' ' ' VAL . 6.3 mt -62.54 -48.99 85.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.713 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -59.13 -42.73 91.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.625 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -64.94 -43.43 92.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.591 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.52 87.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.914 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.17 -46.51 94.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.435 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.2 m -59.63 -43.52 93.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.287 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -34.98 79.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.628 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -59.29 -57.12 14.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.471 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -53.31 -47.41 69.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -29.88 67.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.947 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.37 -29.8 57.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.2 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.41 ' CG1' ' CD ' ' A' ' 57' ' ' LYS . 14.5 p -97.25 3.88 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.591 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.74 36.52 8.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HE2' ' CZ ' ' A' ' 61' ' ' TYR . 11.6 mttt -101.78 -174.75 2.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.893 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m-20 -152.54 176.92 2.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.687 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 24.6 Cg_exo -63.47 -10.56 22.13 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.58 2.187 . . . . 0.0 112.734 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -45.26 -37.72 4.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.661 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 63' ' ' ILE . 3.9 p90 -107.59 154.65 21.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.747 0.308 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HD1' ' CB ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.45 154.17 24.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.961 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 66.1 mt -143.44 111.21 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.101 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -104.01 102.42 12.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.75 98.58 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.075 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -60.53 -77.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.074 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -166.9 -174.22 2.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.656 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -120.16 160.49 22.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.46 129.73 23.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -59.65 -29.62 68.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.34 -68.94 0.22 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -158.07 39.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.909 0.385 . . . . 0.0 110.757 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.25 49.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.318 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.05 57.04 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.361 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 mt -59.61 146.51 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.403 . . . . 0.0 111.316 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 5.2 mp -113.53 111.15 21.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.176 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -152.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.092 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 41' ' ' PHE . 5.6 mt -117.75 27.38 9.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.6 0.238 . . . . 0.0 111.097 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 24.1 m-20 -137.65 -38.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.594 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -54.7 109.16 0.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.872 0.368 . . . . 0.0 111.615 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 27.8 mm -50.74 158.58 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.489 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 86' ' ' ALA . 3.4 mm? -54.88 -59.1 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.269 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 22.0 p -65.3 -14.81 61.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.452 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -80.99 -32.45 34.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.575 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 p -124.95 -45.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.805 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . -76.6 174.12 10.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.992 0.425 . . . . 0.0 111.427 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -143.85 155.16 44.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.7 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -52.82 119.14 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.6 tttp 61.68 71.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -139.62 136.5 34.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.018 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -87.57 147.86 25.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.796 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mt -136.72 153.03 50.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.027 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.3 117.13 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.704 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.25 119.26 37.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 111.702 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.15 123.6 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.47 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -151.32 -174.17 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.032 0.444 . . . . 0.0 111.491 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -125.91 159.06 33.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.962 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -157.18 137.5 12.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.782 0.325 . . . . 0.0 111.384 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.487 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 19.2 tt0 -117.89 59.17 0.79 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.073 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.942 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.84 0.353 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.75 -164.82 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.802 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.49 162.21 29.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.045 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.38 120.61 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.992 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.63 142.3 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.977 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.1 m -110.77 106.03 15.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 m -97.84 103.76 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.93 101.77 2.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.037 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.437 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 4.5 m-85 -78.52 101.88 7.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.425 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.18 -77.0 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.234 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . 6.2 ttt180 -143.89 30.92 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.889 0.375 . . . . 0.0 110.763 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.9 m -142.02 126.88 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -79.51 117.77 20.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.06 109.17 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -74.94 144.23 43.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.05 92.62 7.62 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.65 138.42 6.19 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.802 2.335 . . . . 0.0 112.599 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -113.02 146.39 39.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.61 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.19 -38.74 9.77 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.938 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -121.78 -43.93 2.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.58 10.87 18.55 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.547 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -97.97 35.11 1.77 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.605 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.41 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.5 OUTLIER -110.16 113.15 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.724 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -54.42 157.39 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 44' ' ' ILE . 48.7 t -51.88 -52.11 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.054 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -49.49 -29.73 7.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.077 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.41 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 50.5 m -76.11 -42.18 47.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.805 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.86 -37.66 73.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.606 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.3 mt -64.09 -50.02 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.528 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -57.09 -41.34 78.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.366 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -38.38 90.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.32 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.62 -39.62 73.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.755 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.5 t -58.14 -53.17 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.2 m -59.25 -41.56 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.341 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -27.14 64.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.671 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -68.28 -58.08 4.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.739 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -36.75 75.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.753 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -72.13 -26.06 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.825 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.15 -31.39 25.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.448 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.411 HG23 ' CD ' ' A' ' 57' ' ' LYS . 29.3 m -94.0 17.6 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.649 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 58.6 31.82 21.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.559 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 19.1 mttm -98.17 -177.19 3.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.799 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.27 175.34 2.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.97 -10.05 23.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.776 2.317 . . . . 0.0 112.815 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -47.65 -63.06 1.16 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.905 0.383 . . . . 0.0 111.283 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.438 ' CZ ' ' HD3' ' A' ' 57' ' ' LYS . 2.7 p90 -75.86 145.64 40.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.83 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.483 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.61 154.12 34.66 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.672 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' A' ' 61' ' ' TYR . 62.2 mt -141.4 111.11 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.874 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.483 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.6 OUTLIER -104.84 104.48 14.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.585 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 3.0 t -82.42 98.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -61.67 -68.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.067 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -174.87 -176.93 1.04 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.703 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.7 mt -121.86 160.94 23.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 111.063 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -141.26 136.31 31.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -59.8 -51.7 68.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.22 -31.87 0.95 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.565 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -151.8 75.42 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.32 . . . . 0.0 110.829 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.59 76.75 1.01 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.52 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.25 55.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.543 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 mt -64.47 153.81 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.57 121.77 35.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.832 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.45 -163.07 1.01 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.787 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.3 mt -109.0 42.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.083 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -157.06 32.3 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.4 ' O ' ' CG2' ' A' ' 40' ' ' VAL . 6.1 t0 -134.35 134.03 41.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.098 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 30.6 mm -61.83 158.37 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.399 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.426 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 55.1 tp -65.4 -54.19 32.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.533 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.3 p -72.01 -5.94 38.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.928 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -101.03 -24.66 14.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.518 0.199 . . . . 0.0 111.5 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.08 -34.21 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.771 0.319 . . . . 0.0 111.553 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.74 174.22 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.393 . . . . 0.0 111.275 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -136.08 156.26 48.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -52.59 127.05 21.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.032 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.59 70.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -129.78 134.82 47.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.039 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -99.2 113.42 25.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.798 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.02 167.13 11.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.08 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.44 141.83 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.736 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.437 ' CB ' ' CD1' ' A' ' 24' ' ' PHE . . . -113.18 119.86 39.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.411 . . . . 0.0 111.472 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.9 t -105.16 114.6 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.572 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.413 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 3.2 p90 -144.91 -177.23 5.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.04 0.448 . . . . 0.0 111.503 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -116.28 157.04 25.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.793 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -157.58 133.53 9.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 111.422 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.474 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 2.5 tt0 -101.55 67.41 1.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.745 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.895 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.795 0.331 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -123.61 171.58 9.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.882 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.43 ' CD1' HD23 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -89.77 161.07 16.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.73 120.88 1.48 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 111.201 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.51 156.13 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.881 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.4 m -117.39 119.47 35.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.903 0.382 . . . . 0.0 111.121 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.96 102.91 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.833 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.6 t -83.9 101.61 11.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.432 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 48.4 m-85 -83.57 99.84 10.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.521 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.86 -83.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.301 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -132.58 31.5 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.352 . . . . 0.0 110.761 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 m -138.35 118.71 13.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.76 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.22 120.51 32.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.086 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.5 138.41 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.986 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.75 142.49 27.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.01 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.61 93.78 7.62 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.83 160.39 27.58 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.624 2.216 . . . . 0.0 112.658 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -129.32 129.51 44.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.747 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.38 -41.06 21.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.018 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.11 -33.22 6.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.196 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.25 -0.04 63.6 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.566 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.54 44.68 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.036 0.446 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -114.87 107.75 15.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -53.28 159.25 1.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.055 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 44' ' ' ILE . 40.1 t -51.62 -52.71 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -49.39 -29.04 5.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 110.841 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.8 m -75.85 -45.0 38.08 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.398 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 4.2 pp -72.98 -34.75 66.65 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.896 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.1 mt -66.43 -48.06 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 110.431 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -57.95 -45.79 86.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -37.11 83.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.282 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.55 -37.18 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.829 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.403 HG22 ' CG2' ' A' ' 65' ' ' VAL . 60.9 t -59.41 -54.98 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.325 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -58.11 -44.11 87.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.355 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -35.84 78.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.582 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.413 ' O ' HG21 ' A' ' 55' ' ' VAL . 33.6 t80 -59.99 -57.96 10.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.255 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -49.26 -44.13 43.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.701 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -28.94 68.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.583 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.01 -29.76 43.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.008 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.427 HG22 ' CD ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -98.45 18.14 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.268 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.96 28.68 3.95 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.441 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.427 ' CD ' HG22 ' A' ' 55' ' ' VAL . 18.2 mttt -95.0 -172.46 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.457 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -151.9 172.33 5.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.432 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 36.7 Cg_endo -65.74 -8.09 18.49 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.205 1.937 . . . . 0.0 112.818 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -45.77 -42.92 12.61 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.742 0.306 . . . . 0.0 111.436 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.437 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 7.5 p90 -97.02 161.16 13.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.76 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.479 ' HD1' ' CB ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -87.27 154.34 20.77 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.694 0.283 . . . . 0.0 111.149 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.437 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 86.0 mt -143.11 111.47 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.788 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.476 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -99.25 102.01 13.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.682 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' CG2' HG22 ' A' ' 48' ' ' VAL . 9.9 t -81.43 95.42 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -56.18 -77.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.283 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.26 -177.61 4.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.875 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -115.58 147.91 40.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.94 132.58 42.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -58.33 -28.84 65.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.059 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.36 -59.77 0.53 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.567 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.59 32.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 0.0 110.848 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.53 78.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.44 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.11 62.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.409 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.455 HD13 HG22 ' A' ' 75' ' ' ILE . 11.7 mt -59.5 157.95 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 mp -131.87 121.17 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.22 -174.48 2.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.55 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -104.0 34.1 3.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.92 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -150.17 34.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.186 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.33 132.28 29.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.918 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.8 mm -56.38 154.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.086 0.47 . . . . 0.0 111.318 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.43 HD23 ' CD1' ' A' ' 18' ' ' PHE . 49.3 tp -63.0 -52.77 61.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.288 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 64.5 m -67.89 -11.36 58.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.738 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -97.9 -22.72 16.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 p -111.21 -44.04 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.638 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.33 174.18 6.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.322 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -129.31 149.65 51.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.673 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -51.81 126.43 17.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.151 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm 61.69 67.64 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -136.63 153.29 50.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.3 mtm105 -104.35 146.18 29.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.661 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.7 152.65 49.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.187 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 t -108.29 108.64 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.596 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.68 129.5 36.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.989 0.423 . . . . 0.0 111.809 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.8 t -110.8 126.65 68.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.436 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 24' ' ' PHE . 3.4 p90 -150.16 179.69 7.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.116 0.484 . . . . 0.0 111.432 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -116.13 162.35 17.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.721 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.2 pt-20 -161.58 134.76 6.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.8 0.333 . . . . 0.0 111.456 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.479 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 13.8 tt0 -102.88 72.74 1.22 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.623 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.902 -179.865 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 60.31 162.4 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -81.14 163.2 23.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.926 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -162.74 120.46 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 111.279 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.72 142.57 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.835 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.6 m -114.1 107.62 15.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.997 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.8 m -97.91 137.35 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.979 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.8 m -103.49 102.58 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.24 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 40.6 m-85 -77.13 95.47 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.442 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.9 -73.89 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.144 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' PHE . 1.6 mmt85 -143.54 29.09 1.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 110.565 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.8 m -136.31 114.82 11.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.757 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -87.11 127.38 35.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.23 140.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.114 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.27 149.5 21.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.076 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.81 96.03 10.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.39 127.72 6.74 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.609 2.206 . . . . 0.0 112.303 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.3 154.98 22.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.05 -69.4 1.38 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.576 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -109.15 -17.84 13.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 111.203 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.83 14.97 57.3 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.444 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -100.31 29.13 4.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 110.825 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 ttp -98.2 130.26 44.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -57.63 142.96 43.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.595 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.543 ' O ' HG13 ' A' ' 44' ' ' ILE . 92.7 t -48.46 -45.44 14.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.72 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -50.17 -35.18 25.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.111 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 m -74.57 -37.56 62.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.469 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.28 -39.02 75.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.683 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.1 mt -64.26 -49.4 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.654 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -38.92 80.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.63 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -42.95 84.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.507 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.26 -40.34 81.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.893 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.63 -52.09 58.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.118 0.485 . . . . 0.0 110.471 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -57.27 -43.73 83.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.422 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -38.81 80.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.573 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -58.66 -56.49 21.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.474 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.4 mtm-85 -48.88 -47.8 42.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -32.28 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.062 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 -26.71 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.042 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.432 ' CG1' ' HD2' ' A' ' 57' ' ' LYS . 14.1 p -99.13 1.86 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.53 30.89 6.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.765 0.317 . . . . 0.0 111.435 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.433 ' HE2' ' CE2' ' A' ' 61' ' ' TYR . 11.4 mttt -99.2 -175.14 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.736 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.1 m-20 -146.13 175.85 2.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 24.3 Cg_exo -64.15 -7.92 15.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.89 2.393 . . . . 0.0 112.932 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -48.02 -66.99 0.31 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.88 0.372 . . . . 0.0 110.99 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.47 ' CZ ' ' CD1' ' A' ' 63' ' ' ILE . 1.9 p90 -74.37 160.71 30.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.576 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.479 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -89.49 151.64 21.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.791 0.329 . . . . 0.0 111.258 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 35.0 mt -142.08 111.0 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.686 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.479 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -109.04 101.53 10.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.674 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 11.3 p -86.3 96.74 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.144 0.497 . . . . 0.0 111.032 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -54.29 -81.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.586 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.07 -167.08 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.802 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mt -127.66 164.99 20.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.847 0.356 . . . . 0.0 111.143 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.21 141.92 34.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.839 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -64.59 -35.82 82.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.993 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.54 -77.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.574 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.63 40.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.27 103.15 2.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.441 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.3 58.19 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.582 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 mt -68.32 158.44 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.297 . . . . 0.0 111.046 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -158.41 131.84 7.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.16 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -90.81 -156.61 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.802 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.26 84.92 2.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.85 0.357 . . . . 0.0 110.74 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -171.75 -40.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.09 142.5 41.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 27.6 mm -56.75 156.89 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.17 0.51 . . . . 0.0 111.474 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.429 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 64.6 tp -66.39 -56.7 9.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.293 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.83 -14.74 61.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.584 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -90.53 -28.21 18.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.586 0.231 . . . . 0.0 111.328 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 14.6 p -117.09 4.48 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.83 174.22 11.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.35 . . . . 0.0 111.212 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.77 152.85 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.817 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.54 135.95 54.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.993 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.55 58.1 3.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.769 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -120.78 157.86 28.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.066 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -116.39 137.06 52.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -142.89 154.39 44.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.069 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.62 117.76 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.66 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.83 122.74 34.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.694 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.3 126.37 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.271 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.463 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -155.33 169.72 23.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.239 0.542 . . . . 0.0 112.124 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.91 157.09 25.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.8 136.43 15.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 111.327 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.476 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 6.7 tt0 -105.23 63.96 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.801 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.461 0.119 0 CA-C-O 120.912 0.387 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.03 -166.79 1.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.674 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.49 149.16 46.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.53 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -152.25 120.66 6.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.983 0.42 . . . . 0.0 111.069 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.6 m -132.34 142.42 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.921 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -106.43 125.34 50.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.816 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.66 109.96 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.96 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.1 m -75.27 101.51 4.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 48' ' ' VAL . 7.4 m-85 -84.74 97.32 9.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.705 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.32 -92.87 0.01 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.509 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.34 31.72 6.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.876 0.37 . . . . 0.0 110.641 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.0 m -153.35 117.67 4.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 135.21 33.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.028 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.16 137.08 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.167 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.78 148.94 25.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.9 t -138.93 92.88 10.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.229 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.42 124.94 3.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.767 2.311 . . . . 0.0 112.493 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 m -103.62 136.96 42.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.784 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.38 -41.77 93.34 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.996 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -128.68 -46.53 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.878 0.37 . . . . 0.0 111.236 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.23 12.19 8.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.46 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 -93.85 35.61 1.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.923 0.392 . . . . 0.0 110.576 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.431 ' HG2' ' HB2' ' A' ' 42' ' ' SER . 8.9 ttm -111.17 114.19 27.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.702 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -49.7 144.36 6.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.215 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 44' ' ' ILE . 27.5 t -46.61 -44.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 111.146 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.407 ' CD1' ' HB3' ' A' ' 78' ' ' LEU . 6.0 t80 -50.64 -41.15 54.91 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.531 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.431 ' HB2' ' HG2' ' A' ' 38' ' ' MET . 2.9 m -71.98 -34.41 68.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 110.223 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 tp -66.98 -35.41 79.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.155 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.5 mt -65.88 -51.28 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.547 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -55.76 -36.66 67.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.485 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -67.19 -42.37 84.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.567 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.77 75.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.974 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.428 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 61.2 t -56.41 -52.89 46.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.723 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.1 m -58.31 -44.34 88.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.484 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -62.74 -36.92 84.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.697 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -58.16 -52.94 63.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.534 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -55.19 -49.09 72.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.863 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -70.49 -24.61 62.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.85 -41.41 62.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 0.0 111.28 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.4 p -93.06 9.69 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.668 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 62.8 37.68 12.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.758 0.313 . . . . 0.0 111.466 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.447 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 31.8 mttt -96.54 -174.36 3.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -144.86 172.27 5.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.43 -10.71 22.57 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.822 2.348 . . . . 0.0 112.797 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.21 -59.09 3.11 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.835 0.35 . . . . 0.0 111.45 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.453 ' CE2' HG12 ' A' ' 63' ' ' ILE . 3.6 p90 -79.58 141.24 36.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.71 156.18 32.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.621 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.453 HG12 ' CE2' ' A' ' 61' ' ' TYR . 57.9 mt -142.03 111.22 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.075 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -103.96 105.53 15.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.516 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.452 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 3.1 t -82.54 100.05 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.203 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -63.62 -70.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -168.42 -173.01 1.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.749 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -131.35 158.86 39.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.829 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -142.81 141.14 31.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -61.53 -45.19 95.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.81 -87.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.519 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -120.38 33.8 5.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.797 0.332 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.22 89.56 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.445 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.57 62.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.435 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 75' ' ' ILE . 14.2 mt -56.68 156.05 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.942 0.401 . . . . 0.0 111.104 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 2.6 mt -126.8 115.05 18.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.058 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.71 -163.13 1.01 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.794 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.407 ' HB3' ' CD1' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -117.38 77.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.867 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -174.61 -62.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.238 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -53.05 128.08 26.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.329 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.1 mm -54.12 146.6 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.479 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 tp -60.77 -39.72 89.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.373 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.02 -12.87 61.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.619 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.12 -29.86 12.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.646 0.26 . . . . 0.0 111.392 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.26 -44.7 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.864 0.364 . . . . 0.0 111.668 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.81 174.07 8.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.204 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -145.14 155.39 43.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.677 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -48.8 118.22 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.26 57.84 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -112.69 147.53 36.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.65 148.59 22.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.6 mt -146.2 169.09 19.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.05 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 t -127.7 114.4 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.12 122.68 36.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.44 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.42 112.01 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.415 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 20.2 p90 -141.22 174.46 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.011 0.434 . . . . 0.0 111.282 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -108.48 159.6 16.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.026 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.4 pt-20 -156.53 135.45 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 111.244 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.481 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 30.8 tt0 -107.23 69.52 0.76 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.967 0.413 . . . . 0.0 110.899 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.1 p30 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.957 -179.91 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.457 0.17 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 18' ' ' PHE . 0.7 OUTLIER 44.19 -165.21 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.735 0.302 . . . . 0.0 111.512 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.401 ' N ' ' CG ' ' A' ' 17' ' ' GLU . 0.7 OUTLIER -110.35 165.5 11.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.59 120.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.5 m -137.51 141.91 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.1 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.407 ' CG2' ' CG ' ' A' ' 28' ' ' ARG . 5.8 m -105.55 120.03 40.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.865 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.457 ' CG1' ' CE1' ' A' ' 24' ' ' PHE . 17.1 t -101.61 111.76 32.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -92.13 101.64 14.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CE1' ' CG1' ' A' ' 22' ' ' VAL . 65.9 m-85 -85.52 108.01 17.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.697 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.74 -87.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.377 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -131.55 31.63 4.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.364 . . . . 0.0 110.702 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.1 m -137.76 136.54 37.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' CG ' ' CG2' ' A' ' 21' ' ' THR . 10.3 ttm180 -101.14 137.5 39.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.48 126.67 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -86.96 144.45 26.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.797 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.0 t -142.29 92.64 7.41 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.196 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.62 122.57 2.74 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.788 2.325 . . . . 0.0 112.481 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -91.13 137.45 32.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.79 -53.53 44.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.685 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -117.27 -38.19 3.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.41 17.87 10.92 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.594 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 -104.61 32.6 4.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.707 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 7.8 ttp -101.83 168.91 9.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -100.25 151.05 21.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.695 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 44' ' ' ILE . 57.7 t -50.42 -47.23 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -49.97 -32.5 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.392 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -36.9 47.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.824 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.24 -38.27 68.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.567 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.9 mt -67.44 -45.86 84.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.552 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -59.35 -41.26 88.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.759 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -66.99 -45.83 76.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.46 91.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.134 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.419 HG22 ' CZ ' ' A' ' 24' ' ' PHE . 71.0 t -58.45 -50.71 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.573 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.1 m -57.38 -45.06 84.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.64 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -63.07 -36.69 84.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.77 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -58.39 -57.18 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -54.64 -48.73 71.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.261 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -72.05 -24.45 61.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.327 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.6 -35.07 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 111.267 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.24 9.35 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.537 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.56 52.92 1.67 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.006 0.432 . . . . 0.0 111.197 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 16.0 mttm -122.74 -175.41 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.99 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.2 m-20 -153.32 172.21 5.93 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.472 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 20.5 Cg_endo -61.07 -10.54 15.36 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.339 2.026 . . . . 0.0 112.932 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -43.68 -36.19 2.1 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.7 0.286 . . . . 0.0 111.691 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.458 ' CE2' HG12 ' A' ' 63' ' ' ILE . 4.7 p90 -108.96 159.88 16.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.698 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.476 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -87.06 151.89 22.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 111.196 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.458 HG12 ' CE2' ' A' ' 61' ' ' TYR . 57.2 mt -141.73 111.26 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.746 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.476 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -108.41 107.13 17.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.818 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.404 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 7.7 t -82.56 100.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -57.41 -75.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.51 -171.94 2.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -125.87 157.06 38.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.95 0.405 . . . . 0.0 110.847 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -142.54 161.13 38.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.76 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -79.93 -61.48 1.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.19 79.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.567 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 60.31 44.46 12.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.52 62.11 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.21 46.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.602 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 75' ' ' ILE . 12.3 mt -62.77 154.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.73 0.3 . . . . 0.0 111.001 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.42 144.79 21.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.963 0.411 . . . . 0.0 111.274 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -94.56 -160.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.73 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.58 86.45 2.29 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.764 0.316 . . . . 0.0 110.864 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -176.9 -39.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.83 128.25 35.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 30.9 mm -55.23 157.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.021 0.438 . . . . 0.0 111.638 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.429 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.7 OUTLIER -56.89 -57.0 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.632 -179.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.6 t -74.12 -3.64 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.885 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -95.5 -30.65 13.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.589 0.233 . . . . 0.0 111.4 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.447 HG11 ' N ' ' A' ' 86' ' ' ALA . 10.2 p -120.51 -30.37 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.447 ' N ' HG11 ' A' ' 85' ' ' VAL . . . -109.91 174.22 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 0.0 111.299 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -136.77 155.75 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.838 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.32 133.84 19.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.87 66.21 1.26 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.803 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -124.41 131.51 53.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.11 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -93.84 105.39 17.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.628 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.2 mt -101.12 145.78 28.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.341 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.04 121.36 44.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.592 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.56 122.84 42.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.997 0.427 . . . . 0.0 111.891 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 t -108.45 122.96 63.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.194 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 24' ' ' PHE . 1.8 p90 -149.4 -175.12 4.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.217 0.532 . . . . 0.0 111.615 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.02 154.95 36.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.952 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -155.54 132.73 10.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.738 0.304 . . . . 0.0 111.302 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.465 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -97.77 69.52 2.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.756 0.312 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.42 165.14 12.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.405 ' CE1' HD13 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -63.59 160.71 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.687 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.94 120.62 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.26 142.77 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.013 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 m -104.53 105.73 15.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.35 103.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.2 t -79.16 101.59 8.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.402 ' O ' ' N ' ' A' ' 26' ' ' ARG . 8.4 m-85 -80.1 100.15 8.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.631 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 -79.12 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.319 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . 5.5 mmt85 -139.92 31.18 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.356 . . . . 0.0 110.771 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.7 m -140.92 122.23 14.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.886 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 122.74 29.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.834 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.78 107.5 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.317 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.94 147.99 40.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.723 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -141.29 103.47 6.06 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.339 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -85.5 140.35 7.26 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.731 2.287 . . . . 0.0 112.278 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.8 m -114.8 141.8 47.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.42 -50.28 60.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.743 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -112.63 -29.27 7.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.52 17.11 50.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -109.96 31.69 5.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.832 0.349 . . . . 0.0 110.7 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.9 ttp -93.78 127.34 39.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -58.14 144.8 39.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.586 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 44' ' ' ILE . 43.4 t -47.78 -45.48 11.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.837 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -50.2 -38.01 37.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.181 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.0 t -73.63 -33.0 64.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 110.235 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -72.17 -38.18 69.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.679 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.6 mt -66.51 -43.9 90.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -64.25 -39.5 94.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.605 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -67.44 -37.28 82.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.367 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.79 -37.3 59.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.034 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -60.54 -44.29 96.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.976 0.417 . . . . 0.0 110.585 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.422 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 86.3 m -68.6 -46.69 68.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.531 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.03 -32.73 74.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.705 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CE1' HG11 ' A' ' 55' ' ' VAL . 35.0 t80 -64.33 -57.67 8.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.651 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -52.61 -42.56 64.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -72.2 -30.96 65.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.96 -37.16 69.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.052 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.412 HG11 ' CE1' ' A' ' 51' ' ' TYR . 35.4 m -88.57 7.78 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.539 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 61.47 41.02 13.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 111.333 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 49.5 mttt -101.89 -174.62 2.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.8 OUTLIER -144.46 172.05 5.93 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.571 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 52.0 Cg_endo -69.3 -6.04 17.4 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.281 1.988 . . . . 0.0 112.875 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -49.42 -38.05 27.74 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.711 0.291 . . . . 0.0 111.283 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.471 ' CE2' HG12 ' A' ' 63' ' ' ILE . 3.1 p90 -104.61 149.32 25.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.487 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -80.74 153.66 27.69 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.842 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.471 HG12 ' CE2' ' A' ' 61' ' ' TYR . 48.9 mt -141.95 111.01 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.847 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.487 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.9 OUTLIER -108.94 109.43 20.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.673 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 2.2 t -82.13 102.6 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.247 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -57.45 -77.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -160.07 -179.36 7.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.021 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.87 159.93 20.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -145.52 140.2 27.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.781 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.401 ' CE1' HD22 ' A' ' 92' ' ' LEU . 6.6 m-70 -63.61 -54.91 28.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.28 -52.56 0.16 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.544 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -152.92 31.96 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.79 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.12 75.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.563 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.41 68.96 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.414 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.6 mm -65.18 157.13 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.906 0.384 . . . . 0.0 111.059 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.408 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 3.8 mp -132.65 119.35 20.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.039 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -98.07 173.24 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.68 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.26 76.6 6.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.92 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -176.06 -44.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.013 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.93 138.97 57.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.984 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 30.6 mm -61.05 158.94 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.507 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.44 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -58.01 -59.18 5.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.442 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.5 t -67.44 -12.83 61.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.783 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -90.85 -21.93 21.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.623 0.249 . . . . 0.0 111.485 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.9 -26.58 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.583 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.99 174.64 10.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.372 . . . . 0.0 111.442 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -127.08 159.66 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.477 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 11.7 p-10 -47.51 153.46 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.134 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 35.06 57.72 0.77 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.005 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -110.02 161.57 15.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.981 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -114.7 130.15 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.76 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.401 HD22 ' CE1' ' A' ' 70' ' ' HIS . 2.1 mp -144.55 160.84 40.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.109 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.23 138.62 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.775 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.04 133.47 54.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.423 . . . . 0.0 111.65 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.01 131.9 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.295 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.442 ' HB3' ' HA ' ' A' ' 65' ' ' VAL . 37.2 p90 -152.06 177.73 10.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.013 0.435 . . . . 0.0 111.632 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.61 157.36 22.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.021 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 8.7 pt-20 -154.34 139.32 17.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.686 0.279 . . . . 0.0 111.388 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.477 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 6.1 tt0 -109.72 63.34 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.914 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.943 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.778 0.323 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.07 -172.58 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.417 ' CD1' HD21 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -81.66 152.1 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.738 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -157.85 120.57 3.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.051 0.453 . . . . 0.0 111.167 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 m -136.79 143.23 35.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.835 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.0 m -101.12 116.06 31.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.0 102.84 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.78 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -82.88 102.12 11.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.191 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.411 ' CD2' ' HB2' ' A' ' 51' ' ' TYR . 29.7 m-85 -84.58 98.83 10.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.28 -83.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.299 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -133.51 30.98 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.81 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.4 m -139.21 116.39 11.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -89.09 120.84 30.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.84 116.66 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.03 149.2 39.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.8 t -142.03 95.97 6.72 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.39 108.67 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.661 2.241 . . . . 0.0 112.337 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.404 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -79.23 140.76 37.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.818 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.77 -54.97 29.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.91 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.7 -40.85 2.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.98 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.38 13.51 8.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.647 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.5 mtm-85 -98.79 30.18 3.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.823 0.344 . . . . 0.0 110.724 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -102.53 114.04 27.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.704 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -49.74 148.71 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.71 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 44' ' ' ILE . 23.8 t -46.92 -48.44 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.938 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.428 ' CD2' ' HB3' ' A' ' 78' ' ' LEU . 1.2 t80 -50.81 -44.99 59.17 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.059 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.9 t -58.93 -42.44 89.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.997 0.427 . . . . 0.0 110.328 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.46 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.655 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 40' ' ' VAL . 7.5 mt -64.7 -48.21 85.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.877 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -60.99 -44.86 96.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -39.21 90.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.51 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.35 -34.01 67.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.071 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -63.79 -44.76 98.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.95 0.405 . . . . 0.0 110.721 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.411 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 89.2 m -65.96 -44.49 84.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.548 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -64.77 -27.39 68.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.411 ' HB2' ' CD2' ' A' ' 24' ' ' PHE . 52.5 t80 -69.13 -57.71 5.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.848 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -59.85 -39.29 84.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.055 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -72.27 -35.27 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.03 -29.94 43.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.43 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.403 HG12 ' CG ' ' A' ' 57' ' ' LYS . 14.4 p -87.96 7.74 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.701 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.76 36.2 10.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.798 0.332 . . . . 0.0 111.413 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 43.9 mttt -107.4 -176.61 3.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.842 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.4 m-20 -139.28 175.47 3.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.016 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 20.0 Cg_exo -66.05 -7.85 18.29 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.92 2.414 . . . . 0.0 112.877 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.08 -71.49 0.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.956 0.408 . . . . 0.0 111.113 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.47 ' CZ ' ' CD1' ' A' ' 63' ' ' ILE . 1.3 p90 -64.5 150.71 46.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.809 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.528 ' CZ3' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.18 152.99 25.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.777 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 18.4 mt -143.04 110.39 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.055 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.528 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -113.94 101.93 9.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.63 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.418 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 2.4 t -76.61 97.85 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.151 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -52.28 -70.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.155 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.47 -175.53 3.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 mt -127.56 161.47 28.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.998 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -143.69 159.62 42.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.783 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -77.85 -50.52 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.13 -88.73 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -96.19 41.32 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.814 0.34 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.25 98.18 1.68 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.19 61.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.435 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.1 mt -56.3 158.15 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 111.029 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mt -135.96 106.69 6.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.27 -164.92 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.533 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.428 ' HB3' ' CD2' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -115.96 74.56 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 0.0 110.794 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.48 -52.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.105 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.44 129.03 39.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.033 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.7 mm -54.25 152.97 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.025 0.44 . . . . 0.0 111.511 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.417 HD21 ' CD1' ' A' ' 18' ' ' PHE . 3.0 tp -61.01 -53.32 58.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.371 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.6 p -66.49 -12.17 56.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.687 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.85 -32.39 16.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.656 0.265 . . . . 0.0 111.567 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.23 -45.24 5.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.754 0.312 . . . . 0.0 111.691 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.06 174.09 9.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.384 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -135.58 155.37 50.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -56.37 126.37 26.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.048 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.8 tptt 60.7 69.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -139.7 138.5 36.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -85.9 146.02 26.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.785 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 mt -142.07 145.1 33.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.199 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.0 133.36 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.22 118.0 33.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.374 . . . . 0.0 111.639 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.3 t -104.13 122.71 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.418 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.418 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 1.6 p90 -149.5 -175.34 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.115 0.483 . . . . 0.0 111.709 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -131.55 127.97 38.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.177 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.1 pt-20 -128.46 138.83 52.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.824 0.345 . . . . 0.0 111.004 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -98.44 65.69 1.66 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.809 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.986 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.8 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.755 0.312 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -74.05 146.52 43.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -76.38 165.12 25.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -164.59 120.45 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.034 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.5 m -138.84 141.97 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.127 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 m -101.17 116.11 32.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.659 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.415 HG13 ' CE1' ' A' ' 24' ' ' PHE . 10.7 t -101.83 111.77 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.085 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.52 101.52 13.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE1' HG13 ' A' ' 22' ' ' VAL . 15.1 m-85 -83.76 99.81 10.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.538 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.3 -85.97 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.432 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 24' ' ' PHE . 13.1 mtt-85 -130.18 31.23 4.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.893 0.377 . . . . 0.0 110.838 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.1 m -141.25 120.84 13.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.789 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -94.78 130.13 41.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 m -139.19 120.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.8 148.89 39.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.821 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.46 92.94 14.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.237 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.17 116.79 2.76 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.611 2.207 . . . . 0.0 112.312 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.19 150.98 22.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.78 -68.73 1.54 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.451 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.44 -32.43 9.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.38 3.18 41.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.824 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.9 35.84 1.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.2 ttp -100.57 142.21 32.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.23 146.39 52.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.701 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 44' ' ' ILE . 48.1 t -49.49 -44.78 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.861 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -50.17 -36.79 31.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 m -74.82 -34.62 62.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.154 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -41.98 75.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.528 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.0 mt -64.44 -45.65 95.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.846 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.26 -37.53 80.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.718 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -45.01 76.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.756 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.13 -44.19 76.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.232 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.9 t -54.59 -53.55 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 110.713 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 88.3 m -57.03 -42.57 80.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.383 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -34.53 78.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -60.2 -57.23 13.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.484 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -53.71 -44.96 70.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -32.8 69.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.018 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.65 -29.06 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -94.78 -3.76 10.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.611 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.31 36.26 1.84 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.788 0.328 . . . . 0.0 111.21 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 20.1 mttt -104.58 -176.04 2.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.881 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.6 m-20 -149.47 176.57 2.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.759 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 25.0 Cg_exo -63.42 -9.9 19.57 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.632 2.221 . . . . 0.0 112.869 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -44.7 -32.74 1.6 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.709 0.29 . . . . 0.0 111.73 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.454 ' CZ ' ' HD3' ' A' ' 57' ' ' LYS . 6.7 p90 -110.56 163.1 14.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.832 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.484 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -89.64 154.07 20.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.877 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.9 mt -143.58 110.75 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.157 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.484 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -106.71 101.93 11.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.262 179.244 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.4 t -79.32 94.79 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.007 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -53.37 -70.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.078 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -173.54 -177.68 1.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.834 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mt -116.14 159.92 21.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.962 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -137.23 144.72 42.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.963 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -66.53 -31.06 71.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.74 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.15 -38.56 1.1 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -172.33 35.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.829 0.347 . . . . 0.0 110.801 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.4 72.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.415 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.6 64.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.404 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.1 mt -65.87 158.01 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 111.266 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 mp -133.06 128.17 35.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.758 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -94.92 -166.24 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.36 43.93 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -156.56 26.52 0.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -137.13 144.39 42.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.824 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 29.1 mm -57.09 156.77 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.576 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.422 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 41.4 tp -74.8 -50.7 16.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.269 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.436 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 10.5 t -59.69 -20.26 55.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.361 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -85.54 -59.64 2.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.329 . . . . 0.0 111.377 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 m -76.56 -16.35 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.826 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.02 174.22 10.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 0.0 111.282 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.55 155.06 50.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.866 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -52.67 130.09 31.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.02 66.55 1.03 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -131.85 156.0 46.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.02 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.83 144.35 31.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 mt -144.13 145.34 32.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.004 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.41 119.8 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.53 121.41 37.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.54 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.3 120.27 60.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.762 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -148.23 171.36 16.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.054 0.454 . . . . 0.0 111.128 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -114.55 133.88 55.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.059 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.1 pt-20 -133.67 138.39 45.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.788 0.328 . . . . 0.0 111.212 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.435 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -101.37 69.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.4 t0 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.891 179.874 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.864 0.364 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.42 167.62 9.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.5 155.8 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.17 120.22 2.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.051 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.5 m -132.59 142.86 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.012 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.0 m -103.2 108.92 20.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.92 102.75 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.4 t -85.19 101.55 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.428 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 20.3 m-85 -79.99 99.93 7.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.529 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.92 -80.6 0.02 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.263 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . 2.7 mtt180 -137.08 30.82 2.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.935 0.398 . . . . 0.0 110.636 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 83.1 m -138.65 121.26 16.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.57 126.23 33.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.94 114.06 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -74.88 146.35 41.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.09 93.68 7.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.28 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.22 128.51 3.62 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.818 2.346 . . . . 0.0 112.329 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -98.59 136.94 37.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.858 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.54 77.43 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.77 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.25 -44.07 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.72 18.37 6.09 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.562 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -98.17 29.24 3.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.827 0.346 . . . . 0.0 110.701 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.402 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 6.0 ttp -108.09 133.9 51.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.754 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -70.84 148.42 47.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 44' ' ' ILE . 46.8 t -47.81 -40.76 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 14.5 t80 -50.71 -42.49 57.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.872 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.402 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.8 OUTLIER -72.49 -29.56 63.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.195 179.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.29 -39.85 71.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.525 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.7 mt -65.45 -48.65 82.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.775 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -60.86 -35.67 77.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.713 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -68.93 -42.99 76.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.43 -43.63 66.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -56.24 -48.28 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.5 m -61.17 -49.3 77.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.298 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -31.66 72.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.547 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -62.31 -57.69 10.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.451 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.7 ttm105 -52.42 -44.81 65.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -24.59 61.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.96 -30.17 26.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.222 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 55' ' ' VAL . 12.8 p -103.32 20.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.304 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 48.03 89.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.382 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -155.13 -172.2 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -162.2 177.7 1.86 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.698 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 32.3 Cg_exo -58.46 -13.56 17.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.698 2.265 . . . . 0.0 112.937 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -42.82 -36.73 1.57 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.668 0.271 . . . . 0.0 111.571 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 63' ' ' ILE . 2.1 p90 -115.49 153.02 31.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.697 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.89 154.66 24.49 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 111.194 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 79.6 mt -142.54 110.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.479 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.509 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.6 OUTLIER -105.39 106.3 16.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.061 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 8.7 t -82.49 100.46 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.428 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -61.22 -67.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -176.53 -178.29 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.8 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.1 mt -121.62 155.63 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.979 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -144.8 149.49 35.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -70.07 -43.21 71.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.62 -58.36 0.42 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.452 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.86 80.11 1.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.317 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.04 71.6 1.28 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.559 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.55 54.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.449 HD13 HG22 ' A' ' 75' ' ' ILE . 13.1 mt -58.59 155.37 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 0.0 111.199 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.67 114.13 11.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.088 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -96.19 -163.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.522 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -114.74 78.59 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.59 -46.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.33 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.2 136.53 48.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.084 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 24.6 mm -56.94 157.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.045 0.45 . . . . 0.0 111.467 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 3.2 tp -61.6 -57.6 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.088 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.1 t -57.9 -19.42 29.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.382 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -40.72 26.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.571 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.26 -47.21 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . -72.49 174.16 7.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.264 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -144.64 146.6 32.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.837 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.57 123.79 16.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.02 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.1 58.4 3.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.76 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -118.33 161.26 20.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -114.33 129.08 56.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.7 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.51 160.55 37.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.244 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.7 t -116.22 130.5 70.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.749 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.34 128.59 52.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.542 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.58 121.31 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -149.94 177.51 9.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.366 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.44 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . 0.3 OUTLIER -111.05 156.77 20.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.421 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -153.15 133.03 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.002 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.485 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 28.7 tt0 -98.97 70.19 1.81 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.971 0.415 . . . . 0.0 110.618 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.862 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.801 0.334 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -178.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.417 ' CE2' ' HA ' ' A' ' 83' ' ' CYS . 3.6 t80 -77.17 96.62 4.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.671 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -98.61 119.31 37.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 111.311 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.27 142.26 43.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.703 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -109.03 108.15 18.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.018 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.9 105.75 18.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 t -77.44 101.49 6.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -83.0 100.61 10.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.628 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.43 -87.35 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.325 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.09 31.1 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.708 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -145.47 120.32 9.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.689 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -87.72 125.73 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.9 t -126.76 119.41 53.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.206 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -81.71 149.01 28.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.09 98.85 8.29 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.16 85.51 1.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.767 2.311 . . . . 0.0 112.6 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.4 140.55 56.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.75 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.76 -24.53 19.2 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.954 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.29 -42.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.362 . . . . 0.0 110.99 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.98 11.51 6.94 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.615 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -96.44 30.55 2.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.763 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.6 ttp -109.26 144.01 37.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -67.71 143.46 55.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 44' ' ' ILE . 42.5 t -48.74 -41.78 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.839 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -50.37 -39.74 47.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -31.73 63.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.218 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.45 -39.33 71.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.774 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.2 mt -68.1 -42.17 84.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.855 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -36.86 85.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.514 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -38.29 83.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.319 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.91 -39.19 56.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.904 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -58.7 -43.55 87.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.418 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 90.9 m -68.81 -45.87 70.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.482 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -63.9 -30.52 71.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.682 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -65.55 -57.3 8.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.558 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -55.76 -39.17 70.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -72.13 -45.19 61.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.199 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.54 98.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.106 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' CG1' ' HD2' ' A' ' 57' ' ' LYS . 12.2 p -75.03 -7.15 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.559 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 71.92 35.28 1.36 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.83 0.348 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 8.8 mttt -99.71 -175.52 3.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.5 m-20 -151.09 177.14 1.97 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 34.0 Cg_exo -61.92 -12.3 25.22 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.712 2.275 . . . . 0.0 112.769 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -44.07 -33.0 1.33 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.713 0.292 . . . . 0.0 111.727 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.478 ' CE2' HG12 ' A' ' 63' ' ' ILE . 3.6 p90 -114.67 154.44 28.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.966 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.513 ' CD1' ' CB ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -84.35 151.6 24.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.08 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.478 HG12 ' CE2' ' A' ' 61' ' ' TYR . 54.1 mt -140.22 111.6 4.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.889 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.472 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -107.6 103.44 12.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 179.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.422 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 3.3 t -82.08 110.86 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -76.33 -70.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.096 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -171.21 -177.61 2.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.749 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.81 164.97 18.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -147.98 137.67 22.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -66.71 -60.1 2.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.7 73.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.523 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.4 t0 60.2 36.35 20.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.14 60.81 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.481 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.87 56.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 mt -58.57 152.12 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.832 0.349 . . . . 0.0 111.171 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.6 mp -126.76 111.71 14.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.937 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -94.88 -164.26 1.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.827 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mt -110.87 76.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.969 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.55 -58.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.115 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.41 135.02 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.233 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 27.4 mm -56.11 159.02 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.076 0.465 . . . . 0.0 111.431 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.455 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 15.9 tp -69.8 -54.8 11.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.332 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.417 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -52.94 -23.91 8.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.555 -179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.91 -60.52 2.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.532 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.6 m -73.99 -45.82 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.937 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.37 174.45 7.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.255 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -139.28 155.44 47.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.727 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 0.7 OUTLIER -55.65 143.56 29.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.85 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.9 OUTLIER 40.8 50.91 3.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.502 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -111.36 171.8 7.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.214 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.69 146.15 47.31 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.883 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.55 169.1 21.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.4 p -120.53 121.88 66.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -96.69 119.78 35.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.464 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.85 120.57 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.811 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.422 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 2.2 p90 -146.82 -178.12 6.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.159 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.81 158.91 23.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.32 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 1.8 pt-20 -159.57 136.49 9.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 111.258 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.513 ' CB ' ' CD1' ' A' ' 62' ' ' TRP . 8.9 tt0 -129.37 76.63 1.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.142 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.917 179.957 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.773 0.321 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.06 -177.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.67 146.44 25.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.805 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 120.39 6.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.035 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.98 142.62 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.009 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -106.76 105.92 16.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 m -98.27 116.57 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.084 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.07 101.58 14.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' A' ' 47' ' ' ALA . 6.5 m-85 -79.29 100.14 7.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.688 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.67 -79.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.308 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . 1.4 ptm85 -138.07 31.64 2.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.872 0.368 . . . . 0.0 110.732 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.1 m -140.32 121.89 15.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.973 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.72 115.49 28.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.008 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.1 118.18 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.04 144.84 42.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.94 94.67 14.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.44 101.22 1.38 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.505 2.136 . . . . 0.0 112.301 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 149.63 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.34 -76.69 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.723 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.01 -39.45 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 111.05 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.92 11.76 7.48 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.607 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -97.5 29.77 3.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.838 0.352 . . . . 0.0 110.774 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -103.34 125.12 49.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.56 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -59.8 148.02 36.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.557 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 44' ' ' ILE . 48.4 t -47.79 -46.32 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -50.36 -41.86 52.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.4 t -65.14 -39.83 93.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.055 0.455 . . . . 0.0 109.825 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -66.91 -32.18 73.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.407 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.2 mt -64.11 -53.15 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -38.47 78.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -67.24 -45.12 77.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.424 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . . . -68.86 -43.75 74.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.316 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.0 t -55.84 -53.0 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -58.12 -43.76 87.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.724 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -63.65 -41.93 98.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -57.09 -55.32 36.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.733 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -51.86 -53.76 36.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -72.25 -18.68 61.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.371 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.43 -39.86 27.43 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.751 0.31 . . . . 0.0 111.137 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 p -87.04 6.07 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.512 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.13 49.74 0.61 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 13.4 mttm -116.56 -175.78 2.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.464 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.4 m-20 -145.11 171.25 6.79 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.793 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 31.9 Cg_endo -64.03 -8.8 17.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.455 2.104 . . . . 0.0 113.056 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -46.78 -58.25 4.08 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.904 0.383 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.459 ' CE2' HG12 ' A' ' 63' ' ' ILE . 3.5 p90 -80.1 155.56 27.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.872 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.461 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -84.93 153.58 22.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.852 0.358 . . . . 0.0 110.925 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.459 HG12 ' CE2' ' A' ' 61' ' ' TYR . 55.6 mt -142.54 111.0 2.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.836 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.461 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -110.95 116.24 30.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.854 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.408 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 2.1 t -83.45 101.55 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.954 0.407 . . . . 0.0 111.035 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -64.37 -69.18 0.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.509 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -171.43 166.77 6.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 5.5 mt -111.61 156.16 22.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.996 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -150.26 129.39 12.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.98 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.444 ' CE1' ' CD2' ' A' ' 92' ' ' LEU . 41.8 m-70 -56.91 -58.51 7.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.17 68.95 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.489 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.8 44.36 11.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.862 0.363 . . . . 0.0 110.852 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.73 45.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.43 53.56 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.9 mt -60.27 153.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.234 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 1.4 mp -135.92 124.0 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.715 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -94.58 -164.44 1.17 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.679 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.07 44.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.959 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -152.96 23.63 0.57 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.327 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.07 141.32 47.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.927 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 25.3 mm -59.6 156.11 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.013 0.435 . . . . 0.0 111.436 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 86' ' ' ALA . 2.3 tp -72.92 -51.33 18.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.413 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.8 p -59.98 -18.75 48.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.457 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -87.17 -46.25 9.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.706 0.289 . . . . 0.0 111.523 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.1 m -91.25 -46.2 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . -83.73 174.08 10.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.312 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.35 149.09 37.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.7 125.68 22.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.05 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.27 67.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.937 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -129.88 161.97 29.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.965 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.8 mtm-85 -120.52 105.99 11.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.807 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.444 ' CD2' ' CE1' ' A' ' 70' ' ' HIS . 0.8 OUTLIER -110.47 169.07 8.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.176 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.79 140.21 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.852 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.17 117.08 30.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.383 . . . . 0.0 111.683 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 t -90.09 128.26 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.025 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -163.85 171.43 15.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.504 . . . . 0.0 111.773 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.59 154.76 28.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.219 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.06 132.01 12.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.0 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.428 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 10.6 tt0 -92.1 66.96 5.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.413 . . . . 0.0 110.746 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.875 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.527 0.062 0 CA-C-O 120.791 0.329 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 60.44 -164.17 0.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.761 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.426 ' CD1' HD11 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -59.54 151.21 24.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.805 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.47 120.04 1.77 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.52 142.05 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.196 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -102.72 107.12 17.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.693 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.09 106.31 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.186 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.86 101.15 3.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.486 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.409 ' CE2' ' HA ' ' A' ' 48' ' ' VAL . 5.4 m-85 -81.86 96.82 7.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.689 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.61 -84.36 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.482 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.79 34.17 4.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.9 m -146.46 145.06 30.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.803 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -103.6 110.18 22.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.994 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 t -114.43 111.27 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.04 144.76 34.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.15 96.89 17.02 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.037 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.39 117.14 1.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.787 2.325 . . . . 0.0 112.506 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.418 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -92.6 131.69 37.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.753 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.45 -37.5 66.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.959 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -135.92 -46.39 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 111.136 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.88 16.56 4.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.602 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -97.04 29.85 2.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.906 0.384 . . . . 0.0 110.667 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.413 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.1 OUTLIER -109.6 122.33 47.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.679 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -58.84 157.58 9.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.68 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 44' ' ' ILE . 39.3 t -52.11 -53.44 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.24 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -49.66 -30.8 9.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.185 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.413 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 49.8 m -73.99 -40.91 62.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.051 0.453 . . . . 0.0 110.314 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.05 -37.46 75.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.539 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.5 mt -63.64 -46.72 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.726 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -59.71 -42.67 93.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.615 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.57 -39.81 94.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.638 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.15 -42.64 68.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HA ' ' CE2' ' A' ' 24' ' ' PHE . 98.2 t -56.63 -54.2 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.721 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -58.82 -42.71 89.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.62 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -69.02 -27.34 65.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.784 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -67.41 -57.49 6.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.821 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -58.97 -38.06 78.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.724 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -29.89 64.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.14 -30.23 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.525 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.3 p -87.02 8.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.694 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.79 24.67 5.27 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.534 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -100.95 -176.39 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.323 . . . . 0.0 110.809 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -142.77 177.42 1.86 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.717 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 19.7 Cg_exo -66.27 -5.99 13.81 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.742 2.295 . . . . 0.0 112.84 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -51.55 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.81 0.338 . . . . 0.0 111.044 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.434 ' CE1' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.56 144.53 54.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.793 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.523 ' CZ3' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -76.81 155.62 32.91 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.672 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 66.5 mt -143.66 110.62 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 19.9 tt0 -104.94 107.27 18.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.285 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.435 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 2.7 t -82.45 101.29 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.403 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 96' ' ' PHE . 47.5 m-70 -64.56 -63.96 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.055 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.34 -176.98 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.661 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -127.46 154.4 45.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.971 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -136.05 146.96 47.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.757 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.448 ' CE1' ' CD2' ' A' ' 92' ' ' LEU . 10.7 m-70 -71.61 -44.8 63.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.2 -80.6 0.21 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.67 31.42 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.04 112.26 1.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.582 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.43 83.21 0.23 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.441 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.6 mm -82.05 157.47 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 0.0 111.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.41 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 1.2 mp -125.92 114.24 18.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -98.27 -164.35 1.13 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.828 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -112.68 47.92 1.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.956 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -164.64 30.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.236 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' O ' ' CG2' ' A' ' 40' ' ' VAL . 12.5 t70 -133.8 136.17 44.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.892 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 29.0 mm -62.1 158.55 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.106 0.479 . . . . 0.0 111.475 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.438 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -56.68 -61.16 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.334 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.4 t -66.34 -14.44 62.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.486 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.1 -36.14 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.687 0.28 . . . . 0.0 111.348 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 p -114.81 -44.68 4.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.634 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . -84.85 174.08 10.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.188 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -144.62 154.41 42.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.749 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -54.93 123.04 12.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.975 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.32 71.55 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.819 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -123.15 173.62 7.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -134.51 98.28 4.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.448 ' CD2' ' CE1' ' A' ' 70' ' ' HIS . 3.7 mt -101.63 169.13 9.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.988 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 t -119.51 121.27 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . . . -90.69 117.95 29.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.567 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.67 110.04 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.574 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.426 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 37.1 p90 -142.8 -179.28 6.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.039 0.447 . . . . 0.0 111.386 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -115.11 152.74 32.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.93 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -150.56 134.23 16.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 0.0 111.16 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.47 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 2.0 tt0 -99.46 68.96 1.63 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.938 0.399 . . . . 0.0 110.694 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.1 t0 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.997 179.936 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.892 0.377 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -125.55 -164.05 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.792 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -74.88 158.34 33.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.842 0.353 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.36 120.33 2.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.119 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.2 m -138.04 141.86 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.986 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.4 m -100.05 116.38 31.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.81 109.14 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.974 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 73.2 m -84.62 101.17 11.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 94' ' ' ALA . 37.0 m-85 -88.03 102.36 14.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.589 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.6 -88.63 0.01 OUTLIER Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 24' ' ' PHE . 6.3 mtp180 -128.13 31.44 5.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 110.707 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.8 m -151.44 115.64 5.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.736 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.33 148.05 24.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.271 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 m -144.79 133.2 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.089 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.52 136.56 40.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -127.08 92.68 43.59 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.04 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -83.45 117.29 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.778 2.319 . . . . 0.0 112.358 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.0 t -87.54 136.79 32.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.88 -53.03 48.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.712 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -112.3 -31.57 6.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.726 0.298 . . . . 0.0 110.958 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.06 14.41 59.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.92 35.04 3.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -105.77 138.71 41.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.686 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -59.35 147.69 35.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.985 0.421 . . . . 0.0 111.168 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 44' ' ' ILE . 67.2 t -52.23 -40.2 30.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -49.82 -46.82 51.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.027 0.441 . . . . 0.0 110.649 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 7.0 t -66.14 -34.56 78.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.759 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 tp -67.52 -35.48 79.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.5 mt -65.44 -50.87 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.868 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 6.3 pt20 -60.3 -33.91 73.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.454 ' N ' ' HG3' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -70.18 -47.84 59.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.02 -45.41 77.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.6 t -56.09 -48.1 79.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.869 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.1 m -59.2 -45.61 90.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.23 -32.52 73.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -63.65 -57.43 10.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.7 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -54.95 -38.82 68.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.231 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -45.29 60.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.266 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.82 -48.17 80.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.142 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.43 ' CG2' ' HD2' ' A' ' 57' ' ' LYS . 29.0 m -64.96 -15.37 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.452 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 79.59 31.77 0.25 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.83 0.348 . . . . 0.0 111.312 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.494 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 17.4 mttt -93.97 -173.03 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.512 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.2 m-20 -150.35 170.1 8.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.709 0.29 . . . . 0.0 111.076 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.424 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 55.6 Cg_endo -70.12 57.26 1.63 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.636 2.224 . . . . 0.0 112.67 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -120.58 -23.32 6.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.768 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.494 ' CZ ' ' HD3' ' A' ' 57' ' ' LYS . 9.6 p90 -111.88 154.57 24.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.527 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.478 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -81.36 154.29 26.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.661 0.267 . . . . 0.0 110.753 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.472 HG12 ' CE2' ' A' ' 61' ' ' TYR . 85.6 mt -142.29 111.32 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.026 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.478 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -106.53 101.85 11.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.711 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.436 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 14.8 t -81.42 97.85 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.021 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -58.92 -67.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -177.14 -177.48 0.73 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 mt -123.63 152.11 42.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.28 143.61 31.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -66.28 -69.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.04 101.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.563 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 58.97 44.28 16.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.0 90.26 0.72 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.528 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.68 53.88 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.0 mt -59.34 158.08 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.378 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mt -138.71 117.19 12.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.84 -166.62 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.749 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.86 43.65 1.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.48 25.46 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.283 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -133.89 136.82 44.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 29.5 mm -58.69 155.85 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.063 0.459 . . . . 0.0 111.581 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.4 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -66.3 -52.72 44.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.438 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.8 m -63.92 -14.75 56.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.584 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -91.63 -32.19 15.57 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 m -107.08 -43.72 6.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.86 174.23 6.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.779 0.324 . . . . 0.0 111.253 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -138.41 153.99 48.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.803 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -51.49 124.65 12.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.947 0.403 . . . . 0.0 111.068 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.93 74.3 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.77 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -138.66 151.56 47.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -102.94 140.5 37.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.8 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.34 169.0 17.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.5 108.7 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.916 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . . . -88.5 121.16 30.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.705 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.81 118.03 55.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.598 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.436 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 2.1 p90 -148.73 -174.0 4.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.075 0.464 . . . . 0.0 111.414 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -122.21 155.74 35.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.958 179.15 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 10.0 pt-20 -156.93 130.94 8.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.701 0.286 . . . . 0.0 111.22 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.463 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 16.9 tt0 -97.78 66.73 1.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.732 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.946 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.751 0.31 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -122.9 147.0 47.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.419 ' CE1' ' HA ' ' A' ' 83' ' ' CYS . 0.9 OUTLIER -70.09 166.42 19.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.867 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.85 120.44 1.02 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.97 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.44 142.81 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.005 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.3 m -101.31 117.44 34.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -99.24 104.9 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 7.4 t -81.42 101.33 9.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 94' ' ' ALA . 43.3 m-85 -89.27 103.08 15.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.43 -93.5 0.01 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.736 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mpm_? -119.05 30.93 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 m -156.46 114.5 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.715 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 5.7 ppt_? -105.03 151.81 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.316 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -146.47 145.89 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.093 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -87.74 141.38 28.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.756 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.31 95.25 31.03 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.211 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.82 116.1 2.48 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.68 2.253 . . . . 0.0 112.369 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.4 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -90.62 158.35 16.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.929 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.87 -63.53 2.83 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.645 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.21 -47.62 3.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.958 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.65 7.5 8.83 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.741 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -96.74 39.39 1.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.5 ttp -111.0 123.9 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.862 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.56 145.64 18.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.546 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.538 ' O ' HG13 ' A' ' 44' ' ' ILE . 98.6 t -49.36 -41.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.738 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.429 ' CB ' ' HB3' ' A' ' 78' ' ' LEU . 1.7 t80 -50.24 -42.59 52.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m -70.85 -34.63 71.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.185 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -67.89 -38.91 83.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.512 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 40' ' ' VAL . 3.9 mt -65.1 -45.25 94.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.695 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -59.17 -39.82 83.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.728 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -65.79 -48.19 72.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.714 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.7 -48.65 73.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.1 t -54.03 -48.19 64.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.028 0.442 . . . . 0.0 110.765 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 83.9 m -57.12 -42.9 81.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.521 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.53 -33.05 74.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.779 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -60.5 -56.7 18.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.647 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -43.49 85.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -72.01 -27.35 62.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.39 -39.74 31.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.181 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.3 p -85.67 4.3 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.61 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.56 52.78 2.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.81 0.338 . . . . 0.0 111.257 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 72.3 mttt -116.71 -175.22 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.453 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.1 m-20 -145.86 171.0 7.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.73 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 34.2 Cg_endo -65.02 -7.43 15.29 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.425 2.083 . . . . 0.0 112.903 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -46.86 -37.43 8.79 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 111.446 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.453 ' CE2' HG12 ' A' ' 63' ' ' ILE . 5.9 p90 -104.56 152.59 22.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.478 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.09 154.24 25.69 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.827 0.346 . . . . 0.0 111.058 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.453 HG12 ' CE2' ' A' ' 61' ' ' TYR . 70.1 mt -142.78 111.0 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.849 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.478 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -106.95 107.18 18.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.42 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 4.2 t -83.44 98.89 5.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.011 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -55.26 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.264 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 ptt85 -163.54 -175.16 4.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.87 152.27 47.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 111.023 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -141.51 132.79 26.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.88 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.412 ' CE1' HD22 ' A' ' 92' ' ' LEU . 11.5 m-70 -58.13 -46.85 84.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.1 -61.58 0.21 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.507 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -151.65 77.61 1.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.951 0.405 . . . . 0.0 110.835 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.96 39.45 1.41 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.43 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.22 41.71 0.48 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mt -63.16 157.47 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 0.0 111.066 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 139.68 15.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 111.211 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -108.48 -163.12 0.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.731 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 41' ' ' PHE . 0.3 OUTLIER -98.75 71.61 1.94 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.827 0.346 . . . . 0.0 110.889 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.82 -43.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.4 ' O ' ' CG2' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -72.25 135.02 45.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.736 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 28.2 mm -53.1 155.94 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.158 0.504 . . . . 0.0 111.581 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.404 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 62.9 tp -70.88 -51.56 25.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.493 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.419 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 31.0 p -71.62 -8.15 52.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.73 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.6 -38.34 10.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.641 0.257 . . . . 0.0 111.291 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 p -101.02 -33.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.882 0.372 . . . . 0.0 111.599 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.42 174.23 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.378 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.23 154.85 50.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.51 130.64 36.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 56.37 68.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -132.55 149.17 52.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -97.32 143.62 27.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.412 HD22 ' CE1' ' A' ' 70' ' ' HIS . 12.0 mt -142.86 145.37 33.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.903 0.383 . . . . 0.0 111.202 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.81 116.18 35.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.766 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.433 ' HB2' ' CD1' ' A' ' 24' ' ' PHE . . . -99.48 121.89 41.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.052 0.453 . . . . 0.0 111.716 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 t -109.03 126.79 66.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.34 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.409 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 1.6 p90 -151.41 -179.77 7.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.178 0.513 . . . . 0.0 111.611 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.66 156.66 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.077 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.93 134.38 11.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.466 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 5.0 tt0 -99.06 67.87 1.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.836 -179.953 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 60.59 -177.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.12 159.57 30.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.737 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.23 120.46 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.044 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.8 143.13 40.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -96.12 114.89 26.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.12 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.0 t -104.43 104.31 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.5 t -86.66 101.8 13.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.082 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 44.7 m-85 -85.06 98.47 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.778 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.9 -79.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.357 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -138.19 31.32 2.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.822 0.344 . . . . 0.0 110.791 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.4 m -139.61 112.34 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.812 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -88.65 123.19 32.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 m -135.27 116.74 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.062 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.9 145.58 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.66 103.12 14.8 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.243 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.61 130.13 4.35 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.649 2.233 . . . . 0.0 112.294 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.64 131.42 47.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.03 -48.86 57.6 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.97 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -120.98 -46.07 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.31 11.69 9.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.675 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -97.76 35.02 1.75 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 110.622 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.94 118.73 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.811 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -54.52 149.96 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.616 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 44' ' ' ILE . 48.9 t -48.05 -43.81 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.008 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 78' ' ' LEU . 1.8 t80 -50.38 -49.38 54.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.236 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.3 t -62.33 -35.96 80.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.397 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 tp -66.36 -33.99 76.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.568 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 40' ' ' VAL . 5.3 mt -66.18 -51.18 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.814 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -35.11 72.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.002 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -68.67 -48.13 64.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.93 -47.08 69.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.366 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.432 HG23 ' CZ ' ' A' ' 24' ' ' PHE . 61.2 t -53.09 -53.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.842 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.5 m -56.96 -44.74 82.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -29.89 70.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.911 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -65.58 -57.4 8.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.772 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HA ' HG11 ' A' ' 55' ' ' VAL . 8.9 ptt180 -58.8 -35.19 72.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.887 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -72.6 -29.99 63.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.29 -33.66 25.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.426 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 52' ' ' ARG . 14.9 p -84.7 4.6 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.645 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.87 44.31 4.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 111.258 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -112.69 -174.76 2.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -147.59 176.29 2.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.742 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 18.7 Cg_exo -66.24 -9.29 23.15 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.826 2.35 . . . . 0.0 112.624 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -45.79 -39.4 8.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.714 0.292 . . . . 0.0 111.438 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.447 ' CE2' HG12 ' A' ' 63' ' ' ILE . 6.7 p90 -102.74 145.1 30.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.933 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.479 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.47 155.6 33.73 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.609 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.447 HG12 ' CE2' ' A' ' 61' ' ' TYR . 78.8 mt -142.95 110.97 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.887 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.479 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.2 OUTLIER -106.94 105.36 15.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.561 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.44 ' HA ' ' CB ' ' A' ' 96' ' ' PHE . 1.5 t -83.29 97.29 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.159 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -56.08 -74.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -167.66 178.12 5.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.786 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mt -119.45 156.84 29.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.957 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -138.66 147.01 42.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.962 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -68.14 -64.54 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.89 -53.02 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.474 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.74 34.13 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.24 69.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.44 56.37 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.438 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 mt -62.49 153.38 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 111.099 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.0 114.18 16.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.794 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -163.39 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.17 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -113.54 36.5 3.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 0.0 110.773 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -148.29 26.88 0.95 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 134.28 45.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.882 0.372 . . . . 0.0 110.946 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 29.1 mm -57.91 157.14 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.698 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.423 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -61.84 -56.13 22.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.626 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 34.7 m -71.19 -7.4 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.835 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.67 -37.46 15.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.574 0.226 . . . . 0.0 111.479 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 m -114.9 -31.34 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.69 174.1 6.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 0.0 111.226 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.16 153.96 45.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.7 125.97 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.99 71.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -134.34 157.48 46.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.15 130.85 50.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.533 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.2 mt -138.62 132.7 31.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.354 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.7 m -82.94 134.42 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.436 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -109.86 117.01 32.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.947 0.403 . . . . 0.0 111.768 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.03 127.12 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.344 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.44 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -160.75 174.77 13.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.122 0.487 . . . . 0.0 111.707 -179.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.17 157.95 25.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.242 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 9.7 pt-20 -155.23 135.0 12.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.046 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.47 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 2.3 tt0 -101.44 65.93 1.07 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.892 0.377 . . . . 0.0 111.008 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.956 179.895 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.945 0.402 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -96.94 -177.42 3.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.0 155.95 22.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.824 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -164.53 120.5 1.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.77 142.56 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.046 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.9 m -95.3 119.68 34.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.97 107.55 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.022 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.86 101.59 14.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 43.6 m-85 -85.75 100.75 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.714 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.33 -78.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.294 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 tpm_? -141.84 31.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.729 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.0 m -137.66 125.48 22.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.43 130.42 42.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.7 m -135.35 127.11 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.043 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -74.98 143.22 43.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.986 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.72 92.62 8.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.145 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -84.65 123.03 2.8 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.757 2.305 . . . . 0.0 112.593 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.12 141.87 28.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.745 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.29 -81.79 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.881 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.24 -35.52 9.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 110.978 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.64 14.67 10.15 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 mtt-85 -98.6 28.46 4.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.941 0.4 . . . . 0.0 110.866 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.404 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 10.2 ttp -105.06 145.53 30.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.694 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.46 147.88 33.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 44' ' ' ILE . 59.1 t -48.83 -42.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.666 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -50.23 -38.8 42.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.4 OUTLIER -73.86 -34.58 64.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.278 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 tt -70.15 -38.66 75.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.673 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.1 mt -66.09 -45.83 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.634 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -59.06 -40.62 85.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.709 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -67.9 -44.79 76.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.782 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . . . -66.85 -37.77 85.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.64 -54.11 39.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.412 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -55.86 -42.72 76.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.599 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -37.87 86.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.703 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -58.98 -57.02 14.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.69 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -51.37 -47.74 62.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.96 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -72.28 -25.75 61.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.225 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.49 -38.56 55.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.197 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.6 p -92.28 12.74 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.617 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 57.54 56.86 4.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.905 0.383 . . . . 0.0 111.307 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 65.3 mttt -120.72 -175.39 3.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.6 m-20 -148.05 171.16 6.63 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.506 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 31.6 Cg_endo -64.19 -8.13 15.65 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.371 2.047 . . . . 0.0 112.916 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -46.35 -37.39 7.43 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.64 0.257 . . . . 0.0 111.521 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.447 ' CZ ' HD13 ' A' ' 63' ' ' ILE . 6.0 p90 -104.8 156.13 18.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -85.03 153.79 22.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.164 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.447 HD13 ' CZ ' ' A' ' 61' ' ' TYR . 76.6 mt -142.13 110.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.81 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -103.71 102.91 12.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.648 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 5.8 t -76.52 97.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -57.49 -78.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.0 -177.5 6.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.33 165.0 12.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -148.98 160.56 43.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -94.61 -43.47 8.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.66 -88.39 0.14 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.41 33.02 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.769 0.318 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.45 108.12 0.99 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.4 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.09 95.28 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.403 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mm -93.19 155.26 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 0.0 111.132 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 mp -133.54 118.02 17.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -95.17 -175.36 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.793 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.49 44.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.855 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.4 27.52 0.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.973 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -137.26 134.7 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 31.7 mm -58.78 158.56 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.121 0.486 . . . . 0.0 111.586 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.441 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -58.0 -56.76 17.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.444 -179.433 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 68.9 m -70.66 -7.55 45.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.789 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.22 -30.97 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.678 0.275 . . . . 0.0 111.586 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 m -120.06 -36.09 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.33 174.14 6.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.791 0.329 . . . . 0.0 111.338 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.55 150.52 47.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.752 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.61 132.72 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.01 60.32 2.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.732 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -138.97 134.85 33.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.38 151.2 26.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.763 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.7 mt -146.13 150.85 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.007 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.25 114.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.758 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.27 128.1 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.751 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.93 137.15 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.32 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -167.88 163.32 13.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.129 0.49 . . . . 0.0 111.901 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -104.79 156.81 17.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.11 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -155.27 128.9 8.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.014 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.443 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 20.6 tt0 -86.53 66.85 9.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.036 0.446 . . . . 0.0 110.533 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.89 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.806 0.336 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -64.69 160.32 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.421 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -80.95 157.57 25.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -161.24 120.28 2.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.01 0.434 . . . . 0.0 111.061 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.9 142.9 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.926 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -100.43 118.59 36.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.4 t -97.75 109.59 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.758 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 t -88.3 101.68 14.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 47' ' ' ALA . 55.7 m-85 -84.71 98.51 10.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.395 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.97 -85.42 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.333 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 mmp_? -129.17 31.38 4.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.4 m -138.25 145.09 40.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -105.85 138.3 42.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.027 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.76 108.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.019 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -74.81 149.05 39.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.25 94.12 7.8 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.322 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.28 129.11 4.37 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.645 2.23 . . . . 0.0 112.391 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.6 m -99.66 140.04 34.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.768 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.69 -50.81 62.37 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.576 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -112.28 -29.91 7.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 111.066 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.68 14.24 53.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.523 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.81 35.91 2.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.731 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.2 ttp -104.17 137.61 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -69.77 150.14 47.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.53 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 44' ' ' ILE . 44.3 t -48.86 -42.08 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.968 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -50.17 -43.06 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.32 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -30.48 63.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.579 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 tp -71.38 -39.18 71.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.618 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 40' ' ' VAL . 4.3 mt -67.81 -44.13 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.692 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.21 -38.43 86.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -68.79 -42.73 76.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.604 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.47 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . . . -69.46 -40.77 76.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.296 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.0 t -58.45 -51.84 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.72 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.9 m -58.18 -44.44 88.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.416 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -64.48 -29.93 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.423 ' HB2' ' CD2' ' A' ' 24' ' ' PHE . 7.5 t80 -64.13 -57.88 8.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.656 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -58.77 -32.66 69.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.641 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 11.2 mmtt -72.52 -27.91 62.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.52 26.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.34 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.42 HG22 ' HD2' ' A' ' 57' ' ' LYS . 2.8 m -93.99 18.98 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.583 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 55.16 28.97 11.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.562 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.42 ' HD2' HG22 ' A' ' 55' ' ' VAL . 10.0 mttt -94.54 -169.87 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.835 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m-20 -160.06 177.07 2.21 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.731 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 33.0 Cg_exo -61.49 -12.13 22.99 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.663 2.242 . . . . 0.0 112.767 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -45.02 -53.1 8.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.815 0.341 . . . . 0.0 111.346 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.446 ' CE2' HG12 ' A' ' 63' ' ' ILE . 3.7 p90 -90.44 148.68 22.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.479 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -79.71 155.49 27.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.79 0.328 . . . . 0.0 111.028 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.446 HG12 ' CE2' ' A' ' 61' ' ' TYR . 68.7 mt -142.46 111.02 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.759 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.479 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -104.65 105.33 15.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.651 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.425 ' CG1' ' CG2' ' A' ' 44' ' ' ILE . 1.4 t -83.02 97.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.133 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -53.56 -76.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -159.85 -176.97 6.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.991 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.0 mt -117.49 160.75 20.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.57 159.36 43.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -85.23 -30.78 23.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.773 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.95 -53.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.406 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -156.72 73.01 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 110.784 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.91 57.66 0.54 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.41 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.61 59.0 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.493 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.2 mt -71.66 158.36 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.824 0.345 . . . . 0.0 111.187 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.25 141.43 22.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.7 -162.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.707 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.01 43.49 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.886 0.374 . . . . 0.0 110.944 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.3 25.33 1.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -133.13 132.99 42.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 27.5 mm -56.02 158.38 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.038 0.447 . . . . 0.0 111.534 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.443 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -62.27 -57.55 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.625 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.3 t -67.76 -11.6 58.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.934 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.41 -47.28 11.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.586 0.231 . . . . 0.0 111.516 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.3 m -103.9 -32.75 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.55 173.99 6.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.901 0.381 . . . . 0.0 111.213 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.87 154.44 49.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.766 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -54.34 124.03 14.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.09 70.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -140.21 144.55 36.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.024 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -92.86 148.97 21.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.796 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mt -143.41 146.84 33.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.128 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.3 t -92.12 122.76 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.605 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.85 118.12 35.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.002 0.429 . . . . 0.0 111.822 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 t -103.31 128.18 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.149 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 24' ' ' PHE . 2.1 p90 -153.31 -177.65 6.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.277 0.56 . . . . 0.0 111.718 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -118.06 157.27 27.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.856 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.17 132.15 9.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 0.0 111.125 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.443 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 3.7 tt0 -92.05 73.42 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.05 0.452 . . . . 0.0 110.462 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 t70 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.927 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.689 0.281 . . . . 0.0 110.877 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.02 120.6 1.0 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.04 0.448 . . . . 0.0 111.203 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.927 HG11 ' HB1' ' A' ' 86' ' ' ALA . 12.4 m -136.74 142.56 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -100.57 132.3 46.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 29' ' ' VAL . 9.5 t -113.23 105.7 19.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 t -83.16 101.59 11.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.176 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.522 ' HE1' ' HB1' ' A' ' 47' ' ' ALA . 15.4 m-85 -83.45 100.65 10.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.397 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.48 -78.84 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.444 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 mtt180 -139.16 31.18 2.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.784 0.326 . . . . 0.0 110.973 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.4 m -140.92 122.59 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.17 125.39 38.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.148 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 22' ' ' VAL . 14.7 p -125.41 124.73 67.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.038 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -79.03 140.0 38.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.61 92.64 26.7 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.64 116.75 4.11 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.076 2.517 . . . . 0.0 112.192 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -91.41 120.83 32.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.754 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.78 -53.89 33.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.971 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -106.04 -33.03 8.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.834 0.349 . . . . 0.0 111.067 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.22 -12.09 61.92 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.31 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 56.27 3.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.121 0.486 . . . . 0.0 110.812 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.414 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 1.5 ttp -122.38 114.48 20.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.607 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -53.07 147.59 9.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 80' ' ' ASP . 22.0 t -46.85 -43.43 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 10.6 t80 -50.19 -42.16 50.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.954 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.414 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 4.4 m -71.14 -31.73 68.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.182 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.964 HD13 HD11 ' A' ' 82' ' ' LEU . 4.4 tt -71.77 -38.82 70.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.748 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.9 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.4 mt -64.58 -48.66 83.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.745 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.21 -38.8 87.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -67.85 -43.24 79.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HB1' ' HE1' ' A' ' 24' ' ' PHE . . . -69.83 -44.51 69.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.811 HG21 HG21 ' A' ' 65' ' ' VAL . 92.3 t -54.37 -52.21 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 110.647 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.402 HG23 ' NH2' ' A' ' 52' ' ' ARG . 86.3 m -58.18 -47.23 84.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -29.8 70.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.955 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' O ' HG12 ' A' ' 55' ' ' VAL . 35.2 t80 -62.07 -57.36 11.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.743 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HA ' HG12 ' A' ' 55' ' ' VAL . 9.5 ptt-85 -60.92 -36.34 79.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.838 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.427 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 11.4 tppt? -72.6 -27.74 62.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.145 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.96 -35.54 23.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.5 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.0 p -82.04 1.75 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.796 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 75.33 29.96 0.88 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.739 0.304 . . . . 0.0 111.626 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 7.4 mttt -99.24 -169.9 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.486 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -158.89 170.36 9.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.907 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 43.1 Cg_endo -68.14 61.8 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -124.01 -41.14 2.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.426 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.652 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 9.1 p90 -95.65 150.44 20.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.319 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -78.42 152.94 31.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.748 0.308 . . . . 0.0 110.94 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.652 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 73.0 mt -139.92 110.95 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.81 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -102.14 101.74 12.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.363 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.9 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.9 t -83.21 97.07 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.125 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -58.62 -77.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.443 ' C ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -163.88 -176.77 4.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.169 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.62 HD11 HG13 ' A' ' 22' ' ' VAL . 4.0 mm? -119.16 160.91 21.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.634 ' O ' HG22 ' A' ' 93' ' ' VAL . 3.8 tt0 -152.17 137.48 17.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.657 ' HA ' HD23 ' A' ' 92' ' ' LEU . 14.2 m-70 -64.19 -30.47 71.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.83 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.24 -70.96 0.26 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.518 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.79 35.32 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.838 0.352 . . . . 0.0 111.021 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.51 64.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.49 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.12 60.94 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 76' ' ' LEU . 12.6 mt -59.42 156.18 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 0.0 111.074 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.555 HD23 ' CG1' ' A' ' 85' ' ' VAL . 3.9 mp -130.83 122.03 26.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -109.38 169.23 8.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.538 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.692 ' CD2' HD12 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -86.06 79.99 8.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.062 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.82 -38.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.853 ' O ' HG23 ' A' ' 40' ' ' VAL . 47.5 m-20 -77.08 131.07 38.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.061 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 85' ' ' VAL . 28.4 mm -55.71 158.28 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.096 0.474 . . . . 0.0 111.546 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.964 HD11 HD13 ' A' ' 43' ' ' LEU . 2.2 tp -71.15 -54.58 10.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.094 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -26.45 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.484 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.12 -35.54 17.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 81' ' ' ILE . 16.1 t -97.38 -67.09 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 111.675 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.927 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -66.97 174.29 3.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.291 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.43 154.9 41.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.781 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.46 117.03 1.98 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.67 60.81 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -122.87 142.94 50.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.6 mmm-85 -95.79 154.5 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.657 HD23 ' HA ' ' A' ' 70' ' ' HIS . 55.2 mt -148.87 138.25 21.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.025 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 69' ' ' GLU . 3.2 m -90.15 121.95 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.651 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.56 ' HA ' HD13 ' A' ' 68' ' ' LEU . . . -103.44 121.79 43.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.061 0.457 . . . . 0.0 111.885 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.04 122.97 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.103 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.593 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.2 p90 -151.16 -174.35 4.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.192 0.52 . . . . 0.0 111.586 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -120.62 156.99 30.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.791 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.3 pt-20 -158.23 128.98 6.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.84 0.352 . . . . 0.0 111.224 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.473 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 1.3 tt0 -93.27 70.72 4.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.982 0.42 . . . . 0.0 110.746 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.886 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.473 ' CD1' HD23 ' A' ' 82' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.73 120.82 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.015 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.68 142.49 37.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.1 m -97.67 121.88 40.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.751 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.4 t -103.74 111.49 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.6 t -86.46 101.82 13.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CE1' HG22 ' A' ' 48' ' ' VAL . 51.4 m-85 -85.46 100.26 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.766 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.16 -90.09 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.575 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.67 31.47 6.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.0 m -139.46 144.99 38.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.41 118.2 30.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.84 126.75 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.98 146.66 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.721 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.5 t -129.01 92.73 38.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.064 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -77.71 106.26 2.16 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.869 2.379 . . . . 0.0 112.244 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.419 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -80.67 137.53 36.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.608 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.57 -36.07 7.76 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.061 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -151.55 -45.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.39 13.52 4.75 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.777 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.619 ' CG ' ' O ' ' A' ' 37' ' ' ARG . 8.4 ttm-85 -99.57 29.73 3.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.654 0.74 . . . . 0.0 109.876 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 6.8 ttp -108.86 151.6 26.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.625 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.93 144.62 38.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.607 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 80' ' ' ASP . 58.4 t -48.11 -41.4 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.815 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -50.36 -43.01 54.04 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -33.64 72.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.177 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.981 HD22 HD11 ' A' ' 82' ' ' LEU . 3.5 tp -69.09 -39.41 79.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.654 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.911 ' CG2' HG11 ' A' ' 65' ' ' VAL . 3.9 mt -63.18 -51.35 72.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.732 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -36.96 73.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -68.93 -48.05 64.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.721 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -66.6 -41.21 88.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.328 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 44' ' ' ILE . 97.0 t -58.45 -48.13 86.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 0.0 110.619 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.0 m -58.55 -46.98 85.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.596 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -64.39 -33.73 76.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.691 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.504 ' O ' HG12 ' A' ' 55' ' ' VAL . 20.0 t80 -59.56 -57.16 14.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.683 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.508 ' HA ' HG12 ' A' ' 55' ' ' VAL . 5.7 ttm105 -57.47 -40.37 78.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -72.11 -29.3 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.214 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.43 -30.91 26.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.221 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.9 p -85.3 -2.97 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.598 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 70.58 34.82 2.04 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.733 0.301 . . . . 0.0 111.288 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' CD ' HG11 ' A' ' 55' ' ' VAL . 13.6 mttt -102.93 -175.36 2.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.796 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.9 m-20 -149.69 175.92 2.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 25.3 Cg_exo -63.15 -11.12 23.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.745 2.297 . . . . 0.0 112.738 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -44.97 -33.17 1.91 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.596 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.725 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 2.7 p90 -116.1 145.29 43.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.76 0.315 . . . . 0.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -77.62 154.95 31.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.652 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.725 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 52.1 mt -141.64 110.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.001 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -105.88 108.6 20.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.754 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.911 HG11 ' CG2' ' A' ' 44' ' ' ILE . 2.2 t -80.05 100.09 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 96' ' ' PHE . 97.8 m-70 -57.8 -63.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -176.77 -173.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.009 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 94' ' ' ALA . 94.9 mt -124.1 154.32 40.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.763 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -138.37 141.1 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.984 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.476 ' HA ' HD23 ' A' ' 92' ' ' LEU . 3.9 m-70 -68.44 -46.74 69.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.47 -85.24 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.04 39.1 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.349 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.99 102.03 2.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.98 57.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.412 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 76' ' ' LEU . 13.1 mt -59.22 157.12 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.188 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' N ' HG22 ' A' ' 75' ' ' ILE . 2.2 mp -138.76 123.83 19.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.455 ' OD1' HD12 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -100.44 -167.54 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.455 HD12 ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -108.95 46.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.389 . . . . 0.0 110.826 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -157.45 27.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.897 ' O ' HG23 ' A' ' 40' ' ' VAL . 65.1 m-20 -142.86 134.37 26.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.895 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 85' ' ' VAL . 24.0 mm -52.59 156.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.038 0.447 . . . . 0.0 111.461 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.981 HD11 HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -73.13 -49.02 30.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.401 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.8 t -64.97 -14.53 60.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.608 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -91.0 -45.91 8.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.648 0.261 . . . . 0.0 111.615 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 81' ' ' ILE . 32.2 m -95.73 -39.22 9.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.02 174.11 7.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.885 0.374 . . . . 0.0 111.28 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.03 144.46 48.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.37 132.55 48.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 tptt 61.66 57.69 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -130.0 164.37 24.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.029 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -111.22 151.06 28.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.75 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 70' ' ' HIS . 13.6 mt -143.49 165.66 26.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.151 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.86 117.83 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.791 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.751 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -97.25 113.42 25.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.63 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.99 118.0 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.398 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.69 ' CD2' HG23 ' A' ' 63' ' ' ILE . 17.0 p90 -144.01 174.5 10.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.068 0.461 . . . . 0.0 111.477 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -107.53 158.14 17.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.787 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 12.2 pt-20 -154.66 137.67 15.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.753 0.311 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.487 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 19.6 tt0 -105.46 60.74 0.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.807 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.0 p30 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.858 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.428 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.766 0.317 . . . . 0.0 110.807 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -153.73 120.39 5.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.485 ' CG2' HD11 ' A' ' 43' ' ' LEU . 5.4 m -140.4 142.96 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.069 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -107.29 118.67 37.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.51 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.4 t -97.76 109.29 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 101.63 14.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.061 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.458 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 58.8 m-85 -85.62 102.82 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.504 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.03 -83.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.32 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -133.78 31.28 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.5 m -137.97 122.24 18.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.758 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -96.67 129.53 44.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.13 137.4 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.35 144.73 26.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.022 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.76 HG11 ' HG ' ' A' ' 43' ' ' LEU . 21.2 t -142.25 92.82 7.39 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.37 121.77 2.33 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.735 2.29 . . . . 0.0 112.518 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.428 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -94.28 123.29 37.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.785 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.56 -53.1 30.32 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.063 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.52 -33.6 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 111.081 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.1 6.19 61.86 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.684 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 31.86 2.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.864 0.364 . . . . 0.0 110.669 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.655 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -97.17 139.63 32.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.641 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.713 ' HE2' HD11 ' A' ' 81' ' ' ILE . 3.7 mmtt -67.9 144.7 55.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.394 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -46.67 -54.3 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.818 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.56 ' HD1' HD22 ' A' ' 78' ' ' LEU . 9.7 t80 -50.18 -29.81 10.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.216 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -73.15 -40.77 64.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.398 . . . . 0.0 110.3 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.112 HD13 HD11 ' A' ' 82' ' ' LEU . 3.7 tt -70.85 -38.26 73.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.681 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.865 ' O ' HG23 ' A' ' 48' ' ' VAL . 6.3 mt -62.54 -48.99 85.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.713 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -59.13 -42.73 91.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.625 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -64.94 -43.43 92.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.591 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.458 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -66.91 -39.52 87.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.914 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.919 HG21 HG21 ' A' ' 65' ' ' VAL . 92.9 t -60.17 -46.51 94.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.435 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.2 m -59.63 -43.52 93.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.287 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -34.98 79.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.628 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 55' ' ' VAL . 8.9 t80 -59.29 -57.12 14.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.471 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -53.31 -47.41 69.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -29.88 67.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.947 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.37 -29.8 57.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.2 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.5 p -97.25 3.88 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.591 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.74 36.52 8.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' CD ' HG11 ' A' ' 55' ' ' VAL . 11.6 mttt -101.78 -174.75 2.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.893 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m-20 -152.54 176.92 2.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.687 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 24.6 Cg_exo -63.47 -10.56 22.13 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.58 2.187 . . . . 0.0 112.734 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -45.26 -37.72 4.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.661 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.804 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.9 p90 -107.59 154.65 21.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.747 0.308 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.502 ' CD1' ' HB2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.45 154.17 24.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.961 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.804 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 66.1 mt -143.44 111.21 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.101 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -104.01 102.42 12.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.919 HG21 HG21 ' A' ' 48' ' ' VAL . 5.1 t -84.75 98.58 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.075 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -60.53 -77.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.074 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -166.9 -174.22 2.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.656 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.732 HD11 HG12 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -120.16 160.49 22.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.46 129.73 23.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -59.65 -29.62 68.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.34 -68.94 0.22 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -158.07 39.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.909 0.385 . . . . 0.0 110.757 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.25 49.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.318 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.05 57.04 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.361 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 mt -59.61 146.51 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.403 . . . . 0.0 111.316 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 5.2 mp -113.53 111.15 21.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.176 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -152.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.092 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.56 HD22 ' HD1' ' A' ' 41' ' ' PHE . 5.6 mt -117.75 27.38 9.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.6 0.238 . . . . 0.0 111.097 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 24.1 m-20 -137.65 -38.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.594 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.496 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -54.7 109.16 0.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.872 0.368 . . . . 0.0 111.615 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.713 HD11 ' HE2' ' A' ' 39' ' ' LYS . 27.8 mm -50.74 158.58 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.489 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.112 HD11 HD13 ' A' ' 43' ' ' LEU . 3.4 mm? -54.88 -59.1 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.269 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 22.0 p -65.3 -14.81 61.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.452 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -80.99 -32.45 34.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.575 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 86' ' ' ALA . 11.5 p -124.95 -45.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.805 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.491 ' N ' HG13 ' A' ' 85' ' ' VAL . . . -76.6 174.12 10.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.992 0.425 . . . . 0.0 111.427 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -143.85 155.16 44.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.7 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -52.82 119.14 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.6 tttp 61.68 71.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -139.62 136.5 34.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.018 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -87.57 147.86 25.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.796 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mt -136.72 153.03 50.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.027 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.3 117.13 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.704 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -99.25 119.26 37.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 111.702 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.15 123.6 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.47 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.57 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.5 p90 -151.32 -174.17 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.032 0.444 . . . . 0.0 111.491 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -125.91 159.06 33.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.962 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -157.18 137.5 12.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.782 0.325 . . . . 0.0 111.384 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.502 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 19.2 tt0 -117.89 59.17 0.79 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.073 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.942 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD2' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.029 0 CA-C-O 120.884 0.373 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.38 120.61 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.992 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.63 142.3 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.977 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.1 m -110.77 106.03 15.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 68' ' ' LEU . 1.4 m -97.84 103.76 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.93 101.77 2.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.037 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 4.5 m-85 -78.52 101.88 7.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.425 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.18 -77.0 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.234 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . 6.2 ttt180 -143.89 30.92 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.889 0.375 . . . . 0.0 110.763 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.9 m -142.02 126.88 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -79.51 117.77 20.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 51' ' ' TYR . 21.8 t -113.06 109.17 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -74.94 144.23 43.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.05 92.62 7.62 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.65 138.42 6.19 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.802 2.335 . . . . 0.0 112.599 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.421 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -113.02 146.39 39.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.61 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.19 -38.74 9.77 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.938 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -121.78 -43.93 2.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.512 ' HA2' HD23 ' A' ' 82' ' ' LEU . . . 111.58 10.87 18.55 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.547 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -97.97 35.11 1.77 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.605 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.436 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.5 OUTLIER -110.16 113.15 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.724 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -54.42 157.39 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.7 t -51.88 -52.11 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.054 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.564 ' HD1' HD22 ' A' ' 78' ' ' LEU . 10.7 t80 -49.49 -29.73 7.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.077 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.436 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 50.5 m -76.11 -42.18 47.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.805 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 40' ' ' VAL . 0.8 OUTLIER -70.86 -37.66 73.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.606 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.88 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.3 mt -64.09 -50.02 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.528 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -57.09 -41.34 78.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.366 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -38.38 90.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.32 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.62 -39.62 73.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.755 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.804 HG21 HG21 ' A' ' 65' ' ' VAL . 92.5 t -58.14 -53.17 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.439 HG23 ' NH2' ' A' ' 52' ' ' ARG . 45.2 m -59.25 -41.56 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.341 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -27.14 64.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.671 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.489 ' O ' HG22 ' A' ' 55' ' ' VAL . 27.5 t80 -68.28 -58.08 4.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.739 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.439 ' NH2' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -58.93 -36.75 75.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.753 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -72.13 -26.06 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.825 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.15 -31.39 25.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.448 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.678 HG23 ' HG3' ' A' ' 57' ' ' LYS . 29.3 m -94.0 17.6 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.649 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 58.6 31.82 21.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.559 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HG3' HG23 ' A' ' 55' ' ' VAL . 19.1 mttm -98.17 -177.19 3.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.799 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.27 175.34 2.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.97 -10.05 23.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.776 2.317 . . . . 0.0 112.815 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -47.65 -63.06 1.16 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.905 0.383 . . . . 0.0 111.283 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 2.7 p90 -75.86 145.64 40.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.83 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.492 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.61 154.12 34.66 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.672 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 62.2 mt -141.4 111.11 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.874 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.492 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.6 OUTLIER -104.84 104.48 14.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.585 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.88 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.0 t -82.42 98.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -61.67 -68.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.067 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -174.87 -176.93 1.04 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.703 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.82 HD11 HG12 ' A' ' 44' ' ' ILE . 9.7 mt -121.86 160.94 23.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 111.063 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -141.26 136.31 31.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.417 ' HA ' HD23 ' A' ' 92' ' ' LEU . 8.3 m-70 -59.8 -51.7 68.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.22 -31.87 0.95 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.565 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -151.8 75.42 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.32 . . . . 0.0 110.829 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.59 76.75 1.01 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.52 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.25 55.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.543 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 mt -64.47 153.81 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.471 HD23 ' CG2' ' A' ' 85' ' ' VAL . 4.4 mp -124.57 121.77 35.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.832 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.45 -163.07 1.01 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.787 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.564 HD22 ' HD1' ' A' ' 41' ' ' PHE . 11.3 mt -109.0 42.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.083 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -157.06 32.3 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.918 ' O ' HG23 ' A' ' 40' ' ' VAL . 6.1 t0 -134.35 134.03 41.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.098 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.843 ' O ' HG12 ' A' ' 85' ' ' VAL . 30.6 mm -61.83 158.37 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.399 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.549 HD12 ' HB3' ' A' ' 86' ' ' ALA . 55.1 tp -65.4 -54.19 32.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.533 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.3 p -72.01 -5.94 38.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.928 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -101.03 -24.66 14.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.518 0.199 . . . . 0.0 111.5 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.843 HG12 ' O ' ' A' ' 81' ' ' ILE . 14.9 p -113.08 -34.21 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.771 0.319 . . . . 0.0 111.553 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.549 ' HB3' HD12 ' A' ' 82' ' ' LEU . . . -110.74 174.22 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.393 . . . . 0.0 111.275 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -136.08 156.26 48.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -52.59 127.05 21.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.032 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.59 70.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -129.78 134.82 47.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.039 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -99.2 113.42 25.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.798 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 70' ' ' HIS . 0.8 OUTLIER -117.02 167.13 11.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.08 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.44 141.83 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.736 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 24' ' ' PHE . . . -113.18 119.86 39.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.411 . . . . 0.0 111.472 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.9 t -105.16 114.6 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.572 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.587 ' HD2' HG23 ' A' ' 63' ' ' ILE . 3.2 p90 -144.91 -177.23 5.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.04 0.448 . . . . 0.0 111.503 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -116.28 157.04 25.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.793 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -157.58 133.53 9.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 111.422 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.483 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 2.5 tt0 -101.55 67.41 1.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.745 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.895 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.769 0.319 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.73 120.88 1.48 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 111.201 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 31' ' ' VAL . 16.0 m -133.51 156.13 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.4 m -117.39 119.47 35.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.903 0.382 . . . . 0.0 111.121 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.577 HG23 HG21 ' A' ' 31' ' ' VAL . 24.1 t -97.96 102.91 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.833 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.6 t -83.9 101.61 11.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.5 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 48.4 m-85 -83.57 99.84 10.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.521 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.86 -83.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.301 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -132.58 31.5 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.352 . . . . 0.0 110.761 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 m -138.35 118.71 13.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.76 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.22 120.51 32.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.086 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.5 138.41 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.986 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.75 142.49 27.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.01 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.577 HG21 HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -141.61 93.78 7.62 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.83 160.39 27.58 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.624 2.216 . . . . 0.0 112.658 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -129.32 129.51 44.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.747 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.38 -41.06 21.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.018 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.11 -33.22 6.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.196 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.25 -0.04 63.6 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.566 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.54 44.68 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.036 0.446 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.404 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.2 OUTLIER -114.87 107.75 15.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.612 ' HG2' HD13 ' A' ' 81' ' ' ILE . 4.0 mttt -53.28 159.25 1.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.055 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 80' ' ' ASP . 40.1 t -51.62 -52.71 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -49.39 -29.04 5.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 110.841 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 13.8 m -75.85 -45.0 38.08 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.398 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.71 HD22 HD13 ' A' ' 82' ' ' LEU . 4.2 pp -72.98 -34.75 66.65 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.896 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.927 ' O ' HG23 ' A' ' 48' ' ' VAL . 5.1 mt -66.43 -48.06 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 110.431 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -57.95 -45.79 86.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -37.11 83.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.282 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -72.55 -37.18 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.829 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 44' ' ' ILE . 60.9 t -59.41 -54.98 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.325 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -58.11 -44.11 87.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.355 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -35.84 78.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.582 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.769 ' O ' HG22 ' A' ' 55' ' ' VAL . 33.6 t80 -59.99 -57.96 10.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.255 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -49.26 -44.13 43.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.701 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -28.94 68.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.583 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.01 -29.76 43.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.008 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -98.45 18.14 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.268 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.96 28.68 3.95 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.441 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -95.0 -172.46 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -151.9 172.33 5.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.432 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 36.7 Cg_endo -65.74 -8.09 18.49 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.205 1.937 . . . . 0.0 112.818 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -45.77 -42.92 12.61 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.742 0.306 . . . . 0.0 111.436 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.844 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 7.5 p90 -97.02 161.16 13.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.76 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.497 ' CD1' ' HB2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -87.27 154.34 20.77 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.694 0.283 . . . . 0.0 111.149 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.844 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 86.0 mt -143.11 111.47 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.788 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -99.25 102.01 13.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.682 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.611 HG11 ' CG2' ' A' ' 44' ' ' ILE . 9.9 t -81.43 95.42 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -56.18 -77.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.283 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.26 -177.61 4.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.875 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.56 ' HB3' HD13 ' A' ' 76' ' ' LEU . 1.3 mm? -115.58 147.91 40.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.94 132.58 42.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -58.33 -28.84 65.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.059 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.36 -59.77 0.53 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.567 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.59 32.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 0.0 110.848 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.53 78.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.44 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.11 62.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.409 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 76' ' ' LEU . 11.7 mt -59.5 157.95 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.617 HD23 ' CG2' ' A' ' 85' ' ' VAL . 1.8 mp -131.87 121.17 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' O ' HG11 ' A' ' 40' ' ' VAL . 29.2 m-20 -97.22 -174.48 2.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.55 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.519 HD23 HD12 ' A' ' 44' ' ' ILE . 1.6 mt -104.0 34.1 3.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -150.17 34.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.186 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.901 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -139.33 132.28 29.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.918 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.621 ' O ' HG12 ' A' ' 85' ' ' VAL . 21.8 mm -56.38 154.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.086 0.47 . . . . 0.0 111.318 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.71 HD13 HD22 ' A' ' 43' ' ' LEU . 49.3 tp -63.0 -52.77 61.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.288 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 64.5 m -67.89 -11.36 58.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.738 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -97.9 -22.72 16.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 81' ' ' ILE . 14.4 p -111.21 -44.04 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.638 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.468 ' N ' HG13 ' A' ' 85' ' ' VAL . . . -101.33 174.18 6.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.322 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -129.31 149.65 51.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.673 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -51.81 126.43 17.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.151 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm 61.69 67.64 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -136.63 153.29 50.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.403 ' NH1' ' HB2' ' A' ' 91' ' ' ARG . 2.3 mtm105 -104.35 146.18 29.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.661 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB3' HD12 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -137.7 152.65 49.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.187 -179.687 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 t -108.29 108.64 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.596 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.68 129.5 36.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.989 0.423 . . . . 0.0 111.809 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.8 t -110.8 126.65 68.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.436 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.653 ' HD2' HG23 ' A' ' 63' ' ' ILE . 3.4 p90 -150.16 179.69 7.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.116 0.484 . . . . 0.0 111.432 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -116.13 162.35 17.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.721 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.2 pt-20 -161.58 134.76 6.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.8 0.333 . . . . 0.0 111.456 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.497 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 13.8 tt0 -102.88 72.74 1.22 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.623 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.902 -179.865 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.696 0.284 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -162.74 120.46 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 111.279 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 43' ' ' LEU . 4.3 m -134.72 142.57 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.835 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.6 m -114.1 107.62 15.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.997 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.435 HG23 ' CG2' ' A' ' 29' ' ' VAL . 18.8 m -97.91 137.35 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.979 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.8 m -103.49 102.58 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.24 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 40.6 m-85 -77.13 95.47 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.442 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.9 -73.89 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.144 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' PHE . 1.6 mmt85 -143.54 29.09 1.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 110.565 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.8 m -136.31 114.82 11.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.757 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -87.11 127.38 35.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.435 ' CG2' HG23 ' A' ' 22' ' ' VAL . 23.8 m -133.23 140.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.114 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.27 149.5 21.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.076 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.608 HG11 ' HG ' ' A' ' 43' ' ' LEU . 21.6 t -137.81 96.03 10.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.39 127.72 6.74 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.609 2.206 . . . . 0.0 112.303 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.3 154.98 22.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.05 -69.4 1.38 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.576 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -109.15 -17.84 13.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 111.203 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.83 14.97 57.3 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.444 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -100.31 29.13 4.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 110.825 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 ttp -98.2 130.26 44.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -57.63 142.96 43.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.595 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 80' ' ' ASP . 92.7 t -48.46 -45.44 14.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.72 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -50.17 -35.18 25.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.111 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 m -74.57 -37.56 62.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.469 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.667 HD13 HD13 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -70.28 -39.02 75.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.683 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.883 ' O ' HG23 ' A' ' 48' ' ' VAL . 4.1 mt -64.26 -49.4 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.654 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -38.92 80.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.63 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -42.95 84.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.507 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -68.26 -40.34 81.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.893 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 44' ' ' ILE . 69.4 t -56.63 -52.09 58.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.118 0.485 . . . . 0.0 110.471 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -57.27 -43.73 83.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.422 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -38.81 80.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.573 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' HG12 ' A' ' 55' ' ' VAL . 9.8 t80 -58.66 -56.49 21.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.474 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.4 mtm-85 -48.88 -47.8 42.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -32.28 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.062 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 -26.71 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.042 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.1 p -99.13 1.86 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 67.53 30.89 6.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.765 0.317 . . . . 0.0 111.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HD2' HG11 ' A' ' 55' ' ' VAL . 11.4 mttt -99.2 -175.14 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.736 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.1 m-20 -146.13 175.85 2.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 24.3 Cg_exo -64.15 -7.92 15.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.89 2.393 . . . . 0.0 112.932 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -48.02 -66.99 0.31 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.88 0.372 . . . . 0.0 110.99 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.748 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 1.9 p90 -74.37 160.71 30.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.576 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -89.49 151.64 21.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.791 0.329 . . . . 0.0 111.258 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.748 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 35.0 mt -142.08 111.0 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.686 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.49 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -109.04 101.53 10.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.674 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 65' ' ' VAL . 11.3 p -86.3 96.74 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.144 0.497 . . . . 0.0 111.032 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -54.29 -81.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.586 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.07 -167.08 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.802 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.542 HD11 HG12 ' A' ' 44' ' ' ILE . 4.0 mt -127.66 164.99 20.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.847 0.356 . . . . 0.0 111.143 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.409 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -141.21 141.92 34.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.839 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.546 ' HA ' HD23 ' A' ' 92' ' ' LEU . 14.0 m-70 -64.59 -35.82 82.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.993 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.54 -77.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.574 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.63 40.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.27 103.15 2.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.441 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.3 58.19 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.582 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 76' ' ' LEU . 7.7 mt -68.32 158.44 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.297 . . . . 0.0 111.046 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -158.41 131.84 7.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.16 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -90.81 -156.61 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.802 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.653 ' CD2' HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -112.26 84.92 2.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.85 0.357 . . . . 0.0 110.74 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -171.75 -40.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.928 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.1 m-20 -76.09 142.5 41.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.864 ' O ' HG12 ' A' ' 85' ' ' VAL . 27.6 mm -56.75 156.89 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.17 0.51 . . . . 0.0 111.474 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.667 HD13 HD13 ' A' ' 43' ' ' LEU . 64.6 tp -66.39 -56.7 9.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.293 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.83 -14.74 61.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.584 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -90.53 -28.21 18.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.586 0.231 . . . . 0.0 111.328 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.864 HG12 ' O ' ' A' ' 81' ' ' ILE . 14.6 p -117.09 4.48 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.83 174.22 11.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.35 . . . . 0.0 111.212 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.77 152.85 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.817 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.54 135.95 54.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.993 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.55 58.1 3.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.769 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -120.78 157.86 28.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.066 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -116.39 137.06 52.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 70' ' ' HIS . 1.5 mp -142.89 154.39 44.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.069 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 69' ' ' GLU . 1.4 m -99.62 117.76 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.66 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -91.83 122.74 34.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.694 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.3 126.37 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.271 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.475 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -155.33 169.72 23.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.239 0.542 . . . . 0.0 112.124 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.91 157.09 25.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -153.8 136.43 15.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 111.327 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.48 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 6.7 tt0 -105.23 63.96 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.801 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.721 0.295 . . . . 0.0 110.53 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -152.25 120.66 6.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.983 0.42 . . . . 0.0 111.069 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 86' ' ' ALA . 4.6 m -132.34 142.42 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.921 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -106.43 125.34 50.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.816 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.005 HG12 ' HB2' ' A' ' 94' ' ' ALA . 2.9 t -112.66 109.96 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.96 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.1 m -75.27 101.51 4.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.514 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 7.4 m-85 -84.74 97.32 9.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.705 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.32 -92.87 0.01 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.509 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.34 31.72 6.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.876 0.37 . . . . 0.0 110.641 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.0 m -153.35 117.67 4.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 135.21 33.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.028 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.16 137.08 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.167 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.78 148.94 25.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.9 t -138.93 92.88 10.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.229 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.42 124.94 3.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.767 2.311 . . . . 0.0 112.493 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.52 ' SG ' HD22 ' A' ' 82' ' ' LEU . 8.2 m -103.62 136.96 42.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.784 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.38 -41.77 93.34 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.996 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -128.68 -46.53 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.878 0.37 . . . . 0.0 111.236 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.23 12.19 8.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.46 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 -93.85 35.61 1.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.923 0.392 . . . . 0.0 110.576 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.467 ' HG2' ' HB2' ' A' ' 42' ' ' SER . 8.9 ttm -111.17 114.19 27.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.702 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -49.7 144.36 6.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.215 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 80' ' ' ASP . 27.5 t -46.61 -44.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 111.146 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.628 ' HD1' HD22 ' A' ' 78' ' ' LEU . 6.0 t80 -50.64 -41.15 54.91 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.531 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.467 ' HB2' ' HG2' ' A' ' 38' ' ' MET . 2.9 m -71.98 -34.41 68.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 110.223 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.539 HD13 HD13 ' A' ' 82' ' ' LEU . 2.3 tp -66.98 -35.41 79.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.155 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.969 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.5 mt -65.88 -51.28 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.547 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -55.76 -36.66 67.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.485 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -67.19 -42.37 84.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.567 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -69.48 -41.77 75.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.974 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 65' ' ' VAL . 61.2 t -56.41 -52.89 46.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.723 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.1 m -58.31 -44.34 88.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.484 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -62.74 -36.92 84.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.697 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -58.16 -52.94 63.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.534 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -55.19 -49.09 72.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.863 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -70.49 -24.61 62.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.85 -41.41 62.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 0.0 111.28 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.4 p -93.06 9.69 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.668 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 62.8 37.68 12.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.758 0.313 . . . . 0.0 111.466 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 31.8 mttt -96.54 -174.36 3.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -144.86 172.27 5.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.43 -10.71 22.57 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.822 2.348 . . . . 0.0 112.797 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.21 -59.09 3.11 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.835 0.35 . . . . 0.0 111.45 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.818 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.6 p90 -79.58 141.24 36.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CD1' ' HB2' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -76.71 156.18 32.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.621 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.818 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 57.9 mt -142.03 111.22 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.075 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.488 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -103.96 105.53 15.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.516 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.969 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.1 t -82.54 100.05 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.203 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -63.62 -70.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -168.42 -173.01 1.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.749 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.895 HD11 HG12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -131.35 158.86 39.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.829 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -142.81 141.14 31.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -61.53 -45.19 95.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.81 -87.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.519 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -120.38 33.8 5.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.797 0.332 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.22 89.56 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.445 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.57 62.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.435 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 76' ' ' LEU . 14.2 mt -56.68 156.05 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.942 0.401 . . . . 0.0 111.104 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.881 HD11 HD22 ' A' ' 92' ' ' LEU . 2.6 mt -126.8 115.05 18.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.058 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.71 -163.13 1.01 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.794 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.657 ' CD2' HD12 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -117.38 77.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.867 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -174.61 -62.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.238 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.853 ' O ' HG23 ' A' ' 40' ' ' VAL . 6.6 t0 -53.05 128.08 26.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.329 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 83' ' ' CYS . 24.1 mm -54.12 146.6 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.479 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.744 ' HG ' ' HB3' ' A' ' 86' ' ' ALA . 4.5 tp -60.77 -39.72 89.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.373 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.62 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -67.02 -12.87 61.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.619 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.12 -29.86 12.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.646 0.26 . . . . 0.0 111.392 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 86' ' ' ALA . 32.6 m -104.26 -44.7 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.864 0.364 . . . . 0.0 111.668 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.744 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . . . -88.81 174.07 8.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.204 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -145.14 155.39 43.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.677 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -48.8 118.22 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.26 57.84 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -112.69 147.53 36.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.488 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -96.65 148.59 22.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.881 HD22 HD11 ' A' ' 76' ' ' LEU . 16.6 mt -146.2 169.09 19.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.05 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 t -127.7 114.4 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.005 ' HB2' HG12 ' A' ' 22' ' ' VAL . . . -94.12 122.68 36.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.44 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.42 112.01 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.63 ' CD2' HG23 ' A' ' 63' ' ' ILE . 20.2 p90 -141.22 174.46 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.011 0.434 . . . . 0.0 111.282 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -108.48 159.6 16.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.026 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.4 pt-20 -156.53 135.45 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 111.244 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.489 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 30.8 tt0 -107.23 69.52 0.76 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.967 0.413 . . . . 0.0 110.899 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.1 p30 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.957 -179.91 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.746 ' CE2' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.79 0.329 . . . . 0.0 111.097 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.59 120.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.5 m -137.51 141.91 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.1 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.407 ' CG2' ' CG ' ' A' ' 28' ' ' ARG . 5.8 m -105.55 120.03 40.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.865 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.905 HG13 HD11 ' A' ' 68' ' ' LEU . 17.1 t -101.61 111.76 32.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -92.13 101.64 14.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.663 ' CE2' HG22 ' A' ' 48' ' ' VAL . 65.9 m-85 -85.52 108.01 17.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.697 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.74 -87.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.377 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -131.55 31.63 4.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.364 . . . . 0.0 110.702 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.1 m -137.76 136.54 37.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.407 ' CG ' ' CG2' ' A' ' 21' ' ' THR . 10.3 ttm180 -101.14 137.5 39.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.48 126.67 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -86.96 144.45 26.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.797 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.0 t -142.29 92.64 7.41 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.196 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.62 122.57 2.74 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.788 2.325 . . . . 0.0 112.481 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -91.13 137.45 32.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.79 -53.53 44.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.685 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -117.27 -38.19 3.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.41 17.87 10.92 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.594 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 -104.61 32.6 4.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.707 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 7.8 ttp -101.83 168.91 9.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -100.25 151.05 21.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.695 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 80' ' ' ASP . 57.7 t -50.42 -47.23 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -49.97 -32.5 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.392 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -36.9 47.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.824 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -72.24 -38.27 68.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.567 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.986 HD13 HD23 ' A' ' 68' ' ' LEU . 4.9 mt -67.44 -45.86 84.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.552 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -59.35 -41.26 88.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.759 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -66.99 -45.83 76.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.536 ' HB1' ' HE1' ' A' ' 24' ' ' PHE . . . -65.66 -39.46 91.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.134 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 65' ' ' VAL . 71.0 t -58.45 -50.71 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.573 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.1 m -57.38 -45.06 84.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.64 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -63.07 -36.69 84.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.77 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' O ' HG12 ' A' ' 55' ' ' VAL . 4.8 t80 -58.39 -57.18 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -54.64 -48.73 71.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.261 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -72.05 -24.45 61.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.327 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.6 -35.07 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 111.267 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.6 p -89.24 9.35 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.537 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.56 52.92 1.67 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.006 0.432 . . . . 0.0 111.197 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 16.0 mttm -122.74 -175.41 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.99 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.491 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.2 m-20 -153.32 172.21 5.93 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.472 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 20.5 Cg_endo -61.07 -10.54 15.36 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.339 2.026 . . . . 0.0 112.932 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -43.68 -36.19 2.1 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.7 0.286 . . . . 0.0 111.691 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.74 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 4.7 p90 -108.96 159.88 16.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.698 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.487 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -87.06 151.89 22.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 111.196 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.74 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 57.2 mt -141.73 111.26 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.746 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.487 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -108.41 107.13 17.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.818 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 48' ' ' VAL . 7.7 t -82.56 100.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -57.41 -75.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.513 ' NH1' HG21 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -163.51 -171.94 2.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.986 HD23 HD13 ' A' ' 44' ' ' ILE . 2.2 mm? -125.87 157.06 38.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.95 0.405 . . . . 0.0 110.847 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 75' ' ' ILE . 2.7 mp0 -142.54 161.13 38.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.76 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.584 ' HA ' HD23 ' A' ' 92' ' ' LEU . 35.9 m-70 -79.93 -61.48 1.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.833 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.19 79.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.567 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 60.31 44.46 12.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.52 62.11 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.21 46.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.602 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.513 HG21 ' NH1' ' A' ' 67' ' ' ARG . 12.3 mt -62.77 154.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.73 0.3 . . . . 0.0 111.001 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -155.42 144.79 21.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.963 0.411 . . . . 0.0 111.274 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -94.56 -160.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.73 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.443 HD23 HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -108.58 86.45 2.29 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.764 0.316 . . . . 0.0 110.864 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -176.9 -39.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.878 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -66.83 128.25 35.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.656 ' O ' HG12 ' A' ' 85' ' ' VAL . 30.9 mm -55.23 157.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.021 0.438 . . . . 0.0 111.638 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.746 HD12 ' CE2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -56.89 -57.0 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.632 -179.393 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.6 t -74.12 -3.64 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.885 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -95.5 -30.65 13.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.589 0.233 . . . . 0.0 111.4 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 81' ' ' ILE . 10.2 p -120.51 -30.37 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.91 174.22 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 0.0 111.299 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -136.77 155.75 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.838 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.32 133.84 19.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.87 66.21 1.26 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.803 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -124.41 131.51 53.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.11 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -93.84 105.39 17.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.628 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 70' ' ' HIS . 46.2 mt -101.12 145.78 28.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.341 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.566 ' O ' HD13 ' A' ' 68' ' ' LEU . 23.5 t -94.04 121.36 44.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.592 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.733 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -98.56 122.84 42.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.997 0.427 . . . . 0.0 111.891 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 t -108.45 122.96 63.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.194 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.54 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.8 p90 -149.4 -175.12 4.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.217 0.532 . . . . 0.0 111.615 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.02 154.95 36.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.952 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.2 pt-20 -155.54 132.73 10.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.738 0.304 . . . . 0.0 111.302 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.47 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -97.77 69.52 2.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.716 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.756 0.313 . . . . 0.0 110.687 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.94 120.62 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.26 142.77 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.013 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 m -104.53 105.73 15.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.35 103.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.2 t -79.16 101.59 8.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.507 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 8.4 m-85 -80.1 100.15 8.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.631 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 -79.12 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.319 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . 5.5 mmt85 -139.92 31.18 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.356 . . . . 0.0 110.771 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.7 m -140.92 122.23 14.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.886 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 122.74 29.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.834 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.78 107.5 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.317 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.94 147.99 40.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.723 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.59 HG11 HD22 ' A' ' 43' ' ' LEU . 20.1 t -141.29 103.47 6.06 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.339 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -85.5 140.35 7.26 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.731 2.287 . . . . 0.0 112.278 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.8 m -114.8 141.8 47.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.42 -50.28 60.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.743 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -112.63 -29.27 7.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.52 17.11 50.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -109.96 31.69 5.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.832 0.349 . . . . 0.0 110.7 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.9 ttp -93.78 127.34 39.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -58.14 144.8 39.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.586 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 80' ' ' ASP . 43.4 t -47.78 -45.48 11.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.837 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 67.9 t80 -50.2 -38.01 37.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.181 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.0 t -73.63 -33.0 64.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 110.235 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.742 HD13 ' O ' ' A' ' 43' ' ' LEU . 1.4 tm? -72.17 -38.18 69.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.679 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.821 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.6 mt -66.51 -43.9 90.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -64.25 -39.5 94.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.605 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -67.44 -37.28 82.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.367 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -75.79 -37.3 59.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.034 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -60.54 -44.29 96.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.976 0.417 . . . . 0.0 110.585 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.422 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 86.3 m -68.6 -46.69 68.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.531 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.03 -32.73 74.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.705 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -64.33 -57.67 8.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.651 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -52.61 -42.56 64.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -72.2 -30.96 65.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.96 -37.16 69.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.052 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.446 HG21 ' CE ' ' A' ' 57' ' ' LYS . 35.4 m -88.57 7.78 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.539 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 61.47 41.02 13.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 111.333 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.477 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 49.5 mttt -101.89 -174.62 2.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.454 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.8 OUTLIER -144.46 172.05 5.93 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.571 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 52.0 Cg_endo -69.3 -6.04 17.4 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.281 1.988 . . . . 0.0 112.875 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -49.42 -38.05 27.74 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.711 0.291 . . . . 0.0 111.283 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.768 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.1 p90 -104.61 149.32 25.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -80.74 153.66 27.69 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.842 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.768 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 48.9 mt -141.95 111.01 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.847 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.497 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.9 OUTLIER -108.94 109.43 20.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.673 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.821 HG11 ' CG2' ' A' ' 44' ' ' ILE . 2.2 t -82.13 102.6 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.247 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -57.45 -77.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -160.07 -179.36 7.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.021 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.581 HD11 ' HB2' ' A' ' 94' ' ' ALA . 3.4 mm? -114.87 159.93 20.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -145.52 140.2 27.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.781 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -63.61 -54.91 28.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.28 -52.56 0.16 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.544 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -152.92 31.96 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.79 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.12 75.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.563 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.41 68.96 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.414 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 76' ' ' LEU . 3.6 mm -65.18 157.13 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.906 0.384 . . . . 0.0 111.059 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.632 HD23 ' CG2' ' A' ' 85' ' ' VAL . 3.8 mp -132.65 119.35 20.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.039 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -98.07 173.24 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.68 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.589 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.26 76.6 6.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.92 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -176.06 -44.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.013 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.906 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -66.93 138.97 57.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.984 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 85' ' ' VAL . 30.6 mm -61.05 158.94 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.507 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.716 HD12 ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -58.01 -59.18 5.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.442 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.5 t -67.44 -12.83 61.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.783 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -90.85 -21.93 21.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.623 0.249 . . . . 0.0 111.485 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.632 ' CG2' HD23 ' A' ' 76' ' ' LEU . 14.9 p -110.9 -26.58 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.583 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.99 174.64 10.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.372 . . . . 0.0 111.442 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -127.08 159.66 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.477 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 11.7 p-10 -47.51 153.46 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.134 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 35.06 57.72 0.77 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.005 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -110.02 161.57 15.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.981 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -114.7 130.15 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.76 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.43 HD23 HD11 ' A' ' 76' ' ' LEU . 2.1 mp -144.55 160.84 40.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.109 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.23 138.62 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.775 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -113.04 133.47 54.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.423 . . . . 0.0 111.65 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.01 131.9 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.295 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.478 ' HB3' ' HA ' ' A' ' 65' ' ' VAL . 37.2 p90 -152.06 177.73 10.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.013 0.435 . . . . 0.0 111.632 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.61 157.36 22.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.021 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 8.7 pt-20 -154.34 139.32 17.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.686 0.279 . . . . 0.0 111.388 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.482 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 6.1 tt0 -109.72 63.34 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.914 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.943 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.424 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.771 0.319 . . . . 0.0 110.738 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -157.85 120.57 3.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.051 0.453 . . . . 0.0 111.167 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 m -136.79 143.23 35.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.835 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.0 m -101.12 116.06 31.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.494 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t -98.0 102.84 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.78 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 2.7 t -82.88 102.12 11.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.191 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.505 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 29.7 m-85 -84.58 98.83 10.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.28 -83.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.299 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -133.51 30.98 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.81 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.4 m -139.21 116.39 11.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -89.09 120.84 30.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.84 116.66 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.03 149.2 39.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.8 t -142.03 95.97 6.72 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.39 108.67 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.661 2.241 . . . . 0.0 112.337 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.424 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -79.23 140.76 37.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.818 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.77 -54.97 29.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.91 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.7 -40.85 2.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.98 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.38 13.51 8.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.647 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.5 mtm-85 -98.79 30.18 3.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.823 0.344 . . . . 0.0 110.724 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -102.53 114.04 27.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.704 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -49.74 148.71 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.71 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 80' ' ' ASP . 23.8 t -46.92 -48.44 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.938 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 78' ' ' LEU . 1.2 t80 -50.81 -44.99 59.17 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.059 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.9 t -58.93 -42.44 89.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.997 0.427 . . . . 0.0 110.328 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.46 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.655 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.854 HG23 HG11 ' A' ' 65' ' ' VAL . 7.5 mt -64.7 -48.21 85.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.877 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -60.99 -44.86 96.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -39.21 90.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.51 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.505 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -72.35 -34.01 67.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.071 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.497 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -63.79 -44.76 98.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.95 0.405 . . . . 0.0 110.721 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.411 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 89.2 m -65.96 -44.49 84.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.548 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -64.77 -27.39 68.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.67 ' O ' HG12 ' A' ' 55' ' ' VAL . 52.5 t80 -69.13 -57.71 5.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.848 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.478 ' HA ' HG12 ' A' ' 55' ' ' VAL . 28.2 ptt180 -59.85 -39.29 84.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.055 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -72.27 -35.27 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.03 -29.94 43.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.43 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 51' ' ' TYR . 14.4 p -87.96 7.74 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.701 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.76 36.2 10.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.798 0.332 . . . . 0.0 111.413 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.546 ' HD2' HG11 ' A' ' 55' ' ' VAL . 43.9 mttt -107.4 -176.61 3.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.842 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.4 m-20 -139.28 175.47 3.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.016 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 20.0 Cg_exo -66.05 -7.85 18.29 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.92 2.414 . . . . 0.0 112.877 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.08 -71.49 0.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.956 0.408 . . . . 0.0 111.113 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.776 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 1.3 p90 -64.5 150.71 46.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.809 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.543 ' CZ3' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.18 152.99 25.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.777 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.776 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 18.4 mt -143.04 110.39 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.055 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -113.94 101.93 9.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.63 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.854 HG11 HG23 ' A' ' 44' ' ' ILE . 2.4 t -76.61 97.85 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.151 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -52.28 -70.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.155 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.47 -175.53 3.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 mt -127.56 161.47 28.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.998 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -143.69 159.62 42.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.783 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.57 ' HA ' HD23 ' A' ' 92' ' ' LEU . 12.9 m-70 -77.85 -50.52 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.13 -88.73 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -96.19 41.32 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.814 0.34 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.25 98.18 1.68 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.19 61.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.435 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 76' ' ' LEU . 14.1 mt -56.3 158.15 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 111.029 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.807 HD11 HD22 ' A' ' 92' ' ' LEU . 2.8 mt -135.96 106.69 6.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.531 ' OD1' HD12 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -79.27 -164.92 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.533 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.65 HD23 HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -115.96 74.56 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 0.0 110.794 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.48 -52.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.105 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.825 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -57.44 129.03 39.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.033 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 85' ' ' VAL . 15.7 mm -54.25 152.97 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.025 0.44 . . . . 0.0 111.511 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.01 -53.32 58.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.371 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.6 p -66.49 -12.17 56.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.687 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.85 -32.39 16.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.656 0.265 . . . . 0.0 111.567 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 86' ' ' ALA . 14.7 p -112.23 -45.24 5.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.754 0.312 . . . . 0.0 111.691 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.497 ' N ' HG13 ' A' ' 85' ' ' VAL . . . -86.06 174.09 9.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.384 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -135.58 155.37 50.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -56.37 126.37 26.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.048 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.8 tptt 60.7 69.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -139.7 138.5 36.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -85.9 146.02 26.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.785 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.807 HD22 HD11 ' A' ' 76' ' ' LEU . 8.3 mt -142.07 145.1 33.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.199 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.0 133.36 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.494 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -113.22 118.0 33.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.374 . . . . 0.0 111.639 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.3 t -104.13 122.71 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.418 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.445 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.6 p90 -149.5 -175.34 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.115 0.483 . . . . 0.0 111.709 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -131.55 127.97 38.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.177 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.1 pt-20 -128.46 138.83 52.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.824 0.345 . . . . 0.0 111.004 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -98.44 65.69 1.66 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.809 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.986 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.343 . . . . 0.0 110.878 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -164.59 120.45 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.034 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.5 m -138.84 141.97 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.127 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 m -101.17 116.11 32.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.659 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.735 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 10.7 t -101.83 111.77 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.085 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.52 101.52 13.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.492 ' HE2' HG22 ' A' ' 48' ' ' VAL . 15.1 m-85 -83.76 99.81 10.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.538 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.3 -85.97 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.432 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 24' ' ' PHE . 13.1 mtt-85 -130.18 31.23 4.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.893 0.377 . . . . 0.0 110.838 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.1 m -141.25 120.84 13.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.789 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -94.78 130.13 41.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 m -139.19 120.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.8 148.89 39.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.821 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.46 92.94 14.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.237 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.17 116.79 2.76 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.611 2.207 . . . . 0.0 112.312 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.19 150.98 22.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.78 -68.73 1.54 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.451 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.44 -32.43 9.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.38 3.18 41.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.824 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.9 35.84 1.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.41 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 2.2 ttp -100.57 142.21 32.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.23 146.39 52.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.701 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.943 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.1 t -49.49 -44.78 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.861 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -50.17 -36.79 31.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.41 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 1.1 m -74.82 -34.62 62.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.154 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.464 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -69.34 -41.98 75.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.528 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.909 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.0 mt -64.44 -45.65 95.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.846 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.26 -37.53 80.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.718 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -45.01 76.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.756 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.477 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -68.13 -44.19 76.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.232 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 44' ' ' ILE . 85.9 t -54.59 -53.55 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 110.713 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 88.3 m -57.03 -42.57 80.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.383 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -34.53 78.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 55' ' ' VAL . 32.5 t80 -60.2 -57.23 13.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.484 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HD3' HD12 ' A' ' 63' ' ' ILE . 53.3 mtm180 -53.71 -44.96 70.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -32.8 69.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.018 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.65 -29.06 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 51' ' ' TYR . 14.6 p -94.78 -3.76 10.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.611 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 70.31 36.26 1.84 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.788 0.328 . . . . 0.0 111.21 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.646 ' HD2' HG11 ' A' ' 55' ' ' VAL . 20.1 mttt -104.58 -176.04 2.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.881 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.6 m-20 -149.47 176.57 2.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.759 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 25.0 Cg_exo -63.42 -9.9 19.57 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.632 2.221 . . . . 0.0 112.869 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -44.7 -32.74 1.6 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.709 0.29 . . . . 0.0 111.73 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.883 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 6.7 p90 -110.56 163.1 14.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.832 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -89.64 154.07 20.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.877 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.883 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 79.9 mt -143.58 110.75 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.157 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.488 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -106.71 101.93 11.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.262 179.244 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.909 HG11 ' CG2' ' A' ' 44' ' ' ILE . 5.4 t -79.32 94.79 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.007 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -53.37 -70.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.078 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -173.54 -177.68 1.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.834 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.882 HD11 HG12 ' A' ' 44' ' ' ILE . 6.8 mt -116.14 159.92 21.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.962 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -137.23 144.72 42.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.963 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.614 ' HA ' HD23 ' A' ' 92' ' ' LEU . 2.3 m-70 -66.53 -31.06 71.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.74 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.15 -38.56 1.1 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -172.33 35.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.829 0.347 . . . . 0.0 110.801 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.4 72.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.415 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.6 64.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.404 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 76' ' ' LEU . 9.1 mt -65.87 158.01 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 111.266 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.492 HD23 ' CG2' ' A' ' 85' ' ' VAL . 2.1 mp -133.06 128.17 35.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.758 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.415 ' O ' HG11 ' A' ' 40' ' ' VAL . 2.9 m-20 -94.92 -166.24 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.36 43.93 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -156.56 26.52 0.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.943 ' O ' HG23 ' A' ' 40' ' ' VAL . 4.6 t0 -137.13 144.39 42.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.824 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.844 ' O ' HG22 ' A' ' 85' ' ' VAL . 29.1 mm -57.09 156.77 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.576 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.422 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 41.4 tp -74.8 -50.7 16.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.269 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.44 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 10.5 t -59.69 -20.26 55.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.361 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -85.54 -59.64 2.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.329 . . . . 0.0 111.377 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 81' ' ' ILE . 21.1 m -76.56 -16.35 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.826 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.02 174.22 10.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 0.0 111.282 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.55 155.06 50.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.866 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -52.67 130.09 31.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.02 66.55 1.03 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -131.85 156.0 46.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.02 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.83 144.35 31.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.614 HD23 ' HA ' ' A' ' 70' ' ' HIS . 12.5 mt -144.13 145.34 32.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.004 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.41 119.8 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.735 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -95.53 121.41 37.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.54 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.3 120.27 60.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.762 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' A' ' 65' ' ' VAL . 14.3 p90 -148.23 171.36 16.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.054 0.454 . . . . 0.0 111.128 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -114.55 133.88 55.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.059 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.1 pt-20 -133.67 138.39 45.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.788 0.328 . . . . 0.0 111.212 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.438 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -101.37 69.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.4 t0 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.891 179.874 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.833 0.349 . . . . 0.0 110.854 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.17 120.22 2.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.051 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.532 HG11 ' HB1' ' A' ' 86' ' ' ALA . 3.5 m -132.59 142.86 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.012 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.0 m -103.2 108.92 20.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.4 t -97.92 102.75 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.4 t -85.19 101.55 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.493 ' HE2' HG22 ' A' ' 48' ' ' VAL . 20.3 m-85 -79.99 99.93 7.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.529 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.92 -80.6 0.02 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.263 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . 2.7 mtt180 -137.08 30.82 2.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.935 0.398 . . . . 0.0 110.636 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 83.1 m -138.65 121.26 16.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.57 126.23 33.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.94 114.06 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -74.88 146.35 41.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.41 ' HB ' HG23 ' A' ' 20' ' ' VAL . 21.4 t -142.09 93.68 7.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.28 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.22 128.51 3.62 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.818 2.346 . . . . 0.0 112.329 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.406 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -98.59 136.94 37.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.54 77.43 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.77 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.25 -44.07 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.72 18.37 6.09 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.562 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -98.17 29.24 3.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.827 0.346 . . . . 0.0 110.701 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.422 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 6.0 ttp -108.09 133.9 51.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.754 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -70.84 148.42 47.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 80' ' ' ASP . 46.8 t -47.81 -40.76 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 14.5 t80 -50.71 -42.49 57.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.872 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.422 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.8 OUTLIER -72.49 -29.56 63.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.195 179.546 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.839 ' HG ' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -71.29 -39.85 71.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.525 179.658 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.887 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.7 mt -65.45 -48.65 82.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.775 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -60.86 -35.67 77.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.713 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -68.93 -42.99 76.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HB1' ' HE1' ' A' ' 24' ' ' PHE . . . -71.43 -43.63 66.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 65' ' ' VAL . 93.1 t -56.24 -48.28 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.5 m -61.17 -49.3 77.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.298 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -31.66 72.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.547 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.618 ' O ' HG12 ' A' ' 55' ' ' VAL . 32.0 t80 -62.31 -57.69 10.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.451 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HE ' HD12 ' A' ' 63' ' ' ILE . 11.7 ttm105 -52.42 -44.81 65.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -24.59 61.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.96 -30.17 26.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.222 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.718 HG13 ' HD2' ' A' ' 57' ' ' LYS . 12.8 p -103.32 20.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.304 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 48.03 89.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.382 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.718 ' HD2' HG13 ' A' ' 55' ' ' VAL . 11.0 mttt -155.13 -172.2 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.864 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -162.2 177.7 1.86 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.698 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 32.3 Cg_exo -58.46 -13.56 17.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.698 2.265 . . . . 0.0 112.937 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -42.82 -36.73 1.57 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.668 0.271 . . . . 0.0 111.571 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.822 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 2.1 p90 -115.49 153.02 31.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.697 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.89 154.66 24.49 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 111.194 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.822 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 79.6 mt -142.54 110.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.479 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.519 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.6 OUTLIER -105.39 106.3 16.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.061 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 48' ' ' VAL . 8.7 t -82.49 100.46 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.428 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -61.22 -67.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.632 ' NH1' HD13 ' A' ' 75' ' ' ILE . 1.1 ptp180 -176.53 -178.29 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.8 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.74 HD11 HG12 ' A' ' 44' ' ' ILE . 10.1 mt -121.62 155.63 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.979 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -144.8 149.49 35.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -70.07 -43.21 71.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.62 -58.36 0.42 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.452 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.86 80.11 1.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.317 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.04 71.6 1.28 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.559 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.55 54.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.632 HD13 ' NH1' ' A' ' 67' ' ' ARG . 13.1 mt -58.59 155.37 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 0.0 111.199 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.569 HD23 ' CG2' ' A' ' 85' ' ' VAL . 1.0 OUTLIER -135.67 114.13 11.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.088 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.426 ' O ' HG11 ' A' ' 40' ' ' VAL . 2.5 t0 -96.19 -163.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.522 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.525 HD23 HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -114.74 78.59 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.59 -46.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.33 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.907 ' O ' HG23 ' A' ' 40' ' ' VAL . 9.8 m-20 -71.2 136.53 48.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.084 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 24.6 mm -56.94 157.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.045 0.45 . . . . 0.0 111.467 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.839 HD11 ' HG ' ' A' ' 43' ' ' LEU . 3.2 tp -61.6 -57.6 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.088 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.1 t -57.9 -19.42 29.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.382 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -40.72 26.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.571 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.569 ' CG2' HD23 ' A' ' 76' ' ' LEU . 35.9 m -106.26 -47.21 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -72.49 174.16 7.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.264 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -144.64 146.6 32.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.837 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.57 123.79 16.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.02 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.1 58.4 3.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.76 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -118.33 161.26 20.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -114.33 129.08 56.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.7 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.51 160.55 37.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.244 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.7 t -116.22 130.5 70.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.749 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.472 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -104.34 128.59 52.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.542 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.58 121.31 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.612 ' HD2' HG23 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -149.94 177.51 9.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.366 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . 0.3 OUTLIER -111.05 156.77 20.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.421 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -153.15 133.03 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.002 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.489 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 28.7 tt0 -98.97 70.19 1.81 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.971 0.415 . . . . 0.0 110.618 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.862 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.525 ' CD1' HD21 ' A' ' 82' ' ' LEU . 3.6 t80 . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.628 0.251 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -98.61 119.31 37.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 111.311 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.27 142.26 43.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.703 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -109.03 108.15 18.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.018 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.9 105.75 18.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 t -77.44 101.49 6.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.423 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 10.8 m-85 -83.0 100.61 10.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.628 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.43 -87.35 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.325 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.09 31.1 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.708 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -145.47 120.32 9.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.689 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -87.72 125.73 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.9 t -126.76 119.41 53.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.206 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -81.71 149.01 28.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.09 98.85 8.29 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.16 85.51 1.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.767 2.311 . . . . 0.0 112.6 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.4 140.55 56.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.75 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.76 -24.53 19.2 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.954 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.29 -42.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.362 . . . . 0.0 110.99 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.63 ' HA2' HD23 ' A' ' 82' ' ' LEU . . . 119.98 11.51 6.94 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.615 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -96.44 30.55 2.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.763 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.41 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 10.6 ttp -109.26 144.01 37.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -67.71 143.46 55.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 80' ' ' ASP . 42.5 t -48.74 -41.78 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.839 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 17.6 t80 -50.37 -39.74 47.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.41 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.4 OUTLIER -74.05 -31.73 63.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.218 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.691 HD22 HD13 ' A' ' 82' ' ' LEU . 4.6 tp -71.45 -39.33 71.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.774 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.857 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.2 mt -68.1 -42.17 84.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.855 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -36.86 85.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.514 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -38.29 83.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.319 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.423 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -75.91 -39.19 56.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.904 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.533 HG21 ' CG2' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -58.7 -43.55 87.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.418 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 90.9 m -68.81 -45.87 70.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.482 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -63.9 -30.52 71.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.682 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.659 ' O ' HG12 ' A' ' 55' ' ' VAL . 23.6 t80 -65.55 -57.3 8.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.558 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -55.76 -39.17 70.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -72.13 -45.19 61.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.199 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.54 98.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.106 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.678 HG11 ' HD2' ' A' ' 57' ' ' LYS . 12.2 p -75.03 -7.15 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.559 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 71.92 35.28 1.36 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.83 0.348 . . . . 0.0 111.076 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HD2' HG11 ' A' ' 55' ' ' VAL . 8.8 mttt -99.71 -175.52 3.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.5 m-20 -151.09 177.14 1.97 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 34.0 Cg_exo -61.92 -12.3 25.22 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.712 2.275 . . . . 0.0 112.769 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -44.07 -33.0 1.33 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.713 0.292 . . . . 0.0 111.727 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.756 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.6 p90 -114.67 154.44 28.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.966 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.513 ' CD1' ' CB ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -84.35 151.6 24.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.08 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.756 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 54.1 mt -140.22 111.6 4.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.889 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.482 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -107.6 103.44 12.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 179.608 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.857 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.3 t -82.08 110.86 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -76.33 -70.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.096 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -171.21 -177.61 2.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.749 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.719 HD11 HG12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -123.81 164.97 18.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.927 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.59 ' O ' HG12 ' A' ' 93' ' ' VAL . 22.2 tt0 -147.98 137.67 22.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -66.71 -60.1 2.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.7 73.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.523 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.4 t0 60.2 36.35 20.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.14 60.81 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.481 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.87 56.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 mt -58.57 152.12 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.832 0.349 . . . . 0.0 111.171 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.6 mp -126.76 111.71 14.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.937 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -94.88 -164.26 1.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.827 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.588 ' CD2' HD12 ' A' ' 44' ' ' ILE . 3.5 mt -110.87 76.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.969 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.55 -58.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.115 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.873 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.6 m-20 -57.41 135.02 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.233 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 85' ' ' VAL . 27.4 mm -56.11 159.02 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.076 0.465 . . . . 0.0 111.431 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.691 HD13 HD22 ' A' ' 43' ' ' LEU . 15.9 tp -69.8 -54.8 11.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.332 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -52.94 -23.91 8.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.555 -179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.91 -60.52 2.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.532 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 81' ' ' ILE . 35.6 m -73.99 -45.82 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.937 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.488 ' N ' HG23 ' A' ' 85' ' ' VAL . . . -92.37 174.45 7.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.255 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -139.28 155.44 47.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.727 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 0.7 OUTLIER -55.65 143.56 29.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.85 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.9 OUTLIER 40.8 50.91 3.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.502 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -111.36 171.8 7.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.214 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.69 146.15 47.31 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.883 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -148.55 169.1 21.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 69' ' ' GLU . 12.4 p -120.53 121.88 66.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 24' ' ' PHE . . . -96.69 119.78 35.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.464 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.85 120.57 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.811 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.551 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.2 p90 -146.82 -178.12 6.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.159 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.81 158.91 23.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.32 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 1.8 pt-20 -159.57 136.49 9.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 111.258 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.513 ' CB ' ' CD1' ' A' ' 62' ' ' TRP . 8.9 tt0 -129.37 76.63 1.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.142 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.917 179.957 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.401 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.674 0.274 . . . . 0.0 110.805 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 120.39 6.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.035 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 86' ' ' ALA . 5.8 m -130.98 142.62 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.009 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -106.76 105.92 16.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 m -98.27 116.57 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.084 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.07 101.58 14.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.693 ' HE2' HG22 ' A' ' 48' ' ' VAL . 6.5 m-85 -79.29 100.14 7.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.688 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.67 -79.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.308 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . 1.4 ptm85 -138.07 31.64 2.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.872 0.368 . . . . 0.0 110.732 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.1 m -140.32 121.89 15.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.973 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.72 115.49 28.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.008 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.1 118.18 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.04 144.84 42.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.668 HG11 HD12 ' A' ' 43' ' ' LEU . 21.5 t -135.94 94.67 14.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.44 101.22 1.38 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.505 2.136 . . . . 0.0 112.301 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.592 ' SG ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -75.25 149.63 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.34 -76.69 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.723 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.01 -39.45 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 111.05 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 82' ' ' LEU . . . 118.92 11.76 7.48 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.607 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -97.5 29.77 3.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.838 0.352 . . . . 0.0 110.774 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.415 ' HG2' ' HB3' ' A' ' 42' ' ' SER . 0.3 OUTLIER -103.34 125.12 49.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.56 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HG2' HD13 ' A' ' 81' ' ' ILE . 7.8 mttp -59.8 148.02 36.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.557 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.4 t -47.79 -46.32 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -50.36 -41.86 52.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.415 ' HB3' ' HG2' ' A' ' 38' ' ' MET . 39.4 t -65.14 -39.83 93.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.055 0.455 . . . . 0.0 109.825 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.668 HD12 HG11 ' A' ' 31' ' ' VAL . 20.4 tp -66.91 -32.18 73.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.407 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.927 HG23 HG11 ' A' ' 65' ' ' VAL . 5.2 mt -64.11 -53.15 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -38.47 78.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -67.24 -45.12 77.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.75 74.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.316 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 44' ' ' ILE . 94.0 t -55.84 -53.0 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -58.12 -43.76 87.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.724 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 6.9 tpp180 -63.65 -41.93 98.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.414 ' O ' HG12 ' A' ' 55' ' ' VAL . 13.7 t80 -57.09 -55.32 36.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.733 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -51.86 -53.76 36.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -72.25 -18.68 61.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.371 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 50' ' ' ARG . . . -80.43 -39.86 27.43 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.751 0.31 . . . . 0.0 111.137 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 55' ' ' VAL . 15.0 p -87.04 6.07 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.512 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 69.13 49.74 0.61 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 13.4 mttm -116.56 -175.78 2.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.4 m-20 -145.11 171.25 6.79 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.793 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 31.9 Cg_endo -64.03 -8.8 17.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.455 2.104 . . . . 0.0 113.056 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -46.78 -58.25 4.08 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.904 0.383 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.784 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.5 p90 -80.1 155.56 27.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.872 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -84.93 153.58 22.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.852 0.358 . . . . 0.0 110.925 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.784 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 55.6 mt -142.54 111.0 2.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.836 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -110.95 116.24 30.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.854 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.927 HG11 HG23 ' A' ' 44' ' ' ILE . 2.1 t -83.45 101.55 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.954 0.407 . . . . 0.0 111.035 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -64.37 -69.18 0.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.509 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -171.43 166.77 6.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 5.5 mt -111.61 156.16 22.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.996 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 49.7 mt-10 -150.26 129.39 12.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.98 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.444 ' CE1' ' CD2' ' A' ' 92' ' ' LEU . 41.8 m-70 -56.91 -58.51 7.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.17 68.95 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.489 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.8 44.36 11.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.862 0.363 . . . . 0.0 110.852 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.73 45.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.43 53.56 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 11.9 mt -60.27 153.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.234 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 1.4 mp -135.92 124.0 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.715 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.431 ' O ' HG11 ' A' ' 40' ' ' VAL . 43.1 p-10 -94.58 -164.44 1.17 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.679 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.923 HD23 HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -112.07 44.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.959 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -152.96 23.63 0.57 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.327 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.932 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -134.07 141.32 47.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.927 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.557 ' O ' HG22 ' A' ' 85' ' ' VAL . 25.3 mm -59.6 156.11 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.013 0.435 . . . . 0.0 111.436 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.592 HD22 ' SG ' ' A' ' 33' ' ' CYS . 2.3 tp -72.92 -51.33 18.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.413 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.409 ' SG ' HG21 ' A' ' 81' ' ' ILE . 27.8 p -59.98 -18.75 48.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.457 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -87.17 -46.25 9.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.706 0.289 . . . . 0.0 111.523 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 81' ' ' ILE . 29.1 m -91.25 -46.2 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -83.73 174.08 10.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.312 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.35 149.09 37.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.7 125.68 22.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.05 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.27 67.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.937 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -129.88 161.97 29.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.965 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.8 mtm-85 -120.52 105.99 11.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.807 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -110.47 169.07 8.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.176 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.79 140.21 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.852 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 24' ' ' PHE . . . -113.17 117.08 30.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.383 . . . . 0.0 111.683 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 t -90.09 128.26 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.025 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -163.85 171.43 15.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.504 . . . . 0.0 111.773 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.59 154.76 28.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.219 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.06 132.01 12.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.0 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.431 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 10.6 tt0 -92.1 66.96 5.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.413 . . . . 0.0 110.746 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.875 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.616 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.729 0.299 . . . . 0.0 110.805 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.47 120.04 1.77 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.591 HG11 ' HB1' ' A' ' 86' ' ' ALA . 15.7 m -132.52 142.05 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.196 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -102.72 107.12 17.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.693 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.09 106.31 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.186 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.86 101.15 3.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.486 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.621 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 5.4 m-85 -81.86 96.82 7.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.689 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.61 -84.36 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.482 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.79 34.17 4.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.9 m -146.46 145.06 30.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.803 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -103.6 110.18 22.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.994 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 t -114.43 111.27 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.04 144.76 34.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.775 HG11 ' HG ' ' A' ' 43' ' ' LEU . 22.0 t -133.15 96.89 17.02 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.037 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.39 117.14 1.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.787 2.325 . . . . 0.0 112.506 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.44 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -92.6 131.69 37.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.753 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.45 -37.5 66.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.959 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -135.92 -46.39 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 111.136 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.88 16.56 4.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.602 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -97.04 29.85 2.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.906 0.384 . . . . 0.0 110.667 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.438 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.1 OUTLIER -109.6 122.33 47.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.679 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HG2' HD13 ' A' ' 81' ' ' ILE . 5.0 mtmp? -58.84 157.58 9.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.68 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 80' ' ' ASP . 39.3 t -52.11 -53.44 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.24 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -49.66 -30.8 9.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.185 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.438 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 49.8 m -73.99 -40.91 62.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.051 0.453 . . . . 0.0 110.314 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.914 HD13 HD21 ' A' ' 82' ' ' LEU . 4.4 tt -70.05 -37.46 75.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.539 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.968 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.5 mt -63.64 -46.72 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.726 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -59.71 -42.67 93.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.615 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.57 -39.81 94.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.638 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.15 -42.64 68.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 44' ' ' ILE . 98.2 t -56.63 -54.2 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.721 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 91.6 m -58.82 -42.71 89.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.62 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -69.02 -27.34 65.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.784 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 55' ' ' VAL . 26.4 t80 -67.41 -57.49 6.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.821 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.626 ' CZ ' HD12 ' A' ' 63' ' ' ILE . 5.4 ptm180 -58.97 -38.06 78.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -29.89 64.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.14 -30.23 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.525 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.3 p -87.02 8.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.694 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 69.79 24.67 5.27 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.534 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HZ3' ' HE2' ' A' ' 61' ' ' TYR . 19.4 mttt -100.95 -176.39 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.323 . . . . 0.0 110.809 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -142.77 177.42 1.86 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.717 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 19.7 Cg_exo -66.27 -5.99 13.81 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.742 2.295 . . . . 0.0 112.84 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -51.55 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.81 0.338 . . . . 0.0 111.044 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.855 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.56 144.53 54.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.793 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.539 ' CZ3' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -76.81 155.62 32.91 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.672 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.855 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 66.5 mt -143.66 110.62 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 19.9 tt0 -104.94 107.27 18.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.285 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.968 HG11 ' CG2' ' A' ' 44' ' ' ILE . 2.7 t -82.45 101.29 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.403 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -64.56 -63.96 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.055 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.34 -176.98 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.661 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.761 HD11 HG12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -127.46 154.4 45.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.971 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -136.05 146.96 47.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.757 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.511 ' CE1' HD21 ' A' ' 92' ' ' LEU . 10.7 m-70 -71.61 -44.8 63.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.2 -80.6 0.21 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.67 31.42 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.04 112.26 1.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.582 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.43 83.21 0.23 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.441 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.485 HG22 ' N ' ' A' ' 76' ' ' LEU . 3.6 mm -82.05 157.47 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 0.0 111.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.788 HD11 HD22 ' A' ' 92' ' ' LEU . 1.2 mp -125.92 114.24 18.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.425 ' O ' HG11 ' A' ' 40' ' ' VAL . 1.4 t0 -98.27 -164.35 1.13 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.828 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.402 ' CD2' HD12 ' A' ' 44' ' ' ILE . 1.9 mt -112.68 47.92 1.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.956 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -164.64 30.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.236 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.92 ' O ' HG23 ' A' ' 40' ' ' VAL . 12.5 t70 -133.8 136.17 44.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.892 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 82' ' ' LEU . 29.0 mm -62.1 158.55 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.106 0.479 . . . . 0.0 111.475 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.914 HD21 HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -56.68 -61.16 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.334 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.4 t -66.34 -14.44 62.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.486 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.1 -36.14 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.687 0.28 . . . . 0.0 111.348 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 86' ' ' ALA . 12.8 p -114.81 -44.68 4.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.634 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.908 ' HB3' HD13 ' A' ' 82' ' ' LEU . . . -84.85 174.08 10.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.188 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -144.62 154.41 42.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.749 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -54.93 123.04 12.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.975 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.32 71.55 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.819 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -123.15 173.62 7.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -134.51 98.28 4.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.788 HD22 HD11 ' A' ' 76' ' ' LEU . 3.7 mt -101.63 169.13 9.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.988 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 t -119.51 121.27 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.621 ' HB3' ' HA ' ' A' ' 24' ' ' PHE . . . -90.69 117.95 29.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.567 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.67 110.04 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.574 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.446 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 37.1 p90 -142.8 -179.28 6.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.039 0.447 . . . . 0.0 111.386 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -115.11 152.74 32.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.93 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.1 pp20? -150.56 134.23 16.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.474 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 2.0 tt0 -99.46 68.96 1.63 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.938 0.399 . . . . 0.0 110.694 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.1 t0 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.997 179.936 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.47 ' CD1' HD23 ' A' ' 82' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.842 0.353 . . . . 0.0 110.9 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.36 120.33 2.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.119 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.433 ' HB ' HD11 ' A' ' 92' ' ' LEU . 24.2 m -138.04 141.86 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.986 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.4 m -100.05 116.38 31.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.621 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t -97.81 109.14 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.974 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 73.2 m -84.62 101.17 11.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.509 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 37.0 m-85 -88.03 102.36 14.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.589 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.6 -88.63 0.01 OUTLIER Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 24' ' ' PHE . 6.3 mtp180 -128.13 31.44 5.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 110.707 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.8 m -151.44 115.64 5.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.736 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.4 OUTLIER -98.33 148.05 24.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.271 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 m -144.79 133.2 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.089 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.52 136.56 40.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -127.08 92.68 43.59 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.04 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -83.45 117.29 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.778 2.319 . . . . 0.0 112.358 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 18' ' ' PHE . 2.0 t -87.54 136.79 32.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.88 -53.03 48.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.712 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -112.3 -31.57 6.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.726 0.298 . . . . 0.0 110.958 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.06 14.41 59.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.92 35.04 3.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.488 ' HE3' HD12 ' A' ' 43' ' ' LEU . 15.6 ptt? -105.77 138.71 41.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.686 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -59.35 147.69 35.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.985 0.421 . . . . 0.0 111.168 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.934 HG23 ' O ' ' A' ' 80' ' ' ASP . 67.2 t -52.23 -40.2 30.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -49.82 -46.82 51.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.027 0.441 . . . . 0.0 110.649 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.446 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 7.0 t -66.14 -34.56 78.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.759 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.695 HD13 HD11 ' A' ' 82' ' ' LEU . 6.1 tp -67.52 -35.48 79.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.844 HD12 HD23 ' A' ' 78' ' ' LEU . 4.5 mt -65.44 -50.87 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.868 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 6.3 pt20 -60.3 -33.91 73.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.46 ' N ' ' HG3' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -70.18 -47.84 59.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -67.02 -45.41 77.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 44' ' ' ILE . 83.6 t -56.09 -48.1 79.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.869 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.1 m -59.2 -45.61 90.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.23 -32.52 73.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.729 ' O ' HG22 ' A' ' 55' ' ' VAL . 26.3 t80 -63.65 -57.43 10.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.7 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -54.95 -38.82 68.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.231 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -45.29 60.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.266 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.82 -48.17 80.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.142 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 51' ' ' TYR . 29.0 m -64.96 -15.37 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.452 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 79.59 31.77 0.25 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.83 0.348 . . . . 0.0 111.312 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HD2' HG21 ' A' ' 55' ' ' VAL . 17.4 mttt -93.97 -173.03 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.512 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.2 m-20 -150.35 170.1 8.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.709 0.29 . . . . 0.0 111.076 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 55.6 Cg_endo -70.12 57.26 1.63 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.636 2.224 . . . . 0.0 112.67 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -120.58 -23.32 6.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.768 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.853 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 9.6 p90 -111.88 154.57 24.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.527 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -81.36 154.29 26.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.661 0.267 . . . . 0.0 110.753 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.853 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 85.6 mt -142.29 111.32 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.026 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -106.53 101.85 11.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.711 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 44' ' ' ILE . 14.8 t -81.42 97.85 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.021 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -58.92 -67.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -177.14 -177.48 0.73 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.589 HD11 HG12 ' A' ' 44' ' ' ILE . 7.2 mt -123.63 152.11 42.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.28 143.61 31.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -66.28 -69.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.04 101.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.563 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 58.97 44.28 16.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.0 90.26 0.72 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.528 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.68 53.88 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 76' ' ' LEU . 12.0 mt -59.34 158.08 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.378 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.603 HD13 HD22 ' A' ' 92' ' ' LEU . 1.5 mt -138.71 117.19 12.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.84 -166.62 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.749 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.844 HD23 HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -112.86 43.65 1.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.48 25.46 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.283 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.934 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.1 t70 -133.89 136.82 44.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.883 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.843 ' O ' HG22 ' A' ' 85' ' ' VAL . 29.5 mm -58.69 155.85 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.063 0.459 . . . . 0.0 111.581 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.695 HD11 HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -66.3 -52.72 44.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.438 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.8 m -63.92 -14.75 56.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.584 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -91.63 -32.19 15.57 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 81' ' ' ILE . 13.4 m -107.08 -43.72 6.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.86 174.23 6.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.779 0.324 . . . . 0.0 111.253 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -138.41 153.99 48.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.803 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -51.49 124.65 12.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.947 0.403 . . . . 0.0 111.068 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.93 74.3 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.77 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -138.66 151.56 47.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -102.94 140.5 37.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.8 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.603 HD22 HD13 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -132.34 169.0 17.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.5 108.7 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.916 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.621 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -88.5 121.16 30.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.705 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.81 118.03 55.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.598 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.525 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.1 p90 -148.73 -174.0 4.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.075 0.464 . . . . 0.0 111.414 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -122.21 155.74 35.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.958 179.15 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 10.0 pt-20 -156.93 130.94 8.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.701 0.286 . . . . 0.0 111.22 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.467 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 16.9 tt0 -97.78 66.73 1.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.732 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.946 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.988 0.423 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.85 120.44 1.02 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.97 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 43' ' ' LEU . 4.2 m -139.44 142.81 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.005 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.3 m -101.31 117.44 34.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.613 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 18.6 t -99.24 104.9 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.936 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 7.4 t -81.42 101.33 9.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.408 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 43.3 m-85 -89.27 103.08 15.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.43 -93.5 0.01 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.736 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mpm_? -119.05 30.93 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 m -156.46 114.5 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.715 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 5.7 ppt_? -105.03 151.81 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.316 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -146.47 145.89 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.093 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -87.74 141.38 28.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.756 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.5 t -129.31 95.25 31.03 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.211 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.82 116.1 2.48 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.68 2.253 . . . . 0.0 112.369 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -90.62 158.35 16.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.929 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.87 -63.53 2.83 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.645 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.21 -47.62 3.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.958 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.65 7.5 8.83 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.741 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -96.74 39.39 1.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.409 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 2.5 ttp -111.0 123.9 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.862 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.56 145.64 18.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.546 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 80' ' ' ASP . 98.6 t -49.36 -41.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.738 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.442 ' CB ' ' HB3' ' A' ' 78' ' ' LEU . 1.7 t80 -50.24 -42.59 52.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.409 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 3.1 m -70.85 -34.63 71.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.185 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.891 HD13 HD22 ' A' ' 82' ' ' LEU . 4.1 tp -67.89 -38.91 83.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.512 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.929 ' CG2' HG11 ' A' ' 65' ' ' VAL . 3.9 mt -65.1 -45.25 94.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.695 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -59.17 -39.82 83.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.728 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -65.79 -48.19 72.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.714 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -64.7 -48.65 73.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.914 HG21 HG21 ' A' ' 65' ' ' VAL . 67.1 t -54.03 -48.19 64.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.028 0.442 . . . . 0.0 110.765 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 83.9 m -57.12 -42.9 81.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.521 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.53 -33.05 74.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.779 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.583 ' O ' HG12 ' A' ' 55' ' ' VAL . 8.1 t80 -60.5 -56.7 18.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.647 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -43.49 85.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -72.01 -27.35 62.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.39 -39.74 31.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.181 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.3 p -85.67 4.3 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.61 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.56 52.78 2.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.81 0.338 . . . . 0.0 111.257 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HD2' HG11 ' A' ' 55' ' ' VAL . 72.3 mttt -116.71 -175.22 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.462 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.1 m-20 -145.86 171.0 7.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.73 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 34.2 Cg_endo -65.02 -7.43 15.29 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.425 2.083 . . . . 0.0 112.903 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -46.86 -37.43 8.79 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 111.446 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.826 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 5.9 p90 -104.56 152.59 22.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.09 154.24 25.69 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.827 0.346 . . . . 0.0 111.058 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.826 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 70.1 mt -142.78 111.0 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.849 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.488 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -106.95 107.18 18.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.929 HG11 ' CG2' ' A' ' 44' ' ' ILE . 4.2 t -83.44 98.89 5.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.011 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -55.26 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.264 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 ptt85 -163.54 -175.16 4.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD11 HG12 ' A' ' 44' ' ' ILE . 7.1 mt -126.87 152.27 47.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 111.023 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -141.51 132.79 26.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.88 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.62 ' CE1' HD21 ' A' ' 92' ' ' LEU . 11.5 m-70 -58.13 -46.85 84.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.1 -61.58 0.21 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.507 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -151.65 77.61 1.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.951 0.405 . . . . 0.0 110.835 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.96 39.45 1.41 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.43 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.634 ' O ' HD23 ' A' ' 76' ' ' LEU . . . -159.22 41.71 0.48 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 76' ' ' LEU . 10.6 mt -63.16 157.47 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 0.0 111.066 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.819 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -156.9 139.68 15.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 111.211 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -108.48 -163.12 0.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.731 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -98.75 71.61 1.94 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.827 0.346 . . . . 0.0 110.889 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.82 -43.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.931 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -72.25 135.02 45.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.736 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.775 ' O ' HG12 ' A' ' 85' ' ' VAL . 28.2 mm -53.1 155.94 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.158 0.504 . . . . 0.0 111.581 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.891 HD22 HD13 ' A' ' 43' ' ' LEU . 62.9 tp -70.88 -51.56 25.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.493 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.417 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 31.0 p -71.62 -8.15 52.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.73 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.6 -38.34 10.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.641 0.257 . . . . 0.0 111.291 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.819 HG21 ' HB3' ' A' ' 76' ' ' LEU . 13.7 p -101.02 -33.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.882 0.372 . . . . 0.0 111.599 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.42 174.23 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.378 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.23 154.85 50.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.51 130.64 36.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 56.37 68.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -132.55 149.17 52.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -97.32 143.62 27.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.62 HD21 ' CE1' ' A' ' 70' ' ' HIS . 12.0 mt -142.86 145.37 33.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.903 0.383 . . . . 0.0 111.202 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.81 116.18 35.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.766 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.613 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -99.48 121.89 41.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.052 0.453 . . . . 0.0 111.716 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 t -109.03 126.79 66.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.34 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.576 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.6 p90 -151.41 -179.77 7.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.178 0.513 . . . . 0.0 111.611 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.66 156.66 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.077 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -155.93 134.38 11.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 111.193 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 5.0 tt0 -99.06 67.87 1.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.836 -179.953 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.641 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.738 0.304 . . . . 0.0 110.737 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.23 120.46 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.044 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.52 HG21 HD21 ' A' ' 43' ' ' LEU . 3.3 m -132.8 143.13 40.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -96.12 114.89 26.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.12 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.654 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 20.0 t -104.43 104.31 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 14.5 t -86.66 101.8 13.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.082 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 44.7 m-85 -85.06 98.47 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.778 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.9 -79.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.357 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -138.19 31.32 2.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.822 0.344 . . . . 0.0 110.791 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.557 HG21 ' CD1' ' A' ' 51' ' ' TYR . 87.4 m -139.61 112.34 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -88.65 123.19 32.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 m -135.27 116.74 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.062 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.9 145.58 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.9 t -131.66 103.12 14.8 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.243 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.61 130.13 4.35 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.649 2.233 . . . . 0.0 112.294 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.64 131.42 47.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.03 -48.86 57.6 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.97 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -120.98 -46.07 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.31 11.69 9.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.675 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -97.76 35.02 1.75 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 110.622 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.94 118.73 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.811 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -54.52 149.96 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.616 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.9 t -48.05 -43.81 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.008 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.482 ' CD2' ' HB3' ' A' ' 78' ' ' LEU . 1.8 t80 -50.38 -49.38 54.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.236 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.3 t -62.33 -35.96 80.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.397 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.799 HD13 HD21 ' A' ' 82' ' ' LEU . 6.0 tp -66.36 -33.99 76.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.568 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.868 ' CG2' HG11 ' A' ' 65' ' ' VAL . 5.3 mt -66.18 -51.18 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.814 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -35.11 72.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.002 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -68.67 -48.13 64.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.735 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -67.93 -47.08 69.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.366 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 44' ' ' ILE . 61.2 t -53.09 -53.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.842 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.5 m -56.96 -44.74 82.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -29.89 70.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.911 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.557 ' CD1' HG21 ' A' ' 27' ' ' THR . 4.1 t80 -65.58 -57.4 8.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.772 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HA ' HG12 ' A' ' 55' ' ' VAL . 8.9 ptt180 -58.8 -35.19 72.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.887 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 7.6 mmtt -72.6 -29.99 63.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.29 -33.66 25.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.426 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.9 p -84.7 4.6 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.645 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.87 44.31 4.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 111.258 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -112.69 -174.76 2.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -147.59 176.29 2.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.742 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 18.7 Cg_exo -66.24 -9.29 23.15 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.826 2.35 . . . . 0.0 112.624 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -45.79 -39.4 8.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.714 0.292 . . . . 0.0 111.438 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.848 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 6.7 p90 -102.74 145.1 30.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.933 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.47 155.6 33.73 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.609 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.848 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 78.8 mt -142.95 110.97 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.887 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.489 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.2 OUTLIER -106.94 105.36 15.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.561 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.868 HG11 ' CG2' ' A' ' 44' ' ' ILE . 1.5 t -83.29 97.29 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.159 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -56.08 -74.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -167.66 178.12 5.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.786 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.545 ' HB2' HD12 ' A' ' 76' ' ' LEU . 1.1 mt -119.45 156.84 29.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 1.1 tt0 -138.66 147.01 42.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.775 ' HA ' HD23 ' A' ' 92' ' ' LEU . 4.7 m-70 -68.14 -64.54 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.89 -53.02 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.474 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.74 34.13 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.24 69.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.44 56.37 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.438 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 12.5 mt -62.49 153.38 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 111.099 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.938 HD11 HD22 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -129.0 114.18 16.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.794 179.69 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -163.39 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.17 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.665 HD23 HD12 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -113.54 36.5 3.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 0.0 110.773 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -148.29 26.88 0.95 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.908 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -131.64 134.28 45.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.882 0.372 . . . . 0.0 110.946 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 85' ' ' VAL . 29.1 mm -57.91 157.14 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.698 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.84 HD13 ' HB3' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -61.84 -56.13 22.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.626 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 34.7 m -71.19 -7.4 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.835 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.67 -37.46 15.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.574 0.226 . . . . 0.0 111.479 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 81' ' ' ILE . 8.5 m -114.9 -31.34 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.84 ' HB3' HD13 ' A' ' 82' ' ' LEU . . . -96.69 174.1 6.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 0.0 111.226 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.16 153.96 45.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.7 125.97 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.99 71.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -134.34 157.48 46.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.15 130.85 50.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.533 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.938 HD22 HD11 ' A' ' 76' ' ' LEU . 5.2 mt -138.62 132.7 31.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.354 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 69' ' ' GLU . 4.7 m -82.94 134.42 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.436 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.654 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -109.86 117.01 32.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.947 0.403 . . . . 0.0 111.768 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.03 127.12 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.344 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.459 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -160.75 174.77 13.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.122 0.487 . . . . 0.0 111.707 -179.408 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.17 157.95 25.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.242 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 9.7 pt-20 -155.23 135.0 12.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.046 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.476 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 2.3 tt0 -101.44 65.93 1.07 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.892 0.377 . . . . 0.0 111.008 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.956 179.895 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.556 ' CE2' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.775 0.321 . . . . 0.0 110.824 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -164.53 120.5 1.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.77 142.56 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.046 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.524 HG21 ' HD3' ' A' ' 28' ' ' ARG . 23.9 m -95.3 119.68 34.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 29' ' ' VAL . 21.3 t -98.97 107.55 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.022 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.86 101.59 14.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.479 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 43.6 m-85 -85.75 100.75 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.714 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.33 -78.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.294 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 tpm_? -141.84 31.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.729 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.0 m -137.66 125.48 22.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HD3' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -95.43 130.42 42.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 22' ' ' VAL . 6.7 m -135.35 127.11 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.043 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -74.98 143.22 43.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.986 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.3 t -140.72 92.62 8.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.145 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -84.65 123.03 2.8 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.757 2.305 . . . . 0.0 112.593 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.414 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -94.12 141.87 28.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.745 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.29 -81.79 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.881 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.24 -35.52 9.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 110.978 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.64 14.67 10.15 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 mtt-85 -98.6 28.46 4.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.941 0.4 . . . . 0.0 110.866 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.42 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 10.2 ttp -105.06 145.53 30.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.694 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.46 147.88 33.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 80' ' ' ASP . 59.1 t -48.83 -42.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.666 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -50.23 -38.8 42.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.42 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.4 OUTLIER -73.86 -34.58 64.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.278 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.864 ' CD1' HD11 ' A' ' 82' ' ' LEU . 5.4 tt -70.15 -38.66 75.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.673 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.925 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.1 mt -66.09 -45.83 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.634 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -59.06 -40.62 85.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.709 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -67.9 -44.79 76.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.782 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -66.85 -37.77 85.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 44' ' ' ILE . 75.0 t -59.64 -54.11 39.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.412 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -55.86 -42.72 76.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.599 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -37.87 86.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.703 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 55' ' ' VAL . 56.4 t80 -58.98 -57.02 14.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.69 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -51.37 -47.74 62.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.96 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -72.28 -25.75 61.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.225 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.49 -38.56 55.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.197 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 55' ' ' VAL . 13.6 p -92.28 12.74 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.617 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 57.54 56.86 4.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.905 0.383 . . . . 0.0 111.307 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 65.3 mttt -120.72 -175.39 3.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.468 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.6 m-20 -148.05 171.16 6.63 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.506 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 31.6 Cg_endo -64.19 -8.13 15.65 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.371 2.047 . . . . 0.0 112.916 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -46.35 -37.39 7.43 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.64 0.257 . . . . 0.0 111.521 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.838 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 6.0 p90 -104.8 156.13 18.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -85.03 153.79 22.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.164 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.838 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 76.6 mt -142.13 110.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.81 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -103.71 102.91 12.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.648 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.925 HG11 ' CG2' ' A' ' 44' ' ' ILE . 5.8 t -76.52 97.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -57.49 -78.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.0 -177.5 6.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.638 HD23 HD13 ' A' ' 44' ' ' ILE . 2.0 mm? -112.33 165.0 12.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -148.98 160.56 43.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.645 ' HA ' HD23 ' A' ' 92' ' ' LEU . 16.9 m-70 -94.61 -43.47 8.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.66 -88.39 0.14 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.41 33.02 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.769 0.318 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.45 108.12 0.99 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.4 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.09 95.28 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.403 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 76' ' ' LEU . 3.4 mm -93.19 155.26 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 76' ' ' LEU . 2.0 mp -133.54 118.02 17.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -95.17 -175.36 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.793 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.49 44.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.855 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.4 27.52 0.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.973 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.92 ' O ' HG23 ' A' ' 40' ' ' VAL . 9.3 m-20 -137.26 134.7 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.695 ' O ' HG22 ' A' ' 85' ' ' VAL . 31.7 mm -58.78 158.56 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.121 0.486 . . . . 0.0 111.586 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.864 HD11 ' CD1' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -58.0 -56.76 17.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.444 -179.433 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 68.9 m -70.66 -7.55 45.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.789 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.22 -30.97 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.678 0.275 . . . . 0.0 111.586 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 81' ' ' ILE . 2.4 m -120.06 -36.09 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.33 174.14 6.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.791 0.329 . . . . 0.0 111.338 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.55 150.52 47.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.752 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.61 132.72 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.01 60.32 2.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.732 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -138.97 134.85 33.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.38 151.2 26.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.763 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 70' ' ' HIS . 23.7 mt -146.13 150.85 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.007 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.25 114.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.758 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.449 ' HB2' HG13 ' A' ' 22' ' ' VAL . . . -95.27 128.1 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.751 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.93 137.15 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.32 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -167.88 163.32 13.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.129 0.49 . . . . 0.0 111.901 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -104.79 156.81 17.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.11 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -155.27 128.9 8.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.014 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.446 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 20.6 tt0 -86.53 66.85 9.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.036 0.446 . . . . 0.0 110.533 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.89 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.614 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.763 0.315 . . . . 0.0 110.85 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -161.24 120.28 2.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.01 0.434 . . . . 0.0 111.061 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.698 HG21 HD21 ' A' ' 43' ' ' LEU . 4.1 m -132.9 142.9 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.926 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -100.43 118.59 36.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.529 HG13 HD21 ' A' ' 68' ' ' LEU . 31.4 t -97.75 109.59 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.758 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 t -88.3 101.68 14.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 55.7 m-85 -84.71 98.51 10.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.395 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.97 -85.42 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.333 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 mmp_? -129.17 31.38 4.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.4 m -138.25 145.09 40.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -105.85 138.3 42.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.027 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.76 108.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.019 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -74.81 149.05 39.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.1 t -141.25 94.12 7.8 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.322 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.28 129.11 4.37 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.645 2.23 . . . . 0.0 112.391 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.6 m -99.66 140.04 34.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.768 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.69 -50.81 62.37 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.576 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -112.28 -29.91 7.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 111.066 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.68 14.24 53.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.523 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.81 35.91 2.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.731 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.2 ttp -104.17 137.61 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -69.77 150.14 47.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.53 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 80' ' ' ASP . 44.3 t -48.86 -42.08 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.968 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -50.17 -43.06 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.32 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -30.48 63.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.579 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.096 HD13 HD21 ' A' ' 82' ' ' LEU . 3.3 tp -71.38 -39.18 71.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.618 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.935 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.3 mt -67.81 -44.13 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.692 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.21 -38.43 86.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -68.79 -42.73 76.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.604 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -69.46 -40.77 76.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.296 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 44' ' ' ILE . 98.0 t -58.45 -51.84 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.72 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.9 m -58.18 -44.44 88.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.416 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -64.48 -29.93 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.802 ' O ' HG22 ' A' ' 55' ' ' VAL . 7.5 t80 -64.13 -57.88 8.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.656 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HG3' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -58.77 -32.66 69.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.641 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.42 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 11.2 mmtt -72.52 -27.91 62.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.52 26.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.34 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 51' ' ' TYR . 2.8 m -93.99 18.98 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.583 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 55.16 28.97 11.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.562 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.64 ' HB2' HG23 ' A' ' 55' ' ' VAL . 10.0 mttt -94.54 -169.87 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.835 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m-20 -160.06 177.07 2.21 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.731 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 33.0 Cg_exo -61.49 -12.13 22.99 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.663 2.242 . . . . 0.0 112.767 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -45.02 -53.1 8.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.815 0.341 . . . . 0.0 111.346 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.781 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.7 p90 -90.44 148.68 22.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -79.71 155.49 27.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.79 0.328 . . . . 0.0 111.028 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 68.7 mt -142.46 111.02 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.759 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.482 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -104.65 105.33 15.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.651 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.935 HG11 ' CG2' ' A' ' 44' ' ' ILE . 1.4 t -83.02 97.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.133 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -53.56 -76.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -159.85 -176.97 6.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.991 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.529 HD21 HG13 ' A' ' 22' ' ' VAL . 10.0 mt -117.49 160.75 20.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.57 159.36 43.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.591 ' HA ' HD23 ' A' ' 92' ' ' LEU . 10.9 m-70 -85.23 -30.78 23.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.773 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.95 -53.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.406 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -156.72 73.01 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 110.784 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.91 57.66 0.54 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.41 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.61 59.0 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.493 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 76' ' ' LEU . 7.2 mt -71.66 158.36 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.824 0.345 . . . . 0.0 111.187 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.991 HD11 HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -151.25 141.43 22.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.7 -162.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.707 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.01 43.49 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.886 0.374 . . . . 0.0 110.944 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.3 25.33 1.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.909 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.0 m-20 -133.13 132.99 42.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.993 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.612 ' O ' HG22 ' A' ' 85' ' ' VAL . 27.5 mm -56.02 158.38 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.038 0.447 . . . . 0.0 111.534 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.096 HD21 HD13 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -62.27 -57.55 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.625 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.3 t -67.76 -11.6 58.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.934 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.41 -47.28 11.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.586 0.231 . . . . 0.0 111.516 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 81' ' ' ILE . 6.3 m -103.9 -32.75 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.645 ' HB3' HD13 ' A' ' 82' ' ' LEU . . . -101.55 173.99 6.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.901 0.381 . . . . 0.0 111.213 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.87 154.44 49.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.766 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -54.34 124.03 14.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.09 70.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -140.21 144.55 36.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.024 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -92.86 148.97 21.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.796 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.991 HD22 HD11 ' A' ' 76' ' ' LEU . 1.6 mt -143.41 146.84 33.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.128 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.3 t -92.12 122.76 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.605 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.426 ' HB2' HG13 ' A' ' 22' ' ' VAL . . . -108.85 118.12 35.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.002 0.429 . . . . 0.0 111.822 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 t -103.31 128.18 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.149 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.582 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.1 p90 -153.31 -177.65 6.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.277 0.56 . . . . 0.0 111.718 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -118.06 157.27 27.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.856 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.17 132.15 9.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 0.0 111.125 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.469 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 3.7 tt0 -92.05 73.42 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.05 0.452 . . . . 0.0 110.462 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 t70 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.927 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.82 0.343 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -85.78 -176.86 6.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -80.2 159.87 25.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.877 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.02 120.6 1.0 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.04 0.448 . . . . 0.0 111.203 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.927 HG11 ' HB1' ' A' ' 86' ' ' ALA . 12.4 m -136.74 142.56 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -100.57 132.3 46.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 29' ' ' VAL . 9.5 t -113.23 105.7 19.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 t -83.16 101.59 11.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.176 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.522 ' HE1' ' HB1' ' A' ' 47' ' ' ALA . 15.4 m-85 -83.45 100.65 10.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.397 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.48 -78.84 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.444 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 mtt180 -139.16 31.18 2.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.784 0.326 . . . . 0.0 110.973 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.4 m -140.92 122.59 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.17 125.39 38.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.148 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 22' ' ' VAL . 14.7 p -125.41 124.73 67.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.038 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -79.03 140.0 38.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.61 92.64 26.7 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.64 116.75 4.11 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.076 2.517 . . . . 0.0 112.192 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -91.41 120.83 32.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.754 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.78 -53.89 33.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.971 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -106.04 -33.03 8.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.834 0.349 . . . . 0.0 111.067 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.22 -12.09 61.92 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.31 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 56.27 3.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.121 0.486 . . . . 0.0 110.812 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.414 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 1.5 ttp -122.38 114.48 20.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.607 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -53.07 147.59 9.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 80' ' ' ASP . 22.0 t -46.85 -43.43 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 10.6 t80 -50.19 -42.16 50.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.954 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.414 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 4.4 m -71.14 -31.73 68.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.182 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.964 HD13 HD11 ' A' ' 82' ' ' LEU . 4.4 tt -71.77 -38.82 70.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.748 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.9 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.4 mt -64.58 -48.66 83.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.745 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.21 -38.8 87.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -67.85 -43.24 79.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HB1' ' HE1' ' A' ' 24' ' ' PHE . . . -69.83 -44.51 69.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.811 HG21 HG21 ' A' ' 65' ' ' VAL . 92.3 t -54.37 -52.21 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 110.647 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.402 HG23 ' NH2' ' A' ' 52' ' ' ARG . 86.3 m -58.18 -47.23 84.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -29.8 70.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.955 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' O ' HG12 ' A' ' 55' ' ' VAL . 35.2 t80 -62.07 -57.36 11.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.743 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HA ' HG12 ' A' ' 55' ' ' VAL . 9.5 ptt-85 -60.92 -36.34 79.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.838 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.427 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 11.4 tppt? -72.6 -27.74 62.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.145 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.96 -35.54 23.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.5 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.0 p -82.04 1.75 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.796 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 75.33 29.96 0.88 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.739 0.304 . . . . 0.0 111.626 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 7.4 mttt -99.24 -169.9 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.486 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -158.89 170.36 9.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.907 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 43.1 Cg_endo -68.14 61.8 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -124.01 -41.14 2.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.426 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.652 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 9.1 p90 -95.65 150.44 20.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.319 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -78.42 152.94 31.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.748 0.308 . . . . 0.0 110.94 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.652 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 73.0 mt -139.92 110.95 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.81 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -102.14 101.74 12.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.363 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.9 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.9 t -83.21 97.07 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.125 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -58.62 -77.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.443 ' C ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -163.88 -176.77 4.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.169 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.62 HD11 HG13 ' A' ' 22' ' ' VAL . 4.0 mm? -119.16 160.91 21.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.634 ' O ' HG22 ' A' ' 93' ' ' VAL . 3.8 tt0 -152.17 137.48 17.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.657 ' HA ' HD23 ' A' ' 92' ' ' LEU . 14.2 m-70 -64.19 -30.47 71.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.83 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.24 -70.96 0.26 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.518 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.79 35.32 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.838 0.352 . . . . 0.0 111.021 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.51 64.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.49 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.12 60.94 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 76' ' ' LEU . 12.6 mt -59.42 156.18 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 0.0 111.074 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.555 HD23 ' CG1' ' A' ' 85' ' ' VAL . 3.9 mp -130.83 122.03 26.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -109.38 169.23 8.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.538 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.692 ' CD2' HD12 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -86.06 79.99 8.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.062 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.82 -38.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.853 ' O ' HG23 ' A' ' 40' ' ' VAL . 47.5 m-20 -77.08 131.07 38.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.061 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 85' ' ' VAL . 28.4 mm -55.71 158.28 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.096 0.474 . . . . 0.0 111.546 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.964 HD11 HD13 ' A' ' 43' ' ' LEU . 2.2 tp -71.15 -54.58 10.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.094 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -26.45 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.484 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.12 -35.54 17.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 81' ' ' ILE . 16.1 t -97.38 -67.09 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 111.675 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.927 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -66.97 174.29 3.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.291 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.43 154.9 41.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.781 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.46 117.03 1.98 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.67 60.81 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -122.87 142.94 50.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.6 mmm-85 -95.79 154.5 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.657 HD23 ' HA ' ' A' ' 70' ' ' HIS . 55.2 mt -148.87 138.25 21.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.025 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 69' ' ' GLU . 3.2 m -90.15 121.95 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.651 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.56 ' HA ' HD13 ' A' ' 68' ' ' LEU . . . -103.44 121.79 43.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.061 0.457 . . . . 0.0 111.885 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.04 122.97 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.103 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.593 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.2 p90 -151.16 -174.35 4.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.192 0.52 . . . . 0.0 111.586 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -120.62 156.99 30.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.791 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.3 pt-20 -158.23 128.98 6.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.84 0.352 . . . . 0.0 111.224 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.473 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 1.3 tt0 -93.27 70.72 4.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.982 0.42 . . . . 0.0 110.746 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.886 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.797 0.332 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.08 -164.79 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.812 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.473 ' CD1' HD23 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -99.21 158.32 15.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.73 120.82 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.015 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.68 142.49 37.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.1 m -97.67 121.88 40.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.751 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.4 t -103.74 111.49 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.6 t -86.46 101.82 13.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CE1' HG22 ' A' ' 48' ' ' VAL . 51.4 m-85 -85.46 100.26 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.766 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.16 -90.09 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.575 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.67 31.47 6.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.0 m -139.46 144.99 38.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.41 118.2 30.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.84 126.75 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.98 146.66 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.721 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.5 t -129.01 92.73 38.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.064 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -77.71 106.26 2.16 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.869 2.379 . . . . 0.0 112.244 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.419 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -80.67 137.53 36.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.608 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.57 -36.07 7.76 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.061 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -151.55 -45.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.39 13.52 4.75 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.777 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.619 ' CG ' ' O ' ' A' ' 37' ' ' ARG . 8.4 ttm-85 -99.57 29.73 3.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.654 0.74 . . . . 0.0 109.876 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 6.8 ttp -108.86 151.6 26.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.625 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.93 144.62 38.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.607 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 80' ' ' ASP . 58.4 t -48.11 -41.4 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.815 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -50.36 -43.01 54.04 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -33.64 72.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.177 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.981 HD22 HD11 ' A' ' 82' ' ' LEU . 3.5 tp -69.09 -39.41 79.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.654 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.911 ' CG2' HG11 ' A' ' 65' ' ' VAL . 3.9 mt -63.18 -51.35 72.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.732 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -36.96 73.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -68.93 -48.05 64.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.721 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -66.6 -41.21 88.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.328 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 44' ' ' ILE . 97.0 t -58.45 -48.13 86.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 0.0 110.619 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.0 m -58.55 -46.98 85.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.596 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -64.39 -33.73 76.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.691 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.504 ' O ' HG12 ' A' ' 55' ' ' VAL . 20.0 t80 -59.56 -57.16 14.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.683 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.508 ' HA ' HG12 ' A' ' 55' ' ' VAL . 5.7 ttm105 -57.47 -40.37 78.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -72.11 -29.3 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.214 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.43 -30.91 26.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.221 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.9 p -85.3 -2.97 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.598 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 70.58 34.82 2.04 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.733 0.301 . . . . 0.0 111.288 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' CD ' HG11 ' A' ' 55' ' ' VAL . 13.6 mttt -102.93 -175.36 2.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.796 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.9 m-20 -149.69 175.92 2.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 25.3 Cg_exo -63.15 -11.12 23.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.745 2.297 . . . . 0.0 112.738 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -44.97 -33.17 1.91 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.596 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.725 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 2.7 p90 -116.1 145.29 43.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.76 0.315 . . . . 0.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -77.62 154.95 31.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.652 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.725 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 52.1 mt -141.64 110.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.001 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -105.88 108.6 20.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.754 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.911 HG11 ' CG2' ' A' ' 44' ' ' ILE . 2.2 t -80.05 100.09 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 96' ' ' PHE . 97.8 m-70 -57.8 -63.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -176.77 -173.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.009 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 94' ' ' ALA . 94.9 mt -124.1 154.32 40.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.763 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -138.37 141.1 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.984 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.476 ' HA ' HD23 ' A' ' 92' ' ' LEU . 3.9 m-70 -68.44 -46.74 69.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.47 -85.24 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.04 39.1 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.349 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.99 102.03 2.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.98 57.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.412 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 76' ' ' LEU . 13.1 mt -59.22 157.12 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.188 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' N ' HG22 ' A' ' 75' ' ' ILE . 2.2 mp -138.76 123.83 19.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' OD1' HD12 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -100.44 -167.54 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD12 ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -108.95 46.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.389 . . . . 0.0 110.826 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -157.45 27.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.897 ' O ' HG23 ' A' ' 40' ' ' VAL . 65.1 m-20 -142.86 134.37 26.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.895 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 85' ' ' VAL . 24.0 mm -52.59 156.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.038 0.447 . . . . 0.0 111.461 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.981 HD11 HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -73.13 -49.02 30.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.401 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.8 t -64.97 -14.53 60.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.608 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -91.0 -45.91 8.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.648 0.261 . . . . 0.0 111.615 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 81' ' ' ILE . 32.2 m -95.73 -39.22 9.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.02 174.11 7.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.885 0.374 . . . . 0.0 111.28 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.03 144.46 48.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.37 132.55 48.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 tptt 61.66 57.69 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -130.0 164.37 24.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.029 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -111.22 151.06 28.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.75 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 70' ' ' HIS . 13.6 mt -143.49 165.66 26.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.151 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.86 117.83 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.791 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.751 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -97.25 113.42 25.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.63 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.99 118.0 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.398 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.69 ' CD2' HG23 ' A' ' 63' ' ' ILE . 17.0 p90 -144.01 174.5 10.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.068 0.461 . . . . 0.0 111.477 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -107.53 158.14 17.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.787 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 12.2 pt-20 -154.66 137.67 15.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.753 0.311 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.487 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 19.6 tt0 -105.46 60.74 0.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.807 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.0 p30 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.858 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.734 0.302 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 58.63 -175.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.428 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.6 OUTLIER -59.99 148.99 33.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.807 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -153.73 120.39 5.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.485 ' CG2' HD11 ' A' ' 43' ' ' LEU . 5.4 m -140.4 142.96 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.069 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -107.29 118.67 37.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.51 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.4 t -97.76 109.29 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 101.63 14.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.061 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.458 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 58.8 m-85 -85.62 102.82 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.504 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.03 -83.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.32 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -133.78 31.28 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.5 m -137.97 122.24 18.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.758 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -96.67 129.53 44.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.13 137.4 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.35 144.73 26.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.022 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.76 HG11 ' HG ' ' A' ' 43' ' ' LEU . 21.2 t -142.25 92.82 7.39 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.37 121.77 2.33 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.735 2.29 . . . . 0.0 112.518 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.428 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -94.28 123.29 37.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.785 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.56 -53.1 30.32 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.063 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.52 -33.6 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 111.081 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.1 6.19 61.86 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.684 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 31.86 2.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.864 0.364 . . . . 0.0 110.669 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.655 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -97.17 139.63 32.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.641 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.713 ' HE2' HD11 ' A' ' 81' ' ' ILE . 3.7 mmtt -67.9 144.7 55.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.394 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -46.67 -54.3 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.818 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.56 ' HD1' HD22 ' A' ' 78' ' ' LEU . 9.7 t80 -50.18 -29.81 10.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.216 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -73.15 -40.77 64.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.398 . . . . 0.0 110.3 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.112 HD13 HD11 ' A' ' 82' ' ' LEU . 3.7 tt -70.85 -38.26 73.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.681 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.865 ' O ' HG23 ' A' ' 48' ' ' VAL . 6.3 mt -62.54 -48.99 85.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.713 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -59.13 -42.73 91.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.625 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -64.94 -43.43 92.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.591 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.458 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -66.91 -39.52 87.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.914 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.919 HG21 HG21 ' A' ' 65' ' ' VAL . 92.9 t -60.17 -46.51 94.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.435 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.2 m -59.63 -43.52 93.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.287 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -34.98 79.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.628 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 55' ' ' VAL . 8.9 t80 -59.29 -57.12 14.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.471 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -53.31 -47.41 69.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -29.88 67.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.947 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.37 -29.8 57.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.2 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.5 p -97.25 3.88 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.591 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.74 36.52 8.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' CD ' HG11 ' A' ' 55' ' ' VAL . 11.6 mttt -101.78 -174.75 2.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.893 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m-20 -152.54 176.92 2.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.687 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 24.6 Cg_exo -63.47 -10.56 22.13 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.58 2.187 . . . . 0.0 112.734 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -45.26 -37.72 4.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.661 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.804 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.9 p90 -107.59 154.65 21.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.747 0.308 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.502 ' CD1' ' HB2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.45 154.17 24.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.961 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.804 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 66.1 mt -143.44 111.21 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.101 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -104.01 102.42 12.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.919 HG21 HG21 ' A' ' 48' ' ' VAL . 5.1 t -84.75 98.58 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.075 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -60.53 -77.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.074 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -166.9 -174.22 2.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.656 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.732 HD11 HG12 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -120.16 160.49 22.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.46 129.73 23.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -59.65 -29.62 68.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.34 -68.94 0.22 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -158.07 39.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.909 0.385 . . . . 0.0 110.757 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.25 49.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.318 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.05 57.04 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.361 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 mt -59.61 146.51 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.403 . . . . 0.0 111.316 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 5.2 mp -113.53 111.15 21.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.176 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -152.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.092 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.56 HD22 ' HD1' ' A' ' 41' ' ' PHE . 5.6 mt -117.75 27.38 9.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.6 0.238 . . . . 0.0 111.097 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 24.1 m-20 -137.65 -38.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.594 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.496 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -54.7 109.16 0.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.872 0.368 . . . . 0.0 111.615 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.713 HD11 ' HE2' ' A' ' 39' ' ' LYS . 27.8 mm -50.74 158.58 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.489 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.112 HD11 HD13 ' A' ' 43' ' ' LEU . 3.4 mm? -54.88 -59.1 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.269 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 22.0 p -65.3 -14.81 61.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.452 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -80.99 -32.45 34.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.575 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 86' ' ' ALA . 11.5 p -124.95 -45.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.805 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.491 ' N ' HG13 ' A' ' 85' ' ' VAL . . . -76.6 174.12 10.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.992 0.425 . . . . 0.0 111.427 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -143.85 155.16 44.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.7 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -52.82 119.14 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.6 tttp 61.68 71.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -139.62 136.5 34.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.018 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -87.57 147.86 25.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.796 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mt -136.72 153.03 50.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.027 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.3 117.13 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.704 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -99.25 119.26 37.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 111.702 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.15 123.6 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.47 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.57 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.5 p90 -151.32 -174.17 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.032 0.444 . . . . 0.0 111.491 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -125.91 159.06 33.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.962 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -157.18 137.5 12.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.782 0.325 . . . . 0.0 111.384 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.502 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 19.2 tt0 -117.89 59.17 0.79 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.073 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.942 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.84 0.353 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.75 -164.82 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.802 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD2' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -73.49 162.21 29.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.045 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.38 120.61 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.992 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.63 142.3 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.977 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.1 m -110.77 106.03 15.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 68' ' ' LEU . 1.4 m -97.84 103.76 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.93 101.77 2.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.037 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 4.5 m-85 -78.52 101.88 7.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.425 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.18 -77.0 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.234 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . 6.2 ttt180 -143.89 30.92 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.889 0.375 . . . . 0.0 110.763 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.9 m -142.02 126.88 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -79.51 117.77 20.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 51' ' ' TYR . 21.8 t -113.06 109.17 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -74.94 144.23 43.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.05 92.62 7.62 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.65 138.42 6.19 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.802 2.335 . . . . 0.0 112.599 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.421 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -113.02 146.39 39.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.61 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.19 -38.74 9.77 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.938 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -121.78 -43.93 2.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.512 ' HA2' HD23 ' A' ' 82' ' ' LEU . . . 111.58 10.87 18.55 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.547 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -97.97 35.11 1.77 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.605 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.436 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.5 OUTLIER -110.16 113.15 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.724 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -54.42 157.39 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.7 t -51.88 -52.11 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.054 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.564 ' HD1' HD22 ' A' ' 78' ' ' LEU . 10.7 t80 -49.49 -29.73 7.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.077 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.436 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 50.5 m -76.11 -42.18 47.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.805 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 40' ' ' VAL . 0.8 OUTLIER -70.86 -37.66 73.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.606 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.88 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.3 mt -64.09 -50.02 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.528 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -57.09 -41.34 78.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.366 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -38.38 90.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.32 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.62 -39.62 73.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.755 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.804 HG21 HG21 ' A' ' 65' ' ' VAL . 92.5 t -58.14 -53.17 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.439 HG23 ' NH2' ' A' ' 52' ' ' ARG . 45.2 m -59.25 -41.56 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.341 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -27.14 64.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.671 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.489 ' O ' HG22 ' A' ' 55' ' ' VAL . 27.5 t80 -68.28 -58.08 4.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.739 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' NH2' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -58.93 -36.75 75.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.753 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -72.13 -26.06 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.825 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.15 -31.39 25.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.448 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.678 HG23 ' HG3' ' A' ' 57' ' ' LYS . 29.3 m -94.0 17.6 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.649 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 58.6 31.82 21.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.559 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HG3' HG23 ' A' ' 55' ' ' VAL . 19.1 mttm -98.17 -177.19 3.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.799 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.27 175.34 2.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.97 -10.05 23.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.776 2.317 . . . . 0.0 112.815 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -47.65 -63.06 1.16 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.905 0.383 . . . . 0.0 111.283 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 2.7 p90 -75.86 145.64 40.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.83 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.492 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.61 154.12 34.66 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.672 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 62.2 mt -141.4 111.11 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.874 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.492 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.6 OUTLIER -104.84 104.48 14.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.585 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.88 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.0 t -82.42 98.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -61.67 -68.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.067 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -174.87 -176.93 1.04 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.703 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.82 HD11 HG12 ' A' ' 44' ' ' ILE . 9.7 mt -121.86 160.94 23.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 111.063 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -141.26 136.31 31.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.417 ' HA ' HD23 ' A' ' 92' ' ' LEU . 8.3 m-70 -59.8 -51.7 68.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.22 -31.87 0.95 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.565 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -151.8 75.42 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.32 . . . . 0.0 110.829 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.59 76.75 1.01 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.52 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.25 55.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.543 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 mt -64.47 153.81 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.471 HD23 ' CG2' ' A' ' 85' ' ' VAL . 4.4 mp -124.57 121.77 35.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.832 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.45 -163.07 1.01 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.787 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.564 HD22 ' HD1' ' A' ' 41' ' ' PHE . 11.3 mt -109.0 42.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.083 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -157.06 32.3 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.918 ' O ' HG23 ' A' ' 40' ' ' VAL . 6.1 t0 -134.35 134.03 41.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.098 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.843 ' O ' HG12 ' A' ' 85' ' ' VAL . 30.6 mm -61.83 158.37 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.399 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.549 HD12 ' HB3' ' A' ' 86' ' ' ALA . 55.1 tp -65.4 -54.19 32.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.533 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.3 p -72.01 -5.94 38.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.928 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -101.03 -24.66 14.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.518 0.199 . . . . 0.0 111.5 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.843 HG12 ' O ' ' A' ' 81' ' ' ILE . 14.9 p -113.08 -34.21 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.771 0.319 . . . . 0.0 111.553 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.549 ' HB3' HD12 ' A' ' 82' ' ' LEU . . . -110.74 174.22 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.393 . . . . 0.0 111.275 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -136.08 156.26 48.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -52.59 127.05 21.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.032 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.59 70.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -129.78 134.82 47.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.039 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -99.2 113.42 25.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.798 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 70' ' ' HIS . 0.8 OUTLIER -117.02 167.13 11.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.08 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.44 141.83 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.736 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 24' ' ' PHE . . . -113.18 119.86 39.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.411 . . . . 0.0 111.472 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.9 t -105.16 114.6 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.572 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.587 ' HD2' HG23 ' A' ' 63' ' ' ILE . 3.2 p90 -144.91 -177.23 5.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.04 0.448 . . . . 0.0 111.503 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -116.28 157.04 25.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.793 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -157.58 133.53 9.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 111.422 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.483 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 2.5 tt0 -101.55 67.41 1.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.745 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.895 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.795 0.331 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -123.61 171.58 9.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.882 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -89.77 161.07 16.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.73 120.88 1.48 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 111.201 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 31' ' ' VAL . 16.0 m -133.51 156.13 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.4 m -117.39 119.47 35.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.903 0.382 . . . . 0.0 111.121 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.577 HG23 HG21 ' A' ' 31' ' ' VAL . 24.1 t -97.96 102.91 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.833 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.6 t -83.9 101.61 11.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.5 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 48.4 m-85 -83.57 99.84 10.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.521 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.86 -83.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.301 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -132.58 31.5 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.352 . . . . 0.0 110.761 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 m -138.35 118.71 13.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.76 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.22 120.51 32.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.086 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.5 138.41 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.986 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.75 142.49 27.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.01 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.577 HG21 HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -141.61 93.78 7.62 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.83 160.39 27.58 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.624 2.216 . . . . 0.0 112.658 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -129.32 129.51 44.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.747 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.38 -41.06 21.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.018 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.11 -33.22 6.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.196 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.25 -0.04 63.6 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.566 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.54 44.68 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.036 0.446 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.404 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.2 OUTLIER -114.87 107.75 15.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.612 ' HG2' HD13 ' A' ' 81' ' ' ILE . 4.0 mttt -53.28 159.25 1.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.055 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 80' ' ' ASP . 40.1 t -51.62 -52.71 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -49.39 -29.04 5.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 110.841 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 13.8 m -75.85 -45.0 38.08 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.398 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.71 HD22 HD13 ' A' ' 82' ' ' LEU . 4.2 pp -72.98 -34.75 66.65 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.896 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.927 ' O ' HG23 ' A' ' 48' ' ' VAL . 5.1 mt -66.43 -48.06 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 110.431 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -57.95 -45.79 86.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -37.11 83.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.282 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -72.55 -37.18 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.829 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 44' ' ' ILE . 60.9 t -59.41 -54.98 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.325 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -58.11 -44.11 87.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.355 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -35.84 78.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.582 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.769 ' O ' HG22 ' A' ' 55' ' ' VAL . 33.6 t80 -59.99 -57.96 10.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.255 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -49.26 -44.13 43.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.701 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -28.94 68.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.583 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.01 -29.76 43.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.008 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -98.45 18.14 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.268 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.96 28.68 3.95 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.441 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -95.0 -172.46 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -151.9 172.33 5.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.432 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 36.7 Cg_endo -65.74 -8.09 18.49 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.205 1.937 . . . . 0.0 112.818 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -45.77 -42.92 12.61 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.742 0.306 . . . . 0.0 111.436 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.844 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 7.5 p90 -97.02 161.16 13.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.76 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.497 ' CD1' ' HB2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -87.27 154.34 20.77 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.694 0.283 . . . . 0.0 111.149 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.844 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 86.0 mt -143.11 111.47 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.788 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -99.25 102.01 13.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.682 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.611 HG11 ' CG2' ' A' ' 44' ' ' ILE . 9.9 t -81.43 95.42 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -56.18 -77.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.283 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.26 -177.61 4.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.875 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.56 ' HB3' HD13 ' A' ' 76' ' ' LEU . 1.3 mm? -115.58 147.91 40.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.94 132.58 42.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -58.33 -28.84 65.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.059 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.36 -59.77 0.53 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.567 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.59 32.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 0.0 110.848 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.53 78.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.44 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.11 62.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.409 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 76' ' ' LEU . 11.7 mt -59.5 157.95 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.617 HD23 ' CG2' ' A' ' 85' ' ' VAL . 1.8 mp -131.87 121.17 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' O ' HG11 ' A' ' 40' ' ' VAL . 29.2 m-20 -97.22 -174.48 2.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.55 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.519 HD23 HD12 ' A' ' 44' ' ' ILE . 1.6 mt -104.0 34.1 3.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -150.17 34.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.186 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.901 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -139.33 132.28 29.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.918 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.621 ' O ' HG12 ' A' ' 85' ' ' VAL . 21.8 mm -56.38 154.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.086 0.47 . . . . 0.0 111.318 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.71 HD13 HD22 ' A' ' 43' ' ' LEU . 49.3 tp -63.0 -52.77 61.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.288 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 64.5 m -67.89 -11.36 58.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.738 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -97.9 -22.72 16.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 81' ' ' ILE . 14.4 p -111.21 -44.04 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.638 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.468 ' N ' HG13 ' A' ' 85' ' ' VAL . . . -101.33 174.18 6.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.322 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -129.31 149.65 51.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.673 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -51.81 126.43 17.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.151 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm 61.69 67.64 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -136.63 153.29 50.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' NH1' ' HB2' ' A' ' 91' ' ' ARG . 2.3 mtm105 -104.35 146.18 29.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.661 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB3' HD12 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -137.7 152.65 49.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.187 -179.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 t -108.29 108.64 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.596 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.68 129.5 36.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.989 0.423 . . . . 0.0 111.809 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.8 t -110.8 126.65 68.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.436 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.653 ' HD2' HG23 ' A' ' 63' ' ' ILE . 3.4 p90 -150.16 179.69 7.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.116 0.484 . . . . 0.0 111.432 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -116.13 162.35 17.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.721 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.2 pt-20 -161.58 134.76 6.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.8 0.333 . . . . 0.0 111.456 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.497 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 13.8 tt0 -102.88 72.74 1.22 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.623 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.902 -179.865 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 60.31 162.4 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -81.14 163.2 23.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.926 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -162.74 120.46 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 111.279 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 43' ' ' LEU . 4.3 m -134.72 142.57 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.835 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.6 m -114.1 107.62 15.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.997 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.435 HG23 ' CG2' ' A' ' 29' ' ' VAL . 18.8 m -97.91 137.35 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.979 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.8 m -103.49 102.58 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.24 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 40.6 m-85 -77.13 95.47 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.442 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.9 -73.89 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.144 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' PHE . 1.6 mmt85 -143.54 29.09 1.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 110.565 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.8 m -136.31 114.82 11.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.757 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -87.11 127.38 35.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.435 ' CG2' HG23 ' A' ' 22' ' ' VAL . 23.8 m -133.23 140.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.114 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.27 149.5 21.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.076 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.608 HG11 ' HG ' ' A' ' 43' ' ' LEU . 21.6 t -137.81 96.03 10.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.39 127.72 6.74 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.609 2.206 . . . . 0.0 112.303 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.3 154.98 22.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.05 -69.4 1.38 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.576 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -109.15 -17.84 13.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 111.203 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.83 14.97 57.3 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.444 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -100.31 29.13 4.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 110.825 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 ttp -98.2 130.26 44.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -57.63 142.96 43.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.595 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 80' ' ' ASP . 92.7 t -48.46 -45.44 14.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.72 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -50.17 -35.18 25.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.111 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 m -74.57 -37.56 62.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.469 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.667 HD13 HD13 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -70.28 -39.02 75.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.683 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.883 ' O ' HG23 ' A' ' 48' ' ' VAL . 4.1 mt -64.26 -49.4 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.654 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -38.92 80.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.63 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -42.95 84.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.507 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -68.26 -40.34 81.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.893 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 44' ' ' ILE . 69.4 t -56.63 -52.09 58.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.118 0.485 . . . . 0.0 110.471 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -57.27 -43.73 83.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.422 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -38.81 80.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.573 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' HG12 ' A' ' 55' ' ' VAL . 9.8 t80 -58.66 -56.49 21.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.474 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.4 mtm-85 -48.88 -47.8 42.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -32.28 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.062 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 -26.71 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.042 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.1 p -99.13 1.86 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 67.53 30.89 6.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.765 0.317 . . . . 0.0 111.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HD2' HG11 ' A' ' 55' ' ' VAL . 11.4 mttt -99.2 -175.14 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.736 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.1 m-20 -146.13 175.85 2.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 24.3 Cg_exo -64.15 -7.92 15.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.89 2.393 . . . . 0.0 112.932 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -48.02 -66.99 0.31 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.88 0.372 . . . . 0.0 110.99 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.748 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 1.9 p90 -74.37 160.71 30.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.576 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -89.49 151.64 21.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.791 0.329 . . . . 0.0 111.258 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.748 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 35.0 mt -142.08 111.0 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.686 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.49 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -109.04 101.53 10.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.674 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 65' ' ' VAL . 11.3 p -86.3 96.74 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.144 0.497 . . . . 0.0 111.032 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -54.29 -81.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.586 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.07 -167.08 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.802 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.542 HD11 HG12 ' A' ' 44' ' ' ILE . 4.0 mt -127.66 164.99 20.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.847 0.356 . . . . 0.0 111.143 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.409 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -141.21 141.92 34.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.839 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.546 ' HA ' HD23 ' A' ' 92' ' ' LEU . 14.0 m-70 -64.59 -35.82 82.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.993 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.54 -77.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.574 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.63 40.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.27 103.15 2.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.441 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.3 58.19 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.582 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 76' ' ' LEU . 7.7 mt -68.32 158.44 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.297 . . . . 0.0 111.046 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -158.41 131.84 7.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.16 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -90.81 -156.61 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.802 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.653 ' CD2' HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -112.26 84.92 2.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.85 0.357 . . . . 0.0 110.74 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -171.75 -40.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.928 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.1 m-20 -76.09 142.5 41.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.864 ' O ' HG12 ' A' ' 85' ' ' VAL . 27.6 mm -56.75 156.89 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.17 0.51 . . . . 0.0 111.474 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.667 HD13 HD13 ' A' ' 43' ' ' LEU . 64.6 tp -66.39 -56.7 9.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.293 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.83 -14.74 61.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.584 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -90.53 -28.21 18.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.586 0.231 . . . . 0.0 111.328 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.864 HG12 ' O ' ' A' ' 81' ' ' ILE . 14.6 p -117.09 4.48 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.83 174.22 11.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.35 . . . . 0.0 111.212 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.77 152.85 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.817 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.54 135.95 54.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.993 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.55 58.1 3.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.769 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -120.78 157.86 28.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.066 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -116.39 137.06 52.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 70' ' ' HIS . 1.5 mp -142.89 154.39 44.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.069 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 69' ' ' GLU . 1.4 m -99.62 117.76 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.66 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -91.83 122.74 34.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.694 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.3 126.37 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.271 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.475 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -155.33 169.72 23.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.239 0.542 . . . . 0.0 112.124 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.91 157.09 25.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -153.8 136.43 15.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 111.327 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.48 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 6.7 tt0 -105.23 63.96 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.801 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.461 0.119 0 CA-C-O 120.912 0.387 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.03 -166.79 1.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.674 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -63.49 149.16 46.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.53 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -152.25 120.66 6.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.983 0.42 . . . . 0.0 111.069 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 86' ' ' ALA . 4.6 m -132.34 142.42 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.921 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -106.43 125.34 50.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.816 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.005 HG12 ' HB2' ' A' ' 94' ' ' ALA . 2.9 t -112.66 109.96 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.96 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.1 m -75.27 101.51 4.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.514 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 7.4 m-85 -84.74 97.32 9.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.705 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.32 -92.87 0.01 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.509 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.34 31.72 6.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.876 0.37 . . . . 0.0 110.641 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.0 m -153.35 117.67 4.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 135.21 33.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.028 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.16 137.08 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.167 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.78 148.94 25.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.9 t -138.93 92.88 10.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.229 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.42 124.94 3.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.767 2.311 . . . . 0.0 112.493 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.52 ' SG ' HD22 ' A' ' 82' ' ' LEU . 8.2 m -103.62 136.96 42.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.784 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.38 -41.77 93.34 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.996 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -128.68 -46.53 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.878 0.37 . . . . 0.0 111.236 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.23 12.19 8.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.46 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 -93.85 35.61 1.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.923 0.392 . . . . 0.0 110.576 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.467 ' HG2' ' HB2' ' A' ' 42' ' ' SER . 8.9 ttm -111.17 114.19 27.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.702 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -49.7 144.36 6.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.215 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 80' ' ' ASP . 27.5 t -46.61 -44.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 111.146 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.628 ' HD1' HD22 ' A' ' 78' ' ' LEU . 6.0 t80 -50.64 -41.15 54.91 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.531 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.467 ' HB2' ' HG2' ' A' ' 38' ' ' MET . 2.9 m -71.98 -34.41 68.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 110.223 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.539 HD13 HD13 ' A' ' 82' ' ' LEU . 2.3 tp -66.98 -35.41 79.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.155 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.969 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.5 mt -65.88 -51.28 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.547 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -55.76 -36.66 67.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.485 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -67.19 -42.37 84.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.567 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -69.48 -41.77 75.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.974 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 65' ' ' VAL . 61.2 t -56.41 -52.89 46.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.723 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.1 m -58.31 -44.34 88.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.484 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -62.74 -36.92 84.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.697 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -58.16 -52.94 63.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.534 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -55.19 -49.09 72.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.863 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -70.49 -24.61 62.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.85 -41.41 62.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 0.0 111.28 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.4 p -93.06 9.69 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.668 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 62.8 37.68 12.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.758 0.313 . . . . 0.0 111.466 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 31.8 mttt -96.54 -174.36 3.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -144.86 172.27 5.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.43 -10.71 22.57 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.822 2.348 . . . . 0.0 112.797 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.21 -59.09 3.11 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.835 0.35 . . . . 0.0 111.45 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.818 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.6 p90 -79.58 141.24 36.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CD1' ' HB2' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -76.71 156.18 32.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.621 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.818 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 57.9 mt -142.03 111.22 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.075 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.488 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -103.96 105.53 15.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.516 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.969 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.1 t -82.54 100.05 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.203 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -63.62 -70.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -168.42 -173.01 1.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.749 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.895 HD11 HG12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -131.35 158.86 39.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.829 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -142.81 141.14 31.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -61.53 -45.19 95.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.81 -87.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.519 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -120.38 33.8 5.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.797 0.332 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.22 89.56 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.445 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.57 62.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.435 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 76' ' ' LEU . 14.2 mt -56.68 156.05 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.942 0.401 . . . . 0.0 111.104 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.881 HD11 HD22 ' A' ' 92' ' ' LEU . 2.6 mt -126.8 115.05 18.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.058 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.71 -163.13 1.01 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.794 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.657 ' CD2' HD12 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -117.38 77.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.867 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -174.61 -62.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.238 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.853 ' O ' HG23 ' A' ' 40' ' ' VAL . 6.6 t0 -53.05 128.08 26.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.329 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 83' ' ' CYS . 24.1 mm -54.12 146.6 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.479 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.744 ' HG ' ' HB3' ' A' ' 86' ' ' ALA . 4.5 tp -60.77 -39.72 89.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.373 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.62 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -67.02 -12.87 61.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.619 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.12 -29.86 12.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.646 0.26 . . . . 0.0 111.392 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 86' ' ' ALA . 32.6 m -104.26 -44.7 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.864 0.364 . . . . 0.0 111.668 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.744 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . . . -88.81 174.07 8.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.204 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -145.14 155.39 43.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.677 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -48.8 118.22 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.26 57.84 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -112.69 147.53 36.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.488 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -96.65 148.59 22.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.881 HD22 HD11 ' A' ' 76' ' ' LEU . 16.6 mt -146.2 169.09 19.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.05 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 t -127.7 114.4 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.005 ' HB2' HG12 ' A' ' 22' ' ' VAL . . . -94.12 122.68 36.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.44 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.42 112.01 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.63 ' CD2' HG23 ' A' ' 63' ' ' ILE . 20.2 p90 -141.22 174.46 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.011 0.434 . . . . 0.0 111.282 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -108.48 159.6 16.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.026 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.4 pt-20 -156.53 135.45 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 111.244 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.489 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 30.8 tt0 -107.23 69.52 0.76 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.967 0.413 . . . . 0.0 110.899 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.1 p30 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.957 -179.91 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.457 0.17 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 18' ' ' PHE . 0.7 OUTLIER 44.19 -165.21 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.735 0.302 . . . . 0.0 111.512 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.746 ' CE2' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -110.35 165.5 11.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.59 120.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.5 m -137.51 141.91 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.1 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.407 ' CG2' ' CG ' ' A' ' 28' ' ' ARG . 5.8 m -105.55 120.03 40.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.865 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.905 HG13 HD11 ' A' ' 68' ' ' LEU . 17.1 t -101.61 111.76 32.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -92.13 101.64 14.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.663 ' CE2' HG22 ' A' ' 48' ' ' VAL . 65.9 m-85 -85.52 108.01 17.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.697 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.74 -87.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.377 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -131.55 31.63 4.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.364 . . . . 0.0 110.702 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.1 m -137.76 136.54 37.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' CG ' ' CG2' ' A' ' 21' ' ' THR . 10.3 ttm180 -101.14 137.5 39.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.48 126.67 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -86.96 144.45 26.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.797 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.0 t -142.29 92.64 7.41 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.196 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.62 122.57 2.74 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.788 2.325 . . . . 0.0 112.481 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -91.13 137.45 32.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.79 -53.53 44.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.685 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -117.27 -38.19 3.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.41 17.87 10.92 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.594 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 -104.61 32.6 4.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.707 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 7.8 ttp -101.83 168.91 9.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -100.25 151.05 21.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.695 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 80' ' ' ASP . 57.7 t -50.42 -47.23 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -49.97 -32.5 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.392 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -36.9 47.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.824 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -72.24 -38.27 68.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.567 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.986 HD13 HD23 ' A' ' 68' ' ' LEU . 4.9 mt -67.44 -45.86 84.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.552 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -59.35 -41.26 88.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.759 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -66.99 -45.83 76.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.536 ' HB1' ' HE1' ' A' ' 24' ' ' PHE . . . -65.66 -39.46 91.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.134 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 65' ' ' VAL . 71.0 t -58.45 -50.71 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.573 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.1 m -57.38 -45.06 84.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.64 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -63.07 -36.69 84.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.77 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' O ' HG12 ' A' ' 55' ' ' VAL . 4.8 t80 -58.39 -57.18 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -54.64 -48.73 71.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.261 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -72.05 -24.45 61.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.327 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.6 -35.07 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 111.267 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.6 p -89.24 9.35 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.537 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.56 52.92 1.67 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.006 0.432 . . . . 0.0 111.197 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 16.0 mttm -122.74 -175.41 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.99 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.491 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.2 m-20 -153.32 172.21 5.93 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.472 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 20.5 Cg_endo -61.07 -10.54 15.36 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.339 2.026 . . . . 0.0 112.932 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -43.68 -36.19 2.1 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.7 0.286 . . . . 0.0 111.691 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.74 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 4.7 p90 -108.96 159.88 16.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.698 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.487 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -87.06 151.89 22.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 111.196 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.74 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 57.2 mt -141.73 111.26 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.746 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.487 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -108.41 107.13 17.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.818 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 48' ' ' VAL . 7.7 t -82.56 100.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -57.41 -75.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' NH1' HG21 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -163.51 -171.94 2.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.986 HD23 HD13 ' A' ' 44' ' ' ILE . 2.2 mm? -125.87 157.06 38.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.95 0.405 . . . . 0.0 110.847 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 75' ' ' ILE . 2.7 mp0 -142.54 161.13 38.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.76 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.584 ' HA ' HD23 ' A' ' 92' ' ' LEU . 35.9 m-70 -79.93 -61.48 1.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.833 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.19 79.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.567 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 60.31 44.46 12.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.52 62.11 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.21 46.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.602 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.513 HG21 ' NH1' ' A' ' 67' ' ' ARG . 12.3 mt -62.77 154.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.73 0.3 . . . . 0.0 111.001 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -155.42 144.79 21.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.963 0.411 . . . . 0.0 111.274 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -94.56 -160.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.73 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.443 HD23 HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -108.58 86.45 2.29 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.764 0.316 . . . . 0.0 110.864 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -176.9 -39.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.878 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -66.83 128.25 35.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.656 ' O ' HG12 ' A' ' 85' ' ' VAL . 30.9 mm -55.23 157.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.021 0.438 . . . . 0.0 111.638 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.746 HD12 ' CE2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -56.89 -57.0 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.632 -179.393 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.6 t -74.12 -3.64 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.885 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -95.5 -30.65 13.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.589 0.233 . . . . 0.0 111.4 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 81' ' ' ILE . 10.2 p -120.51 -30.37 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.91 174.22 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 0.0 111.299 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -136.77 155.75 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.838 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.32 133.84 19.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.87 66.21 1.26 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.803 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -124.41 131.51 53.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.11 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -93.84 105.39 17.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.628 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 70' ' ' HIS . 46.2 mt -101.12 145.78 28.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.341 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.566 ' O ' HD13 ' A' ' 68' ' ' LEU . 23.5 t -94.04 121.36 44.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.592 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.733 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -98.56 122.84 42.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.997 0.427 . . . . 0.0 111.891 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 t -108.45 122.96 63.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.194 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.54 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.8 p90 -149.4 -175.12 4.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.217 0.532 . . . . 0.0 111.615 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.02 154.95 36.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.952 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.2 pt-20 -155.54 132.73 10.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.738 0.304 . . . . 0.0 111.302 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.47 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -97.77 69.52 2.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.756 0.312 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.42 165.14 12.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.716 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -63.59 160.71 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.687 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.94 120.62 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.26 142.77 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.013 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 m -104.53 105.73 15.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.35 103.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.2 t -79.16 101.59 8.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.507 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 8.4 m-85 -80.1 100.15 8.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.631 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 -79.12 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.319 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . 5.5 mmt85 -139.92 31.18 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.356 . . . . 0.0 110.771 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.7 m -140.92 122.23 14.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.886 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 122.74 29.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.834 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.78 107.5 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.317 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.94 147.99 40.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.723 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.59 HG11 HD22 ' A' ' 43' ' ' LEU . 20.1 t -141.29 103.47 6.06 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.339 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -85.5 140.35 7.26 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.731 2.287 . . . . 0.0 112.278 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.8 m -114.8 141.8 47.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.42 -50.28 60.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.743 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -112.63 -29.27 7.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.52 17.11 50.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -109.96 31.69 5.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.832 0.349 . . . . 0.0 110.7 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.9 ttp -93.78 127.34 39.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -58.14 144.8 39.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.586 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 80' ' ' ASP . 43.4 t -47.78 -45.48 11.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.837 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 67.9 t80 -50.2 -38.01 37.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.181 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.0 t -73.63 -33.0 64.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 110.235 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.742 HD13 ' O ' ' A' ' 43' ' ' LEU . 1.4 tm? -72.17 -38.18 69.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.679 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.821 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.6 mt -66.51 -43.9 90.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -64.25 -39.5 94.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.605 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -67.44 -37.28 82.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.367 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -75.79 -37.3 59.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.034 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -60.54 -44.29 96.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.976 0.417 . . . . 0.0 110.585 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.422 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 86.3 m -68.6 -46.69 68.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.531 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.03 -32.73 74.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.705 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -64.33 -57.67 8.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.651 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -52.61 -42.56 64.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -72.2 -30.96 65.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.96 -37.16 69.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.052 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.446 HG21 ' CE ' ' A' ' 57' ' ' LYS . 35.4 m -88.57 7.78 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.539 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 61.47 41.02 13.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 111.333 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 49.5 mttt -101.89 -174.62 2.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.454 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.8 OUTLIER -144.46 172.05 5.93 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.571 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 52.0 Cg_endo -69.3 -6.04 17.4 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.281 1.988 . . . . 0.0 112.875 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -49.42 -38.05 27.74 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.711 0.291 . . . . 0.0 111.283 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.768 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.1 p90 -104.61 149.32 25.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -80.74 153.66 27.69 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.842 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.768 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 48.9 mt -141.95 111.01 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.847 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.497 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.9 OUTLIER -108.94 109.43 20.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.673 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.821 HG11 ' CG2' ' A' ' 44' ' ' ILE . 2.2 t -82.13 102.6 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.247 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -57.45 -77.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -160.07 -179.36 7.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.021 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.581 HD11 ' HB2' ' A' ' 94' ' ' ALA . 3.4 mm? -114.87 159.93 20.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -145.52 140.2 27.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.781 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -63.61 -54.91 28.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.28 -52.56 0.16 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.544 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -152.92 31.96 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.79 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.12 75.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.563 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.41 68.96 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.414 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 76' ' ' LEU . 3.6 mm -65.18 157.13 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.906 0.384 . . . . 0.0 111.059 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.632 HD23 ' CG2' ' A' ' 85' ' ' VAL . 3.8 mp -132.65 119.35 20.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.039 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -98.07 173.24 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.68 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.589 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.26 76.6 6.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.92 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -176.06 -44.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.013 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.906 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -66.93 138.97 57.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.984 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 85' ' ' VAL . 30.6 mm -61.05 158.94 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.507 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.716 HD12 ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -58.01 -59.18 5.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.442 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.5 t -67.44 -12.83 61.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.783 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -90.85 -21.93 21.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.623 0.249 . . . . 0.0 111.485 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.632 ' CG2' HD23 ' A' ' 76' ' ' LEU . 14.9 p -110.9 -26.58 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.583 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.99 174.64 10.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.372 . . . . 0.0 111.442 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -127.08 159.66 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.477 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 11.7 p-10 -47.51 153.46 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.134 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 35.06 57.72 0.77 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.005 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -110.02 161.57 15.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.981 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -114.7 130.15 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.76 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.43 HD23 HD11 ' A' ' 76' ' ' LEU . 2.1 mp -144.55 160.84 40.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.109 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.23 138.62 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.775 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -113.04 133.47 54.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.423 . . . . 0.0 111.65 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.01 131.9 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.295 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.478 ' HB3' ' HA ' ' A' ' 65' ' ' VAL . 37.2 p90 -152.06 177.73 10.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.013 0.435 . . . . 0.0 111.632 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.61 157.36 22.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.021 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 8.7 pt-20 -154.34 139.32 17.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.686 0.279 . . . . 0.0 111.388 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.482 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 6.1 tt0 -109.72 63.34 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.914 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.943 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.778 0.323 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.07 -172.58 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.424 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -81.66 152.1 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.738 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -157.85 120.57 3.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.051 0.453 . . . . 0.0 111.167 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 m -136.79 143.23 35.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.835 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.0 m -101.12 116.06 31.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.494 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t -98.0 102.84 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.78 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 2.7 t -82.88 102.12 11.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.191 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.505 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 29.7 m-85 -84.58 98.83 10.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.28 -83.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.299 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -133.51 30.98 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.81 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.4 m -139.21 116.39 11.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -89.09 120.84 30.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.84 116.66 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.03 149.2 39.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.8 t -142.03 95.97 6.72 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.39 108.67 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.661 2.241 . . . . 0.0 112.337 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.424 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -79.23 140.76 37.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.818 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.77 -54.97 29.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.91 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.7 -40.85 2.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.98 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.38 13.51 8.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.647 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.5 mtm-85 -98.79 30.18 3.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.823 0.344 . . . . 0.0 110.724 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -102.53 114.04 27.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.704 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -49.74 148.71 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.71 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 80' ' ' ASP . 23.8 t -46.92 -48.44 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.938 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 78' ' ' LEU . 1.2 t80 -50.81 -44.99 59.17 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.059 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.9 t -58.93 -42.44 89.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.997 0.427 . . . . 0.0 110.328 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.46 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.655 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.854 HG23 HG11 ' A' ' 65' ' ' VAL . 7.5 mt -64.7 -48.21 85.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.877 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -60.99 -44.86 96.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -39.21 90.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.51 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.505 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -72.35 -34.01 67.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.071 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.497 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -63.79 -44.76 98.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.95 0.405 . . . . 0.0 110.721 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.411 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 89.2 m -65.96 -44.49 84.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.548 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -64.77 -27.39 68.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.67 ' O ' HG12 ' A' ' 55' ' ' VAL . 52.5 t80 -69.13 -57.71 5.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.848 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.478 ' HA ' HG12 ' A' ' 55' ' ' VAL . 28.2 ptt180 -59.85 -39.29 84.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.055 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -72.27 -35.27 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.03 -29.94 43.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.43 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 51' ' ' TYR . 14.4 p -87.96 7.74 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.701 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.76 36.2 10.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.798 0.332 . . . . 0.0 111.413 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.546 ' HD2' HG11 ' A' ' 55' ' ' VAL . 43.9 mttt -107.4 -176.61 3.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.842 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.4 m-20 -139.28 175.47 3.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.016 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 20.0 Cg_exo -66.05 -7.85 18.29 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.92 2.414 . . . . 0.0 112.877 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.08 -71.49 0.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.956 0.408 . . . . 0.0 111.113 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.776 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 1.3 p90 -64.5 150.71 46.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.809 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.543 ' CZ3' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.18 152.99 25.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.777 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.776 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 18.4 mt -143.04 110.39 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.055 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -113.94 101.93 9.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.63 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.854 HG11 HG23 ' A' ' 44' ' ' ILE . 2.4 t -76.61 97.85 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.151 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -52.28 -70.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.155 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.47 -175.53 3.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 mt -127.56 161.47 28.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.998 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -143.69 159.62 42.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.783 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.57 ' HA ' HD23 ' A' ' 92' ' ' LEU . 12.9 m-70 -77.85 -50.52 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.13 -88.73 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -96.19 41.32 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.814 0.34 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.25 98.18 1.68 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.19 61.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.435 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 76' ' ' LEU . 14.1 mt -56.3 158.15 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 111.029 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.807 HD11 HD22 ' A' ' 92' ' ' LEU . 2.8 mt -135.96 106.69 6.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.531 ' OD1' HD12 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -79.27 -164.92 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.533 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.65 HD23 HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -115.96 74.56 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 0.0 110.794 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.48 -52.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.105 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.825 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -57.44 129.03 39.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.033 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 85' ' ' VAL . 15.7 mm -54.25 152.97 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.025 0.44 . . . . 0.0 111.511 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.01 -53.32 58.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.371 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.6 p -66.49 -12.17 56.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.687 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.85 -32.39 16.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.656 0.265 . . . . 0.0 111.567 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 86' ' ' ALA . 14.7 p -112.23 -45.24 5.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.754 0.312 . . . . 0.0 111.691 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.497 ' N ' HG13 ' A' ' 85' ' ' VAL . . . -86.06 174.09 9.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.384 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -135.58 155.37 50.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -56.37 126.37 26.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.048 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.8 tptt 60.7 69.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -139.7 138.5 36.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -85.9 146.02 26.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.785 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.807 HD22 HD11 ' A' ' 76' ' ' LEU . 8.3 mt -142.07 145.1 33.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.199 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.0 133.36 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.494 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -113.22 118.0 33.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.374 . . . . 0.0 111.639 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.3 t -104.13 122.71 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.418 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.445 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.6 p90 -149.5 -175.34 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.115 0.483 . . . . 0.0 111.709 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -131.55 127.97 38.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.177 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.1 pt-20 -128.46 138.83 52.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.824 0.345 . . . . 0.0 111.004 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -98.44 65.69 1.66 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.809 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.986 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.8 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.755 0.312 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -74.05 146.52 43.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -76.38 165.12 25.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -164.59 120.45 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.034 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.5 m -138.84 141.97 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.127 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 m -101.17 116.11 32.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.659 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.735 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 10.7 t -101.83 111.77 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.085 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.52 101.52 13.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.492 ' HE2' HG22 ' A' ' 48' ' ' VAL . 15.1 m-85 -83.76 99.81 10.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.538 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.3 -85.97 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.432 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 24' ' ' PHE . 13.1 mtt-85 -130.18 31.23 4.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.893 0.377 . . . . 0.0 110.838 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.1 m -141.25 120.84 13.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.789 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -94.78 130.13 41.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 m -139.19 120.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.8 148.89 39.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.821 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.46 92.94 14.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.237 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.17 116.79 2.76 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.611 2.207 . . . . 0.0 112.312 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.19 150.98 22.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.78 -68.73 1.54 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.451 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.44 -32.43 9.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.38 3.18 41.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.824 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.9 35.84 1.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.41 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 2.2 ttp -100.57 142.21 32.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.23 146.39 52.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.701 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.943 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.1 t -49.49 -44.78 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.861 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -50.17 -36.79 31.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.41 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 1.1 m -74.82 -34.62 62.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.154 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.464 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -69.34 -41.98 75.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.528 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.909 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.0 mt -64.44 -45.65 95.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.846 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.26 -37.53 80.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.718 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -45.01 76.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.756 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.477 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -68.13 -44.19 76.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.232 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 44' ' ' ILE . 85.9 t -54.59 -53.55 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 110.713 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 88.3 m -57.03 -42.57 80.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.383 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -34.53 78.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 55' ' ' VAL . 32.5 t80 -60.2 -57.23 13.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.484 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HD3' HD12 ' A' ' 63' ' ' ILE . 53.3 mtm180 -53.71 -44.96 70.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -32.8 69.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.018 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.65 -29.06 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 51' ' ' TYR . 14.6 p -94.78 -3.76 10.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.611 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 70.31 36.26 1.84 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.788 0.328 . . . . 0.0 111.21 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.646 ' HD2' HG11 ' A' ' 55' ' ' VAL . 20.1 mttt -104.58 -176.04 2.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.881 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.6 m-20 -149.47 176.57 2.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.759 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 25.0 Cg_exo -63.42 -9.9 19.57 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.632 2.221 . . . . 0.0 112.869 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -44.7 -32.74 1.6 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.709 0.29 . . . . 0.0 111.73 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.883 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 6.7 p90 -110.56 163.1 14.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.832 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -89.64 154.07 20.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.877 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.883 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 79.9 mt -143.58 110.75 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.157 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.488 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -106.71 101.93 11.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.262 179.244 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.909 HG11 ' CG2' ' A' ' 44' ' ' ILE . 5.4 t -79.32 94.79 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.007 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -53.37 -70.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.078 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -173.54 -177.68 1.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.834 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.882 HD11 HG12 ' A' ' 44' ' ' ILE . 6.8 mt -116.14 159.92 21.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.962 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -137.23 144.72 42.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.963 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.614 ' HA ' HD23 ' A' ' 92' ' ' LEU . 2.3 m-70 -66.53 -31.06 71.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.74 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.15 -38.56 1.1 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -172.33 35.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.829 0.347 . . . . 0.0 110.801 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.4 72.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.415 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.6 64.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.404 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 76' ' ' LEU . 9.1 mt -65.87 158.01 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 111.266 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.492 HD23 ' CG2' ' A' ' 85' ' ' VAL . 2.1 mp -133.06 128.17 35.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.758 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.415 ' O ' HG11 ' A' ' 40' ' ' VAL . 2.9 m-20 -94.92 -166.24 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.36 43.93 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -156.56 26.52 0.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.943 ' O ' HG23 ' A' ' 40' ' ' VAL . 4.6 t0 -137.13 144.39 42.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.824 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.844 ' O ' HG22 ' A' ' 85' ' ' VAL . 29.1 mm -57.09 156.77 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.576 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.422 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 41.4 tp -74.8 -50.7 16.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.269 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.44 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 10.5 t -59.69 -20.26 55.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.361 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -85.54 -59.64 2.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.329 . . . . 0.0 111.377 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 81' ' ' ILE . 21.1 m -76.56 -16.35 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.826 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.02 174.22 10.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 0.0 111.282 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.55 155.06 50.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.866 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -52.67 130.09 31.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.02 66.55 1.03 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -131.85 156.0 46.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.02 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.83 144.35 31.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.614 HD23 ' HA ' ' A' ' 70' ' ' HIS . 12.5 mt -144.13 145.34 32.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.004 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.41 119.8 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.735 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -95.53 121.41 37.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.54 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.3 120.27 60.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.762 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' A' ' 65' ' ' VAL . 14.3 p90 -148.23 171.36 16.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.054 0.454 . . . . 0.0 111.128 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -114.55 133.88 55.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.059 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.1 pt-20 -133.67 138.39 45.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.788 0.328 . . . . 0.0 111.212 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.438 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -101.37 69.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.4 t0 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.891 179.874 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.864 0.364 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.42 167.62 9.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -67.5 155.8 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.17 120.22 2.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.051 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.532 HG11 ' HB1' ' A' ' 86' ' ' ALA . 3.5 m -132.59 142.86 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.012 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.0 m -103.2 108.92 20.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.4 t -97.92 102.75 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.4 t -85.19 101.55 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.493 ' HE2' HG22 ' A' ' 48' ' ' VAL . 20.3 m-85 -79.99 99.93 7.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.529 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.92 -80.6 0.02 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.263 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . 2.7 mtt180 -137.08 30.82 2.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.935 0.398 . . . . 0.0 110.636 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 83.1 m -138.65 121.26 16.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.57 126.23 33.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.94 114.06 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -74.88 146.35 41.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.41 ' HB ' HG23 ' A' ' 20' ' ' VAL . 21.4 t -142.09 93.68 7.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.28 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.22 128.51 3.62 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.818 2.346 . . . . 0.0 112.329 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.406 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -98.59 136.94 37.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.54 77.43 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.77 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.25 -44.07 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.72 18.37 6.09 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.562 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -98.17 29.24 3.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.827 0.346 . . . . 0.0 110.701 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.422 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 6.0 ttp -108.09 133.9 51.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.754 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -70.84 148.42 47.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 80' ' ' ASP . 46.8 t -47.81 -40.76 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 14.5 t80 -50.71 -42.49 57.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.872 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.422 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.8 OUTLIER -72.49 -29.56 63.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.195 179.546 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.839 ' HG ' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -71.29 -39.85 71.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.525 179.658 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.887 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.7 mt -65.45 -48.65 82.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.775 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -60.86 -35.67 77.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.713 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -68.93 -42.99 76.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HB1' ' HE1' ' A' ' 24' ' ' PHE . . . -71.43 -43.63 66.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 65' ' ' VAL . 93.1 t -56.24 -48.28 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.5 m -61.17 -49.3 77.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.298 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -31.66 72.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.547 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.618 ' O ' HG12 ' A' ' 55' ' ' VAL . 32.0 t80 -62.31 -57.69 10.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.451 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HE ' HD12 ' A' ' 63' ' ' ILE . 11.7 ttm105 -52.42 -44.81 65.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -24.59 61.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.96 -30.17 26.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.222 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.718 HG13 ' HD2' ' A' ' 57' ' ' LYS . 12.8 p -103.32 20.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.304 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 48.03 89.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.382 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.718 ' HD2' HG13 ' A' ' 55' ' ' VAL . 11.0 mttt -155.13 -172.2 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.864 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -162.2 177.7 1.86 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.698 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 32.3 Cg_exo -58.46 -13.56 17.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.698 2.265 . . . . 0.0 112.937 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -42.82 -36.73 1.57 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.668 0.271 . . . . 0.0 111.571 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.822 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 2.1 p90 -115.49 153.02 31.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.697 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.89 154.66 24.49 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 111.194 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.822 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 79.6 mt -142.54 110.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.479 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.519 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.6 OUTLIER -105.39 106.3 16.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.061 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 48' ' ' VAL . 8.7 t -82.49 100.46 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.428 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -61.22 -67.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.632 ' NH1' HD13 ' A' ' 75' ' ' ILE . 1.1 ptp180 -176.53 -178.29 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.8 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.74 HD11 HG12 ' A' ' 44' ' ' ILE . 10.1 mt -121.62 155.63 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.979 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -144.8 149.49 35.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -70.07 -43.21 71.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.62 -58.36 0.42 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.452 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.86 80.11 1.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.317 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.04 71.6 1.28 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.559 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.55 54.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.632 HD13 ' NH1' ' A' ' 67' ' ' ARG . 13.1 mt -58.59 155.37 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 0.0 111.199 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.569 HD23 ' CG2' ' A' ' 85' ' ' VAL . 1.0 OUTLIER -135.67 114.13 11.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.088 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.426 ' O ' HG11 ' A' ' 40' ' ' VAL . 2.5 t0 -96.19 -163.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.522 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.525 HD23 HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -114.74 78.59 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.59 -46.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.33 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.907 ' O ' HG23 ' A' ' 40' ' ' VAL . 9.8 m-20 -71.2 136.53 48.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.084 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 24.6 mm -56.94 157.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.045 0.45 . . . . 0.0 111.467 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.839 HD11 ' HG ' ' A' ' 43' ' ' LEU . 3.2 tp -61.6 -57.6 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.088 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.1 t -57.9 -19.42 29.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.382 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -40.72 26.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.571 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.569 ' CG2' HD23 ' A' ' 76' ' ' LEU . 35.9 m -106.26 -47.21 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -72.49 174.16 7.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.264 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -144.64 146.6 32.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.837 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.57 123.79 16.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.02 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.1 58.4 3.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.76 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -118.33 161.26 20.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -114.33 129.08 56.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.7 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.51 160.55 37.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.244 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.7 t -116.22 130.5 70.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.749 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.472 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -104.34 128.59 52.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.542 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.58 121.31 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.612 ' HD2' HG23 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -149.94 177.51 9.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.366 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . 0.3 OUTLIER -111.05 156.77 20.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.421 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -153.15 133.03 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.002 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.489 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 28.7 tt0 -98.97 70.19 1.81 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.971 0.415 . . . . 0.0 110.618 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.862 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.801 0.334 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -178.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.525 ' CD1' HD21 ' A' ' 82' ' ' LEU . 3.6 t80 -77.17 96.62 4.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.671 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -98.61 119.31 37.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 111.311 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.27 142.26 43.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.703 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -109.03 108.15 18.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.018 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.9 105.75 18.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 t -77.44 101.49 6.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.423 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 10.8 m-85 -83.0 100.61 10.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.628 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.43 -87.35 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.325 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.09 31.1 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.708 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -145.47 120.32 9.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.689 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -87.72 125.73 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.9 t -126.76 119.41 53.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.206 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -81.71 149.01 28.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.09 98.85 8.29 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.16 85.51 1.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.767 2.311 . . . . 0.0 112.6 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.4 140.55 56.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.75 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.76 -24.53 19.2 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.954 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.29 -42.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.362 . . . . 0.0 110.99 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.63 ' HA2' HD23 ' A' ' 82' ' ' LEU . . . 119.98 11.51 6.94 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.615 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -96.44 30.55 2.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.763 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.41 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 10.6 ttp -109.26 144.01 37.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -67.71 143.46 55.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 80' ' ' ASP . 42.5 t -48.74 -41.78 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.839 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 17.6 t80 -50.37 -39.74 47.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.41 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.4 OUTLIER -74.05 -31.73 63.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.218 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.691 HD22 HD13 ' A' ' 82' ' ' LEU . 4.6 tp -71.45 -39.33 71.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.774 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.857 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.2 mt -68.1 -42.17 84.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.855 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -36.86 85.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.514 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -38.29 83.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.319 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.423 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -75.91 -39.19 56.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.904 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.533 HG21 ' CG2' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -58.7 -43.55 87.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.418 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 90.9 m -68.81 -45.87 70.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.482 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -63.9 -30.52 71.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.682 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.659 ' O ' HG12 ' A' ' 55' ' ' VAL . 23.6 t80 -65.55 -57.3 8.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.558 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -55.76 -39.17 70.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -72.13 -45.19 61.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.199 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.54 98.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.106 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.678 HG11 ' HD2' ' A' ' 57' ' ' LYS . 12.2 p -75.03 -7.15 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.559 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 71.92 35.28 1.36 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.83 0.348 . . . . 0.0 111.076 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HD2' HG11 ' A' ' 55' ' ' VAL . 8.8 mttt -99.71 -175.52 3.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.5 m-20 -151.09 177.14 1.97 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 34.0 Cg_exo -61.92 -12.3 25.22 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.712 2.275 . . . . 0.0 112.769 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -44.07 -33.0 1.33 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.713 0.292 . . . . 0.0 111.727 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.756 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.6 p90 -114.67 154.44 28.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.966 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.513 ' CD1' ' CB ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -84.35 151.6 24.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.08 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.756 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 54.1 mt -140.22 111.6 4.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.889 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.482 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -107.6 103.44 12.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 179.608 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.857 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.3 t -82.08 110.86 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -76.33 -70.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.096 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -171.21 -177.61 2.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.749 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.719 HD11 HG12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -123.81 164.97 18.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.927 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.59 ' O ' HG12 ' A' ' 93' ' ' VAL . 22.2 tt0 -147.98 137.67 22.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -66.71 -60.1 2.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.7 73.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.523 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.4 t0 60.2 36.35 20.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.14 60.81 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.481 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.87 56.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 mt -58.57 152.12 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.832 0.349 . . . . 0.0 111.171 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.6 mp -126.76 111.71 14.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.937 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -94.88 -164.26 1.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.827 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.588 ' CD2' HD12 ' A' ' 44' ' ' ILE . 3.5 mt -110.87 76.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.969 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.55 -58.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.115 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.873 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.6 m-20 -57.41 135.02 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.233 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 85' ' ' VAL . 27.4 mm -56.11 159.02 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.076 0.465 . . . . 0.0 111.431 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.691 HD13 HD22 ' A' ' 43' ' ' LEU . 15.9 tp -69.8 -54.8 11.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.332 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -52.94 -23.91 8.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.555 -179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.91 -60.52 2.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.532 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 81' ' ' ILE . 35.6 m -73.99 -45.82 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.937 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.488 ' N ' HG23 ' A' ' 85' ' ' VAL . . . -92.37 174.45 7.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.255 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -139.28 155.44 47.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.727 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 0.7 OUTLIER -55.65 143.56 29.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.85 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.9 OUTLIER 40.8 50.91 3.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.502 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -111.36 171.8 7.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.214 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.69 146.15 47.31 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.883 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -148.55 169.1 21.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 69' ' ' GLU . 12.4 p -120.53 121.88 66.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 24' ' ' PHE . . . -96.69 119.78 35.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.464 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.85 120.57 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.811 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.551 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.2 p90 -146.82 -178.12 6.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.159 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.81 158.91 23.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.32 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 1.8 pt-20 -159.57 136.49 9.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 111.258 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.513 ' CB ' ' CD1' ' A' ' 62' ' ' TRP . 8.9 tt0 -129.37 76.63 1.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.142 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.917 179.957 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.773 0.321 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.06 -177.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.401 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -87.67 146.44 25.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.805 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 120.39 6.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.035 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 86' ' ' ALA . 5.8 m -130.98 142.62 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.009 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -106.76 105.92 16.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 m -98.27 116.57 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.084 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.07 101.58 14.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.693 ' HE2' HG22 ' A' ' 48' ' ' VAL . 6.5 m-85 -79.29 100.14 7.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.688 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.67 -79.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.308 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . 1.4 ptm85 -138.07 31.64 2.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.872 0.368 . . . . 0.0 110.732 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.1 m -140.32 121.89 15.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.973 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.72 115.49 28.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.008 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.1 118.18 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.04 144.84 42.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.668 HG11 HD12 ' A' ' 43' ' ' LEU . 21.5 t -135.94 94.67 14.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.44 101.22 1.38 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.505 2.136 . . . . 0.0 112.301 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.592 ' SG ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -75.25 149.63 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.34 -76.69 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.723 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.01 -39.45 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 111.05 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 82' ' ' LEU . . . 118.92 11.76 7.48 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.607 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -97.5 29.77 3.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.838 0.352 . . . . 0.0 110.774 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.415 ' HG2' ' HB3' ' A' ' 42' ' ' SER . 0.3 OUTLIER -103.34 125.12 49.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.56 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HG2' HD13 ' A' ' 81' ' ' ILE . 7.8 mttp -59.8 148.02 36.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.557 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.4 t -47.79 -46.32 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -50.36 -41.86 52.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.415 ' HB3' ' HG2' ' A' ' 38' ' ' MET . 39.4 t -65.14 -39.83 93.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.055 0.455 . . . . 0.0 109.825 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.668 HD12 HG11 ' A' ' 31' ' ' VAL . 20.4 tp -66.91 -32.18 73.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.407 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.927 HG23 HG11 ' A' ' 65' ' ' VAL . 5.2 mt -64.11 -53.15 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -38.47 78.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -67.24 -45.12 77.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.75 74.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.316 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 44' ' ' ILE . 94.0 t -55.84 -53.0 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -58.12 -43.76 87.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.724 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 6.9 tpp180 -63.65 -41.93 98.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.414 ' O ' HG12 ' A' ' 55' ' ' VAL . 13.7 t80 -57.09 -55.32 36.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.733 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -51.86 -53.76 36.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -72.25 -18.68 61.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.371 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 50' ' ' ARG . . . -80.43 -39.86 27.43 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.751 0.31 . . . . 0.0 111.137 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 55' ' ' VAL . 15.0 p -87.04 6.07 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.512 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 69.13 49.74 0.61 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 13.4 mttm -116.56 -175.78 2.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.4 m-20 -145.11 171.25 6.79 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.793 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 31.9 Cg_endo -64.03 -8.8 17.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.455 2.104 . . . . 0.0 113.056 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -46.78 -58.25 4.08 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.904 0.383 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.784 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.5 p90 -80.1 155.56 27.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.872 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -84.93 153.58 22.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.852 0.358 . . . . 0.0 110.925 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.784 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 55.6 mt -142.54 111.0 2.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.836 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -110.95 116.24 30.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.854 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.927 HG11 HG23 ' A' ' 44' ' ' ILE . 2.1 t -83.45 101.55 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.954 0.407 . . . . 0.0 111.035 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -64.37 -69.18 0.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.509 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -171.43 166.77 6.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 5.5 mt -111.61 156.16 22.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.996 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 49.7 mt-10 -150.26 129.39 12.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.98 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.444 ' CE1' ' CD2' ' A' ' 92' ' ' LEU . 41.8 m-70 -56.91 -58.51 7.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.17 68.95 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.489 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.8 44.36 11.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.862 0.363 . . . . 0.0 110.852 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.73 45.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.43 53.56 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 11.9 mt -60.27 153.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.234 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 1.4 mp -135.92 124.0 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.715 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.431 ' O ' HG11 ' A' ' 40' ' ' VAL . 43.1 p-10 -94.58 -164.44 1.17 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.679 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.923 HD23 HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -112.07 44.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.959 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -152.96 23.63 0.57 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.327 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.932 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -134.07 141.32 47.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.927 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.557 ' O ' HG22 ' A' ' 85' ' ' VAL . 25.3 mm -59.6 156.11 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.013 0.435 . . . . 0.0 111.436 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.592 HD22 ' SG ' ' A' ' 33' ' ' CYS . 2.3 tp -72.92 -51.33 18.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.413 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.409 ' SG ' HG21 ' A' ' 81' ' ' ILE . 27.8 p -59.98 -18.75 48.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.457 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -87.17 -46.25 9.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.706 0.289 . . . . 0.0 111.523 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 81' ' ' ILE . 29.1 m -91.25 -46.2 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -83.73 174.08 10.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.312 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.35 149.09 37.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.7 125.68 22.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.05 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.27 67.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.937 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -129.88 161.97 29.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.965 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.8 mtm-85 -120.52 105.99 11.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.807 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -110.47 169.07 8.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.176 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.79 140.21 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.852 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 24' ' ' PHE . . . -113.17 117.08 30.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.383 . . . . 0.0 111.683 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 t -90.09 128.26 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.025 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -163.85 171.43 15.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.504 . . . . 0.0 111.773 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.59 154.76 28.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.219 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.06 132.01 12.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.0 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.431 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 10.6 tt0 -92.1 66.96 5.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.413 . . . . 0.0 110.746 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.875 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.527 0.062 0 CA-C-O 120.791 0.329 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 60.44 -164.17 0.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.761 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.616 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -59.54 151.21 24.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.805 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.47 120.04 1.77 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.591 HG11 ' HB1' ' A' ' 86' ' ' ALA . 15.7 m -132.52 142.05 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.196 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -102.72 107.12 17.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.693 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.09 106.31 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.186 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.86 101.15 3.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.486 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.621 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 5.4 m-85 -81.86 96.82 7.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.689 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.61 -84.36 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.482 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.79 34.17 4.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.9 m -146.46 145.06 30.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.803 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -103.6 110.18 22.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.994 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 t -114.43 111.27 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.04 144.76 34.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.775 HG11 ' HG ' ' A' ' 43' ' ' LEU . 22.0 t -133.15 96.89 17.02 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.037 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.39 117.14 1.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.787 2.325 . . . . 0.0 112.506 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.44 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -92.6 131.69 37.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.753 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.45 -37.5 66.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.959 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -135.92 -46.39 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 111.136 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.88 16.56 4.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.602 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -97.04 29.85 2.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.906 0.384 . . . . 0.0 110.667 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.438 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.1 OUTLIER -109.6 122.33 47.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.679 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HG2' HD13 ' A' ' 81' ' ' ILE . 5.0 mtmp? -58.84 157.58 9.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.68 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 80' ' ' ASP . 39.3 t -52.11 -53.44 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.24 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -49.66 -30.8 9.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.185 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.438 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 49.8 m -73.99 -40.91 62.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.051 0.453 . . . . 0.0 110.314 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.914 HD13 HD21 ' A' ' 82' ' ' LEU . 4.4 tt -70.05 -37.46 75.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.539 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.968 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.5 mt -63.64 -46.72 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.726 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -59.71 -42.67 93.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.615 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.57 -39.81 94.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.638 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.15 -42.64 68.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 44' ' ' ILE . 98.2 t -56.63 -54.2 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.721 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 91.6 m -58.82 -42.71 89.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.62 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -69.02 -27.34 65.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.784 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 55' ' ' VAL . 26.4 t80 -67.41 -57.49 6.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.821 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.626 ' CZ ' HD12 ' A' ' 63' ' ' ILE . 5.4 ptm180 -58.97 -38.06 78.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -29.89 64.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.14 -30.23 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.525 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.3 p -87.02 8.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.694 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 69.79 24.67 5.27 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.534 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HZ3' ' HE2' ' A' ' 61' ' ' TYR . 19.4 mttt -100.95 -176.39 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.323 . . . . 0.0 110.809 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -142.77 177.42 1.86 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.717 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 19.7 Cg_exo -66.27 -5.99 13.81 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.742 2.295 . . . . 0.0 112.84 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -51.55 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.81 0.338 . . . . 0.0 111.044 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.855 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.56 144.53 54.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.793 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.539 ' CZ3' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -76.81 155.62 32.91 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.672 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.855 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 66.5 mt -143.66 110.62 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 19.9 tt0 -104.94 107.27 18.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.285 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.968 HG11 ' CG2' ' A' ' 44' ' ' ILE . 2.7 t -82.45 101.29 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.403 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -64.56 -63.96 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.055 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.34 -176.98 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.661 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.761 HD11 HG12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -127.46 154.4 45.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.971 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -136.05 146.96 47.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.757 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.511 ' CE1' HD21 ' A' ' 92' ' ' LEU . 10.7 m-70 -71.61 -44.8 63.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.2 -80.6 0.21 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.67 31.42 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.04 112.26 1.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.582 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.43 83.21 0.23 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.441 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.485 HG22 ' N ' ' A' ' 76' ' ' LEU . 3.6 mm -82.05 157.47 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 0.0 111.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.788 HD11 HD22 ' A' ' 92' ' ' LEU . 1.2 mp -125.92 114.24 18.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.425 ' O ' HG11 ' A' ' 40' ' ' VAL . 1.4 t0 -98.27 -164.35 1.13 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.828 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.402 ' CD2' HD12 ' A' ' 44' ' ' ILE . 1.9 mt -112.68 47.92 1.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.956 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -164.64 30.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.236 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.92 ' O ' HG23 ' A' ' 40' ' ' VAL . 12.5 t70 -133.8 136.17 44.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.892 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 82' ' ' LEU . 29.0 mm -62.1 158.55 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.106 0.479 . . . . 0.0 111.475 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.914 HD21 HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -56.68 -61.16 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.334 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.4 t -66.34 -14.44 62.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.486 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.1 -36.14 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.687 0.28 . . . . 0.0 111.348 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 86' ' ' ALA . 12.8 p -114.81 -44.68 4.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.634 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.908 ' HB3' HD13 ' A' ' 82' ' ' LEU . . . -84.85 174.08 10.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.188 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -144.62 154.41 42.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.749 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -54.93 123.04 12.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.975 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.32 71.55 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.819 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -123.15 173.62 7.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -134.51 98.28 4.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.788 HD22 HD11 ' A' ' 76' ' ' LEU . 3.7 mt -101.63 169.13 9.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.988 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 t -119.51 121.27 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.621 ' HB3' ' HA ' ' A' ' 24' ' ' PHE . . . -90.69 117.95 29.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.567 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.67 110.04 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.574 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.446 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 37.1 p90 -142.8 -179.28 6.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.039 0.447 . . . . 0.0 111.386 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -115.11 152.74 32.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.93 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.1 pp20? -150.56 134.23 16.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.474 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 2.0 tt0 -99.46 68.96 1.63 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.938 0.399 . . . . 0.0 110.694 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.1 t0 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.997 179.936 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.892 0.377 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -125.55 -164.05 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.792 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.47 ' CD1' HD23 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -74.88 158.34 33.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.842 0.353 . . . . 0.0 110.9 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.36 120.33 2.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.119 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.433 ' HB ' HD11 ' A' ' 92' ' ' LEU . 24.2 m -138.04 141.86 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.986 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.4 m -100.05 116.38 31.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.621 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t -97.81 109.14 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.974 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 73.2 m -84.62 101.17 11.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.509 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 37.0 m-85 -88.03 102.36 14.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.589 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.6 -88.63 0.01 OUTLIER Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 24' ' ' PHE . 6.3 mtp180 -128.13 31.44 5.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 110.707 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.8 m -151.44 115.64 5.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.736 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.4 OUTLIER -98.33 148.05 24.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.271 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 m -144.79 133.2 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.089 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.52 136.56 40.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -127.08 92.68 43.59 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.04 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -83.45 117.29 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.778 2.319 . . . . 0.0 112.358 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 18' ' ' PHE . 2.0 t -87.54 136.79 32.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.88 -53.03 48.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.712 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -112.3 -31.57 6.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.726 0.298 . . . . 0.0 110.958 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.06 14.41 59.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.92 35.04 3.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.488 ' HE3' HD12 ' A' ' 43' ' ' LEU . 15.6 ptt? -105.77 138.71 41.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.686 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -59.35 147.69 35.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.985 0.421 . . . . 0.0 111.168 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.934 HG23 ' O ' ' A' ' 80' ' ' ASP . 67.2 t -52.23 -40.2 30.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -49.82 -46.82 51.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.027 0.441 . . . . 0.0 110.649 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.446 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 7.0 t -66.14 -34.56 78.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.759 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.695 HD13 HD11 ' A' ' 82' ' ' LEU . 6.1 tp -67.52 -35.48 79.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.844 HD12 HD23 ' A' ' 78' ' ' LEU . 4.5 mt -65.44 -50.87 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.868 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 6.3 pt20 -60.3 -33.91 73.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.46 ' N ' ' HG3' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -70.18 -47.84 59.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -67.02 -45.41 77.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 44' ' ' ILE . 83.6 t -56.09 -48.1 79.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.869 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.1 m -59.2 -45.61 90.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.23 -32.52 73.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.729 ' O ' HG22 ' A' ' 55' ' ' VAL . 26.3 t80 -63.65 -57.43 10.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.7 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -54.95 -38.82 68.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.231 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -45.29 60.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.266 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.82 -48.17 80.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.142 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 51' ' ' TYR . 29.0 m -64.96 -15.37 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.452 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 79.59 31.77 0.25 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.83 0.348 . . . . 0.0 111.312 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HD2' HG21 ' A' ' 55' ' ' VAL . 17.4 mttt -93.97 -173.03 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.512 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.2 m-20 -150.35 170.1 8.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.709 0.29 . . . . 0.0 111.076 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 55.6 Cg_endo -70.12 57.26 1.63 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.636 2.224 . . . . 0.0 112.67 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -120.58 -23.32 6.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.768 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.853 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 9.6 p90 -111.88 154.57 24.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.527 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -81.36 154.29 26.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.661 0.267 . . . . 0.0 110.753 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.853 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 85.6 mt -142.29 111.32 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.026 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -106.53 101.85 11.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.711 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 44' ' ' ILE . 14.8 t -81.42 97.85 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.021 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -58.92 -67.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -177.14 -177.48 0.73 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.589 HD11 HG12 ' A' ' 44' ' ' ILE . 7.2 mt -123.63 152.11 42.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.28 143.61 31.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -66.28 -69.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.04 101.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.563 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 58.97 44.28 16.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.0 90.26 0.72 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.528 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.68 53.88 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 76' ' ' LEU . 12.0 mt -59.34 158.08 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.378 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.603 HD13 HD22 ' A' ' 92' ' ' LEU . 1.5 mt -138.71 117.19 12.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.84 -166.62 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.749 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.844 HD23 HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -112.86 43.65 1.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.48 25.46 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.283 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.934 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.1 t70 -133.89 136.82 44.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.883 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.843 ' O ' HG22 ' A' ' 85' ' ' VAL . 29.5 mm -58.69 155.85 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.063 0.459 . . . . 0.0 111.581 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.695 HD11 HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -66.3 -52.72 44.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.438 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.8 m -63.92 -14.75 56.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.584 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -91.63 -32.19 15.57 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 81' ' ' ILE . 13.4 m -107.08 -43.72 6.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.86 174.23 6.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.779 0.324 . . . . 0.0 111.253 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -138.41 153.99 48.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.803 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -51.49 124.65 12.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.947 0.403 . . . . 0.0 111.068 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.93 74.3 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.77 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -138.66 151.56 47.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -102.94 140.5 37.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.8 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.603 HD22 HD13 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -132.34 169.0 17.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.5 108.7 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.916 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.621 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -88.5 121.16 30.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.705 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.81 118.03 55.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.598 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.525 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.1 p90 -148.73 -174.0 4.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.075 0.464 . . . . 0.0 111.414 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -122.21 155.74 35.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.958 179.15 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 10.0 pt-20 -156.93 130.94 8.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.701 0.286 . . . . 0.0 111.22 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.467 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 16.9 tt0 -97.78 66.73 1.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.732 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.946 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.751 0.31 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -122.9 147.0 47.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.9 OUTLIER -70.09 166.42 19.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.867 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.85 120.44 1.02 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.97 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 43' ' ' LEU . 4.2 m -139.44 142.81 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.005 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.3 m -101.31 117.44 34.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.613 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 18.6 t -99.24 104.9 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.936 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 7.4 t -81.42 101.33 9.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.408 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 43.3 m-85 -89.27 103.08 15.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.43 -93.5 0.01 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.736 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mpm_? -119.05 30.93 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 m -156.46 114.5 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.715 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 5.7 ppt_? -105.03 151.81 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.316 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -146.47 145.89 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.093 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -87.74 141.38 28.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.756 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.5 t -129.31 95.25 31.03 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.211 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.82 116.1 2.48 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.68 2.253 . . . . 0.0 112.369 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -90.62 158.35 16.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.929 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.87 -63.53 2.83 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.645 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.21 -47.62 3.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.958 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.65 7.5 8.83 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.741 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -96.74 39.39 1.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.409 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 2.5 ttp -111.0 123.9 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.862 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.56 145.64 18.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.546 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 80' ' ' ASP . 98.6 t -49.36 -41.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.738 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.442 ' CB ' ' HB3' ' A' ' 78' ' ' LEU . 1.7 t80 -50.24 -42.59 52.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.409 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 3.1 m -70.85 -34.63 71.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.185 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.891 HD13 HD22 ' A' ' 82' ' ' LEU . 4.1 tp -67.89 -38.91 83.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.512 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.929 ' CG2' HG11 ' A' ' 65' ' ' VAL . 3.9 mt -65.1 -45.25 94.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.695 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -59.17 -39.82 83.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.728 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -65.79 -48.19 72.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.714 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -64.7 -48.65 73.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.914 HG21 HG21 ' A' ' 65' ' ' VAL . 67.1 t -54.03 -48.19 64.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.028 0.442 . . . . 0.0 110.765 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 83.9 m -57.12 -42.9 81.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.521 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.53 -33.05 74.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.779 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.583 ' O ' HG12 ' A' ' 55' ' ' VAL . 8.1 t80 -60.5 -56.7 18.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.647 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -43.49 85.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -72.01 -27.35 62.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.39 -39.74 31.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.181 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.3 p -85.67 4.3 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.61 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.56 52.78 2.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.81 0.338 . . . . 0.0 111.257 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HD2' HG11 ' A' ' 55' ' ' VAL . 72.3 mttt -116.71 -175.22 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.1 m-20 -145.86 171.0 7.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.73 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 34.2 Cg_endo -65.02 -7.43 15.29 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.425 2.083 . . . . 0.0 112.903 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -46.86 -37.43 8.79 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 111.446 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.826 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 5.9 p90 -104.56 152.59 22.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.09 154.24 25.69 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.827 0.346 . . . . 0.0 111.058 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.826 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 70.1 mt -142.78 111.0 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.849 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.488 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -106.95 107.18 18.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.929 HG11 ' CG2' ' A' ' 44' ' ' ILE . 4.2 t -83.44 98.89 5.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.011 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -55.26 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.264 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 ptt85 -163.54 -175.16 4.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD11 HG12 ' A' ' 44' ' ' ILE . 7.1 mt -126.87 152.27 47.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 111.023 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -141.51 132.79 26.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.88 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.62 ' CE1' HD21 ' A' ' 92' ' ' LEU . 11.5 m-70 -58.13 -46.85 84.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.1 -61.58 0.21 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.507 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -151.65 77.61 1.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.951 0.405 . . . . 0.0 110.835 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.96 39.45 1.41 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.43 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.634 ' O ' HD23 ' A' ' 76' ' ' LEU . . . -159.22 41.71 0.48 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 76' ' ' LEU . 10.6 mt -63.16 157.47 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 0.0 111.066 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.819 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -156.9 139.68 15.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 111.211 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -108.48 -163.12 0.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.731 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -98.75 71.61 1.94 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.827 0.346 . . . . 0.0 110.889 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.82 -43.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.931 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -72.25 135.02 45.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.736 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.775 ' O ' HG12 ' A' ' 85' ' ' VAL . 28.2 mm -53.1 155.94 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.158 0.504 . . . . 0.0 111.581 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.891 HD22 HD13 ' A' ' 43' ' ' LEU . 62.9 tp -70.88 -51.56 25.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.493 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.417 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 31.0 p -71.62 -8.15 52.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.73 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.6 -38.34 10.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.641 0.257 . . . . 0.0 111.291 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.819 HG21 ' HB3' ' A' ' 76' ' ' LEU . 13.7 p -101.02 -33.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.882 0.372 . . . . 0.0 111.599 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.42 174.23 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.378 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.23 154.85 50.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.51 130.64 36.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 56.37 68.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -132.55 149.17 52.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -97.32 143.62 27.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.62 HD21 ' CE1' ' A' ' 70' ' ' HIS . 12.0 mt -142.86 145.37 33.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.903 0.383 . . . . 0.0 111.202 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.81 116.18 35.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.766 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.613 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -99.48 121.89 41.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.052 0.453 . . . . 0.0 111.716 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 t -109.03 126.79 66.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.34 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.576 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.6 p90 -151.41 -179.77 7.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.178 0.513 . . . . 0.0 111.611 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.66 156.66 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.077 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -155.93 134.38 11.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 111.193 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 5.0 tt0 -99.06 67.87 1.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.836 -179.953 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 60.59 -177.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.641 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -76.12 159.57 30.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.737 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.23 120.46 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.044 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.52 HG21 HD21 ' A' ' 43' ' ' LEU . 3.3 m -132.8 143.13 40.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -96.12 114.89 26.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.12 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.654 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 20.0 t -104.43 104.31 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 14.5 t -86.66 101.8 13.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.082 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 44.7 m-85 -85.06 98.47 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.778 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.9 -79.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.357 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -138.19 31.32 2.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.822 0.344 . . . . 0.0 110.791 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.557 HG21 ' CD1' ' A' ' 51' ' ' TYR . 87.4 m -139.61 112.34 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -88.65 123.19 32.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 m -135.27 116.74 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.062 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.9 145.58 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.9 t -131.66 103.12 14.8 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.243 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.61 130.13 4.35 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.649 2.233 . . . . 0.0 112.294 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.64 131.42 47.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.03 -48.86 57.6 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.97 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -120.98 -46.07 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.31 11.69 9.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.675 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -97.76 35.02 1.75 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 110.622 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.94 118.73 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.811 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -54.52 149.96 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.616 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.9 t -48.05 -43.81 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.008 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.482 ' CD2' ' HB3' ' A' ' 78' ' ' LEU . 1.8 t80 -50.38 -49.38 54.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.236 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.3 t -62.33 -35.96 80.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.397 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.799 HD13 HD21 ' A' ' 82' ' ' LEU . 6.0 tp -66.36 -33.99 76.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.568 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.868 ' CG2' HG11 ' A' ' 65' ' ' VAL . 5.3 mt -66.18 -51.18 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.814 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -35.11 72.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.002 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -68.67 -48.13 64.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.735 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -67.93 -47.08 69.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.366 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 44' ' ' ILE . 61.2 t -53.09 -53.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.842 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.5 m -56.96 -44.74 82.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -29.89 70.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.911 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.557 ' CD1' HG21 ' A' ' 27' ' ' THR . 4.1 t80 -65.58 -57.4 8.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.772 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HA ' HG12 ' A' ' 55' ' ' VAL . 8.9 ptt180 -58.8 -35.19 72.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.887 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 7.6 mmtt -72.6 -29.99 63.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.29 -33.66 25.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.426 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.9 p -84.7 4.6 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.645 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.87 44.31 4.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 111.258 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -112.69 -174.76 2.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -147.59 176.29 2.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.742 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 18.7 Cg_exo -66.24 -9.29 23.15 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.826 2.35 . . . . 0.0 112.624 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -45.79 -39.4 8.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.714 0.292 . . . . 0.0 111.438 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.848 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 6.7 p90 -102.74 145.1 30.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.933 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.47 155.6 33.73 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.609 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.848 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 78.8 mt -142.95 110.97 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.887 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.489 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.2 OUTLIER -106.94 105.36 15.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.561 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.868 HG11 ' CG2' ' A' ' 44' ' ' ILE . 1.5 t -83.29 97.29 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.159 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -56.08 -74.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -167.66 178.12 5.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.786 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.545 ' HB2' HD12 ' A' ' 76' ' ' LEU . 1.1 mt -119.45 156.84 29.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 1.1 tt0 -138.66 147.01 42.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.775 ' HA ' HD23 ' A' ' 92' ' ' LEU . 4.7 m-70 -68.14 -64.54 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.89 -53.02 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.474 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.74 34.13 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.24 69.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.44 56.37 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.438 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 12.5 mt -62.49 153.38 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 111.099 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.938 HD11 HD22 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -129.0 114.18 16.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.794 179.69 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -163.39 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.17 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.665 HD23 HD12 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -113.54 36.5 3.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 0.0 110.773 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -148.29 26.88 0.95 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.908 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -131.64 134.28 45.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.882 0.372 . . . . 0.0 110.946 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 85' ' ' VAL . 29.1 mm -57.91 157.14 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.698 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.84 HD13 ' HB3' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -61.84 -56.13 22.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.626 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 34.7 m -71.19 -7.4 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.835 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.67 -37.46 15.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.574 0.226 . . . . 0.0 111.479 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 81' ' ' ILE . 8.5 m -114.9 -31.34 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.84 ' HB3' HD13 ' A' ' 82' ' ' LEU . . . -96.69 174.1 6.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 0.0 111.226 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.16 153.96 45.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.7 125.97 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.99 71.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -134.34 157.48 46.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.15 130.85 50.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.533 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.938 HD22 HD11 ' A' ' 76' ' ' LEU . 5.2 mt -138.62 132.7 31.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.354 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 69' ' ' GLU . 4.7 m -82.94 134.42 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.436 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.654 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -109.86 117.01 32.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.947 0.403 . . . . 0.0 111.768 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.03 127.12 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.344 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.459 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -160.75 174.77 13.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.122 0.487 . . . . 0.0 111.707 -179.408 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.17 157.95 25.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.242 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 9.7 pt-20 -155.23 135.0 12.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.046 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.476 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 2.3 tt0 -101.44 65.93 1.07 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.892 0.377 . . . . 0.0 111.008 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.956 179.895 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.945 0.402 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -96.94 -177.42 3.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.556 ' CE2' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -84.0 155.95 22.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.824 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -164.53 120.5 1.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.77 142.56 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.046 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.524 HG21 ' HD3' ' A' ' 28' ' ' ARG . 23.9 m -95.3 119.68 34.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 29' ' ' VAL . 21.3 t -98.97 107.55 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.022 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.86 101.59 14.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.479 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 43.6 m-85 -85.75 100.75 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.714 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.33 -78.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.294 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 tpm_? -141.84 31.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.729 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.0 m -137.66 125.48 22.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HD3' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -95.43 130.42 42.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 22' ' ' VAL . 6.7 m -135.35 127.11 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.043 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -74.98 143.22 43.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.986 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.3 t -140.72 92.62 8.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.145 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -84.65 123.03 2.8 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.757 2.305 . . . . 0.0 112.593 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.414 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -94.12 141.87 28.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.745 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.29 -81.79 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.881 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.24 -35.52 9.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 110.978 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.64 14.67 10.15 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 mtt-85 -98.6 28.46 4.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.941 0.4 . . . . 0.0 110.866 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.42 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 10.2 ttp -105.06 145.53 30.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.694 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.46 147.88 33.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 80' ' ' ASP . 59.1 t -48.83 -42.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.666 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -50.23 -38.8 42.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.42 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.4 OUTLIER -73.86 -34.58 64.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.278 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.864 ' CD1' HD11 ' A' ' 82' ' ' LEU . 5.4 tt -70.15 -38.66 75.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.673 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.925 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.1 mt -66.09 -45.83 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.634 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -59.06 -40.62 85.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.709 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -67.9 -44.79 76.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.782 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -66.85 -37.77 85.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 44' ' ' ILE . 75.0 t -59.64 -54.11 39.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.412 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -55.86 -42.72 76.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.599 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -37.87 86.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.703 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 55' ' ' VAL . 56.4 t80 -58.98 -57.02 14.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.69 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -51.37 -47.74 62.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.96 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -72.28 -25.75 61.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.225 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.49 -38.56 55.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.197 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 55' ' ' VAL . 13.6 p -92.28 12.74 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.617 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 57.54 56.86 4.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.905 0.383 . . . . 0.0 111.307 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 65.3 mttt -120.72 -175.39 3.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.468 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.6 m-20 -148.05 171.16 6.63 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.506 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 31.6 Cg_endo -64.19 -8.13 15.65 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.371 2.047 . . . . 0.0 112.916 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -46.35 -37.39 7.43 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.64 0.257 . . . . 0.0 111.521 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.838 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 6.0 p90 -104.8 156.13 18.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -85.03 153.79 22.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.164 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.838 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 76.6 mt -142.13 110.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.81 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -103.71 102.91 12.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.648 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.925 HG11 ' CG2' ' A' ' 44' ' ' ILE . 5.8 t -76.52 97.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -57.49 -78.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.0 -177.5 6.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.638 HD23 HD13 ' A' ' 44' ' ' ILE . 2.0 mm? -112.33 165.0 12.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -148.98 160.56 43.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.645 ' HA ' HD23 ' A' ' 92' ' ' LEU . 16.9 m-70 -94.61 -43.47 8.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.66 -88.39 0.14 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.41 33.02 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.769 0.318 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.45 108.12 0.99 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.4 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.09 95.28 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.403 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 76' ' ' LEU . 3.4 mm -93.19 155.26 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 76' ' ' LEU . 2.0 mp -133.54 118.02 17.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -95.17 -175.36 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.793 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.49 44.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.855 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.4 27.52 0.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.973 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.92 ' O ' HG23 ' A' ' 40' ' ' VAL . 9.3 m-20 -137.26 134.7 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.695 ' O ' HG22 ' A' ' 85' ' ' VAL . 31.7 mm -58.78 158.56 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.121 0.486 . . . . 0.0 111.586 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.864 HD11 ' CD1' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -58.0 -56.76 17.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.444 -179.433 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 68.9 m -70.66 -7.55 45.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.789 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.22 -30.97 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.678 0.275 . . . . 0.0 111.586 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 81' ' ' ILE . 2.4 m -120.06 -36.09 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.33 174.14 6.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.791 0.329 . . . . 0.0 111.338 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.55 150.52 47.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.752 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.61 132.72 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.01 60.32 2.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.732 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -138.97 134.85 33.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.38 151.2 26.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.763 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 70' ' ' HIS . 23.7 mt -146.13 150.85 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.007 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.25 114.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.758 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.449 ' HB2' HG13 ' A' ' 22' ' ' VAL . . . -95.27 128.1 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.751 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.93 137.15 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.32 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -167.88 163.32 13.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.129 0.49 . . . . 0.0 111.901 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -104.79 156.81 17.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.11 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -155.27 128.9 8.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.014 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.446 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 20.6 tt0 -86.53 66.85 9.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.036 0.446 . . . . 0.0 110.533 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.89 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.806 0.336 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -64.69 160.32 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.614 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -80.95 157.57 25.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -161.24 120.28 2.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.01 0.434 . . . . 0.0 111.061 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.698 HG21 HD21 ' A' ' 43' ' ' LEU . 4.1 m -132.9 142.9 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.926 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -100.43 118.59 36.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.529 HG13 HD21 ' A' ' 68' ' ' LEU . 31.4 t -97.75 109.59 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.758 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 t -88.3 101.68 14.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 55.7 m-85 -84.71 98.51 10.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.395 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.97 -85.42 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.333 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 mmp_? -129.17 31.38 4.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.4 m -138.25 145.09 40.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -105.85 138.3 42.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.027 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.76 108.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.019 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -74.81 149.05 39.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.1 t -141.25 94.12 7.8 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.322 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.28 129.11 4.37 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.645 2.23 . . . . 0.0 112.391 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.6 m -99.66 140.04 34.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.768 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.69 -50.81 62.37 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.576 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -112.28 -29.91 7.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 111.066 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.68 14.24 53.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.523 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.81 35.91 2.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.731 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.2 ttp -104.17 137.61 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -69.77 150.14 47.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.53 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 80' ' ' ASP . 44.3 t -48.86 -42.08 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.968 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -50.17 -43.06 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.32 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -30.48 63.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.579 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.096 HD13 HD21 ' A' ' 82' ' ' LEU . 3.3 tp -71.38 -39.18 71.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.618 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.935 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.3 mt -67.81 -44.13 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.692 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.21 -38.43 86.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -68.79 -42.73 76.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.604 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -69.46 -40.77 76.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.296 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 44' ' ' ILE . 98.0 t -58.45 -51.84 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.72 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.9 m -58.18 -44.44 88.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.416 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -64.48 -29.93 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.802 ' O ' HG22 ' A' ' 55' ' ' VAL . 7.5 t80 -64.13 -57.88 8.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.656 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HG3' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -58.77 -32.66 69.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.641 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.42 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 11.2 mmtt -72.52 -27.91 62.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.52 26.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.34 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 51' ' ' TYR . 2.8 m -93.99 18.98 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.583 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 55.16 28.97 11.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.562 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.64 ' HB2' HG23 ' A' ' 55' ' ' VAL . 10.0 mttt -94.54 -169.87 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.835 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m-20 -160.06 177.07 2.21 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.731 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 33.0 Cg_exo -61.49 -12.13 22.99 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.663 2.242 . . . . 0.0 112.767 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -45.02 -53.1 8.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.815 0.341 . . . . 0.0 111.346 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.781 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.7 p90 -90.44 148.68 22.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -79.71 155.49 27.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.79 0.328 . . . . 0.0 111.028 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 68.7 mt -142.46 111.02 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.759 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.482 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -104.65 105.33 15.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.651 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.935 HG11 ' CG2' ' A' ' 44' ' ' ILE . 1.4 t -83.02 97.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.133 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -53.56 -76.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -159.85 -176.97 6.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.991 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.529 HD21 HG13 ' A' ' 22' ' ' VAL . 10.0 mt -117.49 160.75 20.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.57 159.36 43.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.591 ' HA ' HD23 ' A' ' 92' ' ' LEU . 10.9 m-70 -85.23 -30.78 23.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.773 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.95 -53.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.406 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -156.72 73.01 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 110.784 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.91 57.66 0.54 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.41 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.61 59.0 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.493 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 76' ' ' LEU . 7.2 mt -71.66 158.36 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.824 0.345 . . . . 0.0 111.187 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.991 HD11 HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -151.25 141.43 22.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.7 -162.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.707 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.01 43.49 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.886 0.374 . . . . 0.0 110.944 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.3 25.33 1.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.909 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.0 m-20 -133.13 132.99 42.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.993 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.612 ' O ' HG22 ' A' ' 85' ' ' VAL . 27.5 mm -56.02 158.38 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.038 0.447 . . . . 0.0 111.534 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.096 HD21 HD13 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -62.27 -57.55 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.625 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.3 t -67.76 -11.6 58.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.934 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.41 -47.28 11.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.586 0.231 . . . . 0.0 111.516 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 81' ' ' ILE . 6.3 m -103.9 -32.75 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.645 ' HB3' HD13 ' A' ' 82' ' ' LEU . . . -101.55 173.99 6.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.901 0.381 . . . . 0.0 111.213 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.87 154.44 49.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.766 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -54.34 124.03 14.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.09 70.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -140.21 144.55 36.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.024 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -92.86 148.97 21.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.796 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.991 HD22 HD11 ' A' ' 76' ' ' LEU . 1.6 mt -143.41 146.84 33.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.128 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.3 t -92.12 122.76 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.605 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.426 ' HB2' HG13 ' A' ' 22' ' ' VAL . . . -108.85 118.12 35.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.002 0.429 . . . . 0.0 111.822 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 t -103.31 128.18 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.149 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.582 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.1 p90 -153.31 -177.65 6.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.277 0.56 . . . . 0.0 111.718 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -118.06 157.27 27.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.856 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.17 132.15 9.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 0.0 111.125 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.469 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 3.7 tt0 -92.05 73.42 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.05 0.452 . . . . 0.0 110.462 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 t70 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.927 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.689 0.281 . . . . 0.0 110.877 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.02 120.6 1.0 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.04 0.448 . . . . 0.0 111.203 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.927 HG11 ' HB1' ' A' ' 86' ' ' ALA . 12.4 m -136.74 142.56 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -100.57 132.3 46.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 29' ' ' VAL . 9.5 t -113.23 105.7 19.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 t -83.16 101.59 11.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.176 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.522 ' HE1' ' HB1' ' A' ' 47' ' ' ALA . 15.4 m-85 -83.45 100.65 10.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.397 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.48 -78.84 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.444 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 mtt180 -139.16 31.18 2.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.784 0.326 . . . . 0.0 110.973 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.4 m -140.92 122.59 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.17 125.39 38.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.148 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 22' ' ' VAL . 14.7 p -125.41 124.73 67.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.038 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -79.03 140.0 38.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.61 92.64 26.7 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.64 116.75 4.11 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.076 2.517 . . . . 0.0 112.192 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -91.41 120.83 32.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.754 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.78 -53.89 33.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.971 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -106.04 -33.03 8.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.834 0.349 . . . . 0.0 111.067 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.22 -12.09 61.92 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.31 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 56.27 3.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.121 0.486 . . . . 0.0 110.812 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.414 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 1.5 ttp -122.38 114.48 20.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.607 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -53.07 147.59 9.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 80' ' ' ASP . 22.0 t -46.85 -43.43 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 10.6 t80 -50.19 -42.16 50.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.954 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.414 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 4.4 m -71.14 -31.73 68.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.182 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.964 HD13 HD11 ' A' ' 82' ' ' LEU . 4.4 tt -71.77 -38.82 70.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.748 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.9 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.4 mt -64.58 -48.66 83.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.745 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.21 -38.8 87.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -67.85 -43.24 79.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HB1' ' HE1' ' A' ' 24' ' ' PHE . . . -69.83 -44.51 69.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.811 HG21 HG21 ' A' ' 65' ' ' VAL . 92.3 t -54.37 -52.21 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 110.647 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.402 HG23 ' NH2' ' A' ' 52' ' ' ARG . 86.3 m -58.18 -47.23 84.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -29.8 70.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.955 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' O ' HG12 ' A' ' 55' ' ' VAL . 35.2 t80 -62.07 -57.36 11.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.743 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HA ' HG12 ' A' ' 55' ' ' VAL . 9.5 ptt-85 -60.92 -36.34 79.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.838 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.427 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 11.4 tppt? -72.6 -27.74 62.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.145 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.96 -35.54 23.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.5 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.0 p -82.04 1.75 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.796 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 75.33 29.96 0.88 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.739 0.304 . . . . 0.0 111.626 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 7.4 mttt -99.24 -169.9 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.486 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -158.89 170.36 9.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.907 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 43.1 Cg_endo -68.14 61.8 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -124.01 -41.14 2.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.426 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.652 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 9.1 p90 -95.65 150.44 20.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.319 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -78.42 152.94 31.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.748 0.308 . . . . 0.0 110.94 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.652 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 73.0 mt -139.92 110.95 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.81 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -102.14 101.74 12.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.363 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.9 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.9 t -83.21 97.07 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.125 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -58.62 -77.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.443 ' C ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -163.88 -176.77 4.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.169 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.62 HD11 HG13 ' A' ' 22' ' ' VAL . 4.0 mm? -119.16 160.91 21.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.634 ' O ' HG22 ' A' ' 93' ' ' VAL . 3.8 tt0 -152.17 137.48 17.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.657 ' HA ' HD23 ' A' ' 92' ' ' LEU . 14.2 m-70 -64.19 -30.47 71.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.83 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.24 -70.96 0.26 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.518 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.79 35.32 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.838 0.352 . . . . 0.0 111.021 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.51 64.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.49 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.12 60.94 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 76' ' ' LEU . 12.6 mt -59.42 156.18 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 0.0 111.074 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.555 HD23 ' CG1' ' A' ' 85' ' ' VAL . 3.9 mp -130.83 122.03 26.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -109.38 169.23 8.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.538 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.692 ' CD2' HD12 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -86.06 79.99 8.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.062 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.82 -38.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.853 ' O ' HG23 ' A' ' 40' ' ' VAL . 47.5 m-20 -77.08 131.07 38.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.061 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 85' ' ' VAL . 28.4 mm -55.71 158.28 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.096 0.474 . . . . 0.0 111.546 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.964 HD11 HD13 ' A' ' 43' ' ' LEU . 2.2 tp -71.15 -54.58 10.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.094 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -26.45 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.484 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.12 -35.54 17.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 81' ' ' ILE . 16.1 t -97.38 -67.09 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 111.675 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.927 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -66.97 174.29 3.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.291 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.43 154.9 41.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.781 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.46 117.03 1.98 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.67 60.81 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -122.87 142.94 50.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.6 mmm-85 -95.79 154.5 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.657 HD23 ' HA ' ' A' ' 70' ' ' HIS . 55.2 mt -148.87 138.25 21.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.025 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 69' ' ' GLU . 3.2 m -90.15 121.95 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.651 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.56 ' HA ' HD13 ' A' ' 68' ' ' LEU . . . -103.44 121.79 43.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.061 0.457 . . . . 0.0 111.885 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.04 122.97 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.103 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.593 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.2 p90 -151.16 -174.35 4.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.192 0.52 . . . . 0.0 111.586 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -120.62 156.99 30.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.791 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.3 pt-20 -158.23 128.98 6.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.84 0.352 . . . . 0.0 111.224 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.473 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 1.3 tt0 -93.27 70.72 4.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.982 0.42 . . . . 0.0 110.746 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.886 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.473 ' CD1' HD23 ' A' ' 82' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.73 120.82 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.015 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.68 142.49 37.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.1 m -97.67 121.88 40.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.751 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.4 t -103.74 111.49 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.6 t -86.46 101.82 13.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CE1' HG22 ' A' ' 48' ' ' VAL . 51.4 m-85 -85.46 100.26 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.766 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.16 -90.09 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.575 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.67 31.47 6.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.0 m -139.46 144.99 38.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.41 118.2 30.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.84 126.75 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.98 146.66 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.721 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.5 t -129.01 92.73 38.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.064 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -77.71 106.26 2.16 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.869 2.379 . . . . 0.0 112.244 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.419 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -80.67 137.53 36.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.608 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.57 -36.07 7.76 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.061 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -151.55 -45.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.39 13.52 4.75 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.777 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.619 ' CG ' ' O ' ' A' ' 37' ' ' ARG . 8.4 ttm-85 -99.57 29.73 3.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.654 0.74 . . . . 0.0 109.876 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 6.8 ttp -108.86 151.6 26.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.625 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.93 144.62 38.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.607 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 80' ' ' ASP . 58.4 t -48.11 -41.4 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.815 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -50.36 -43.01 54.04 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -33.64 72.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.177 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.981 HD22 HD11 ' A' ' 82' ' ' LEU . 3.5 tp -69.09 -39.41 79.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.654 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.911 ' CG2' HG11 ' A' ' 65' ' ' VAL . 3.9 mt -63.18 -51.35 72.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.732 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -36.96 73.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -68.93 -48.05 64.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.721 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -66.6 -41.21 88.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.328 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 44' ' ' ILE . 97.0 t -58.45 -48.13 86.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 0.0 110.619 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.0 m -58.55 -46.98 85.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.596 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -64.39 -33.73 76.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.691 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.504 ' O ' HG12 ' A' ' 55' ' ' VAL . 20.0 t80 -59.56 -57.16 14.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.683 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.508 ' HA ' HG12 ' A' ' 55' ' ' VAL . 5.7 ttm105 -57.47 -40.37 78.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -72.11 -29.3 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.214 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.43 -30.91 26.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.221 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.9 p -85.3 -2.97 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.598 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 70.58 34.82 2.04 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.733 0.301 . . . . 0.0 111.288 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' CD ' HG11 ' A' ' 55' ' ' VAL . 13.6 mttt -102.93 -175.36 2.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.796 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.9 m-20 -149.69 175.92 2.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 25.3 Cg_exo -63.15 -11.12 23.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.745 2.297 . . . . 0.0 112.738 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -44.97 -33.17 1.91 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.596 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.725 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 2.7 p90 -116.1 145.29 43.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.76 0.315 . . . . 0.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -77.62 154.95 31.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.652 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.725 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 52.1 mt -141.64 110.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.001 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -105.88 108.6 20.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.754 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.911 HG11 ' CG2' ' A' ' 44' ' ' ILE . 2.2 t -80.05 100.09 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 96' ' ' PHE . 97.8 m-70 -57.8 -63.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -176.77 -173.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.009 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 94' ' ' ALA . 94.9 mt -124.1 154.32 40.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.763 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -138.37 141.1 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.984 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.476 ' HA ' HD23 ' A' ' 92' ' ' LEU . 3.9 m-70 -68.44 -46.74 69.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.47 -85.24 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.04 39.1 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.349 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.99 102.03 2.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.98 57.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.412 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 76' ' ' LEU . 13.1 mt -59.22 157.12 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.188 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' N ' HG22 ' A' ' 75' ' ' ILE . 2.2 mp -138.76 123.83 19.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.455 ' OD1' HD12 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -100.44 -167.54 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.455 HD12 ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -108.95 46.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.389 . . . . 0.0 110.826 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -157.45 27.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.897 ' O ' HG23 ' A' ' 40' ' ' VAL . 65.1 m-20 -142.86 134.37 26.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.895 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 85' ' ' VAL . 24.0 mm -52.59 156.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.038 0.447 . . . . 0.0 111.461 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.981 HD11 HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -73.13 -49.02 30.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.401 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.8 t -64.97 -14.53 60.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.608 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -91.0 -45.91 8.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.648 0.261 . . . . 0.0 111.615 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 81' ' ' ILE . 32.2 m -95.73 -39.22 9.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.02 174.11 7.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.885 0.374 . . . . 0.0 111.28 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.03 144.46 48.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.37 132.55 48.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 tptt 61.66 57.69 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -130.0 164.37 24.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.029 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -111.22 151.06 28.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.75 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 70' ' ' HIS . 13.6 mt -143.49 165.66 26.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.151 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.86 117.83 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.791 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.751 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -97.25 113.42 25.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.63 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.99 118.0 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.398 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.69 ' CD2' HG23 ' A' ' 63' ' ' ILE . 17.0 p90 -144.01 174.5 10.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.068 0.461 . . . . 0.0 111.477 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -107.53 158.14 17.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.787 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 12.2 pt-20 -154.66 137.67 15.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.753 0.311 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.487 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 19.6 tt0 -105.46 60.74 0.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.807 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.0 p30 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.858 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.428 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.766 0.317 . . . . 0.0 110.807 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -153.73 120.39 5.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.485 ' CG2' HD11 ' A' ' 43' ' ' LEU . 5.4 m -140.4 142.96 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.069 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -107.29 118.67 37.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.51 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.4 t -97.76 109.29 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 101.63 14.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.061 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.458 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 58.8 m-85 -85.62 102.82 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.504 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.03 -83.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.32 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -133.78 31.28 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.5 m -137.97 122.24 18.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.758 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -96.67 129.53 44.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.13 137.4 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.35 144.73 26.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.022 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.76 HG11 ' HG ' ' A' ' 43' ' ' LEU . 21.2 t -142.25 92.82 7.39 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.37 121.77 2.33 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.735 2.29 . . . . 0.0 112.518 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.428 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -94.28 123.29 37.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.785 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.56 -53.1 30.32 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.063 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.52 -33.6 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 111.081 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.1 6.19 61.86 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.684 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 31.86 2.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.864 0.364 . . . . 0.0 110.669 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.655 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -97.17 139.63 32.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.641 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.713 ' HE2' HD11 ' A' ' 81' ' ' ILE . 3.7 mmtt -67.9 144.7 55.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.394 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -46.67 -54.3 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.818 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.56 ' HD1' HD22 ' A' ' 78' ' ' LEU . 9.7 t80 -50.18 -29.81 10.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.216 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -73.15 -40.77 64.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.398 . . . . 0.0 110.3 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.112 HD13 HD11 ' A' ' 82' ' ' LEU . 3.7 tt -70.85 -38.26 73.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.681 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.865 ' O ' HG23 ' A' ' 48' ' ' VAL . 6.3 mt -62.54 -48.99 85.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.713 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -59.13 -42.73 91.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.625 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -64.94 -43.43 92.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.591 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.458 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -66.91 -39.52 87.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.914 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.919 HG21 HG21 ' A' ' 65' ' ' VAL . 92.9 t -60.17 -46.51 94.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.435 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.2 m -59.63 -43.52 93.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.287 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -34.98 79.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.628 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 55' ' ' VAL . 8.9 t80 -59.29 -57.12 14.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.471 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -53.31 -47.41 69.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -29.88 67.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.947 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.37 -29.8 57.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.2 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.5 p -97.25 3.88 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.591 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.74 36.52 8.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' CD ' HG11 ' A' ' 55' ' ' VAL . 11.6 mttt -101.78 -174.75 2.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.893 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m-20 -152.54 176.92 2.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.687 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 24.6 Cg_exo -63.47 -10.56 22.13 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.58 2.187 . . . . 0.0 112.734 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -45.26 -37.72 4.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.661 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.804 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.9 p90 -107.59 154.65 21.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.747 0.308 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.502 ' CD1' ' HB2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.45 154.17 24.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.961 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.804 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 66.1 mt -143.44 111.21 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.101 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -104.01 102.42 12.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.919 HG21 HG21 ' A' ' 48' ' ' VAL . 5.1 t -84.75 98.58 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.075 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -60.53 -77.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.074 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -166.9 -174.22 2.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.656 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.732 HD11 HG12 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -120.16 160.49 22.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.46 129.73 23.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -59.65 -29.62 68.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.34 -68.94 0.22 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -158.07 39.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.909 0.385 . . . . 0.0 110.757 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.25 49.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.318 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.05 57.04 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.361 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 mt -59.61 146.51 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.403 . . . . 0.0 111.316 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 5.2 mp -113.53 111.15 21.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.176 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -152.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.092 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.56 HD22 ' HD1' ' A' ' 41' ' ' PHE . 5.6 mt -117.75 27.38 9.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.6 0.238 . . . . 0.0 111.097 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 24.1 m-20 -137.65 -38.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.594 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.496 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -54.7 109.16 0.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.872 0.368 . . . . 0.0 111.615 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.713 HD11 ' HE2' ' A' ' 39' ' ' LYS . 27.8 mm -50.74 158.58 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.489 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.112 HD11 HD13 ' A' ' 43' ' ' LEU . 3.4 mm? -54.88 -59.1 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.269 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 22.0 p -65.3 -14.81 61.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.452 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -80.99 -32.45 34.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.575 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 86' ' ' ALA . 11.5 p -124.95 -45.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.805 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.491 ' N ' HG13 ' A' ' 85' ' ' VAL . . . -76.6 174.12 10.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.992 0.425 . . . . 0.0 111.427 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -143.85 155.16 44.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.7 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -52.82 119.14 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.6 tttp 61.68 71.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -139.62 136.5 34.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.018 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -87.57 147.86 25.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.796 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mt -136.72 153.03 50.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.027 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.3 117.13 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.704 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -99.25 119.26 37.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 111.702 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.15 123.6 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.47 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.57 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.5 p90 -151.32 -174.17 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.032 0.444 . . . . 0.0 111.491 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -125.91 159.06 33.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.962 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -157.18 137.5 12.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.782 0.325 . . . . 0.0 111.384 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.502 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 19.2 tt0 -117.89 59.17 0.79 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.073 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.942 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD2' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.029 0 CA-C-O 120.884 0.373 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.38 120.61 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.992 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.63 142.3 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.977 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.1 m -110.77 106.03 15.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 68' ' ' LEU . 1.4 m -97.84 103.76 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.93 101.77 2.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.037 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 4.5 m-85 -78.52 101.88 7.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.425 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.18 -77.0 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.234 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . 6.2 ttt180 -143.89 30.92 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.889 0.375 . . . . 0.0 110.763 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.9 m -142.02 126.88 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -79.51 117.77 20.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 51' ' ' TYR . 21.8 t -113.06 109.17 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -74.94 144.23 43.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.05 92.62 7.62 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.65 138.42 6.19 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.802 2.335 . . . . 0.0 112.599 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.421 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -113.02 146.39 39.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.61 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.19 -38.74 9.77 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.938 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -121.78 -43.93 2.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.512 ' HA2' HD23 ' A' ' 82' ' ' LEU . . . 111.58 10.87 18.55 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.547 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -97.97 35.11 1.77 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.605 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.436 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.5 OUTLIER -110.16 113.15 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.724 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -54.42 157.39 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.7 t -51.88 -52.11 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.054 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.564 ' HD1' HD22 ' A' ' 78' ' ' LEU . 10.7 t80 -49.49 -29.73 7.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.077 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.436 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 50.5 m -76.11 -42.18 47.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.805 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 40' ' ' VAL . 0.8 OUTLIER -70.86 -37.66 73.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.606 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.88 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.3 mt -64.09 -50.02 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.528 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -57.09 -41.34 78.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.366 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -38.38 90.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.32 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.62 -39.62 73.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.755 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.804 HG21 HG21 ' A' ' 65' ' ' VAL . 92.5 t -58.14 -53.17 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.439 HG23 ' NH2' ' A' ' 52' ' ' ARG . 45.2 m -59.25 -41.56 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.341 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -27.14 64.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.671 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.489 ' O ' HG22 ' A' ' 55' ' ' VAL . 27.5 t80 -68.28 -58.08 4.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.739 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.439 ' NH2' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -58.93 -36.75 75.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.753 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -72.13 -26.06 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.825 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.15 -31.39 25.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.448 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.678 HG23 ' HG3' ' A' ' 57' ' ' LYS . 29.3 m -94.0 17.6 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.649 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 58.6 31.82 21.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.559 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HG3' HG23 ' A' ' 55' ' ' VAL . 19.1 mttm -98.17 -177.19 3.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.799 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.27 175.34 2.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.97 -10.05 23.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.776 2.317 . . . . 0.0 112.815 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -47.65 -63.06 1.16 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.905 0.383 . . . . 0.0 111.283 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 2.7 p90 -75.86 145.64 40.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.83 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.492 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.61 154.12 34.66 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.672 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 62.2 mt -141.4 111.11 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.874 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.492 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.6 OUTLIER -104.84 104.48 14.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.585 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.88 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.0 t -82.42 98.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.466 ' HD2' HG12 ' A' ' 95' ' ' VAL . 83.1 m-70 -61.67 -68.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.067 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -174.87 -176.93 1.04 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.703 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.82 HD11 HG12 ' A' ' 44' ' ' ILE . 9.7 mt -121.86 160.94 23.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 111.063 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -141.26 136.31 31.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.417 ' HA ' HD23 ' A' ' 92' ' ' LEU . 8.3 m-70 -59.8 -51.7 68.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.22 -31.87 0.95 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.565 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -151.8 75.42 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.32 . . . . 0.0 110.829 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.59 76.75 1.01 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.52 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.25 55.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.543 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 mt -64.47 153.81 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.471 HD23 ' CG2' ' A' ' 85' ' ' VAL . 4.4 mp -124.57 121.77 35.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.832 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.45 -163.07 1.01 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.787 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.564 HD22 ' HD1' ' A' ' 41' ' ' PHE . 11.3 mt -109.0 42.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.083 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -157.06 32.3 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.918 ' O ' HG23 ' A' ' 40' ' ' VAL . 6.1 t0 -134.35 134.03 41.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.098 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.843 ' O ' HG12 ' A' ' 85' ' ' VAL . 30.6 mm -61.83 158.37 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.399 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.549 HD12 ' HB3' ' A' ' 86' ' ' ALA . 55.1 tp -65.4 -54.19 32.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.533 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.3 p -72.01 -5.94 38.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.928 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -101.03 -24.66 14.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.518 0.199 . . . . 0.0 111.5 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.843 HG12 ' O ' ' A' ' 81' ' ' ILE . 14.9 p -113.08 -34.21 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.771 0.319 . . . . 0.0 111.553 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.549 ' HB3' HD12 ' A' ' 82' ' ' LEU . . . -110.74 174.22 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.393 . . . . 0.0 111.275 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -136.08 156.26 48.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -52.59 127.05 21.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.032 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.59 70.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -129.78 134.82 47.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.039 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -99.2 113.42 25.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.798 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 70' ' ' HIS . 0.8 OUTLIER -117.02 167.13 11.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.08 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.44 141.83 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.736 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 24' ' ' PHE . . . -113.18 119.86 39.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.411 . . . . 0.0 111.472 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.466 HG12 ' HD2' ' A' ' 66' ' ' HIS . 31.9 t -105.16 114.6 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.572 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.587 ' HD2' HG23 ' A' ' 63' ' ' ILE . 3.2 p90 -144.91 -177.23 5.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.04 0.448 . . . . 0.0 111.503 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -116.28 157.04 25.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.793 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -157.58 133.53 9.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 111.422 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.483 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 2.5 tt0 -101.55 67.41 1.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.745 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.895 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.769 0.319 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.73 120.88 1.48 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 111.201 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 31' ' ' VAL . 16.0 m -133.51 156.13 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.4 m -117.39 119.47 35.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.903 0.382 . . . . 0.0 111.121 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.577 HG23 HG21 ' A' ' 31' ' ' VAL . 24.1 t -97.96 102.91 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.833 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.6 t -83.9 101.61 11.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.5 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 48.4 m-85 -83.57 99.84 10.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.521 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.86 -83.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.301 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -132.58 31.5 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.352 . . . . 0.0 110.761 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 m -138.35 118.71 13.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.76 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.22 120.51 32.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.086 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.5 138.41 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.986 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.75 142.49 27.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.01 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.577 HG21 HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -141.61 93.78 7.62 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.83 160.39 27.58 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.624 2.216 . . . . 0.0 112.658 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -129.32 129.51 44.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.747 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.38 -41.06 21.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.018 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.11 -33.22 6.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.196 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.25 -0.04 63.6 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.566 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.54 44.68 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.036 0.446 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.404 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.2 OUTLIER -114.87 107.75 15.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.612 ' HG2' HD13 ' A' ' 81' ' ' ILE . 4.0 mttt -53.28 159.25 1.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.055 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 80' ' ' ASP . 40.1 t -51.62 -52.71 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -49.39 -29.04 5.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 110.841 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 13.8 m -75.85 -45.0 38.08 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.398 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.71 HD22 HD13 ' A' ' 82' ' ' LEU . 4.2 pp -72.98 -34.75 66.65 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.896 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.927 ' O ' HG23 ' A' ' 48' ' ' VAL . 5.1 mt -66.43 -48.06 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 110.431 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -57.95 -45.79 86.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -37.11 83.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.282 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -72.55 -37.18 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.829 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 44' ' ' ILE . 60.9 t -59.41 -54.98 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.325 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -58.11 -44.11 87.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.355 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -35.84 78.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.582 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.769 ' O ' HG22 ' A' ' 55' ' ' VAL . 33.6 t80 -59.99 -57.96 10.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.255 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -49.26 -44.13 43.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.701 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -28.94 68.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.583 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.01 -29.76 43.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.008 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -98.45 18.14 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.268 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.96 28.68 3.95 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.441 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -95.0 -172.46 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -151.9 172.33 5.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.432 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 36.7 Cg_endo -65.74 -8.09 18.49 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.205 1.937 . . . . 0.0 112.818 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -45.77 -42.92 12.61 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.742 0.306 . . . . 0.0 111.436 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.844 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 7.5 p90 -97.02 161.16 13.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.76 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.497 ' CD1' ' HB2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -87.27 154.34 20.77 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.694 0.283 . . . . 0.0 111.149 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.844 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 86.0 mt -143.11 111.47 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.788 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -99.25 102.01 13.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.682 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.611 HG11 ' CG2' ' A' ' 44' ' ' ILE . 9.9 t -81.43 95.42 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -56.18 -77.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.283 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.26 -177.61 4.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.875 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.56 ' HB3' HD13 ' A' ' 76' ' ' LEU . 1.3 mm? -115.58 147.91 40.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.94 132.58 42.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -58.33 -28.84 65.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.059 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.36 -59.77 0.53 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.567 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.59 32.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 0.0 110.848 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.53 78.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.44 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.11 62.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.409 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 76' ' ' LEU . 11.7 mt -59.5 157.95 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.617 HD23 ' CG2' ' A' ' 85' ' ' VAL . 1.8 mp -131.87 121.17 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' O ' HG11 ' A' ' 40' ' ' VAL . 29.2 m-20 -97.22 -174.48 2.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.55 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.519 HD23 HD12 ' A' ' 44' ' ' ILE . 1.6 mt -104.0 34.1 3.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -150.17 34.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.186 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.901 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -139.33 132.28 29.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.918 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.621 ' O ' HG12 ' A' ' 85' ' ' VAL . 21.8 mm -56.38 154.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.086 0.47 . . . . 0.0 111.318 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.71 HD13 HD22 ' A' ' 43' ' ' LEU . 49.3 tp -63.0 -52.77 61.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.288 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 64.5 m -67.89 -11.36 58.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.738 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -97.9 -22.72 16.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 81' ' ' ILE . 14.4 p -111.21 -44.04 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.638 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.468 ' N ' HG13 ' A' ' 85' ' ' VAL . . . -101.33 174.18 6.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.322 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -129.31 149.65 51.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.673 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -51.81 126.43 17.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.151 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm 61.69 67.64 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -136.63 153.29 50.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.403 ' NH1' ' HB2' ' A' ' 91' ' ' ARG . 2.3 mtm105 -104.35 146.18 29.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.661 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB3' HD12 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -137.7 152.65 49.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.187 -179.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 t -108.29 108.64 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.596 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.68 129.5 36.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.989 0.423 . . . . 0.0 111.809 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.8 t -110.8 126.65 68.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.436 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.653 ' HD2' HG23 ' A' ' 63' ' ' ILE . 3.4 p90 -150.16 179.69 7.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.116 0.484 . . . . 0.0 111.432 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -116.13 162.35 17.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.721 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.2 pt-20 -161.58 134.76 6.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.8 0.333 . . . . 0.0 111.456 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.497 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 13.8 tt0 -102.88 72.74 1.22 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.623 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.902 -179.865 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.696 0.284 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -162.74 120.46 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 111.279 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 43' ' ' LEU . 4.3 m -134.72 142.57 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.835 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.6 m -114.1 107.62 15.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.997 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.435 HG23 ' CG2' ' A' ' 29' ' ' VAL . 18.8 m -97.91 137.35 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.979 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.8 m -103.49 102.58 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.24 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 40.6 m-85 -77.13 95.47 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.442 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.9 -73.89 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.144 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' PHE . 1.6 mmt85 -143.54 29.09 1.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 110.565 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.8 m -136.31 114.82 11.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.757 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -87.11 127.38 35.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.435 ' CG2' HG23 ' A' ' 22' ' ' VAL . 23.8 m -133.23 140.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.114 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.27 149.5 21.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.076 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.608 HG11 ' HG ' ' A' ' 43' ' ' LEU . 21.6 t -137.81 96.03 10.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.39 127.72 6.74 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.609 2.206 . . . . 0.0 112.303 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.3 154.98 22.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.05 -69.4 1.38 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.576 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -109.15 -17.84 13.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 111.203 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.83 14.97 57.3 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.444 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -100.31 29.13 4.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 110.825 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 ttp -98.2 130.26 44.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -57.63 142.96 43.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.595 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 80' ' ' ASP . 92.7 t -48.46 -45.44 14.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.72 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -50.17 -35.18 25.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.111 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 m -74.57 -37.56 62.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.469 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.667 HD13 HD13 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -70.28 -39.02 75.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.683 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.883 ' O ' HG23 ' A' ' 48' ' ' VAL . 4.1 mt -64.26 -49.4 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.654 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -38.92 80.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.63 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -42.95 84.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.507 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -68.26 -40.34 81.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.893 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 44' ' ' ILE . 69.4 t -56.63 -52.09 58.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.118 0.485 . . . . 0.0 110.471 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -57.27 -43.73 83.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.422 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -38.81 80.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.573 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' HG12 ' A' ' 55' ' ' VAL . 9.8 t80 -58.66 -56.49 21.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.474 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.4 mtm-85 -48.88 -47.8 42.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -32.28 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.062 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 -26.71 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.042 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.1 p -99.13 1.86 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 67.53 30.89 6.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.765 0.317 . . . . 0.0 111.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HD2' HG11 ' A' ' 55' ' ' VAL . 11.4 mttt -99.2 -175.14 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.736 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.1 m-20 -146.13 175.85 2.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 24.3 Cg_exo -64.15 -7.92 15.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.89 2.393 . . . . 0.0 112.932 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -48.02 -66.99 0.31 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.88 0.372 . . . . 0.0 110.99 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.748 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 1.9 p90 -74.37 160.71 30.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.576 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -89.49 151.64 21.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.791 0.329 . . . . 0.0 111.258 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.748 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 35.0 mt -142.08 111.0 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.686 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.49 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -109.04 101.53 10.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.674 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 65' ' ' VAL . 11.3 p -86.3 96.74 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.144 0.497 . . . . 0.0 111.032 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -54.29 -81.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.586 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.07 -167.08 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.802 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.542 HD11 HG12 ' A' ' 44' ' ' ILE . 4.0 mt -127.66 164.99 20.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.847 0.356 . . . . 0.0 111.143 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.409 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -141.21 141.92 34.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.839 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.546 ' HA ' HD23 ' A' ' 92' ' ' LEU . 14.0 m-70 -64.59 -35.82 82.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.993 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.54 -77.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.574 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.63 40.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.27 103.15 2.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.441 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.3 58.19 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.582 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 76' ' ' LEU . 7.7 mt -68.32 158.44 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.297 . . . . 0.0 111.046 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -158.41 131.84 7.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.16 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -90.81 -156.61 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.802 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.653 ' CD2' HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -112.26 84.92 2.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.85 0.357 . . . . 0.0 110.74 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -171.75 -40.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.928 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.1 m-20 -76.09 142.5 41.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.864 ' O ' HG12 ' A' ' 85' ' ' VAL . 27.6 mm -56.75 156.89 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.17 0.51 . . . . 0.0 111.474 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.667 HD13 HD13 ' A' ' 43' ' ' LEU . 64.6 tp -66.39 -56.7 9.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.293 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.83 -14.74 61.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.584 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -90.53 -28.21 18.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.586 0.231 . . . . 0.0 111.328 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.864 HG12 ' O ' ' A' ' 81' ' ' ILE . 14.6 p -117.09 4.48 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.83 174.22 11.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.35 . . . . 0.0 111.212 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.77 152.85 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.817 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.54 135.95 54.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.993 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.55 58.1 3.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.769 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -120.78 157.86 28.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.066 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -116.39 137.06 52.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 70' ' ' HIS . 1.5 mp -142.89 154.39 44.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.069 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 69' ' ' GLU . 1.4 m -99.62 117.76 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.66 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -91.83 122.74 34.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.694 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.3 126.37 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.271 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.475 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -155.33 169.72 23.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.239 0.542 . . . . 0.0 112.124 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.91 157.09 25.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -153.8 136.43 15.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 111.327 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.48 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 6.7 tt0 -105.23 63.96 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.801 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.721 0.295 . . . . 0.0 110.53 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -152.25 120.66 6.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.983 0.42 . . . . 0.0 111.069 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 86' ' ' ALA . 4.6 m -132.34 142.42 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.921 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -106.43 125.34 50.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.816 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.005 HG12 ' HB2' ' A' ' 94' ' ' ALA . 2.9 t -112.66 109.96 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.96 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.1 m -75.27 101.51 4.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.514 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 7.4 m-85 -84.74 97.32 9.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.705 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.32 -92.87 0.01 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.509 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.34 31.72 6.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.876 0.37 . . . . 0.0 110.641 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.0 m -153.35 117.67 4.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 135.21 33.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.028 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.16 137.08 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.167 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.78 148.94 25.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.9 t -138.93 92.88 10.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.229 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.42 124.94 3.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.767 2.311 . . . . 0.0 112.493 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.52 ' SG ' HD22 ' A' ' 82' ' ' LEU . 8.2 m -103.62 136.96 42.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.784 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.38 -41.77 93.34 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.996 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -128.68 -46.53 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.878 0.37 . . . . 0.0 111.236 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.23 12.19 8.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.46 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 -93.85 35.61 1.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.923 0.392 . . . . 0.0 110.576 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.467 ' HG2' ' HB2' ' A' ' 42' ' ' SER . 8.9 ttm -111.17 114.19 27.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.702 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -49.7 144.36 6.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.215 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 80' ' ' ASP . 27.5 t -46.61 -44.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 111.146 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.628 ' HD1' HD22 ' A' ' 78' ' ' LEU . 6.0 t80 -50.64 -41.15 54.91 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.531 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.467 ' HB2' ' HG2' ' A' ' 38' ' ' MET . 2.9 m -71.98 -34.41 68.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 110.223 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.539 HD13 HD13 ' A' ' 82' ' ' LEU . 2.3 tp -66.98 -35.41 79.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.155 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.969 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.5 mt -65.88 -51.28 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.547 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -55.76 -36.66 67.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.485 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -67.19 -42.37 84.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.567 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -69.48 -41.77 75.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.974 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 65' ' ' VAL . 61.2 t -56.41 -52.89 46.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.723 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.1 m -58.31 -44.34 88.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.484 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -62.74 -36.92 84.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.697 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -58.16 -52.94 63.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.534 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -55.19 -49.09 72.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.863 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -70.49 -24.61 62.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.85 -41.41 62.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 0.0 111.28 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.4 p -93.06 9.69 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.668 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 62.8 37.68 12.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.758 0.313 . . . . 0.0 111.466 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 31.8 mttt -96.54 -174.36 3.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -144.86 172.27 5.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.43 -10.71 22.57 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.822 2.348 . . . . 0.0 112.797 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.21 -59.09 3.11 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.835 0.35 . . . . 0.0 111.45 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.818 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.6 p90 -79.58 141.24 36.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CD1' ' HB2' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -76.71 156.18 32.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.621 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.818 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 57.9 mt -142.03 111.22 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.075 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.488 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -103.96 105.53 15.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.516 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.969 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.1 t -82.54 100.05 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.203 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -63.62 -70.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -168.42 -173.01 1.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.749 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.895 HD11 HG12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -131.35 158.86 39.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.829 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -142.81 141.14 31.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -61.53 -45.19 95.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.81 -87.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.519 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -120.38 33.8 5.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.797 0.332 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.22 89.56 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.445 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.57 62.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.435 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 76' ' ' LEU . 14.2 mt -56.68 156.05 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.942 0.401 . . . . 0.0 111.104 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.881 HD11 HD22 ' A' ' 92' ' ' LEU . 2.6 mt -126.8 115.05 18.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.058 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.71 -163.13 1.01 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.794 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.657 ' CD2' HD12 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -117.38 77.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.867 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -174.61 -62.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.238 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.853 ' O ' HG23 ' A' ' 40' ' ' VAL . 6.6 t0 -53.05 128.08 26.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.329 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 83' ' ' CYS . 24.1 mm -54.12 146.6 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.479 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.744 ' HG ' ' HB3' ' A' ' 86' ' ' ALA . 4.5 tp -60.77 -39.72 89.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.373 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.62 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -67.02 -12.87 61.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.619 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.12 -29.86 12.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.646 0.26 . . . . 0.0 111.392 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 86' ' ' ALA . 32.6 m -104.26 -44.7 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.864 0.364 . . . . 0.0 111.668 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.744 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . . . -88.81 174.07 8.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.204 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -145.14 155.39 43.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.677 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -48.8 118.22 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.26 57.84 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -112.69 147.53 36.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.488 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -96.65 148.59 22.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.881 HD22 HD11 ' A' ' 76' ' ' LEU . 16.6 mt -146.2 169.09 19.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.05 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 t -127.7 114.4 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.005 ' HB2' HG12 ' A' ' 22' ' ' VAL . . . -94.12 122.68 36.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.44 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.42 112.01 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.63 ' CD2' HG23 ' A' ' 63' ' ' ILE . 20.2 p90 -141.22 174.46 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.011 0.434 . . . . 0.0 111.282 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -108.48 159.6 16.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.026 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.4 pt-20 -156.53 135.45 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 111.244 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.489 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 30.8 tt0 -107.23 69.52 0.76 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.967 0.413 . . . . 0.0 110.899 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.1 p30 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.957 -179.91 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.746 ' CE2' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.79 0.329 . . . . 0.0 111.097 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.59 120.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.5 m -137.51 141.91 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.1 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.407 ' CG2' ' CG ' ' A' ' 28' ' ' ARG . 5.8 m -105.55 120.03 40.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.865 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.905 HG13 HD11 ' A' ' 68' ' ' LEU . 17.1 t -101.61 111.76 32.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -92.13 101.64 14.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.663 ' CE2' HG22 ' A' ' 48' ' ' VAL . 65.9 m-85 -85.52 108.01 17.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.697 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.74 -87.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.377 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -131.55 31.63 4.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.364 . . . . 0.0 110.702 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.1 m -137.76 136.54 37.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.407 ' CG ' ' CG2' ' A' ' 21' ' ' THR . 10.3 ttm180 -101.14 137.5 39.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.48 126.67 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -86.96 144.45 26.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.797 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.0 t -142.29 92.64 7.41 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.196 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.62 122.57 2.74 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.788 2.325 . . . . 0.0 112.481 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -91.13 137.45 32.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.79 -53.53 44.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.685 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -117.27 -38.19 3.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.41 17.87 10.92 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.594 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 -104.61 32.6 4.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.707 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 7.8 ttp -101.83 168.91 9.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -100.25 151.05 21.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.695 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 80' ' ' ASP . 57.7 t -50.42 -47.23 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -49.97 -32.5 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.392 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -36.9 47.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.824 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -72.24 -38.27 68.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.567 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.986 HD13 HD23 ' A' ' 68' ' ' LEU . 4.9 mt -67.44 -45.86 84.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.552 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -59.35 -41.26 88.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.759 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -66.99 -45.83 76.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.536 ' HB1' ' HE1' ' A' ' 24' ' ' PHE . . . -65.66 -39.46 91.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.134 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 65' ' ' VAL . 71.0 t -58.45 -50.71 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.573 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.1 m -57.38 -45.06 84.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.64 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -63.07 -36.69 84.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.77 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' O ' HG12 ' A' ' 55' ' ' VAL . 4.8 t80 -58.39 -57.18 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -54.64 -48.73 71.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.261 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -72.05 -24.45 61.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.327 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.6 -35.07 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 111.267 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.6 p -89.24 9.35 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.537 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.56 52.92 1.67 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.006 0.432 . . . . 0.0 111.197 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 16.0 mttm -122.74 -175.41 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.99 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.491 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.2 m-20 -153.32 172.21 5.93 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.472 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 20.5 Cg_endo -61.07 -10.54 15.36 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.339 2.026 . . . . 0.0 112.932 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -43.68 -36.19 2.1 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.7 0.286 . . . . 0.0 111.691 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.74 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 4.7 p90 -108.96 159.88 16.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.698 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.487 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -87.06 151.89 22.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 111.196 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.74 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 57.2 mt -141.73 111.26 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.746 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.487 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -108.41 107.13 17.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.818 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 48' ' ' VAL . 7.7 t -82.56 100.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -57.41 -75.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.513 ' NH1' HG21 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -163.51 -171.94 2.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.986 HD23 HD13 ' A' ' 44' ' ' ILE . 2.2 mm? -125.87 157.06 38.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.95 0.405 . . . . 0.0 110.847 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 75' ' ' ILE . 2.7 mp0 -142.54 161.13 38.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.76 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.584 ' HA ' HD23 ' A' ' 92' ' ' LEU . 35.9 m-70 -79.93 -61.48 1.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.833 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.19 79.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.567 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 60.31 44.46 12.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.52 62.11 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.21 46.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.602 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.513 HG21 ' NH1' ' A' ' 67' ' ' ARG . 12.3 mt -62.77 154.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.73 0.3 . . . . 0.0 111.001 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -155.42 144.79 21.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.963 0.411 . . . . 0.0 111.274 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -94.56 -160.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.73 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.443 HD23 HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -108.58 86.45 2.29 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.764 0.316 . . . . 0.0 110.864 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -176.9 -39.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.878 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -66.83 128.25 35.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.656 ' O ' HG12 ' A' ' 85' ' ' VAL . 30.9 mm -55.23 157.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.021 0.438 . . . . 0.0 111.638 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.746 HD12 ' CE2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -56.89 -57.0 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.632 -179.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.6 t -74.12 -3.64 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.885 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -95.5 -30.65 13.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.589 0.233 . . . . 0.0 111.4 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 81' ' ' ILE . 10.2 p -120.51 -30.37 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.91 174.22 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 0.0 111.299 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -136.77 155.75 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.838 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.32 133.84 19.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.87 66.21 1.26 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.803 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -124.41 131.51 53.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.11 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -93.84 105.39 17.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.628 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 70' ' ' HIS . 46.2 mt -101.12 145.78 28.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.341 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.566 ' O ' HD13 ' A' ' 68' ' ' LEU . 23.5 t -94.04 121.36 44.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.592 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.733 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -98.56 122.84 42.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.997 0.427 . . . . 0.0 111.891 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 t -108.45 122.96 63.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.194 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.54 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.8 p90 -149.4 -175.12 4.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.217 0.532 . . . . 0.0 111.615 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.02 154.95 36.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.952 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.2 pt-20 -155.54 132.73 10.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.738 0.304 . . . . 0.0 111.302 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.47 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -97.77 69.52 2.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.716 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.756 0.313 . . . . 0.0 110.687 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.94 120.62 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.26 142.77 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.013 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 m -104.53 105.73 15.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.35 103.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.2 t -79.16 101.59 8.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.507 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 8.4 m-85 -80.1 100.15 8.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.631 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 -79.12 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.319 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . 5.5 mmt85 -139.92 31.18 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.356 . . . . 0.0 110.771 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.7 m -140.92 122.23 14.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.886 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 122.74 29.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.834 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.78 107.5 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.317 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.94 147.99 40.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.723 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.59 HG11 HD22 ' A' ' 43' ' ' LEU . 20.1 t -141.29 103.47 6.06 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.339 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -85.5 140.35 7.26 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.731 2.287 . . . . 0.0 112.278 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.8 m -114.8 141.8 47.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.42 -50.28 60.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.743 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -112.63 -29.27 7.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.52 17.11 50.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -109.96 31.69 5.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.832 0.349 . . . . 0.0 110.7 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.9 ttp -93.78 127.34 39.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -58.14 144.8 39.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.586 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 80' ' ' ASP . 43.4 t -47.78 -45.48 11.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.837 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 67.9 t80 -50.2 -38.01 37.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.181 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.0 t -73.63 -33.0 64.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 110.235 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.742 HD13 ' O ' ' A' ' 43' ' ' LEU . 1.4 tm? -72.17 -38.18 69.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.679 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.821 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.6 mt -66.51 -43.9 90.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -64.25 -39.5 94.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.605 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -67.44 -37.28 82.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.367 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -75.79 -37.3 59.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.034 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -60.54 -44.29 96.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.976 0.417 . . . . 0.0 110.585 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.422 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 86.3 m -68.6 -46.69 68.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.531 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.03 -32.73 74.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.705 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -64.33 -57.67 8.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.651 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -52.61 -42.56 64.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -72.2 -30.96 65.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.96 -37.16 69.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.052 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.446 HG21 ' CE ' ' A' ' 57' ' ' LYS . 35.4 m -88.57 7.78 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.539 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 61.47 41.02 13.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 111.333 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.477 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 49.5 mttt -101.89 -174.62 2.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.454 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.8 OUTLIER -144.46 172.05 5.93 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.571 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 52.0 Cg_endo -69.3 -6.04 17.4 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.281 1.988 . . . . 0.0 112.875 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -49.42 -38.05 27.74 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.711 0.291 . . . . 0.0 111.283 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.768 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.1 p90 -104.61 149.32 25.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -80.74 153.66 27.69 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.842 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.768 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 48.9 mt -141.95 111.01 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.847 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.497 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.9 OUTLIER -108.94 109.43 20.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.673 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.821 HG11 ' CG2' ' A' ' 44' ' ' ILE . 2.2 t -82.13 102.6 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.247 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -57.45 -77.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -160.07 -179.36 7.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.021 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.581 HD11 ' HB2' ' A' ' 94' ' ' ALA . 3.4 mm? -114.87 159.93 20.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -145.52 140.2 27.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.781 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -63.61 -54.91 28.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.28 -52.56 0.16 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.544 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -152.92 31.96 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.79 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.12 75.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.563 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.41 68.96 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.414 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 76' ' ' LEU . 3.6 mm -65.18 157.13 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.906 0.384 . . . . 0.0 111.059 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.632 HD23 ' CG2' ' A' ' 85' ' ' VAL . 3.8 mp -132.65 119.35 20.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.039 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -98.07 173.24 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.68 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.589 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.26 76.6 6.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.92 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -176.06 -44.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.013 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.906 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -66.93 138.97 57.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.984 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 85' ' ' VAL . 30.6 mm -61.05 158.94 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.507 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.716 HD12 ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -58.01 -59.18 5.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.442 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.5 t -67.44 -12.83 61.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.783 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -90.85 -21.93 21.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.623 0.249 . . . . 0.0 111.485 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.632 ' CG2' HD23 ' A' ' 76' ' ' LEU . 14.9 p -110.9 -26.58 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.583 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.99 174.64 10.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.372 . . . . 0.0 111.442 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -127.08 159.66 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.477 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 11.7 p-10 -47.51 153.46 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.134 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 35.06 57.72 0.77 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.005 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -110.02 161.57 15.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.981 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -114.7 130.15 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.76 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.43 HD23 HD11 ' A' ' 76' ' ' LEU . 2.1 mp -144.55 160.84 40.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.109 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.23 138.62 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.775 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -113.04 133.47 54.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.423 . . . . 0.0 111.65 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.01 131.9 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.295 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.478 ' HB3' ' HA ' ' A' ' 65' ' ' VAL . 37.2 p90 -152.06 177.73 10.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.013 0.435 . . . . 0.0 111.632 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.61 157.36 22.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.021 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 8.7 pt-20 -154.34 139.32 17.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.686 0.279 . . . . 0.0 111.388 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.482 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 6.1 tt0 -109.72 63.34 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.914 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.943 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.424 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.771 0.319 . . . . 0.0 110.738 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -157.85 120.57 3.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.051 0.453 . . . . 0.0 111.167 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 m -136.79 143.23 35.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.835 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.0 m -101.12 116.06 31.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.494 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t -98.0 102.84 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.78 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 2.7 t -82.88 102.12 11.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.191 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.505 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 29.7 m-85 -84.58 98.83 10.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.28 -83.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.299 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -133.51 30.98 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.81 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.4 m -139.21 116.39 11.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -89.09 120.84 30.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.84 116.66 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.03 149.2 39.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.8 t -142.03 95.97 6.72 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.39 108.67 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.661 2.241 . . . . 0.0 112.337 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.424 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -79.23 140.76 37.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.818 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.77 -54.97 29.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.91 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.7 -40.85 2.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.98 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.38 13.51 8.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.647 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.5 mtm-85 -98.79 30.18 3.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.823 0.344 . . . . 0.0 110.724 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -102.53 114.04 27.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.704 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -49.74 148.71 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.71 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 80' ' ' ASP . 23.8 t -46.92 -48.44 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.938 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 78' ' ' LEU . 1.2 t80 -50.81 -44.99 59.17 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.059 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.9 t -58.93 -42.44 89.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.997 0.427 . . . . 0.0 110.328 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.46 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.655 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.854 HG23 HG11 ' A' ' 65' ' ' VAL . 7.5 mt -64.7 -48.21 85.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.877 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -60.99 -44.86 96.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -39.21 90.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.51 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.505 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -72.35 -34.01 67.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.071 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.497 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -63.79 -44.76 98.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.95 0.405 . . . . 0.0 110.721 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.411 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 89.2 m -65.96 -44.49 84.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.548 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -64.77 -27.39 68.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.67 ' O ' HG12 ' A' ' 55' ' ' VAL . 52.5 t80 -69.13 -57.71 5.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.848 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.478 ' HA ' HG12 ' A' ' 55' ' ' VAL . 28.2 ptt180 -59.85 -39.29 84.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.055 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -72.27 -35.27 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.03 -29.94 43.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.43 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 51' ' ' TYR . 14.4 p -87.96 7.74 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.701 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.76 36.2 10.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.798 0.332 . . . . 0.0 111.413 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.546 ' HD2' HG11 ' A' ' 55' ' ' VAL . 43.9 mttt -107.4 -176.61 3.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.842 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.4 m-20 -139.28 175.47 3.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.016 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 20.0 Cg_exo -66.05 -7.85 18.29 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.92 2.414 . . . . 0.0 112.877 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.08 -71.49 0.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.956 0.408 . . . . 0.0 111.113 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.776 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 1.3 p90 -64.5 150.71 46.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.809 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.543 ' CZ3' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.18 152.99 25.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.777 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.776 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 18.4 mt -143.04 110.39 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.055 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -113.94 101.93 9.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.63 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.854 HG11 HG23 ' A' ' 44' ' ' ILE . 2.4 t -76.61 97.85 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.151 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -52.28 -70.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.155 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.47 -175.53 3.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 mt -127.56 161.47 28.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.998 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -143.69 159.62 42.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.783 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.57 ' HA ' HD23 ' A' ' 92' ' ' LEU . 12.9 m-70 -77.85 -50.52 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.13 -88.73 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -96.19 41.32 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.814 0.34 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.25 98.18 1.68 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.19 61.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.435 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 76' ' ' LEU . 14.1 mt -56.3 158.15 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 111.029 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.807 HD11 HD22 ' A' ' 92' ' ' LEU . 2.8 mt -135.96 106.69 6.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.531 ' OD1' HD12 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -79.27 -164.92 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.533 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.65 HD23 HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -115.96 74.56 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 0.0 110.794 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.48 -52.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.105 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.825 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -57.44 129.03 39.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.033 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 85' ' ' VAL . 15.7 mm -54.25 152.97 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.025 0.44 . . . . 0.0 111.511 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.01 -53.32 58.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.371 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.6 p -66.49 -12.17 56.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.687 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.85 -32.39 16.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.656 0.265 . . . . 0.0 111.567 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 86' ' ' ALA . 14.7 p -112.23 -45.24 5.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.754 0.312 . . . . 0.0 111.691 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.497 ' N ' HG13 ' A' ' 85' ' ' VAL . . . -86.06 174.09 9.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.384 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -135.58 155.37 50.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -56.37 126.37 26.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.048 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.8 tptt 60.7 69.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -139.7 138.5 36.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -85.9 146.02 26.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.785 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.807 HD22 HD11 ' A' ' 76' ' ' LEU . 8.3 mt -142.07 145.1 33.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.199 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.0 133.36 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.494 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -113.22 118.0 33.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.374 . . . . 0.0 111.639 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.3 t -104.13 122.71 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.418 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.445 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.6 p90 -149.5 -175.34 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.115 0.483 . . . . 0.0 111.709 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -131.55 127.97 38.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.177 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.1 pt-20 -128.46 138.83 52.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.824 0.345 . . . . 0.0 111.004 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -98.44 65.69 1.66 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.809 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.986 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.343 . . . . 0.0 110.878 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -164.59 120.45 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.034 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.5 m -138.84 141.97 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.127 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 m -101.17 116.11 32.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.659 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.735 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 10.7 t -101.83 111.77 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.085 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.52 101.52 13.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.492 ' HE2' HG22 ' A' ' 48' ' ' VAL . 15.1 m-85 -83.76 99.81 10.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.538 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.3 -85.97 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.432 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 24' ' ' PHE . 13.1 mtt-85 -130.18 31.23 4.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.893 0.377 . . . . 0.0 110.838 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.1 m -141.25 120.84 13.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.789 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -94.78 130.13 41.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 m -139.19 120.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.8 148.89 39.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.821 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.46 92.94 14.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.237 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.17 116.79 2.76 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.611 2.207 . . . . 0.0 112.312 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.19 150.98 22.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.78 -68.73 1.54 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.451 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.44 -32.43 9.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.38 3.18 41.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.824 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.9 35.84 1.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.41 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 2.2 ttp -100.57 142.21 32.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.23 146.39 52.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.701 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.943 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.1 t -49.49 -44.78 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.861 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -50.17 -36.79 31.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.41 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 1.1 m -74.82 -34.62 62.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.154 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.464 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -69.34 -41.98 75.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.528 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.909 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.0 mt -64.44 -45.65 95.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.846 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.26 -37.53 80.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.718 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -45.01 76.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.756 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.477 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -68.13 -44.19 76.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.232 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 44' ' ' ILE . 85.9 t -54.59 -53.55 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 110.713 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 88.3 m -57.03 -42.57 80.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.383 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -34.53 78.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 55' ' ' VAL . 32.5 t80 -60.2 -57.23 13.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.484 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HD3' HD12 ' A' ' 63' ' ' ILE . 53.3 mtm180 -53.71 -44.96 70.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -32.8 69.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.018 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.65 -29.06 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 51' ' ' TYR . 14.6 p -94.78 -3.76 10.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.611 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 70.31 36.26 1.84 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.788 0.328 . . . . 0.0 111.21 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.646 ' HD2' HG11 ' A' ' 55' ' ' VAL . 20.1 mttt -104.58 -176.04 2.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.881 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.6 m-20 -149.47 176.57 2.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.759 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 25.0 Cg_exo -63.42 -9.9 19.57 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.632 2.221 . . . . 0.0 112.869 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -44.7 -32.74 1.6 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.709 0.29 . . . . 0.0 111.73 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.883 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 6.7 p90 -110.56 163.1 14.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.832 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -89.64 154.07 20.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.877 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.883 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 79.9 mt -143.58 110.75 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.157 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.488 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -106.71 101.93 11.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.262 179.244 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.909 HG11 ' CG2' ' A' ' 44' ' ' ILE . 5.4 t -79.32 94.79 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.007 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -53.37 -70.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.078 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -173.54 -177.68 1.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.834 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.882 HD11 HG12 ' A' ' 44' ' ' ILE . 6.8 mt -116.14 159.92 21.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.962 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -137.23 144.72 42.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.963 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.614 ' HA ' HD23 ' A' ' 92' ' ' LEU . 2.3 m-70 -66.53 -31.06 71.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.74 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.15 -38.56 1.1 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -172.33 35.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.829 0.347 . . . . 0.0 110.801 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.4 72.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.415 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.6 64.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.404 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 76' ' ' LEU . 9.1 mt -65.87 158.01 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 111.266 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.492 HD23 ' CG2' ' A' ' 85' ' ' VAL . 2.1 mp -133.06 128.17 35.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.758 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.415 ' O ' HG11 ' A' ' 40' ' ' VAL . 2.9 m-20 -94.92 -166.24 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.36 43.93 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -156.56 26.52 0.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.943 ' O ' HG23 ' A' ' 40' ' ' VAL . 4.6 t0 -137.13 144.39 42.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.824 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.844 ' O ' HG22 ' A' ' 85' ' ' VAL . 29.1 mm -57.09 156.77 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.576 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.422 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 41.4 tp -74.8 -50.7 16.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.269 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.44 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 10.5 t -59.69 -20.26 55.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.361 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -85.54 -59.64 2.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.329 . . . . 0.0 111.377 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 81' ' ' ILE . 21.1 m -76.56 -16.35 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.826 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.02 174.22 10.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 0.0 111.282 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.55 155.06 50.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.866 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -52.67 130.09 31.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.02 66.55 1.03 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -131.85 156.0 46.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.02 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.83 144.35 31.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.614 HD23 ' HA ' ' A' ' 70' ' ' HIS . 12.5 mt -144.13 145.34 32.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.004 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.41 119.8 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.735 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -95.53 121.41 37.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.54 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.3 120.27 60.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.762 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' A' ' 65' ' ' VAL . 14.3 p90 -148.23 171.36 16.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.054 0.454 . . . . 0.0 111.128 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -114.55 133.88 55.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.059 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.1 pt-20 -133.67 138.39 45.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.788 0.328 . . . . 0.0 111.212 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.438 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -101.37 69.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.4 t0 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.891 179.874 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.833 0.349 . . . . 0.0 110.854 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.17 120.22 2.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.051 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.532 HG11 ' HB1' ' A' ' 86' ' ' ALA . 3.5 m -132.59 142.86 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.012 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.0 m -103.2 108.92 20.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.4 t -97.92 102.75 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.4 t -85.19 101.55 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.493 ' HE2' HG22 ' A' ' 48' ' ' VAL . 20.3 m-85 -79.99 99.93 7.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.529 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.92 -80.6 0.02 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.263 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . 2.7 mtt180 -137.08 30.82 2.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.935 0.398 . . . . 0.0 110.636 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 83.1 m -138.65 121.26 16.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.57 126.23 33.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.94 114.06 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -74.88 146.35 41.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.41 ' HB ' HG23 ' A' ' 20' ' ' VAL . 21.4 t -142.09 93.68 7.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.28 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.22 128.51 3.62 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.818 2.346 . . . . 0.0 112.329 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.406 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -98.59 136.94 37.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.54 77.43 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.77 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.25 -44.07 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.72 18.37 6.09 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.562 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -98.17 29.24 3.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.827 0.346 . . . . 0.0 110.701 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.422 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 6.0 ttp -108.09 133.9 51.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.754 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -70.84 148.42 47.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 80' ' ' ASP . 46.8 t -47.81 -40.76 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 14.5 t80 -50.71 -42.49 57.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.872 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.422 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.8 OUTLIER -72.49 -29.56 63.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.195 179.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.839 ' HG ' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -71.29 -39.85 71.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.525 179.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.887 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.7 mt -65.45 -48.65 82.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.775 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -60.86 -35.67 77.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.713 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -68.93 -42.99 76.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HB1' ' HE1' ' A' ' 24' ' ' PHE . . . -71.43 -43.63 66.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 65' ' ' VAL . 93.1 t -56.24 -48.28 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.5 m -61.17 -49.3 77.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.298 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -31.66 72.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.547 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.618 ' O ' HG12 ' A' ' 55' ' ' VAL . 32.0 t80 -62.31 -57.69 10.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.451 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HE ' HD12 ' A' ' 63' ' ' ILE . 11.7 ttm105 -52.42 -44.81 65.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -24.59 61.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.96 -30.17 26.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.222 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.718 HG13 ' HD2' ' A' ' 57' ' ' LYS . 12.8 p -103.32 20.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.304 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 48.03 89.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.382 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.718 ' HD2' HG13 ' A' ' 55' ' ' VAL . 11.0 mttt -155.13 -172.2 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.864 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -162.2 177.7 1.86 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.698 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 32.3 Cg_exo -58.46 -13.56 17.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.698 2.265 . . . . 0.0 112.937 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -42.82 -36.73 1.57 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.668 0.271 . . . . 0.0 111.571 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.822 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 2.1 p90 -115.49 153.02 31.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.697 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.89 154.66 24.49 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 111.194 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.822 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 79.6 mt -142.54 110.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.479 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.519 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.6 OUTLIER -105.39 106.3 16.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.061 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 48' ' ' VAL . 8.7 t -82.49 100.46 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.428 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -61.22 -67.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.632 ' NH1' HD13 ' A' ' 75' ' ' ILE . 1.1 ptp180 -176.53 -178.29 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.8 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.74 HD11 HG12 ' A' ' 44' ' ' ILE . 10.1 mt -121.62 155.63 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.979 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -144.8 149.49 35.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -70.07 -43.21 71.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.62 -58.36 0.42 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.452 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.86 80.11 1.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.317 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.04 71.6 1.28 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.559 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.55 54.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.632 HD13 ' NH1' ' A' ' 67' ' ' ARG . 13.1 mt -58.59 155.37 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 0.0 111.199 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.569 HD23 ' CG2' ' A' ' 85' ' ' VAL . 1.0 OUTLIER -135.67 114.13 11.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.088 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.426 ' O ' HG11 ' A' ' 40' ' ' VAL . 2.5 t0 -96.19 -163.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.522 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.525 HD23 HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -114.74 78.59 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.59 -46.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.33 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.907 ' O ' HG23 ' A' ' 40' ' ' VAL . 9.8 m-20 -71.2 136.53 48.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.084 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 24.6 mm -56.94 157.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.045 0.45 . . . . 0.0 111.467 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.839 HD11 ' HG ' ' A' ' 43' ' ' LEU . 3.2 tp -61.6 -57.6 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.088 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.1 t -57.9 -19.42 29.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.382 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -40.72 26.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.571 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.569 ' CG2' HD23 ' A' ' 76' ' ' LEU . 35.9 m -106.26 -47.21 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -72.49 174.16 7.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.264 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -144.64 146.6 32.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.837 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.57 123.79 16.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.02 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.1 58.4 3.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.76 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -118.33 161.26 20.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -114.33 129.08 56.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.7 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.51 160.55 37.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.244 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.7 t -116.22 130.5 70.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.749 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.472 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -104.34 128.59 52.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.542 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.58 121.31 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.612 ' HD2' HG23 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -149.94 177.51 9.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.366 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . 0.3 OUTLIER -111.05 156.77 20.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.421 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -153.15 133.03 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.002 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.489 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 28.7 tt0 -98.97 70.19 1.81 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.971 0.415 . . . . 0.0 110.618 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.862 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.525 ' CD1' HD21 ' A' ' 82' ' ' LEU . 3.6 t80 . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.628 0.251 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -98.61 119.31 37.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 111.311 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.27 142.26 43.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.703 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -109.03 108.15 18.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.018 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.9 105.75 18.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 t -77.44 101.49 6.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.423 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 10.8 m-85 -83.0 100.61 10.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.628 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.43 -87.35 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.325 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.09 31.1 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.708 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -145.47 120.32 9.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.689 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -87.72 125.73 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.9 t -126.76 119.41 53.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.206 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -81.71 149.01 28.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.09 98.85 8.29 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.16 85.51 1.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.767 2.311 . . . . 0.0 112.6 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.4 140.55 56.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.75 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.76 -24.53 19.2 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.954 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.29 -42.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.362 . . . . 0.0 110.99 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.63 ' HA2' HD23 ' A' ' 82' ' ' LEU . . . 119.98 11.51 6.94 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.615 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -96.44 30.55 2.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.763 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.41 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 10.6 ttp -109.26 144.01 37.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -67.71 143.46 55.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 80' ' ' ASP . 42.5 t -48.74 -41.78 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.839 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 17.6 t80 -50.37 -39.74 47.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.41 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.4 OUTLIER -74.05 -31.73 63.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.218 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.691 HD22 HD13 ' A' ' 82' ' ' LEU . 4.6 tp -71.45 -39.33 71.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.774 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.857 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.2 mt -68.1 -42.17 84.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.855 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -36.86 85.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.514 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -38.29 83.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.319 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.423 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -75.91 -39.19 56.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.904 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.533 HG21 ' CG2' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -58.7 -43.55 87.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.418 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 90.9 m -68.81 -45.87 70.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.482 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -63.9 -30.52 71.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.682 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.659 ' O ' HG12 ' A' ' 55' ' ' VAL . 23.6 t80 -65.55 -57.3 8.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.558 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -55.76 -39.17 70.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -72.13 -45.19 61.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.199 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.54 98.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.106 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.678 HG11 ' HD2' ' A' ' 57' ' ' LYS . 12.2 p -75.03 -7.15 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.559 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 71.92 35.28 1.36 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.83 0.348 . . . . 0.0 111.076 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HD2' HG11 ' A' ' 55' ' ' VAL . 8.8 mttt -99.71 -175.52 3.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.5 m-20 -151.09 177.14 1.97 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 34.0 Cg_exo -61.92 -12.3 25.22 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.712 2.275 . . . . 0.0 112.769 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -44.07 -33.0 1.33 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.713 0.292 . . . . 0.0 111.727 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.756 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.6 p90 -114.67 154.44 28.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.966 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.513 ' CD1' ' CB ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -84.35 151.6 24.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.08 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.756 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 54.1 mt -140.22 111.6 4.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.889 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.482 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -107.6 103.44 12.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 179.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.857 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.3 t -82.08 110.86 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -76.33 -70.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.096 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -171.21 -177.61 2.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.749 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.719 HD11 HG12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -123.81 164.97 18.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.927 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.59 ' O ' HG12 ' A' ' 93' ' ' VAL . 22.2 tt0 -147.98 137.67 22.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -66.71 -60.1 2.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.7 73.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.523 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.4 t0 60.2 36.35 20.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.14 60.81 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.481 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.87 56.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 mt -58.57 152.12 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.832 0.349 . . . . 0.0 111.171 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.6 mp -126.76 111.71 14.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.937 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -94.88 -164.26 1.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.827 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.588 ' CD2' HD12 ' A' ' 44' ' ' ILE . 3.5 mt -110.87 76.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.969 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.55 -58.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.115 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.873 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.6 m-20 -57.41 135.02 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.233 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 85' ' ' VAL . 27.4 mm -56.11 159.02 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.076 0.465 . . . . 0.0 111.431 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.691 HD13 HD22 ' A' ' 43' ' ' LEU . 15.9 tp -69.8 -54.8 11.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.332 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -52.94 -23.91 8.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.555 -179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.91 -60.52 2.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.532 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 81' ' ' ILE . 35.6 m -73.99 -45.82 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.937 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.488 ' N ' HG23 ' A' ' 85' ' ' VAL . . . -92.37 174.45 7.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.255 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -139.28 155.44 47.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.727 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 0.7 OUTLIER -55.65 143.56 29.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.85 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.9 OUTLIER 40.8 50.91 3.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.502 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -111.36 171.8 7.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.214 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.69 146.15 47.31 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.883 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -148.55 169.1 21.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 69' ' ' GLU . 12.4 p -120.53 121.88 66.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 24' ' ' PHE . . . -96.69 119.78 35.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.464 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.85 120.57 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.811 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.551 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.2 p90 -146.82 -178.12 6.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.159 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.81 158.91 23.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.32 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 1.8 pt-20 -159.57 136.49 9.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 111.258 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.513 ' CB ' ' CD1' ' A' ' 62' ' ' TRP . 8.9 tt0 -129.37 76.63 1.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.142 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.917 179.957 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.401 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.674 0.274 . . . . 0.0 110.805 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 120.39 6.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.035 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 86' ' ' ALA . 5.8 m -130.98 142.62 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.009 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -106.76 105.92 16.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 m -98.27 116.57 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.084 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.07 101.58 14.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.693 ' HE2' HG22 ' A' ' 48' ' ' VAL . 6.5 m-85 -79.29 100.14 7.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.688 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.67 -79.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.308 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . 1.4 ptm85 -138.07 31.64 2.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.872 0.368 . . . . 0.0 110.732 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.1 m -140.32 121.89 15.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.973 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.72 115.49 28.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.008 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.1 118.18 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.04 144.84 42.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.668 HG11 HD12 ' A' ' 43' ' ' LEU . 21.5 t -135.94 94.67 14.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.44 101.22 1.38 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.505 2.136 . . . . 0.0 112.301 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.592 ' SG ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -75.25 149.63 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.34 -76.69 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.723 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.01 -39.45 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 111.05 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 82' ' ' LEU . . . 118.92 11.76 7.48 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.607 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -97.5 29.77 3.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.838 0.352 . . . . 0.0 110.774 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.415 ' HG2' ' HB3' ' A' ' 42' ' ' SER . 0.3 OUTLIER -103.34 125.12 49.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.56 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HG2' HD13 ' A' ' 81' ' ' ILE . 7.8 mttp -59.8 148.02 36.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.557 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.4 t -47.79 -46.32 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -50.36 -41.86 52.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.415 ' HB3' ' HG2' ' A' ' 38' ' ' MET . 39.4 t -65.14 -39.83 93.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.055 0.455 . . . . 0.0 109.825 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.668 HD12 HG11 ' A' ' 31' ' ' VAL . 20.4 tp -66.91 -32.18 73.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.407 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.927 HG23 HG11 ' A' ' 65' ' ' VAL . 5.2 mt -64.11 -53.15 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -38.47 78.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -67.24 -45.12 77.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.75 74.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.316 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 44' ' ' ILE . 94.0 t -55.84 -53.0 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -58.12 -43.76 87.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.724 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 6.9 tpp180 -63.65 -41.93 98.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.414 ' O ' HG12 ' A' ' 55' ' ' VAL . 13.7 t80 -57.09 -55.32 36.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.733 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -51.86 -53.76 36.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -72.25 -18.68 61.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.371 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 50' ' ' ARG . . . -80.43 -39.86 27.43 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.751 0.31 . . . . 0.0 111.137 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 55' ' ' VAL . 15.0 p -87.04 6.07 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.512 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 69.13 49.74 0.61 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 13.4 mttm -116.56 -175.78 2.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.4 m-20 -145.11 171.25 6.79 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.793 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 31.9 Cg_endo -64.03 -8.8 17.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.455 2.104 . . . . 0.0 113.056 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -46.78 -58.25 4.08 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.904 0.383 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.784 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.5 p90 -80.1 155.56 27.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.872 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -84.93 153.58 22.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.852 0.358 . . . . 0.0 110.925 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.784 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 55.6 mt -142.54 111.0 2.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.836 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -110.95 116.24 30.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.854 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.927 HG11 HG23 ' A' ' 44' ' ' ILE . 2.1 t -83.45 101.55 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.954 0.407 . . . . 0.0 111.035 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -64.37 -69.18 0.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.509 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -171.43 166.77 6.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 5.5 mt -111.61 156.16 22.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.996 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 49.7 mt-10 -150.26 129.39 12.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.98 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.444 ' CE1' ' CD2' ' A' ' 92' ' ' LEU . 41.8 m-70 -56.91 -58.51 7.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.17 68.95 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.489 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.8 44.36 11.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.862 0.363 . . . . 0.0 110.852 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.73 45.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.43 53.56 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 11.9 mt -60.27 153.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.234 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 1.4 mp -135.92 124.0 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.715 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.431 ' O ' HG11 ' A' ' 40' ' ' VAL . 43.1 p-10 -94.58 -164.44 1.17 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.679 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.923 HD23 HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -112.07 44.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.959 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -152.96 23.63 0.57 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.327 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.932 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -134.07 141.32 47.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.927 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.557 ' O ' HG22 ' A' ' 85' ' ' VAL . 25.3 mm -59.6 156.11 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.013 0.435 . . . . 0.0 111.436 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.592 HD22 ' SG ' ' A' ' 33' ' ' CYS . 2.3 tp -72.92 -51.33 18.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.413 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.409 ' SG ' HG21 ' A' ' 81' ' ' ILE . 27.8 p -59.98 -18.75 48.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.457 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -87.17 -46.25 9.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.706 0.289 . . . . 0.0 111.523 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 81' ' ' ILE . 29.1 m -91.25 -46.2 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -83.73 174.08 10.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.312 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.35 149.09 37.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.7 125.68 22.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.05 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.27 67.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.937 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -129.88 161.97 29.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.965 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.8 mtm-85 -120.52 105.99 11.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.807 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -110.47 169.07 8.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.176 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.79 140.21 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.852 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 24' ' ' PHE . . . -113.17 117.08 30.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.383 . . . . 0.0 111.683 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 t -90.09 128.26 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.025 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -163.85 171.43 15.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.504 . . . . 0.0 111.773 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.59 154.76 28.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.219 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.06 132.01 12.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.0 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.431 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 10.6 tt0 -92.1 66.96 5.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.413 . . . . 0.0 110.746 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.875 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.616 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.729 0.299 . . . . 0.0 110.805 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.47 120.04 1.77 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.591 HG11 ' HB1' ' A' ' 86' ' ' ALA . 15.7 m -132.52 142.05 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.196 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -102.72 107.12 17.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.693 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.09 106.31 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.186 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.86 101.15 3.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.486 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.621 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 5.4 m-85 -81.86 96.82 7.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.689 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.61 -84.36 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.482 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.79 34.17 4.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.9 m -146.46 145.06 30.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.803 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -103.6 110.18 22.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.994 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 t -114.43 111.27 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.04 144.76 34.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.775 HG11 ' HG ' ' A' ' 43' ' ' LEU . 22.0 t -133.15 96.89 17.02 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.037 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.39 117.14 1.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.787 2.325 . . . . 0.0 112.506 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.44 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -92.6 131.69 37.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.753 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.45 -37.5 66.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.959 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -135.92 -46.39 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 111.136 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.88 16.56 4.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.602 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -97.04 29.85 2.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.906 0.384 . . . . 0.0 110.667 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.438 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.1 OUTLIER -109.6 122.33 47.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.679 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HG2' HD13 ' A' ' 81' ' ' ILE . 5.0 mtmp? -58.84 157.58 9.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.68 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 80' ' ' ASP . 39.3 t -52.11 -53.44 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.24 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -49.66 -30.8 9.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.185 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.438 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 49.8 m -73.99 -40.91 62.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.051 0.453 . . . . 0.0 110.314 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.914 HD13 HD21 ' A' ' 82' ' ' LEU . 4.4 tt -70.05 -37.46 75.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.539 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.968 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.5 mt -63.64 -46.72 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.726 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -59.71 -42.67 93.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.615 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.57 -39.81 94.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.638 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.15 -42.64 68.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 44' ' ' ILE . 98.2 t -56.63 -54.2 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.721 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 91.6 m -58.82 -42.71 89.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.62 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -69.02 -27.34 65.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.784 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 55' ' ' VAL . 26.4 t80 -67.41 -57.49 6.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.821 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.626 ' CZ ' HD12 ' A' ' 63' ' ' ILE . 5.4 ptm180 -58.97 -38.06 78.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -29.89 64.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.14 -30.23 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.525 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.3 p -87.02 8.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.694 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 69.79 24.67 5.27 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.534 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HZ3' ' HE2' ' A' ' 61' ' ' TYR . 19.4 mttt -100.95 -176.39 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.323 . . . . 0.0 110.809 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -142.77 177.42 1.86 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.717 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 19.7 Cg_exo -66.27 -5.99 13.81 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.742 2.295 . . . . 0.0 112.84 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -51.55 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.81 0.338 . . . . 0.0 111.044 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.855 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.56 144.53 54.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.793 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.539 ' CZ3' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -76.81 155.62 32.91 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.672 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.855 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 66.5 mt -143.66 110.62 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 19.9 tt0 -104.94 107.27 18.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.285 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.968 HG11 ' CG2' ' A' ' 44' ' ' ILE . 2.7 t -82.45 101.29 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.403 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.493 ' HD2' HG12 ' A' ' 95' ' ' VAL . 47.5 m-70 -64.56 -63.96 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.055 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.34 -176.98 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.661 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.761 HD11 HG12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -127.46 154.4 45.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.971 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -136.05 146.96 47.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.757 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.511 ' CE1' HD21 ' A' ' 92' ' ' LEU . 10.7 m-70 -71.61 -44.8 63.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.2 -80.6 0.21 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.67 31.42 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.04 112.26 1.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.582 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.43 83.21 0.23 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.441 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.485 HG22 ' N ' ' A' ' 76' ' ' LEU . 3.6 mm -82.05 157.47 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 0.0 111.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.788 HD11 HD22 ' A' ' 92' ' ' LEU . 1.2 mp -125.92 114.24 18.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.425 ' O ' HG11 ' A' ' 40' ' ' VAL . 1.4 t0 -98.27 -164.35 1.13 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.828 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.402 ' CD2' HD12 ' A' ' 44' ' ' ILE . 1.9 mt -112.68 47.92 1.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.956 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -164.64 30.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.236 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.92 ' O ' HG23 ' A' ' 40' ' ' VAL . 12.5 t70 -133.8 136.17 44.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.892 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 82' ' ' LEU . 29.0 mm -62.1 158.55 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.106 0.479 . . . . 0.0 111.475 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.914 HD21 HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -56.68 -61.16 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.334 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.4 t -66.34 -14.44 62.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.486 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.1 -36.14 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.687 0.28 . . . . 0.0 111.348 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 86' ' ' ALA . 12.8 p -114.81 -44.68 4.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.634 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.908 ' HB3' HD13 ' A' ' 82' ' ' LEU . . . -84.85 174.08 10.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.188 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -144.62 154.41 42.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.749 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -54.93 123.04 12.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.975 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.32 71.55 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.819 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -123.15 173.62 7.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -134.51 98.28 4.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.788 HD22 HD11 ' A' ' 76' ' ' LEU . 3.7 mt -101.63 169.13 9.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.988 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 t -119.51 121.27 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.621 ' HB3' ' HA ' ' A' ' 24' ' ' PHE . . . -90.69 117.95 29.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.567 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.493 HG12 ' HD2' ' A' ' 66' ' ' HIS . 22.1 t -105.67 110.04 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.574 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.446 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 37.1 p90 -142.8 -179.28 6.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.039 0.447 . . . . 0.0 111.386 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -115.11 152.74 32.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.93 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.1 pp20? -150.56 134.23 16.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.474 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 2.0 tt0 -99.46 68.96 1.63 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.938 0.399 . . . . 0.0 110.694 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.1 t0 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.997 179.936 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.47 ' CD1' HD23 ' A' ' 82' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.842 0.353 . . . . 0.0 110.9 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.36 120.33 2.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.119 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.433 ' HB ' HD11 ' A' ' 92' ' ' LEU . 24.2 m -138.04 141.86 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.986 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.4 m -100.05 116.38 31.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.621 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t -97.81 109.14 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.974 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 73.2 m -84.62 101.17 11.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.509 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 37.0 m-85 -88.03 102.36 14.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.589 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.6 -88.63 0.01 OUTLIER Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 24' ' ' PHE . 6.3 mtp180 -128.13 31.44 5.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 110.707 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.8 m -151.44 115.64 5.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.736 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.4 OUTLIER -98.33 148.05 24.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.271 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 m -144.79 133.2 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.089 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.52 136.56 40.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -127.08 92.68 43.59 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.04 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -83.45 117.29 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.778 2.319 . . . . 0.0 112.358 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 18' ' ' PHE . 2.0 t -87.54 136.79 32.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.88 -53.03 48.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.712 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -112.3 -31.57 6.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.726 0.298 . . . . 0.0 110.958 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.06 14.41 59.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.92 35.04 3.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.488 ' HE3' HD12 ' A' ' 43' ' ' LEU . 15.6 ptt? -105.77 138.71 41.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.686 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -59.35 147.69 35.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.985 0.421 . . . . 0.0 111.168 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.934 HG23 ' O ' ' A' ' 80' ' ' ASP . 67.2 t -52.23 -40.2 30.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -49.82 -46.82 51.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.027 0.441 . . . . 0.0 110.649 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.446 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 7.0 t -66.14 -34.56 78.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.759 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.695 HD13 HD11 ' A' ' 82' ' ' LEU . 6.1 tp -67.52 -35.48 79.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.844 HD12 HD23 ' A' ' 78' ' ' LEU . 4.5 mt -65.44 -50.87 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.868 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 6.3 pt20 -60.3 -33.91 73.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.46 ' N ' ' HG3' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -70.18 -47.84 59.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -67.02 -45.41 77.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 44' ' ' ILE . 83.6 t -56.09 -48.1 79.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.869 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.1 m -59.2 -45.61 90.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.23 -32.52 73.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.729 ' O ' HG22 ' A' ' 55' ' ' VAL . 26.3 t80 -63.65 -57.43 10.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.7 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -54.95 -38.82 68.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.231 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -45.29 60.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.266 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.82 -48.17 80.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.142 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 51' ' ' TYR . 29.0 m -64.96 -15.37 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.452 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 79.59 31.77 0.25 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.83 0.348 . . . . 0.0 111.312 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HD2' HG21 ' A' ' 55' ' ' VAL . 17.4 mttt -93.97 -173.03 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.512 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.2 m-20 -150.35 170.1 8.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.709 0.29 . . . . 0.0 111.076 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 55.6 Cg_endo -70.12 57.26 1.63 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.636 2.224 . . . . 0.0 112.67 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -120.58 -23.32 6.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.768 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.853 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 9.6 p90 -111.88 154.57 24.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.527 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -81.36 154.29 26.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.661 0.267 . . . . 0.0 110.753 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.853 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 85.6 mt -142.29 111.32 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.026 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -106.53 101.85 11.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.711 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 44' ' ' ILE . 14.8 t -81.42 97.85 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.021 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.466 ' HD2' HG12 ' A' ' 95' ' ' VAL . 88.3 m-70 -58.92 -67.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -177.14 -177.48 0.73 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.589 HD11 HG12 ' A' ' 44' ' ' ILE . 7.2 mt -123.63 152.11 42.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.28 143.61 31.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -66.28 -69.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.04 101.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.563 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 58.97 44.28 16.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.0 90.26 0.72 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.528 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.68 53.88 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 76' ' ' LEU . 12.0 mt -59.34 158.08 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.378 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.603 HD13 HD22 ' A' ' 92' ' ' LEU . 1.5 mt -138.71 117.19 12.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.84 -166.62 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.749 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.844 HD23 HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -112.86 43.65 1.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.48 25.46 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.283 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.934 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.1 t70 -133.89 136.82 44.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.883 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.843 ' O ' HG22 ' A' ' 85' ' ' VAL . 29.5 mm -58.69 155.85 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.063 0.459 . . . . 0.0 111.581 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.695 HD11 HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -66.3 -52.72 44.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.438 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.8 m -63.92 -14.75 56.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.584 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -91.63 -32.19 15.57 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 81' ' ' ILE . 13.4 m -107.08 -43.72 6.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.86 174.23 6.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.779 0.324 . . . . 0.0 111.253 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -138.41 153.99 48.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.803 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -51.49 124.65 12.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.947 0.403 . . . . 0.0 111.068 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.93 74.3 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.77 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -138.66 151.56 47.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -102.94 140.5 37.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.8 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.603 HD22 HD13 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -132.34 169.0 17.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.5 108.7 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.916 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.621 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -88.5 121.16 30.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.705 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.466 HG12 ' HD2' ' A' ' 66' ' ' HIS . 22.0 t -109.81 118.03 55.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.598 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.525 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.1 p90 -148.73 -174.0 4.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.075 0.464 . . . . 0.0 111.414 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -122.21 155.74 35.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.958 179.15 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 10.0 pt-20 -156.93 130.94 8.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.701 0.286 . . . . 0.0 111.22 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.467 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 16.9 tt0 -97.78 66.73 1.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.732 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.946 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.988 0.423 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.85 120.44 1.02 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.97 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 43' ' ' LEU . 4.2 m -139.44 142.81 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.005 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.3 m -101.31 117.44 34.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.613 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 18.6 t -99.24 104.9 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.936 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 7.4 t -81.42 101.33 9.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.408 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 43.3 m-85 -89.27 103.08 15.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.43 -93.5 0.01 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.736 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mpm_? -119.05 30.93 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 m -156.46 114.5 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.715 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 5.7 ppt_? -105.03 151.81 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.316 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -146.47 145.89 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.093 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -87.74 141.38 28.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.756 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.5 t -129.31 95.25 31.03 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.211 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.82 116.1 2.48 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.68 2.253 . . . . 0.0 112.369 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -90.62 158.35 16.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.929 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.87 -63.53 2.83 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.645 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.21 -47.62 3.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.958 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.65 7.5 8.83 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.741 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -96.74 39.39 1.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.409 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 2.5 ttp -111.0 123.9 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.862 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.56 145.64 18.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.546 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 80' ' ' ASP . 98.6 t -49.36 -41.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.738 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.442 ' CB ' ' HB3' ' A' ' 78' ' ' LEU . 1.7 t80 -50.24 -42.59 52.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.409 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 3.1 m -70.85 -34.63 71.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.185 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.891 HD13 HD22 ' A' ' 82' ' ' LEU . 4.1 tp -67.89 -38.91 83.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.512 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.929 ' CG2' HG11 ' A' ' 65' ' ' VAL . 3.9 mt -65.1 -45.25 94.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.695 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -59.17 -39.82 83.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.728 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -65.79 -48.19 72.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.714 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -64.7 -48.65 73.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.914 HG21 HG21 ' A' ' 65' ' ' VAL . 67.1 t -54.03 -48.19 64.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.028 0.442 . . . . 0.0 110.765 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 83.9 m -57.12 -42.9 81.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.521 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.53 -33.05 74.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.779 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.583 ' O ' HG12 ' A' ' 55' ' ' VAL . 8.1 t80 -60.5 -56.7 18.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.647 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -43.49 85.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -72.01 -27.35 62.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.39 -39.74 31.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.181 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.3 p -85.67 4.3 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.61 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.56 52.78 2.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.81 0.338 . . . . 0.0 111.257 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HD2' HG11 ' A' ' 55' ' ' VAL . 72.3 mttt -116.71 -175.22 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.462 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.1 m-20 -145.86 171.0 7.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.73 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 34.2 Cg_endo -65.02 -7.43 15.29 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.425 2.083 . . . . 0.0 112.903 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -46.86 -37.43 8.79 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 111.446 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.826 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 5.9 p90 -104.56 152.59 22.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.09 154.24 25.69 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.827 0.346 . . . . 0.0 111.058 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.826 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 70.1 mt -142.78 111.0 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.849 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.488 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -106.95 107.18 18.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.929 HG11 ' CG2' ' A' ' 44' ' ' ILE . 4.2 t -83.44 98.89 5.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.011 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -55.26 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.264 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 ptt85 -163.54 -175.16 4.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD11 HG12 ' A' ' 44' ' ' ILE . 7.1 mt -126.87 152.27 47.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 111.023 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -141.51 132.79 26.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.88 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.62 ' CE1' HD21 ' A' ' 92' ' ' LEU . 11.5 m-70 -58.13 -46.85 84.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.1 -61.58 0.21 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.507 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -151.65 77.61 1.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.951 0.405 . . . . 0.0 110.835 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.96 39.45 1.41 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.43 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.634 ' O ' HD23 ' A' ' 76' ' ' LEU . . . -159.22 41.71 0.48 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 76' ' ' LEU . 10.6 mt -63.16 157.47 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 0.0 111.066 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.819 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -156.9 139.68 15.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 111.211 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -108.48 -163.12 0.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.731 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -98.75 71.61 1.94 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.827 0.346 . . . . 0.0 110.889 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.82 -43.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.931 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -72.25 135.02 45.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.736 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.775 ' O ' HG12 ' A' ' 85' ' ' VAL . 28.2 mm -53.1 155.94 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.158 0.504 . . . . 0.0 111.581 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.891 HD22 HD13 ' A' ' 43' ' ' LEU . 62.9 tp -70.88 -51.56 25.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.493 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.417 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 31.0 p -71.62 -8.15 52.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.73 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.6 -38.34 10.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.641 0.257 . . . . 0.0 111.291 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.819 HG21 ' HB3' ' A' ' 76' ' ' LEU . 13.7 p -101.02 -33.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.882 0.372 . . . . 0.0 111.599 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.42 174.23 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.378 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.23 154.85 50.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.51 130.64 36.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 56.37 68.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -132.55 149.17 52.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -97.32 143.62 27.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.62 HD21 ' CE1' ' A' ' 70' ' ' HIS . 12.0 mt -142.86 145.37 33.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.903 0.383 . . . . 0.0 111.202 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.81 116.18 35.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.766 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.613 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -99.48 121.89 41.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.052 0.453 . . . . 0.0 111.716 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 t -109.03 126.79 66.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.34 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.576 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.6 p90 -151.41 -179.77 7.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.178 0.513 . . . . 0.0 111.611 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.66 156.66 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.077 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -155.93 134.38 11.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 111.193 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 5.0 tt0 -99.06 67.87 1.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.836 -179.953 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.641 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.738 0.304 . . . . 0.0 110.737 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.23 120.46 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.044 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.52 HG21 HD21 ' A' ' 43' ' ' LEU . 3.3 m -132.8 143.13 40.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -96.12 114.89 26.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.12 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.654 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 20.0 t -104.43 104.31 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 14.5 t -86.66 101.8 13.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.082 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 44.7 m-85 -85.06 98.47 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.778 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.9 -79.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.357 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -138.19 31.32 2.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.822 0.344 . . . . 0.0 110.791 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.557 HG21 ' CD1' ' A' ' 51' ' ' TYR . 87.4 m -139.61 112.34 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -88.65 123.19 32.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 m -135.27 116.74 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.062 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.9 145.58 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.9 t -131.66 103.12 14.8 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.243 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.61 130.13 4.35 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.649 2.233 . . . . 0.0 112.294 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.64 131.42 47.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.03 -48.86 57.6 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.97 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -120.98 -46.07 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.31 11.69 9.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.675 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -97.76 35.02 1.75 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 110.622 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.94 118.73 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.811 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -54.52 149.96 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.616 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.9 t -48.05 -43.81 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.008 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.482 ' CD2' ' HB3' ' A' ' 78' ' ' LEU . 1.8 t80 -50.38 -49.38 54.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.236 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.3 t -62.33 -35.96 80.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.397 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.799 HD13 HD21 ' A' ' 82' ' ' LEU . 6.0 tp -66.36 -33.99 76.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.568 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.868 ' CG2' HG11 ' A' ' 65' ' ' VAL . 5.3 mt -66.18 -51.18 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.814 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -35.11 72.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.002 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -68.67 -48.13 64.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.735 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -67.93 -47.08 69.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.366 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 44' ' ' ILE . 61.2 t -53.09 -53.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.842 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.5 m -56.96 -44.74 82.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -29.89 70.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.911 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.557 ' CD1' HG21 ' A' ' 27' ' ' THR . 4.1 t80 -65.58 -57.4 8.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.772 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HA ' HG12 ' A' ' 55' ' ' VAL . 8.9 ptt180 -58.8 -35.19 72.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.887 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 7.6 mmtt -72.6 -29.99 63.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.29 -33.66 25.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.426 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.9 p -84.7 4.6 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.645 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.87 44.31 4.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 111.258 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -112.69 -174.76 2.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -147.59 176.29 2.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.742 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 18.7 Cg_exo -66.24 -9.29 23.15 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.826 2.35 . . . . 0.0 112.624 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -45.79 -39.4 8.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.714 0.292 . . . . 0.0 111.438 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.848 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 6.7 p90 -102.74 145.1 30.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.933 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.47 155.6 33.73 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.609 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.848 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 78.8 mt -142.95 110.97 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.887 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.489 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.2 OUTLIER -106.94 105.36 15.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.561 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.868 HG11 ' CG2' ' A' ' 44' ' ' ILE . 1.5 t -83.29 97.29 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.159 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -56.08 -74.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -167.66 178.12 5.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.786 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.545 ' HB2' HD12 ' A' ' 76' ' ' LEU . 1.1 mt -119.45 156.84 29.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 1.1 tt0 -138.66 147.01 42.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.775 ' HA ' HD23 ' A' ' 92' ' ' LEU . 4.7 m-70 -68.14 -64.54 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.89 -53.02 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.474 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.74 34.13 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.24 69.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.44 56.37 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.438 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 12.5 mt -62.49 153.38 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 111.099 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.938 HD11 HD22 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -129.0 114.18 16.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.794 179.69 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -163.39 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.17 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.665 HD23 HD12 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -113.54 36.5 3.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 0.0 110.773 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -148.29 26.88 0.95 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.908 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -131.64 134.28 45.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.882 0.372 . . . . 0.0 110.946 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 85' ' ' VAL . 29.1 mm -57.91 157.14 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.698 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.84 HD13 ' HB3' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -61.84 -56.13 22.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.626 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 34.7 m -71.19 -7.4 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.835 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.67 -37.46 15.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.574 0.226 . . . . 0.0 111.479 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 81' ' ' ILE . 8.5 m -114.9 -31.34 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.84 ' HB3' HD13 ' A' ' 82' ' ' LEU . . . -96.69 174.1 6.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 0.0 111.226 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.16 153.96 45.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.7 125.97 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.99 71.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -134.34 157.48 46.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.15 130.85 50.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.533 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.938 HD22 HD11 ' A' ' 76' ' ' LEU . 5.2 mt -138.62 132.7 31.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.354 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 69' ' ' GLU . 4.7 m -82.94 134.42 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.436 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.654 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -109.86 117.01 32.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.947 0.403 . . . . 0.0 111.768 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.03 127.12 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.344 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.459 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -160.75 174.77 13.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.122 0.487 . . . . 0.0 111.707 -179.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.17 157.95 25.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.242 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 9.7 pt-20 -155.23 135.0 12.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.046 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.476 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 2.3 tt0 -101.44 65.93 1.07 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.892 0.377 . . . . 0.0 111.008 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.956 179.895 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.556 ' CE2' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.775 0.321 . . . . 0.0 110.824 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -164.53 120.5 1.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.77 142.56 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.046 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.524 HG21 ' HD3' ' A' ' 28' ' ' ARG . 23.9 m -95.3 119.68 34.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 29' ' ' VAL . 21.3 t -98.97 107.55 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.022 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.86 101.59 14.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.479 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 43.6 m-85 -85.75 100.75 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.714 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.33 -78.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.294 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 tpm_? -141.84 31.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.729 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.0 m -137.66 125.48 22.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HD3' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -95.43 130.42 42.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 22' ' ' VAL . 6.7 m -135.35 127.11 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.043 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -74.98 143.22 43.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.986 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.3 t -140.72 92.62 8.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.145 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -84.65 123.03 2.8 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.757 2.305 . . . . 0.0 112.593 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.414 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -94.12 141.87 28.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.745 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.29 -81.79 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.881 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.24 -35.52 9.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 110.978 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.64 14.67 10.15 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 mtt-85 -98.6 28.46 4.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.941 0.4 . . . . 0.0 110.866 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.42 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 10.2 ttp -105.06 145.53 30.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.694 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.46 147.88 33.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 80' ' ' ASP . 59.1 t -48.83 -42.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.666 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -50.23 -38.8 42.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.42 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.4 OUTLIER -73.86 -34.58 64.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.278 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.864 ' CD1' HD11 ' A' ' 82' ' ' LEU . 5.4 tt -70.15 -38.66 75.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.673 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.925 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.1 mt -66.09 -45.83 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.634 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -59.06 -40.62 85.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.709 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -67.9 -44.79 76.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.782 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -66.85 -37.77 85.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 44' ' ' ILE . 75.0 t -59.64 -54.11 39.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.412 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -55.86 -42.72 76.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.599 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -37.87 86.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.703 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 55' ' ' VAL . 56.4 t80 -58.98 -57.02 14.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.69 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -51.37 -47.74 62.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.96 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -72.28 -25.75 61.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.225 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.49 -38.56 55.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.197 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 55' ' ' VAL . 13.6 p -92.28 12.74 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.617 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 57.54 56.86 4.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.905 0.383 . . . . 0.0 111.307 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 65.3 mttt -120.72 -175.39 3.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.468 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.6 m-20 -148.05 171.16 6.63 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.506 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 31.6 Cg_endo -64.19 -8.13 15.65 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.371 2.047 . . . . 0.0 112.916 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -46.35 -37.39 7.43 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.64 0.257 . . . . 0.0 111.521 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.838 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 6.0 p90 -104.8 156.13 18.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -85.03 153.79 22.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.164 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.838 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 76.6 mt -142.13 110.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.81 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -103.71 102.91 12.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.648 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.925 HG11 ' CG2' ' A' ' 44' ' ' ILE . 5.8 t -76.52 97.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -57.49 -78.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.0 -177.5 6.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.638 HD23 HD13 ' A' ' 44' ' ' ILE . 2.0 mm? -112.33 165.0 12.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -148.98 160.56 43.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.645 ' HA ' HD23 ' A' ' 92' ' ' LEU . 16.9 m-70 -94.61 -43.47 8.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.66 -88.39 0.14 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.41 33.02 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.769 0.318 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.45 108.12 0.99 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.4 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.09 95.28 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.403 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 76' ' ' LEU . 3.4 mm -93.19 155.26 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 76' ' ' LEU . 2.0 mp -133.54 118.02 17.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -95.17 -175.36 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.793 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.49 44.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.855 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.4 27.52 0.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.973 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.92 ' O ' HG23 ' A' ' 40' ' ' VAL . 9.3 m-20 -137.26 134.7 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.695 ' O ' HG22 ' A' ' 85' ' ' VAL . 31.7 mm -58.78 158.56 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.121 0.486 . . . . 0.0 111.586 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.864 HD11 ' CD1' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -58.0 -56.76 17.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.444 -179.433 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 68.9 m -70.66 -7.55 45.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.789 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.22 -30.97 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.678 0.275 . . . . 0.0 111.586 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 81' ' ' ILE . 2.4 m -120.06 -36.09 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.33 174.14 6.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.791 0.329 . . . . 0.0 111.338 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.55 150.52 47.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.752 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.61 132.72 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.01 60.32 2.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.732 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -138.97 134.85 33.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.38 151.2 26.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.763 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 70' ' ' HIS . 23.7 mt -146.13 150.85 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.007 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.25 114.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.758 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.449 ' HB2' HG13 ' A' ' 22' ' ' VAL . . . -95.27 128.1 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.751 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.93 137.15 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.32 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -167.88 163.32 13.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.129 0.49 . . . . 0.0 111.901 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -104.79 156.81 17.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.11 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -155.27 128.9 8.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.014 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.446 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 20.6 tt0 -86.53 66.85 9.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.036 0.446 . . . . 0.0 110.533 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.89 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.614 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.763 0.315 . . . . 0.0 110.85 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -161.24 120.28 2.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.01 0.434 . . . . 0.0 111.061 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.698 HG21 HD21 ' A' ' 43' ' ' LEU . 4.1 m -132.9 142.9 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.926 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -100.43 118.59 36.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.529 HG13 HD21 ' A' ' 68' ' ' LEU . 31.4 t -97.75 109.59 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.758 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 t -88.3 101.68 14.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 55.7 m-85 -84.71 98.51 10.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.395 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.97 -85.42 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.333 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 mmp_? -129.17 31.38 4.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.4 m -138.25 145.09 40.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -105.85 138.3 42.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.027 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.76 108.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.019 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -74.81 149.05 39.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.1 t -141.25 94.12 7.8 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.322 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.28 129.11 4.37 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.645 2.23 . . . . 0.0 112.391 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.6 m -99.66 140.04 34.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.768 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.69 -50.81 62.37 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.576 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -112.28 -29.91 7.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 111.066 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.68 14.24 53.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.523 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.81 35.91 2.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.731 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.2 ttp -104.17 137.61 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -69.77 150.14 47.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.53 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 80' ' ' ASP . 44.3 t -48.86 -42.08 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.968 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -50.17 -43.06 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.32 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -30.48 63.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.579 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.096 HD13 HD21 ' A' ' 82' ' ' LEU . 3.3 tp -71.38 -39.18 71.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.618 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.935 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.3 mt -67.81 -44.13 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.692 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.21 -38.43 86.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -68.79 -42.73 76.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.604 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -69.46 -40.77 76.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.296 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 44' ' ' ILE . 98.0 t -58.45 -51.84 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.72 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.9 m -58.18 -44.44 88.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.416 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -64.48 -29.93 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.802 ' O ' HG22 ' A' ' 55' ' ' VAL . 7.5 t80 -64.13 -57.88 8.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.656 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HG3' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -58.77 -32.66 69.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.641 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.42 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 11.2 mmtt -72.52 -27.91 62.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.52 26.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.34 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 51' ' ' TYR . 2.8 m -93.99 18.98 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.583 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 55.16 28.97 11.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.562 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.64 ' HB2' HG23 ' A' ' 55' ' ' VAL . 10.0 mttt -94.54 -169.87 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.835 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m-20 -160.06 177.07 2.21 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.731 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 33.0 Cg_exo -61.49 -12.13 22.99 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.663 2.242 . . . . 0.0 112.767 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -45.02 -53.1 8.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.815 0.341 . . . . 0.0 111.346 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.781 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.7 p90 -90.44 148.68 22.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -79.71 155.49 27.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.79 0.328 . . . . 0.0 111.028 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 68.7 mt -142.46 111.02 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.759 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.482 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -104.65 105.33 15.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.651 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.935 HG11 ' CG2' ' A' ' 44' ' ' ILE . 1.4 t -83.02 97.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.133 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -53.56 -76.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -159.85 -176.97 6.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.991 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.529 HD21 HG13 ' A' ' 22' ' ' VAL . 10.0 mt -117.49 160.75 20.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.57 159.36 43.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.591 ' HA ' HD23 ' A' ' 92' ' ' LEU . 10.9 m-70 -85.23 -30.78 23.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.773 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.95 -53.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.406 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -156.72 73.01 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 110.784 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.91 57.66 0.54 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.41 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.61 59.0 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.493 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 76' ' ' LEU . 7.2 mt -71.66 158.36 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.824 0.345 . . . . 0.0 111.187 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.991 HD11 HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -151.25 141.43 22.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.7 -162.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.707 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.01 43.49 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.886 0.374 . . . . 0.0 110.944 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.3 25.33 1.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.909 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.0 m-20 -133.13 132.99 42.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.993 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.612 ' O ' HG22 ' A' ' 85' ' ' VAL . 27.5 mm -56.02 158.38 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.038 0.447 . . . . 0.0 111.534 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.096 HD21 HD13 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -62.27 -57.55 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.625 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.3 t -67.76 -11.6 58.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.934 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.41 -47.28 11.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.586 0.231 . . . . 0.0 111.516 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 81' ' ' ILE . 6.3 m -103.9 -32.75 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.645 ' HB3' HD13 ' A' ' 82' ' ' LEU . . . -101.55 173.99 6.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.901 0.381 . . . . 0.0 111.213 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.87 154.44 49.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.766 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -54.34 124.03 14.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.09 70.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -140.21 144.55 36.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.024 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -92.86 148.97 21.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.796 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.991 HD22 HD11 ' A' ' 76' ' ' LEU . 1.6 mt -143.41 146.84 33.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.128 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.3 t -92.12 122.76 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.605 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.426 ' HB2' HG13 ' A' ' 22' ' ' VAL . . . -108.85 118.12 35.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.002 0.429 . . . . 0.0 111.822 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 t -103.31 128.18 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.149 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.582 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.1 p90 -153.31 -177.65 6.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.277 0.56 . . . . 0.0 111.718 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -118.06 157.27 27.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.856 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.17 132.15 9.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 0.0 111.125 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.469 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 3.7 tt0 -92.05 73.42 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.05 0.452 . . . . 0.0 110.462 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 t70 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.927 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.82 0.343 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -85.78 -176.86 6.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -80.2 159.87 25.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.877 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.02 120.6 1.0 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.04 0.448 . . . . 0.0 111.203 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.927 HG11 ' HB1' ' A' ' 86' ' ' ALA . 12.4 m -136.74 142.56 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -100.57 132.3 46.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 29' ' ' VAL . 9.5 t -113.23 105.7 19.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 t -83.16 101.59 11.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.176 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.522 ' HE1' ' HB1' ' A' ' 47' ' ' ALA . 15.4 m-85 -83.45 100.65 10.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.397 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.48 -78.84 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.444 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 mtt180 -139.16 31.18 2.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.784 0.326 . . . . 0.0 110.973 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.4 m -140.92 122.59 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.17 125.39 38.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.148 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 22' ' ' VAL . 14.7 p -125.41 124.73 67.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.038 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -79.03 140.0 38.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.61 92.64 26.7 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.64 116.75 4.11 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.076 2.517 . . . . 0.0 112.192 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -91.41 120.83 32.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.754 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.78 -53.89 33.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.971 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -106.04 -33.03 8.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.834 0.349 . . . . 0.0 111.067 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.22 -12.09 61.92 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.31 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 56.27 3.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.121 0.486 . . . . 0.0 110.812 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.414 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 1.5 ttp -122.38 114.48 20.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.607 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -53.07 147.59 9.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 80' ' ' ASP . 22.0 t -46.85 -43.43 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 10.6 t80 -50.19 -42.16 50.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.954 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.414 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 4.4 m -71.14 -31.73 68.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.182 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.964 HD13 HD11 ' A' ' 82' ' ' LEU . 4.4 tt -71.77 -38.82 70.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.748 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.9 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.4 mt -64.58 -48.66 83.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.745 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.21 -38.8 87.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -67.85 -43.24 79.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HB1' ' HE1' ' A' ' 24' ' ' PHE . . . -69.83 -44.51 69.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.811 HG21 HG21 ' A' ' 65' ' ' VAL . 92.3 t -54.37 -52.21 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 110.647 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.402 HG23 ' NH2' ' A' ' 52' ' ' ARG . 86.3 m -58.18 -47.23 84.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -29.8 70.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.955 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' O ' HG12 ' A' ' 55' ' ' VAL . 35.2 t80 -62.07 -57.36 11.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.743 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HA ' HG12 ' A' ' 55' ' ' VAL . 9.5 ptt-85 -60.92 -36.34 79.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.838 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.427 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 11.4 tppt? -72.6 -27.74 62.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.145 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.96 -35.54 23.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.5 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.0 p -82.04 1.75 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.796 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 75.33 29.96 0.88 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.739 0.304 . . . . 0.0 111.626 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 7.4 mttt -99.24 -169.9 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.486 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -158.89 170.36 9.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.907 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 43.1 Cg_endo -68.14 61.8 1.02 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -124.01 -41.14 2.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.426 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.652 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 9.1 p90 -95.65 150.44 20.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.319 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -78.42 152.94 31.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.748 0.308 . . . . 0.0 110.94 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.652 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 73.0 mt -139.92 110.95 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.81 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -102.14 101.74 12.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.363 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.9 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.9 t -83.21 97.07 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.125 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -58.62 -77.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.443 ' C ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -163.88 -176.77 4.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.169 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.62 HD11 HG13 ' A' ' 22' ' ' VAL . 4.0 mm? -119.16 160.91 21.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.634 ' O ' HG22 ' A' ' 93' ' ' VAL . 3.8 tt0 -152.17 137.48 17.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.657 ' HA ' HD23 ' A' ' 92' ' ' LEU . 14.2 m-70 -64.19 -30.47 71.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.83 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.24 -70.96 0.26 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.518 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.79 35.32 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.838 0.352 . . . . 0.0 111.021 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 163.51 64.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.49 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.12 60.94 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 76' ' ' LEU . 12.6 mt -59.42 156.18 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.803 0.335 . . . . 0.0 111.074 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.555 HD23 ' CG1' ' A' ' 85' ' ' VAL . 3.9 mp -130.83 122.03 26.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -109.38 169.23 8.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.538 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.692 ' CD2' HD12 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -86.06 79.99 8.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.062 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.82 -38.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.853 ' O ' HG23 ' A' ' 40' ' ' VAL . 47.5 m-20 -77.08 131.07 38.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.061 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 85' ' ' VAL . 28.4 mm -55.71 158.28 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.096 0.474 . . . . 0.0 111.546 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.964 HD11 HD13 ' A' ' 43' ' ' LEU . 2.2 tp -71.15 -54.58 10.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.094 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -26.45 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.484 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.12 -35.54 17.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 81' ' ' ILE . 16.1 t -97.38 -67.09 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 0.0 111.675 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.927 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -66.97 174.29 3.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.291 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.43 154.9 41.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.781 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.46 117.03 1.98 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.67 60.81 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -122.87 142.94 50.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.6 mmm-85 -95.79 154.5 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.657 HD23 ' HA ' ' A' ' 70' ' ' HIS . 55.2 mt -148.87 138.25 21.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.025 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 69' ' ' GLU . 3.2 m -90.15 121.95 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.651 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.56 ' HA ' HD13 ' A' ' 68' ' ' LEU . . . -103.44 121.79 43.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.061 0.457 . . . . 0.0 111.885 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.04 122.97 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.103 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.593 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.2 p90 -151.16 -174.35 4.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.192 0.52 . . . . 0.0 111.586 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -120.62 156.99 30.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.791 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.3 pt-20 -158.23 128.98 6.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.84 0.352 . . . . 0.0 111.224 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.473 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 1.3 tt0 -93.27 70.72 4.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.982 0.42 . . . . 0.0 110.746 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.886 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.797 0.332 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.08 -164.79 1.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.812 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.473 ' CD1' HD23 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -99.21 158.32 15.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.73 120.82 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.015 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.68 142.49 37.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.109 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.1 m -97.67 121.88 40.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.751 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.4 t -103.74 111.49 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.6 t -86.46 101.82 13.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CE1' HG22 ' A' ' 48' ' ' VAL . 51.4 m-85 -85.46 100.26 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.766 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.16 -90.09 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.575 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.67 31.47 6.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.0 m -139.46 144.99 38.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.41 118.2 30.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.84 126.75 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.98 146.66 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.721 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.5 t -129.01 92.73 38.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.064 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -77.71 106.26 2.16 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.869 2.379 . . . . 0.0 112.244 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.419 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -80.67 137.53 36.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.608 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.57 -36.07 7.76 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.061 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -151.55 -45.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.39 13.52 4.75 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.777 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.619 ' CG ' ' O ' ' A' ' 37' ' ' ARG . 8.4 ttm-85 -99.57 29.73 3.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.654 0.74 . . . . 0.0 109.876 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 6.8 ttp -108.86 151.6 26.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.625 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.93 144.62 38.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.607 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 80' ' ' ASP . 58.4 t -48.11 -41.4 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.815 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -50.36 -43.01 54.04 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -33.64 72.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.177 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.981 HD22 HD11 ' A' ' 82' ' ' LEU . 3.5 tp -69.09 -39.41 79.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.654 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.911 ' CG2' HG11 ' A' ' 65' ' ' VAL . 3.9 mt -63.18 -51.35 72.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.732 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -36.96 73.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -68.93 -48.05 64.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.721 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -66.6 -41.21 88.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.328 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 44' ' ' ILE . 97.0 t -58.45 -48.13 86.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 0.0 110.619 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.0 m -58.55 -46.98 85.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.596 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -64.39 -33.73 76.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.691 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.504 ' O ' HG12 ' A' ' 55' ' ' VAL . 20.0 t80 -59.56 -57.16 14.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.683 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.508 ' HA ' HG12 ' A' ' 55' ' ' VAL . 5.7 ttm105 -57.47 -40.37 78.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -72.11 -29.3 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.214 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.43 -30.91 26.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.221 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.9 p -85.3 -2.97 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.598 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 70.58 34.82 2.04 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.733 0.301 . . . . 0.0 111.288 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' CD ' HG11 ' A' ' 55' ' ' VAL . 13.6 mttt -102.93 -175.36 2.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.796 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.9 m-20 -149.69 175.92 2.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 25.3 Cg_exo -63.15 -11.12 23.55 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.745 2.297 . . . . 0.0 112.738 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -44.97 -33.17 1.91 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.596 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.725 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 2.7 p90 -116.1 145.29 43.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.76 0.315 . . . . 0.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -77.62 154.95 31.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.652 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.725 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 52.1 mt -141.64 110.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.001 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -105.88 108.6 20.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.754 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.911 HG11 ' CG2' ' A' ' 44' ' ' ILE . 2.2 t -80.05 100.09 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 96' ' ' PHE . 97.8 m-70 -57.8 -63.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -176.77 -173.84 0.52 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.009 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 94' ' ' ALA . 94.9 mt -124.1 154.32 40.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.763 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -138.37 141.1 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.984 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.476 ' HA ' HD23 ' A' ' 92' ' ' LEU . 3.9 m-70 -68.44 -46.74 69.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.47 -85.24 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.04 39.1 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.349 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.99 102.03 2.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.98 57.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.412 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 76' ' ' LEU . 13.1 mt -59.22 157.12 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.188 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' N ' HG22 ' A' ' 75' ' ' ILE . 2.2 mp -138.76 123.83 19.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' OD1' HD12 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -100.44 -167.54 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD12 ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -108.95 46.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.389 . . . . 0.0 110.826 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -157.45 27.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.897 ' O ' HG23 ' A' ' 40' ' ' VAL . 65.1 m-20 -142.86 134.37 26.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.895 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 85' ' ' VAL . 24.0 mm -52.59 156.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.038 0.447 . . . . 0.0 111.461 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.981 HD11 HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -73.13 -49.02 30.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.401 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.8 t -64.97 -14.53 60.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.608 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -91.0 -45.91 8.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.648 0.261 . . . . 0.0 111.615 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 81' ' ' ILE . 32.2 m -95.73 -39.22 9.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.02 174.11 7.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.885 0.374 . . . . 0.0 111.28 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.03 144.46 48.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.37 132.55 48.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 tptt 61.66 57.69 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -130.0 164.37 24.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.029 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -111.22 151.06 28.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.75 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 70' ' ' HIS . 13.6 mt -143.49 165.66 26.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.151 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.86 117.83 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.791 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.751 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -97.25 113.42 25.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.63 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.99 118.0 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.398 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.69 ' CD2' HG23 ' A' ' 63' ' ' ILE . 17.0 p90 -144.01 174.5 10.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.068 0.461 . . . . 0.0 111.477 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -107.53 158.14 17.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.787 179.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 12.2 pt-20 -154.66 137.67 15.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.753 0.311 . . . . 0.0 111.533 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.487 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 19.6 tt0 -105.46 60.74 0.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.807 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.0 p30 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.858 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.734 0.302 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 58.63 -175.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.428 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.6 OUTLIER -59.99 148.99 33.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.807 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -153.73 120.39 5.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.485 ' CG2' HD11 ' A' ' 43' ' ' LEU . 5.4 m -140.4 142.96 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.069 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -107.29 118.67 37.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.51 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.4 t -97.76 109.29 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.85 101.63 14.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.061 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.458 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 58.8 m-85 -85.62 102.82 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.504 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.03 -83.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.32 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -133.78 31.28 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.5 m -137.97 122.24 18.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.758 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -96.67 129.53 44.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.13 137.4 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.35 144.73 26.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.022 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.76 HG11 ' HG ' ' A' ' 43' ' ' LEU . 21.2 t -142.25 92.82 7.39 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.37 121.77 2.33 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.735 2.29 . . . . 0.0 112.518 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.428 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -94.28 123.29 37.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.785 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.56 -53.1 30.32 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.063 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.52 -33.6 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 111.081 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.1 6.19 61.86 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.684 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 31.86 2.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.864 0.364 . . . . 0.0 110.669 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.655 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -97.17 139.63 32.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.641 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.713 ' HE2' HD11 ' A' ' 81' ' ' ILE . 3.7 mmtt -67.9 144.7 55.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.394 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -46.67 -54.3 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.818 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.56 ' HD1' HD22 ' A' ' 78' ' ' LEU . 9.7 t80 -50.18 -29.81 10.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.216 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -73.15 -40.77 64.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.398 . . . . 0.0 110.3 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.112 HD13 HD11 ' A' ' 82' ' ' LEU . 3.7 tt -70.85 -38.26 73.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.681 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.865 ' O ' HG23 ' A' ' 48' ' ' VAL . 6.3 mt -62.54 -48.99 85.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.713 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -59.13 -42.73 91.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.625 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -64.94 -43.43 92.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.591 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.458 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -66.91 -39.52 87.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.914 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.919 HG21 HG21 ' A' ' 65' ' ' VAL . 92.9 t -60.17 -46.51 94.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.435 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.2 m -59.63 -43.52 93.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.287 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -34.98 79.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.628 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 55' ' ' VAL . 8.9 t80 -59.29 -57.12 14.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.471 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -53.31 -47.41 69.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -29.88 67.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.947 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.37 -29.8 57.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.2 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.5 p -97.25 3.88 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.591 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.74 36.52 8.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' CD ' HG11 ' A' ' 55' ' ' VAL . 11.6 mttt -101.78 -174.75 2.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.893 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m-20 -152.54 176.92 2.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.687 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 24.6 Cg_exo -63.47 -10.56 22.13 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.58 2.187 . . . . 0.0 112.734 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -45.26 -37.72 4.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.661 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.804 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.9 p90 -107.59 154.65 21.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.747 0.308 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.502 ' CD1' ' HB2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.45 154.17 24.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.961 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.804 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 66.1 mt -143.44 111.21 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.101 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -104.01 102.42 12.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.919 HG21 HG21 ' A' ' 48' ' ' VAL . 5.1 t -84.75 98.58 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.075 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -60.53 -77.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.074 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -166.9 -174.22 2.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.656 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.732 HD11 HG12 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -120.16 160.49 22.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.46 129.73 23.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -59.65 -29.62 68.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.34 -68.94 0.22 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -158.07 39.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.909 0.385 . . . . 0.0 110.757 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.25 49.42 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.318 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.05 57.04 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.361 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 mt -59.61 146.51 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.403 . . . . 0.0 111.316 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 5.2 mp -113.53 111.15 21.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.176 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -152.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.092 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.56 HD22 ' HD1' ' A' ' 41' ' ' PHE . 5.6 mt -117.75 27.38 9.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.6 0.238 . . . . 0.0 111.097 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 24.1 m-20 -137.65 -38.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.594 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.496 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -54.7 109.16 0.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.872 0.368 . . . . 0.0 111.615 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.713 HD11 ' HE2' ' A' ' 39' ' ' LYS . 27.8 mm -50.74 158.58 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.489 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.112 HD11 HD13 ' A' ' 43' ' ' LEU . 3.4 mm? -54.88 -59.1 5.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.269 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 22.0 p -65.3 -14.81 61.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.452 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -80.99 -32.45 34.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.575 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 86' ' ' ALA . 11.5 p -124.95 -45.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.805 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.491 ' N ' HG13 ' A' ' 85' ' ' VAL . . . -76.6 174.12 10.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.992 0.425 . . . . 0.0 111.427 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -143.85 155.16 44.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.7 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -52.82 119.14 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.6 tttp 61.68 71.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -139.62 136.5 34.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.018 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -87.57 147.86 25.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.796 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mt -136.72 153.03 50.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.027 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.3 t -99.3 117.13 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.704 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -99.25 119.26 37.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 111.702 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.15 123.6 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.47 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.57 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.5 p90 -151.32 -174.17 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.032 0.444 . . . . 0.0 111.491 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -125.91 159.06 33.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.962 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -157.18 137.5 12.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.782 0.325 . . . . 0.0 111.384 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.502 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 19.2 tt0 -117.89 59.17 0.79 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.073 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.942 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.84 0.353 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.75 -164.82 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.802 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD2' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -73.49 162.21 29.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.045 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.38 120.61 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.992 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.63 142.3 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.977 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.1 m -110.77 106.03 15.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 68' ' ' LEU . 1.4 m -97.84 103.76 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.93 101.77 2.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.037 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 4.5 m-85 -78.52 101.88 7.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.425 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.18 -77.0 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.234 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . 6.2 ttt180 -143.89 30.92 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.889 0.375 . . . . 0.0 110.763 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.9 m -142.02 126.88 18.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -79.51 117.77 20.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 51' ' ' TYR . 21.8 t -113.06 109.17 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -74.94 144.23 43.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.05 92.62 7.62 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.65 138.42 6.19 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.802 2.335 . . . . 0.0 112.599 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.421 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -113.02 146.39 39.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.61 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.19 -38.74 9.77 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.938 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -121.78 -43.93 2.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.512 ' HA2' HD23 ' A' ' 82' ' ' LEU . . . 111.58 10.87 18.55 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.547 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -97.97 35.11 1.77 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.605 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.436 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.5 OUTLIER -110.16 113.15 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.724 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -54.42 157.39 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.7 t -51.88 -52.11 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.054 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.564 ' HD1' HD22 ' A' ' 78' ' ' LEU . 10.7 t80 -49.49 -29.73 7.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.077 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.436 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 50.5 m -76.11 -42.18 47.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.805 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 40' ' ' VAL . 0.8 OUTLIER -70.86 -37.66 73.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.606 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.88 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.3 mt -64.09 -50.02 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.528 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -57.09 -41.34 78.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.366 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -38.38 90.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.32 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.62 -39.62 73.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.755 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.804 HG21 HG21 ' A' ' 65' ' ' VAL . 92.5 t -58.14 -53.17 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.439 HG23 ' NH2' ' A' ' 52' ' ' ARG . 45.2 m -59.25 -41.56 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.341 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -27.14 64.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.671 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.489 ' O ' HG22 ' A' ' 55' ' ' VAL . 27.5 t80 -68.28 -58.08 4.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.739 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' NH2' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -58.93 -36.75 75.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.753 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -72.13 -26.06 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.825 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.15 -31.39 25.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.448 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.678 HG23 ' HG3' ' A' ' 57' ' ' LYS . 29.3 m -94.0 17.6 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.649 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 58.6 31.82 21.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.559 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HG3' HG23 ' A' ' 55' ' ' VAL . 19.1 mttm -98.17 -177.19 3.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.799 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.27 175.34 2.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.97 -10.05 23.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.776 2.317 . . . . 0.0 112.815 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -47.65 -63.06 1.16 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.905 0.383 . . . . 0.0 111.283 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 2.7 p90 -75.86 145.64 40.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.83 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.492 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.61 154.12 34.66 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.672 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 62.2 mt -141.4 111.11 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.874 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.492 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.6 OUTLIER -104.84 104.48 14.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.585 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.88 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.0 t -82.42 98.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.466 ' HD2' HG12 ' A' ' 95' ' ' VAL . 83.1 m-70 -61.67 -68.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.067 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -174.87 -176.93 1.04 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.703 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.82 HD11 HG12 ' A' ' 44' ' ' ILE . 9.7 mt -121.86 160.94 23.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 111.063 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -141.26 136.31 31.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.417 ' HA ' HD23 ' A' ' 92' ' ' LEU . 8.3 m-70 -59.8 -51.7 68.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.22 -31.87 0.95 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.565 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -151.8 75.42 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.32 . . . . 0.0 110.829 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.59 76.75 1.01 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.52 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.25 55.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.543 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 mt -64.47 153.81 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.471 HD23 ' CG2' ' A' ' 85' ' ' VAL . 4.4 mp -124.57 121.77 35.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.832 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.45 -163.07 1.01 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.787 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.564 HD22 ' HD1' ' A' ' 41' ' ' PHE . 11.3 mt -109.0 42.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.083 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -157.06 32.3 0.29 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.918 ' O ' HG23 ' A' ' 40' ' ' VAL . 6.1 t0 -134.35 134.03 41.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.098 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.843 ' O ' HG12 ' A' ' 85' ' ' VAL . 30.6 mm -61.83 158.37 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.399 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.549 HD12 ' HB3' ' A' ' 86' ' ' ALA . 55.1 tp -65.4 -54.19 32.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.533 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.3 p -72.01 -5.94 38.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.928 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -101.03 -24.66 14.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.518 0.199 . . . . 0.0 111.5 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.843 HG12 ' O ' ' A' ' 81' ' ' ILE . 14.9 p -113.08 -34.21 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.771 0.319 . . . . 0.0 111.553 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.549 ' HB3' HD12 ' A' ' 82' ' ' LEU . . . -110.74 174.22 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.393 . . . . 0.0 111.275 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -136.08 156.26 48.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -52.59 127.05 21.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.032 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.59 70.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -129.78 134.82 47.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.039 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -99.2 113.42 25.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.798 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 70' ' ' HIS . 0.8 OUTLIER -117.02 167.13 11.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.08 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.44 141.83 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.736 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 24' ' ' PHE . . . -113.18 119.86 39.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.411 . . . . 0.0 111.472 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.466 HG12 ' HD2' ' A' ' 66' ' ' HIS . 31.9 t -105.16 114.6 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.572 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.587 ' HD2' HG23 ' A' ' 63' ' ' ILE . 3.2 p90 -144.91 -177.23 5.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.04 0.448 . . . . 0.0 111.503 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -116.28 157.04 25.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.793 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -157.58 133.53 9.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 111.422 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.483 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 2.5 tt0 -101.55 67.41 1.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.745 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.895 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.795 0.331 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -123.61 171.58 9.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.882 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -89.77 161.07 16.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.73 120.88 1.48 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 111.201 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 31' ' ' VAL . 16.0 m -133.51 156.13 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.4 m -117.39 119.47 35.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.903 0.382 . . . . 0.0 111.121 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.577 HG23 HG21 ' A' ' 31' ' ' VAL . 24.1 t -97.96 102.91 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.833 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.6 t -83.9 101.61 11.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.5 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 48.4 m-85 -83.57 99.84 10.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.521 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.86 -83.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.301 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -132.58 31.5 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.352 . . . . 0.0 110.761 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 m -138.35 118.71 13.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.76 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.22 120.51 32.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.086 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.5 138.41 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.986 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.75 142.49 27.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.01 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.577 HG21 HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -141.61 93.78 7.62 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.83 160.39 27.58 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.624 2.216 . . . . 0.0 112.658 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -129.32 129.51 44.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.747 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.38 -41.06 21.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.018 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.11 -33.22 6.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.196 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.25 -0.04 63.6 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.566 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.54 44.68 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.036 0.446 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.404 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.2 OUTLIER -114.87 107.75 15.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.612 ' HG2' HD13 ' A' ' 81' ' ' ILE . 4.0 mttt -53.28 159.25 1.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.055 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 80' ' ' ASP . 40.1 t -51.62 -52.71 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -49.39 -29.04 5.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 110.841 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 13.8 m -75.85 -45.0 38.08 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.398 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.71 HD22 HD13 ' A' ' 82' ' ' LEU . 4.2 pp -72.98 -34.75 66.65 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.896 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.927 ' O ' HG23 ' A' ' 48' ' ' VAL . 5.1 mt -66.43 -48.06 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 110.431 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -57.95 -45.79 86.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -37.11 83.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.282 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -72.55 -37.18 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.829 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 44' ' ' ILE . 60.9 t -59.41 -54.98 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.325 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -58.11 -44.11 87.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.355 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -35.84 78.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.582 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.769 ' O ' HG22 ' A' ' 55' ' ' VAL . 33.6 t80 -59.99 -57.96 10.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.255 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -49.26 -44.13 43.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.701 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -28.94 68.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.583 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.01 -29.76 43.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.008 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -98.45 18.14 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.268 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.96 28.68 3.95 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.441 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -95.0 -172.46 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -151.9 172.33 5.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.432 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 36.7 Cg_endo -65.74 -8.09 18.49 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.205 1.937 . . . . 0.0 112.818 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -45.77 -42.92 12.61 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.742 0.306 . . . . 0.0 111.436 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.844 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 7.5 p90 -97.02 161.16 13.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.76 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.497 ' CD1' ' HB2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -87.27 154.34 20.77 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.694 0.283 . . . . 0.0 111.149 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.844 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 86.0 mt -143.11 111.47 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.788 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -99.25 102.01 13.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.682 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.611 HG11 ' CG2' ' A' ' 44' ' ' ILE . 9.9 t -81.43 95.42 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -56.18 -77.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.283 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.26 -177.61 4.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.875 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.56 ' HB3' HD13 ' A' ' 76' ' ' LEU . 1.3 mm? -115.58 147.91 40.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.94 132.58 42.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -58.33 -28.84 65.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.059 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.36 -59.77 0.53 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.567 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.59 32.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 0.0 110.848 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.53 78.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.44 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.11 62.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.409 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 76' ' ' LEU . 11.7 mt -59.5 157.95 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.617 HD23 ' CG2' ' A' ' 85' ' ' VAL . 1.8 mp -131.87 121.17 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' O ' HG11 ' A' ' 40' ' ' VAL . 29.2 m-20 -97.22 -174.48 2.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.55 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.519 HD23 HD12 ' A' ' 44' ' ' ILE . 1.6 mt -104.0 34.1 3.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.92 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -150.17 34.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.186 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.901 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -139.33 132.28 29.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.918 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.621 ' O ' HG12 ' A' ' 85' ' ' VAL . 21.8 mm -56.38 154.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.086 0.47 . . . . 0.0 111.318 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.71 HD13 HD22 ' A' ' 43' ' ' LEU . 49.3 tp -63.0 -52.77 61.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.288 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 64.5 m -67.89 -11.36 58.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.738 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -97.9 -22.72 16.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 81' ' ' ILE . 14.4 p -111.21 -44.04 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.638 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.468 ' N ' HG13 ' A' ' 85' ' ' VAL . . . -101.33 174.18 6.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.322 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -129.31 149.65 51.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.673 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -51.81 126.43 17.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.151 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm 61.69 67.64 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -136.63 153.29 50.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' NH1' ' HB2' ' A' ' 91' ' ' ARG . 2.3 mtm105 -104.35 146.18 29.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.661 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB3' HD12 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -137.7 152.65 49.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.187 -179.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 t -108.29 108.64 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.596 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.68 129.5 36.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.989 0.423 . . . . 0.0 111.809 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.8 t -110.8 126.65 68.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.436 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.653 ' HD2' HG23 ' A' ' 63' ' ' ILE . 3.4 p90 -150.16 179.69 7.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.116 0.484 . . . . 0.0 111.432 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -116.13 162.35 17.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.721 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.2 pt-20 -161.58 134.76 6.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.8 0.333 . . . . 0.0 111.456 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.497 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 13.8 tt0 -102.88 72.74 1.22 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.623 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.902 -179.865 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 60.31 162.4 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -81.14 163.2 23.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.926 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -162.74 120.46 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 111.279 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 43' ' ' LEU . 4.3 m -134.72 142.57 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.835 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.6 m -114.1 107.62 15.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.997 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.435 HG23 ' CG2' ' A' ' 29' ' ' VAL . 18.8 m -97.91 137.35 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.979 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.8 m -103.49 102.58 12.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.24 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 40.6 m-85 -77.13 95.47 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.442 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.9 -73.89 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.144 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' PHE . 1.6 mmt85 -143.54 29.09 1.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 110.565 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.8 m -136.31 114.82 11.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.757 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -87.11 127.38 35.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.435 ' CG2' HG23 ' A' ' 22' ' ' VAL . 23.8 m -133.23 140.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.114 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.27 149.5 21.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.076 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.608 HG11 ' HG ' ' A' ' 43' ' ' LEU . 21.6 t -137.81 96.03 10.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.39 127.72 6.74 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.609 2.206 . . . . 0.0 112.303 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.3 154.98 22.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.05 -69.4 1.38 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.576 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -109.15 -17.84 13.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 111.203 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.83 14.97 57.3 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.444 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -100.31 29.13 4.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 110.825 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 ttp -98.2 130.26 44.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -57.63 142.96 43.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.595 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 80' ' ' ASP . 92.7 t -48.46 -45.44 14.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.72 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -50.17 -35.18 25.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.111 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 m -74.57 -37.56 62.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.469 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.667 HD13 HD13 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -70.28 -39.02 75.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.683 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.883 ' O ' HG23 ' A' ' 48' ' ' VAL . 4.1 mt -64.26 -49.4 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.654 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -38.92 80.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.63 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -42.95 84.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.507 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -68.26 -40.34 81.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.893 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 44' ' ' ILE . 69.4 t -56.63 -52.09 58.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.118 0.485 . . . . 0.0 110.471 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -57.27 -43.73 83.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.422 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -38.81 80.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.573 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' HG12 ' A' ' 55' ' ' VAL . 9.8 t80 -58.66 -56.49 21.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.474 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.4 mtm-85 -48.88 -47.8 42.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -32.28 67.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.062 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 -26.71 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.042 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.1 p -99.13 1.86 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 67.53 30.89 6.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.765 0.317 . . . . 0.0 111.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HD2' HG11 ' A' ' 55' ' ' VAL . 11.4 mttt -99.2 -175.14 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.736 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.1 m-20 -146.13 175.85 2.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 24.3 Cg_exo -64.15 -7.92 15.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.89 2.393 . . . . 0.0 112.932 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -48.02 -66.99 0.31 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.88 0.372 . . . . 0.0 110.99 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.748 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 1.9 p90 -74.37 160.71 30.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.576 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -89.49 151.64 21.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.791 0.329 . . . . 0.0 111.258 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.748 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 35.0 mt -142.08 111.0 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.686 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.49 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -109.04 101.53 10.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.674 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 65' ' ' VAL . 11.3 p -86.3 96.74 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.144 0.497 . . . . 0.0 111.032 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -54.29 -81.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.586 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.07 -167.08 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.802 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.542 HD11 HG12 ' A' ' 44' ' ' ILE . 4.0 mt -127.66 164.99 20.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.847 0.356 . . . . 0.0 111.143 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.409 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -141.21 141.92 34.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.839 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.546 ' HA ' HD23 ' A' ' 92' ' ' LEU . 14.0 m-70 -64.59 -35.82 82.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.993 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.54 -77.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.574 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.63 40.36 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.27 103.15 2.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.441 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.3 58.19 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.582 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 76' ' ' LEU . 7.7 mt -68.32 158.44 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.297 . . . . 0.0 111.046 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -158.41 131.84 7.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.16 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -90.81 -156.61 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.802 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.653 ' CD2' HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -112.26 84.92 2.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.85 0.357 . . . . 0.0 110.74 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -171.75 -40.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.928 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.1 m-20 -76.09 142.5 41.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.864 ' O ' HG12 ' A' ' 85' ' ' VAL . 27.6 mm -56.75 156.89 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.17 0.51 . . . . 0.0 111.474 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.667 HD13 HD13 ' A' ' 43' ' ' LEU . 64.6 tp -66.39 -56.7 9.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.293 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.83 -14.74 61.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.584 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -90.53 -28.21 18.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.586 0.231 . . . . 0.0 111.328 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.864 HG12 ' O ' ' A' ' 81' ' ' ILE . 14.6 p -117.09 4.48 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.83 174.22 11.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.35 . . . . 0.0 111.212 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.77 152.85 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.817 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.54 135.95 54.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.993 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.55 58.1 3.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.769 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -120.78 157.86 28.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.066 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -116.39 137.06 52.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 70' ' ' HIS . 1.5 mp -142.89 154.39 44.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.069 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 69' ' ' GLU . 1.4 m -99.62 117.76 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.66 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . . . -91.83 122.74 34.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.694 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.3 126.37 48.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.271 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.475 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -155.33 169.72 23.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.239 0.542 . . . . 0.0 112.124 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.91 157.09 25.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -153.8 136.43 15.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 111.327 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.48 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 6.7 tt0 -105.23 63.96 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.801 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.461 0.119 0 CA-C-O 120.912 0.387 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.03 -166.79 1.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.674 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -63.49 149.16 46.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.53 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -152.25 120.66 6.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.983 0.42 . . . . 0.0 111.069 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.534 HG11 ' HB1' ' A' ' 86' ' ' ALA . 4.6 m -132.34 142.42 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.921 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -106.43 125.34 50.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.816 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.005 HG12 ' HB2' ' A' ' 94' ' ' ALA . 2.9 t -112.66 109.96 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.96 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.1 m -75.27 101.51 4.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.938 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.514 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 7.4 m-85 -84.74 97.32 9.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.705 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.32 -92.87 0.01 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.509 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.34 31.72 6.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.876 0.37 . . . . 0.0 110.641 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.0 m -153.35 117.67 4.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 135.21 33.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.028 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.16 137.08 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.167 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.78 148.94 25.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.9 t -138.93 92.88 10.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.229 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.42 124.94 3.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.767 2.311 . . . . 0.0 112.493 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.52 ' SG ' HD22 ' A' ' 82' ' ' LEU . 8.2 m -103.62 136.96 42.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.784 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.38 -41.77 93.34 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.996 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -128.68 -46.53 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.878 0.37 . . . . 0.0 111.236 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.23 12.19 8.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.46 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 -93.85 35.61 1.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.923 0.392 . . . . 0.0 110.576 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.467 ' HG2' ' HB2' ' A' ' 42' ' ' SER . 8.9 ttm -111.17 114.19 27.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.702 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -49.7 144.36 6.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.215 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 80' ' ' ASP . 27.5 t -46.61 -44.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 111.146 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.628 ' HD1' HD22 ' A' ' 78' ' ' LEU . 6.0 t80 -50.64 -41.15 54.91 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.531 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.467 ' HB2' ' HG2' ' A' ' 38' ' ' MET . 2.9 m -71.98 -34.41 68.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 110.223 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.539 HD13 HD13 ' A' ' 82' ' ' LEU . 2.3 tp -66.98 -35.41 79.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.155 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.969 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.5 mt -65.88 -51.28 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.547 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -55.76 -36.66 67.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.485 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -67.19 -42.37 84.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.567 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -69.48 -41.77 75.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.974 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 65' ' ' VAL . 61.2 t -56.41 -52.89 46.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.723 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.1 m -58.31 -44.34 88.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.484 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -62.74 -36.92 84.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.697 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -58.16 -52.94 63.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.534 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -55.19 -49.09 72.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.863 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -70.49 -24.61 62.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.85 -41.41 62.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 0.0 111.28 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.4 p -93.06 9.69 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.668 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 62.8 37.68 12.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.758 0.313 . . . . 0.0 111.466 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 31.8 mttt -96.54 -174.36 3.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -144.86 172.27 5.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.43 -10.71 22.57 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.822 2.348 . . . . 0.0 112.797 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.21 -59.09 3.11 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.835 0.35 . . . . 0.0 111.45 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.818 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.6 p90 -79.58 141.24 36.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CD1' ' HB2' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -76.71 156.18 32.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.621 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.818 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 57.9 mt -142.03 111.22 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.075 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.488 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -103.96 105.53 15.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.516 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.969 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.1 t -82.54 100.05 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.203 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -63.62 -70.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -168.42 -173.01 1.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.749 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.895 HD11 HG12 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -131.35 158.86 39.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.829 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -142.81 141.14 31.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -61.53 -45.19 95.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.81 -87.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.519 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -120.38 33.8 5.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.797 0.332 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.22 89.56 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.445 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.57 62.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.435 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 76' ' ' LEU . 14.2 mt -56.68 156.05 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.942 0.401 . . . . 0.0 111.104 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.881 HD11 HD22 ' A' ' 92' ' ' LEU . 2.6 mt -126.8 115.05 18.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.058 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.71 -163.13 1.01 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.794 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.657 ' CD2' HD12 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -117.38 77.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.867 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -174.61 -62.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.238 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.853 ' O ' HG23 ' A' ' 40' ' ' VAL . 6.6 t0 -53.05 128.08 26.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.329 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 83' ' ' CYS . 24.1 mm -54.12 146.6 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.479 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.744 ' HG ' ' HB3' ' A' ' 86' ' ' ALA . 4.5 tp -60.77 -39.72 89.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.373 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.62 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -67.02 -12.87 61.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.619 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.12 -29.86 12.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.646 0.26 . . . . 0.0 111.392 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 86' ' ' ALA . 32.6 m -104.26 -44.7 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.864 0.364 . . . . 0.0 111.668 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.744 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . . . -88.81 174.07 8.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.204 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -145.14 155.39 43.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.677 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -48.8 118.22 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.26 57.84 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -112.69 147.53 36.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.488 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -96.65 148.59 22.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.881 HD22 HD11 ' A' ' 76' ' ' LEU . 16.6 mt -146.2 169.09 19.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.05 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 t -127.7 114.4 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.005 ' HB2' HG12 ' A' ' 22' ' ' VAL . . . -94.12 122.68 36.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.44 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.42 112.01 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.63 ' CD2' HG23 ' A' ' 63' ' ' ILE . 20.2 p90 -141.22 174.46 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.011 0.434 . . . . 0.0 111.282 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -108.48 159.6 16.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.026 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.4 pt-20 -156.53 135.45 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 111.244 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.489 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 30.8 tt0 -107.23 69.52 0.76 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.967 0.413 . . . . 0.0 110.899 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.1 p30 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.957 -179.91 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.457 0.17 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 18' ' ' PHE . 0.7 OUTLIER 44.19 -165.21 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.735 0.302 . . . . 0.0 111.512 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.746 ' CE2' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -110.35 165.5 11.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.59 120.73 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.5 m -137.51 141.91 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.1 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.407 ' CG2' ' CG ' ' A' ' 28' ' ' ARG . 5.8 m -105.55 120.03 40.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.865 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.905 HG13 HD11 ' A' ' 68' ' ' LEU . 17.1 t -101.61 111.76 32.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 m -92.13 101.64 14.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.663 ' CE2' HG22 ' A' ' 48' ' ' VAL . 65.9 m-85 -85.52 108.01 17.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.697 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.74 -87.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.377 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -131.55 31.63 4.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.364 . . . . 0.0 110.702 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.1 m -137.76 136.54 37.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' CG ' ' CG2' ' A' ' 21' ' ' THR . 10.3 ttm180 -101.14 137.5 39.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.48 126.67 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -86.96 144.45 26.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.797 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.0 t -142.29 92.64 7.41 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.196 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.62 122.57 2.74 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.788 2.325 . . . . 0.0 112.481 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -91.13 137.45 32.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.79 -53.53 44.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.685 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -117.27 -38.19 3.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.41 17.87 10.92 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.594 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 -104.61 32.6 4.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.707 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 7.8 ttp -101.83 168.91 9.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -100.25 151.05 21.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.695 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 80' ' ' ASP . 57.7 t -50.42 -47.23 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -49.97 -32.5 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.392 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -36.9 47.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.824 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -72.24 -38.27 68.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.567 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.986 HD13 HD23 ' A' ' 68' ' ' LEU . 4.9 mt -67.44 -45.86 84.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.552 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -59.35 -41.26 88.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.759 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -66.99 -45.83 76.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.721 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.536 ' HB1' ' HE1' ' A' ' 24' ' ' PHE . . . -65.66 -39.46 91.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.134 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 65' ' ' VAL . 71.0 t -58.45 -50.71 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.573 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.1 m -57.38 -45.06 84.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.64 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -63.07 -36.69 84.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.77 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' O ' HG12 ' A' ' 55' ' ' VAL . 4.8 t80 -58.39 -57.18 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -54.64 -48.73 71.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.261 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -72.05 -24.45 61.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.327 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.6 -35.07 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 111.267 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.6 p -89.24 9.35 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.537 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.56 52.92 1.67 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.006 0.432 . . . . 0.0 111.197 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 16.0 mttm -122.74 -175.41 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.99 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.491 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.2 m-20 -153.32 172.21 5.93 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.472 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 20.5 Cg_endo -61.07 -10.54 15.36 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.339 2.026 . . . . 0.0 112.932 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -43.68 -36.19 2.1 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.7 0.286 . . . . 0.0 111.691 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.74 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 4.7 p90 -108.96 159.88 16.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.698 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.487 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -87.06 151.89 22.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 111.196 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.74 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 57.2 mt -141.73 111.26 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.746 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.487 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -108.41 107.13 17.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.818 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 48' ' ' VAL . 7.7 t -82.56 100.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -57.41 -75.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' NH1' HG21 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -163.51 -171.94 2.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.986 HD23 HD13 ' A' ' 44' ' ' ILE . 2.2 mm? -125.87 157.06 38.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.95 0.405 . . . . 0.0 110.847 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 75' ' ' ILE . 2.7 mp0 -142.54 161.13 38.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.76 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.584 ' HA ' HD23 ' A' ' 92' ' ' LEU . 35.9 m-70 -79.93 -61.48 1.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.833 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.19 79.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.567 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 60.31 44.46 12.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.52 62.11 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.21 46.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.602 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.513 HG21 ' NH1' ' A' ' 67' ' ' ARG . 12.3 mt -62.77 154.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.73 0.3 . . . . 0.0 111.001 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -155.42 144.79 21.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.963 0.411 . . . . 0.0 111.274 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -94.56 -160.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.73 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.443 HD23 HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -108.58 86.45 2.29 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.764 0.316 . . . . 0.0 110.864 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -176.9 -39.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.878 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -66.83 128.25 35.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.656 ' O ' HG12 ' A' ' 85' ' ' VAL . 30.9 mm -55.23 157.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.021 0.438 . . . . 0.0 111.638 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.746 HD12 ' CE2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -56.89 -57.0 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.632 -179.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.6 t -74.12 -3.64 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.885 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -95.5 -30.65 13.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.589 0.233 . . . . 0.0 111.4 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 81' ' ' ILE . 10.2 p -120.51 -30.37 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.91 174.22 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 0.0 111.299 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -136.77 155.75 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.838 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.32 133.84 19.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.87 66.21 1.26 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.803 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -124.41 131.51 53.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.11 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -93.84 105.39 17.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.628 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 70' ' ' HIS . 46.2 mt -101.12 145.78 28.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.341 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.566 ' O ' HD13 ' A' ' 68' ' ' LEU . 23.5 t -94.04 121.36 44.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.592 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.733 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -98.56 122.84 42.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.997 0.427 . . . . 0.0 111.891 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 t -108.45 122.96 63.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.194 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.54 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.8 p90 -149.4 -175.12 4.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.217 0.532 . . . . 0.0 111.615 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.02 154.95 36.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.952 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.2 pt-20 -155.54 132.73 10.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.738 0.304 . . . . 0.0 111.302 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.47 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -97.77 69.52 2.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.756 0.312 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.42 165.14 12.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.716 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -63.59 160.71 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.687 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.94 120.62 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.26 142.77 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.013 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 m -104.53 105.73 15.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.35 103.15 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.2 t -79.16 101.59 8.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.507 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 8.4 m-85 -80.1 100.15 8.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.631 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 -79.12 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.319 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . 5.5 mmt85 -139.92 31.18 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.356 . . . . 0.0 110.771 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.7 m -140.92 122.23 14.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.886 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 122.74 29.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.834 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.78 107.5 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.317 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.94 147.99 40.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.723 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.59 HG11 HD22 ' A' ' 43' ' ' LEU . 20.1 t -141.29 103.47 6.06 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.339 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -85.5 140.35 7.26 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.731 2.287 . . . . 0.0 112.278 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.8 m -114.8 141.8 47.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.42 -50.28 60.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.743 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -112.63 -29.27 7.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.52 17.11 50.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -109.96 31.69 5.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.832 0.349 . . . . 0.0 110.7 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.9 ttp -93.78 127.34 39.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -58.14 144.8 39.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.586 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 80' ' ' ASP . 43.4 t -47.78 -45.48 11.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.837 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 67.9 t80 -50.2 -38.01 37.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.181 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.0 t -73.63 -33.0 64.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 110.235 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.742 HD13 ' O ' ' A' ' 43' ' ' LEU . 1.4 tm? -72.17 -38.18 69.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.679 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.821 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.6 mt -66.51 -43.9 90.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -64.25 -39.5 94.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.605 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -67.44 -37.28 82.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.367 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -75.79 -37.3 59.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.034 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -60.54 -44.29 96.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.976 0.417 . . . . 0.0 110.585 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.422 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 86.3 m -68.6 -46.69 68.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.531 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.03 -32.73 74.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.705 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -64.33 -57.67 8.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.651 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -52.61 -42.56 64.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -72.2 -30.96 65.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.96 -37.16 69.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.052 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.446 HG21 ' CE ' ' A' ' 57' ' ' LYS . 35.4 m -88.57 7.78 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.539 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 61.47 41.02 13.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 111.333 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 49.5 mttt -101.89 -174.62 2.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.454 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.8 OUTLIER -144.46 172.05 5.93 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.571 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 52.0 Cg_endo -69.3 -6.04 17.4 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.281 1.988 . . . . 0.0 112.875 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -49.42 -38.05 27.74 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.711 0.291 . . . . 0.0 111.283 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.768 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.1 p90 -104.61 149.32 25.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -80.74 153.66 27.69 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.842 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.768 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 48.9 mt -141.95 111.01 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.847 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.497 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.9 OUTLIER -108.94 109.43 20.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.673 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.821 HG11 ' CG2' ' A' ' 44' ' ' ILE . 2.2 t -82.13 102.6 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.247 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -57.45 -77.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -160.07 -179.36 7.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.021 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.581 HD11 ' HB2' ' A' ' 94' ' ' ALA . 3.4 mm? -114.87 159.93 20.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -145.52 140.2 27.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.781 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -63.61 -54.91 28.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.28 -52.56 0.16 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.544 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -152.92 31.96 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.79 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.12 75.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.563 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.41 68.96 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.414 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 76' ' ' LEU . 3.6 mm -65.18 157.13 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.906 0.384 . . . . 0.0 111.059 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.632 HD23 ' CG2' ' A' ' 85' ' ' VAL . 3.8 mp -132.65 119.35 20.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.039 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -98.07 173.24 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.68 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.589 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.26 76.6 6.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.92 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -176.06 -44.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.013 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.906 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -66.93 138.97 57.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.984 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 85' ' ' VAL . 30.6 mm -61.05 158.94 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.507 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.716 HD12 ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -58.01 -59.18 5.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.442 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.5 t -67.44 -12.83 61.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.783 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -90.85 -21.93 21.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.623 0.249 . . . . 0.0 111.485 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.632 ' CG2' HD23 ' A' ' 76' ' ' LEU . 14.9 p -110.9 -26.58 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.583 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.99 174.64 10.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.372 . . . . 0.0 111.442 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -127.08 159.66 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.477 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 11.7 p-10 -47.51 153.46 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.134 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 35.06 57.72 0.77 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.005 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -110.02 161.57 15.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.981 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -114.7 130.15 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.76 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.43 HD23 HD11 ' A' ' 76' ' ' LEU . 2.1 mp -144.55 160.84 40.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.109 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.23 138.62 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.775 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -113.04 133.47 54.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.423 . . . . 0.0 111.65 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.01 131.9 58.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.295 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.478 ' HB3' ' HA ' ' A' ' 65' ' ' VAL . 37.2 p90 -152.06 177.73 10.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.013 0.435 . . . . 0.0 111.632 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.61 157.36 22.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.021 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 8.7 pt-20 -154.34 139.32 17.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.686 0.279 . . . . 0.0 111.388 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.482 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 6.1 tt0 -109.72 63.34 0.6 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.914 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.943 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.778 0.323 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.07 -172.58 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.424 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -81.66 152.1 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.738 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -157.85 120.57 3.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.051 0.453 . . . . 0.0 111.167 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 m -136.79 143.23 35.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.835 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.0 m -101.12 116.06 31.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.494 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t -98.0 102.84 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.78 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 2.7 t -82.88 102.12 11.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.191 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.505 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 29.7 m-85 -84.58 98.83 10.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.28 -83.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.299 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -133.51 30.98 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.81 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.4 m -139.21 116.39 11.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -89.09 120.84 30.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.84 116.66 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.03 149.2 39.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.8 t -142.03 95.97 6.72 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.39 108.67 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.661 2.241 . . . . 0.0 112.337 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.424 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -79.23 140.76 37.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.818 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -54.77 -54.97 29.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.91 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.7 -40.85 2.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.98 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.38 13.51 8.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.647 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.5 mtm-85 -98.79 30.18 3.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.823 0.344 . . . . 0.0 110.724 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -102.53 114.04 27.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.704 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -49.74 148.71 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.71 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 80' ' ' ASP . 23.8 t -46.92 -48.44 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.938 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 78' ' ' LEU . 1.2 t80 -50.81 -44.99 59.17 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.059 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.9 t -58.93 -42.44 89.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.997 0.427 . . . . 0.0 110.328 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.46 -30.96 71.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.655 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.854 HG23 HG11 ' A' ' 65' ' ' VAL . 7.5 mt -64.7 -48.21 85.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.877 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -60.99 -44.86 96.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -39.21 90.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.51 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.505 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -72.35 -34.01 67.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.071 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.497 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -63.79 -44.76 98.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.95 0.405 . . . . 0.0 110.721 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.411 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 89.2 m -65.96 -44.49 84.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.548 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -64.77 -27.39 68.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.67 ' O ' HG12 ' A' ' 55' ' ' VAL . 52.5 t80 -69.13 -57.71 5.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.848 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.478 ' HA ' HG12 ' A' ' 55' ' ' VAL . 28.2 ptt180 -59.85 -39.29 84.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.055 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -72.27 -35.27 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.03 -29.94 43.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.43 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 51' ' ' TYR . 14.4 p -87.96 7.74 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.701 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.76 36.2 10.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.798 0.332 . . . . 0.0 111.413 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.546 ' HD2' HG11 ' A' ' 55' ' ' VAL . 43.9 mttt -107.4 -176.61 3.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.842 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.4 m-20 -139.28 175.47 3.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.016 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 20.0 Cg_exo -66.05 -7.85 18.29 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.92 2.414 . . . . 0.0 112.877 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.08 -71.49 0.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.956 0.408 . . . . 0.0 111.113 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.776 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 1.3 p90 -64.5 150.71 46.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.809 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.543 ' CZ3' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.18 152.99 25.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.777 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.776 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 18.4 mt -143.04 110.39 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.055 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -113.94 101.93 9.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.63 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.854 HG11 HG23 ' A' ' 44' ' ' ILE . 2.4 t -76.61 97.85 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.151 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -52.28 -70.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.155 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.47 -175.53 3.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 mt -127.56 161.47 28.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.998 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -143.69 159.62 42.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.783 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.57 ' HA ' HD23 ' A' ' 92' ' ' LEU . 12.9 m-70 -77.85 -50.52 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.13 -88.73 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -96.19 41.32 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.814 0.34 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.25 98.18 1.68 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.19 61.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.435 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 76' ' ' LEU . 14.1 mt -56.3 158.15 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 111.029 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.807 HD11 HD22 ' A' ' 92' ' ' LEU . 2.8 mt -135.96 106.69 6.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.103 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.531 ' OD1' HD12 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -79.27 -164.92 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.533 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.65 HD23 HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -115.96 74.56 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 0.0 110.794 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.48 -52.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.105 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.825 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -57.44 129.03 39.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.033 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 85' ' ' VAL . 15.7 mm -54.25 152.97 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.025 0.44 . . . . 0.0 111.511 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.01 -53.32 58.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.371 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.6 p -66.49 -12.17 56.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.687 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.85 -32.39 16.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.656 0.265 . . . . 0.0 111.567 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 86' ' ' ALA . 14.7 p -112.23 -45.24 5.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.754 0.312 . . . . 0.0 111.691 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.497 ' N ' HG13 ' A' ' 85' ' ' VAL . . . -86.06 174.09 9.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.384 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -135.58 155.37 50.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -56.37 126.37 26.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.048 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.8 tptt 60.7 69.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -139.7 138.5 36.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -85.9 146.02 26.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.785 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.807 HD22 HD11 ' A' ' 76' ' ' LEU . 8.3 mt -142.07 145.1 33.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.199 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.0 133.36 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.494 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -113.22 118.0 33.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.374 . . . . 0.0 111.639 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.3 t -104.13 122.71 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.418 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.445 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.6 p90 -149.5 -175.34 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.115 0.483 . . . . 0.0 111.709 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -131.55 127.97 38.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.177 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.1 pt-20 -128.46 138.83 52.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.824 0.345 . . . . 0.0 111.004 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -98.44 65.69 1.66 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.809 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.986 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.8 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.755 0.312 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -74.05 146.52 43.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -76.38 165.12 25.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -164.59 120.45 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.034 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.5 m -138.84 141.97 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.127 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 m -101.17 116.11 32.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.659 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.735 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 10.7 t -101.83 111.77 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.085 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.52 101.52 13.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.492 ' HE2' HG22 ' A' ' 48' ' ' VAL . 15.1 m-85 -83.76 99.81 10.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.538 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.3 -85.97 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.432 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 24' ' ' PHE . 13.1 mtt-85 -130.18 31.23 4.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.893 0.377 . . . . 0.0 110.838 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.1 m -141.25 120.84 13.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.789 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -94.78 130.13 41.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 m -139.19 120.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.8 148.89 39.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.821 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.46 92.94 14.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.237 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.17 116.79 2.76 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.611 2.207 . . . . 0.0 112.312 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.19 150.98 22.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.78 -68.73 1.54 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.451 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -104.44 -32.43 9.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.38 3.18 41.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.824 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.9 35.84 1.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.41 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 2.2 ttp -100.57 142.21 32.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.23 146.39 52.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.701 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.943 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.1 t -49.49 -44.78 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.861 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -50.17 -36.79 31.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.41 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 1.1 m -74.82 -34.62 62.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.154 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.464 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -69.34 -41.98 75.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.528 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.909 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.0 mt -64.44 -45.65 95.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.846 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.26 -37.53 80.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.718 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -45.01 76.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.756 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.477 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -68.13 -44.19 76.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.232 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 44' ' ' ILE . 85.9 t -54.59 -53.55 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 110.713 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 88.3 m -57.03 -42.57 80.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.383 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -34.53 78.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 55' ' ' VAL . 32.5 t80 -60.2 -57.23 13.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.484 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HD3' HD12 ' A' ' 63' ' ' ILE . 53.3 mtm180 -53.71 -44.96 70.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -32.8 69.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.018 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.65 -29.06 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 51' ' ' TYR . 14.6 p -94.78 -3.76 10.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.611 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 70.31 36.26 1.84 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.788 0.328 . . . . 0.0 111.21 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.646 ' HD2' HG11 ' A' ' 55' ' ' VAL . 20.1 mttt -104.58 -176.04 2.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.881 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.6 m-20 -149.47 176.57 2.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.759 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 25.0 Cg_exo -63.42 -9.9 19.57 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.632 2.221 . . . . 0.0 112.869 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -44.7 -32.74 1.6 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.709 0.29 . . . . 0.0 111.73 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.883 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 6.7 p90 -110.56 163.1 14.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.832 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -89.64 154.07 20.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.877 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.883 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 79.9 mt -143.58 110.75 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.157 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.488 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -106.71 101.93 11.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.262 179.244 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.909 HG11 ' CG2' ' A' ' 44' ' ' ILE . 5.4 t -79.32 94.79 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.007 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -53.37 -70.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.078 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -173.54 -177.68 1.5 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.834 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.882 HD11 HG12 ' A' ' 44' ' ' ILE . 6.8 mt -116.14 159.92 21.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.962 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -137.23 144.72 42.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.963 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.614 ' HA ' HD23 ' A' ' 92' ' ' LEU . 2.3 m-70 -66.53 -31.06 71.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.74 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.15 -38.56 1.1 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -172.33 35.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.829 0.347 . . . . 0.0 110.801 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.4 72.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.415 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.6 64.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.404 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 76' ' ' LEU . 9.1 mt -65.87 158.01 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 111.266 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.492 HD23 ' CG2' ' A' ' 85' ' ' VAL . 2.1 mp -133.06 128.17 35.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.758 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.415 ' O ' HG11 ' A' ' 40' ' ' VAL . 2.9 m-20 -94.92 -166.24 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.36 43.93 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.962 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -156.56 26.52 0.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.943 ' O ' HG23 ' A' ' 40' ' ' VAL . 4.6 t0 -137.13 144.39 42.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.824 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.844 ' O ' HG22 ' A' ' 85' ' ' VAL . 29.1 mm -57.09 156.77 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.576 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.422 ' N ' ' CG2' ' A' ' 81' ' ' ILE . 41.4 tp -74.8 -50.7 16.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.269 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.44 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 10.5 t -59.69 -20.26 55.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.361 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -85.54 -59.64 2.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.329 . . . . 0.0 111.377 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 81' ' ' ILE . 21.1 m -76.56 -16.35 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.826 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.02 174.22 10.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 0.0 111.282 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.55 155.06 50.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.866 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -52.67 130.09 31.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.02 66.55 1.03 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -131.85 156.0 46.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.02 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.83 144.35 31.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.614 HD23 ' HA ' ' A' ' 70' ' ' HIS . 12.5 mt -144.13 145.34 32.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.004 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.41 119.8 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.735 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -95.53 121.41 37.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.54 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.3 120.27 60.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.762 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' A' ' 65' ' ' VAL . 14.3 p90 -148.23 171.36 16.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.054 0.454 . . . . 0.0 111.128 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -114.55 133.88 55.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.059 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 6.1 pt-20 -133.67 138.39 45.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.788 0.328 . . . . 0.0 111.212 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.438 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -101.37 69.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.4 t0 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.891 179.874 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.864 0.364 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.42 167.62 9.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -67.5 155.8 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.17 120.22 2.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.051 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.532 HG11 ' HB1' ' A' ' 86' ' ' ALA . 3.5 m -132.59 142.86 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.012 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.0 m -103.2 108.92 20.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.4 t -97.92 102.75 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.4 t -85.19 101.55 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.493 ' HE2' HG22 ' A' ' 48' ' ' VAL . 20.3 m-85 -79.99 99.93 7.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.529 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.92 -80.6 0.02 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.263 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . 2.7 mtt180 -137.08 30.82 2.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.935 0.398 . . . . 0.0 110.636 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 83.1 m -138.65 121.26 16.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.57 126.23 33.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.94 114.06 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -74.88 146.35 41.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.41 ' HB ' HG23 ' A' ' 20' ' ' VAL . 21.4 t -142.09 93.68 7.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.28 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.22 128.51 3.62 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.818 2.346 . . . . 0.0 112.329 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.406 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -98.59 136.94 37.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.54 77.43 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.77 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.25 -44.07 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.72 18.37 6.09 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.562 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -98.17 29.24 3.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.827 0.346 . . . . 0.0 110.701 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.422 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 6.0 ttp -108.09 133.9 51.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.754 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -70.84 148.42 47.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 80' ' ' ASP . 46.8 t -47.81 -40.76 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 14.5 t80 -50.71 -42.49 57.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.872 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.422 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.8 OUTLIER -72.49 -29.56 63.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.195 179.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.839 ' HG ' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -71.29 -39.85 71.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.525 179.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.887 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.7 mt -65.45 -48.65 82.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.775 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -60.86 -35.67 77.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.713 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -68.93 -42.99 76.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HB1' ' HE1' ' A' ' 24' ' ' PHE . . . -71.43 -43.63 66.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 65' ' ' VAL . 93.1 t -56.24 -48.28 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.5 m -61.17 -49.3 77.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.298 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -31.66 72.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.547 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.618 ' O ' HG12 ' A' ' 55' ' ' VAL . 32.0 t80 -62.31 -57.69 10.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.451 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HE ' HD12 ' A' ' 63' ' ' ILE . 11.7 ttm105 -52.42 -44.81 65.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -24.59 61.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.96 -30.17 26.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.222 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.718 HG13 ' HD2' ' A' ' 57' ' ' LYS . 12.8 p -103.32 20.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.304 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 48.03 89.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.382 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.718 ' HD2' HG13 ' A' ' 55' ' ' VAL . 11.0 mttt -155.13 -172.2 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.864 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -162.2 177.7 1.86 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.698 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 32.3 Cg_exo -58.46 -13.56 17.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.698 2.265 . . . . 0.0 112.937 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -42.82 -36.73 1.57 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.668 0.271 . . . . 0.0 111.571 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.822 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 2.1 p90 -115.49 153.02 31.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.697 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.89 154.66 24.49 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 111.194 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.822 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 79.6 mt -142.54 110.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.479 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.519 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.6 OUTLIER -105.39 106.3 16.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.061 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 48' ' ' VAL . 8.7 t -82.49 100.46 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.428 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -61.22 -67.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.632 ' NH1' HD13 ' A' ' 75' ' ' ILE . 1.1 ptp180 -176.53 -178.29 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.8 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.74 HD11 HG12 ' A' ' 44' ' ' ILE . 10.1 mt -121.62 155.63 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.979 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -144.8 149.49 35.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -70.07 -43.21 71.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.62 -58.36 0.42 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.452 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.86 80.11 1.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.317 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.04 71.6 1.28 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.559 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.55 54.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.632 HD13 ' NH1' ' A' ' 67' ' ' ARG . 13.1 mt -58.59 155.37 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 0.0 111.199 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.569 HD23 ' CG2' ' A' ' 85' ' ' VAL . 1.0 OUTLIER -135.67 114.13 11.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.088 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.426 ' O ' HG11 ' A' ' 40' ' ' VAL . 2.5 t0 -96.19 -163.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.522 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.525 HD23 HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -114.74 78.59 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.59 -46.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.33 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.907 ' O ' HG23 ' A' ' 40' ' ' VAL . 9.8 m-20 -71.2 136.53 48.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.084 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 82' ' ' LEU . 24.6 mm -56.94 157.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.045 0.45 . . . . 0.0 111.467 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.839 HD11 ' HG ' ' A' ' 43' ' ' LEU . 3.2 tp -61.6 -57.6 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.088 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.1 t -57.9 -19.42 29.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.382 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -40.72 26.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.571 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.569 ' CG2' HD23 ' A' ' 76' ' ' LEU . 35.9 m -106.26 -47.21 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -72.49 174.16 7.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.264 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -144.64 146.6 32.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.837 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.57 123.79 16.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.02 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.1 58.4 3.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.76 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -118.33 161.26 20.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -114.33 129.08 56.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.7 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.51 160.55 37.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.244 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.7 t -116.22 130.5 70.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.749 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.472 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -104.34 128.59 52.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.542 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.58 121.31 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.612 ' HD2' HG23 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -149.94 177.51 9.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.366 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . 0.3 OUTLIER -111.05 156.77 20.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.421 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -153.15 133.03 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.002 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.489 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 28.7 tt0 -98.97 70.19 1.81 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.971 0.415 . . . . 0.0 110.618 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.862 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.801 0.334 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -178.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.525 ' CD1' HD21 ' A' ' 82' ' ' LEU . 3.6 t80 -77.17 96.62 4.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.671 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -98.61 119.31 37.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 111.311 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.27 142.26 43.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.703 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -109.03 108.15 18.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.018 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.9 105.75 18.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 t -77.44 101.49 6.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.423 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 10.8 m-85 -83.0 100.61 10.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.628 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.43 -87.35 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.325 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.09 31.1 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.708 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -145.47 120.32 9.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.689 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -87.72 125.73 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.9 t -126.76 119.41 53.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.206 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -81.71 149.01 28.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.09 98.85 8.29 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.16 85.51 1.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.767 2.311 . . . . 0.0 112.6 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.4 140.55 56.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.75 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -52.76 -24.53 19.2 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.954 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.29 -42.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.362 . . . . 0.0 110.99 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.63 ' HA2' HD23 ' A' ' 82' ' ' LEU . . . 119.98 11.51 6.94 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.615 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -96.44 30.55 2.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.763 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.41 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 10.6 ttp -109.26 144.01 37.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -67.71 143.46 55.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 80' ' ' ASP . 42.5 t -48.74 -41.78 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.839 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 17.6 t80 -50.37 -39.74 47.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.8 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.41 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.4 OUTLIER -74.05 -31.73 63.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.218 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.691 HD22 HD13 ' A' ' 82' ' ' LEU . 4.6 tp -71.45 -39.33 71.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.774 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.857 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.2 mt -68.1 -42.17 84.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.855 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -36.86 85.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.514 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -38.29 83.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.319 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.423 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -75.91 -39.19 56.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.904 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.533 HG21 ' CG2' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -58.7 -43.55 87.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.418 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 90.9 m -68.81 -45.87 70.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.482 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -63.9 -30.52 71.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.682 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.659 ' O ' HG12 ' A' ' 55' ' ' VAL . 23.6 t80 -65.55 -57.3 8.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.558 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -55.76 -39.17 70.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -72.13 -45.19 61.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.199 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.54 98.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.106 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.678 HG11 ' HD2' ' A' ' 57' ' ' LYS . 12.2 p -75.03 -7.15 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.559 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 71.92 35.28 1.36 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.83 0.348 . . . . 0.0 111.076 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HD2' HG11 ' A' ' 55' ' ' VAL . 8.8 mttt -99.71 -175.52 3.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.5 m-20 -151.09 177.14 1.97 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 34.0 Cg_exo -61.92 -12.3 25.22 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.712 2.275 . . . . 0.0 112.769 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -44.07 -33.0 1.33 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.713 0.292 . . . . 0.0 111.727 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.756 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.6 p90 -114.67 154.44 28.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.966 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.513 ' CD1' ' CB ' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -84.35 151.6 24.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.08 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.756 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 54.1 mt -140.22 111.6 4.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.889 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.482 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -107.6 103.44 12.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 179.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.857 HG11 ' CG2' ' A' ' 44' ' ' ILE . 3.3 t -82.08 110.86 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -76.33 -70.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.096 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -171.21 -177.61 2.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.749 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.719 HD11 HG12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -123.81 164.97 18.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.927 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.59 ' O ' HG12 ' A' ' 93' ' ' VAL . 22.2 tt0 -147.98 137.67 22.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -66.71 -60.1 2.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.7 73.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.523 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.4 t0 60.2 36.35 20.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.14 60.81 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.481 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.87 56.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.9 mt -58.57 152.12 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.832 0.349 . . . . 0.0 111.171 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.6 mp -126.76 111.71 14.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.937 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -94.88 -164.26 1.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.827 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.588 ' CD2' HD12 ' A' ' 44' ' ' ILE . 3.5 mt -110.87 76.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.969 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.55 -58.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.115 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.873 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.6 m-20 -57.41 135.02 56.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.233 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 85' ' ' VAL . 27.4 mm -56.11 159.02 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.076 0.465 . . . . 0.0 111.431 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.691 HD13 HD22 ' A' ' 43' ' ' LEU . 15.9 tp -69.8 -54.8 11.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.332 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -52.94 -23.91 8.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.555 -179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.91 -60.52 2.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.532 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 81' ' ' ILE . 35.6 m -73.99 -45.82 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.937 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.488 ' N ' HG23 ' A' ' 85' ' ' VAL . . . -92.37 174.45 7.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.255 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -139.28 155.44 47.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.727 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 0.7 OUTLIER -55.65 143.56 29.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.85 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.9 OUTLIER 40.8 50.91 3.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.502 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -111.36 171.8 7.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.214 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.69 146.15 47.31 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.883 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -148.55 169.1 21.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 69' ' ' GLU . 12.4 p -120.53 121.88 66.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 24' ' ' PHE . . . -96.69 119.78 35.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.464 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.85 120.57 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.811 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.551 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.2 p90 -146.82 -178.12 6.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.159 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.81 158.91 23.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.32 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 1.8 pt-20 -159.57 136.49 9.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 111.258 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.513 ' CB ' ' CD1' ' A' ' 62' ' ' TRP . 8.9 tt0 -129.37 76.63 1.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.142 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.3 t0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.917 179.957 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.773 0.321 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.06 -177.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.401 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -87.67 146.44 25.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.805 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 120.39 6.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.035 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 86' ' ' ALA . 5.8 m -130.98 142.62 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.009 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -106.76 105.92 16.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 m -98.27 116.57 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.084 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.07 101.58 14.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.693 ' HE2' HG22 ' A' ' 48' ' ' VAL . 6.5 m-85 -79.29 100.14 7.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.688 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.67 -79.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.308 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . 1.4 ptm85 -138.07 31.64 2.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.872 0.368 . . . . 0.0 110.732 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.1 m -140.32 121.89 15.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.973 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.72 115.49 28.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.008 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.1 118.18 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.04 144.84 42.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.668 HG11 HD12 ' A' ' 43' ' ' LEU . 21.5 t -135.94 94.67 14.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.44 101.22 1.38 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.505 2.136 . . . . 0.0 112.301 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.592 ' SG ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -75.25 149.63 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.34 -76.69 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.723 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.01 -39.45 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 111.05 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 82' ' ' LEU . . . 118.92 11.76 7.48 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.607 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -97.5 29.77 3.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.838 0.352 . . . . 0.0 110.774 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.415 ' HG2' ' HB3' ' A' ' 42' ' ' SER . 0.3 OUTLIER -103.34 125.12 49.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.56 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HG2' HD13 ' A' ' 81' ' ' ILE . 7.8 mttp -59.8 148.02 36.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.557 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.4 t -47.79 -46.32 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -50.36 -41.86 52.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.415 ' HB3' ' HG2' ' A' ' 38' ' ' MET . 39.4 t -65.14 -39.83 93.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.055 0.455 . . . . 0.0 109.825 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.668 HD12 HG11 ' A' ' 31' ' ' VAL . 20.4 tp -66.91 -32.18 73.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.407 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.927 HG23 HG11 ' A' ' 65' ' ' VAL . 5.2 mt -64.11 -53.15 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -38.47 78.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -67.24 -45.12 77.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.75 74.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.316 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 44' ' ' ILE . 94.0 t -55.84 -53.0 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -58.12 -43.76 87.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.724 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 6.9 tpp180 -63.65 -41.93 98.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.788 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.414 ' O ' HG12 ' A' ' 55' ' ' VAL . 13.7 t80 -57.09 -55.32 36.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.733 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -51.86 -53.76 36.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -72.25 -18.68 61.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.371 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 50' ' ' ARG . . . -80.43 -39.86 27.43 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.751 0.31 . . . . 0.0 111.137 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 55' ' ' VAL . 15.0 p -87.04 6.07 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.512 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 69.13 49.74 0.61 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 13.4 mttm -116.56 -175.78 2.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.4 m-20 -145.11 171.25 6.79 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.793 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 31.9 Cg_endo -64.03 -8.8 17.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.455 2.104 . . . . 0.0 113.056 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -46.78 -58.25 4.08 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.904 0.383 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.784 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.5 p90 -80.1 155.56 27.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.872 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -84.93 153.58 22.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.852 0.358 . . . . 0.0 110.925 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.784 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 55.6 mt -142.54 111.0 2.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.836 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -110.95 116.24 30.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.854 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.927 HG11 HG23 ' A' ' 44' ' ' ILE . 2.1 t -83.45 101.55 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.954 0.407 . . . . 0.0 111.035 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -64.37 -69.18 0.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.509 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -171.43 166.77 6.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 5.5 mt -111.61 156.16 22.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.996 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 49.7 mt-10 -150.26 129.39 12.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.98 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.444 ' CE1' ' CD2' ' A' ' 92' ' ' LEU . 41.8 m-70 -56.91 -58.51 7.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.17 68.95 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.489 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.8 44.36 11.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.862 0.363 . . . . 0.0 110.852 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.73 45.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.43 53.56 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 11.9 mt -60.27 153.84 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.234 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 1.4 mp -135.92 124.0 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.715 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.431 ' O ' HG11 ' A' ' 40' ' ' VAL . 43.1 p-10 -94.58 -164.44 1.17 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.679 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.923 HD23 HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -112.07 44.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.959 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -152.96 23.63 0.57 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.327 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.932 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -134.07 141.32 47.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.927 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.557 ' O ' HG22 ' A' ' 85' ' ' VAL . 25.3 mm -59.6 156.11 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.013 0.435 . . . . 0.0 111.436 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.592 HD22 ' SG ' ' A' ' 33' ' ' CYS . 2.3 tp -72.92 -51.33 18.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.413 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.409 ' SG ' HG21 ' A' ' 81' ' ' ILE . 27.8 p -59.98 -18.75 48.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.457 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -87.17 -46.25 9.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.706 0.289 . . . . 0.0 111.523 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 81' ' ' ILE . 29.1 m -91.25 -46.2 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -83.73 174.08 10.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.312 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.35 149.09 37.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.7 125.68 22.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.05 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.27 67.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.937 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -129.88 161.97 29.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.965 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.8 mtm-85 -120.52 105.99 11.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.807 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -110.47 169.07 8.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.176 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.79 140.21 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.852 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 24' ' ' PHE . . . -113.17 117.08 30.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.383 . . . . 0.0 111.683 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 t -90.09 128.26 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.025 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -163.85 171.43 15.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.504 . . . . 0.0 111.773 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.59 154.76 28.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.219 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.06 132.01 12.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.0 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.431 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 10.6 tt0 -92.1 66.96 5.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.413 . . . . 0.0 110.746 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.875 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.527 0.062 0 CA-C-O 120.791 0.329 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 60.44 -164.17 0.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.761 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.616 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -59.54 151.21 24.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.805 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.47 120.04 1.77 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.591 HG11 ' HB1' ' A' ' 86' ' ' ALA . 15.7 m -132.52 142.05 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.196 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -102.72 107.12 17.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.693 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.09 106.31 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.186 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.86 101.15 3.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.486 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.621 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 5.4 m-85 -81.86 96.82 7.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.689 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.61 -84.36 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.482 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.79 34.17 4.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.9 m -146.46 145.06 30.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.803 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -103.6 110.18 22.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.994 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 t -114.43 111.27 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.04 144.76 34.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.775 HG11 ' HG ' ' A' ' 43' ' ' LEU . 22.0 t -133.15 96.89 17.02 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.037 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.39 117.14 1.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.787 2.325 . . . . 0.0 112.506 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.44 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -92.6 131.69 37.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.753 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.45 -37.5 66.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.959 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -135.92 -46.39 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 111.136 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.88 16.56 4.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.602 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -97.04 29.85 2.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.906 0.384 . . . . 0.0 110.667 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.438 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 0.1 OUTLIER -109.6 122.33 47.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.679 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HG2' HD13 ' A' ' 81' ' ' ILE . 5.0 mtmp? -58.84 157.58 9.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.68 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 80' ' ' ASP . 39.3 t -52.11 -53.44 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.24 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -49.66 -30.8 9.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.185 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.438 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 49.8 m -73.99 -40.91 62.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.051 0.453 . . . . 0.0 110.314 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.914 HD13 HD21 ' A' ' 82' ' ' LEU . 4.4 tt -70.05 -37.46 75.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.539 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.968 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.5 mt -63.64 -46.72 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.726 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -59.71 -42.67 93.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.615 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.57 -39.81 94.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.638 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.15 -42.64 68.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 44' ' ' ILE . 98.2 t -56.63 -54.2 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.721 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 91.6 m -58.82 -42.71 89.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.62 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -69.02 -27.34 65.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.784 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 55' ' ' VAL . 26.4 t80 -67.41 -57.49 6.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.821 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.626 ' CZ ' HD12 ' A' ' 63' ' ' ILE . 5.4 ptm180 -58.97 -38.06 78.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -29.89 64.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.14 -30.23 26.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.525 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.3 p -87.02 8.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.694 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 69.79 24.67 5.27 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.534 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HZ3' ' HE2' ' A' ' 61' ' ' TYR . 19.4 mttt -100.95 -176.39 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.323 . . . . 0.0 110.809 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -142.77 177.42 1.86 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.717 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 19.7 Cg_exo -66.27 -5.99 13.81 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.742 2.295 . . . . 0.0 112.84 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -51.55 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.81 0.338 . . . . 0.0 111.044 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.855 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -61.56 144.53 54.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.793 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.539 ' CZ3' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -76.81 155.62 32.91 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.672 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.855 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 66.5 mt -143.66 110.62 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 62' ' ' TRP . 19.9 tt0 -104.94 107.27 18.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.285 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.968 HG11 ' CG2' ' A' ' 44' ' ' ILE . 2.7 t -82.45 101.29 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.403 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.493 ' HD2' HG12 ' A' ' 95' ' ' VAL . 47.5 m-70 -64.56 -63.96 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.055 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.34 -176.98 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.661 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.761 HD11 HG12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -127.46 154.4 45.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.971 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -136.05 146.96 47.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.757 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.511 ' CE1' HD21 ' A' ' 92' ' ' LEU . 10.7 m-70 -71.61 -44.8 63.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.2 -80.6 0.21 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.67 31.42 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.04 112.26 1.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.582 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.43 83.21 0.23 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.441 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.485 HG22 ' N ' ' A' ' 76' ' ' LEU . 3.6 mm -82.05 157.47 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.789 0.328 . . . . 0.0 111.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.788 HD11 HD22 ' A' ' 92' ' ' LEU . 1.2 mp -125.92 114.24 18.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.425 ' O ' HG11 ' A' ' 40' ' ' VAL . 1.4 t0 -98.27 -164.35 1.13 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.828 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.402 ' CD2' HD12 ' A' ' 44' ' ' ILE . 1.9 mt -112.68 47.92 1.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.956 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -164.64 30.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.236 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.92 ' O ' HG23 ' A' ' 40' ' ' VAL . 12.5 t70 -133.8 136.17 44.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.892 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 82' ' ' LEU . 29.0 mm -62.1 158.55 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.106 0.479 . . . . 0.0 111.475 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.914 HD21 HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -56.68 -61.16 2.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.334 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.4 t -66.34 -14.44 62.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.486 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.1 -36.14 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.687 0.28 . . . . 0.0 111.348 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 86' ' ' ALA . 12.8 p -114.81 -44.68 4.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.634 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.908 ' HB3' HD13 ' A' ' 82' ' ' LEU . . . -84.85 174.08 10.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.188 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -144.62 154.41 42.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.749 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -54.93 123.04 12.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.975 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.32 71.55 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.819 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -123.15 173.62 7.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -134.51 98.28 4.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.788 HD22 HD11 ' A' ' 76' ' ' LEU . 3.7 mt -101.63 169.13 9.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.988 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 t -119.51 121.27 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.621 ' HB3' ' HA ' ' A' ' 24' ' ' PHE . . . -90.69 117.95 29.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.567 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.493 HG12 ' HD2' ' A' ' 66' ' ' HIS . 22.1 t -105.67 110.04 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.574 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.446 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 37.1 p90 -142.8 -179.28 6.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.039 0.447 . . . . 0.0 111.386 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -115.11 152.74 32.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.93 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 2.1 pp20? -150.56 134.23 16.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.75 0.31 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.474 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 2.0 tt0 -99.46 68.96 1.63 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.938 0.399 . . . . 0.0 110.694 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.1 t0 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.997 179.936 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.892 0.377 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -125.55 -164.05 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.792 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.47 ' CD1' HD23 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -74.88 158.34 33.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.842 0.353 . . . . 0.0 110.9 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.36 120.33 2.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.119 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.433 ' HB ' HD11 ' A' ' 92' ' ' LEU . 24.2 m -138.04 141.86 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.986 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.4 m -100.05 116.38 31.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.621 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 21.7 t -97.81 109.14 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.974 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 73.2 m -84.62 101.17 11.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.509 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 37.0 m-85 -88.03 102.36 14.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.589 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.6 -88.63 0.01 OUTLIER Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 24' ' ' PHE . 6.3 mtp180 -128.13 31.44 5.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 110.707 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.8 m -151.44 115.64 5.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.736 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.4 OUTLIER -98.33 148.05 24.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.271 -179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 m -144.79 133.2 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.089 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.52 136.56 40.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -127.08 92.68 43.59 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.04 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -83.45 117.29 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.778 2.319 . . . . 0.0 112.358 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 18' ' ' PHE . 2.0 t -87.54 136.79 32.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.88 -53.03 48.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.712 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -112.3 -31.57 6.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.726 0.298 . . . . 0.0 110.958 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.06 14.41 59.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.92 35.04 3.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.488 ' HE3' HD12 ' A' ' 43' ' ' LEU . 15.6 ptt? -105.77 138.71 41.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.686 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -59.35 147.69 35.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.985 0.421 . . . . 0.0 111.168 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.934 HG23 ' O ' ' A' ' 80' ' ' ASP . 67.2 t -52.23 -40.2 30.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -49.82 -46.82 51.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.027 0.441 . . . . 0.0 110.649 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.446 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 7.0 t -66.14 -34.56 78.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.759 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.695 HD13 HD11 ' A' ' 82' ' ' LEU . 6.1 tp -67.52 -35.48 79.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.844 HD12 HD23 ' A' ' 78' ' ' LEU . 4.5 mt -65.44 -50.87 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.868 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 6.3 pt20 -60.3 -33.91 73.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.46 ' N ' ' HG3' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -70.18 -47.84 59.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB1' ' HE2' ' A' ' 24' ' ' PHE . . . -67.02 -45.41 77.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 44' ' ' ILE . 83.6 t -56.09 -48.1 79.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.869 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.1 m -59.2 -45.61 90.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.23 -32.52 73.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.819 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.729 ' O ' HG22 ' A' ' 55' ' ' VAL . 26.3 t80 -63.65 -57.43 10.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.7 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -54.95 -38.82 68.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.231 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -45.29 60.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.266 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.82 -48.17 80.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.142 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 51' ' ' TYR . 29.0 m -64.96 -15.37 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.452 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . 79.59 31.77 0.25 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.83 0.348 . . . . 0.0 111.312 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HD2' HG21 ' A' ' 55' ' ' VAL . 17.4 mttt -93.97 -173.03 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.512 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.2 m-20 -150.35 170.1 8.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.709 0.29 . . . . 0.0 111.076 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 55.6 Cg_endo -70.12 57.26 1.63 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.636 2.224 . . . . 0.0 112.67 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -120.58 -23.32 6.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.768 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.853 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 9.6 p90 -111.88 154.57 24.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.527 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -81.36 154.29 26.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.661 0.267 . . . . 0.0 110.753 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.853 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 85.6 mt -142.29 111.32 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.026 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -106.53 101.85 11.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.711 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.778 HG11 ' CG2' ' A' ' 44' ' ' ILE . 14.8 t -81.42 97.85 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.021 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.466 ' HD2' HG12 ' A' ' 95' ' ' VAL . 88.3 m-70 -58.92 -67.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -177.14 -177.48 0.73 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.589 HD11 HG12 ' A' ' 44' ' ' ILE . 7.2 mt -123.63 152.11 42.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.28 143.61 31.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -66.28 -69.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.04 101.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.563 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 58.97 44.28 16.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.0 90.26 0.72 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.528 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.68 53.88 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.485 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 76' ' ' LEU . 12.0 mt -59.34 158.08 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.378 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.603 HD13 HD22 ' A' ' 92' ' ' LEU . 1.5 mt -138.71 117.19 12.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.84 -166.62 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.749 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.844 HD23 HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -112.86 43.65 1.64 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.48 25.46 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.283 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.934 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.1 t70 -133.89 136.82 44.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.883 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.843 ' O ' HG22 ' A' ' 85' ' ' VAL . 29.5 mm -58.69 155.85 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.063 0.459 . . . . 0.0 111.581 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.695 HD11 HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -66.3 -52.72 44.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.438 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.8 m -63.92 -14.75 56.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.584 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -91.63 -32.19 15.57 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 81' ' ' ILE . 13.4 m -107.08 -43.72 6.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.86 174.23 6.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.779 0.324 . . . . 0.0 111.253 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -138.41 153.99 48.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.803 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -51.49 124.65 12.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.947 0.403 . . . . 0.0 111.068 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.93 74.3 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.77 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -138.66 151.56 47.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -102.94 140.5 37.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.8 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.603 HD22 HD13 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -132.34 169.0 17.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.5 108.7 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.916 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.621 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -88.5 121.16 30.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.705 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.466 HG12 ' HD2' ' A' ' 66' ' ' HIS . 22.0 t -109.81 118.03 55.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.598 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.525 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.1 p90 -148.73 -174.0 4.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.075 0.464 . . . . 0.0 111.414 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -122.21 155.74 35.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.958 179.15 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 10.0 pt-20 -156.93 130.94 8.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.701 0.286 . . . . 0.0 111.22 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.467 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 16.9 tt0 -97.78 66.73 1.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.732 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.946 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.751 0.31 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -122.9 147.0 47.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 0.9 OUTLIER -70.09 166.42 19.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.867 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.85 120.44 1.02 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.97 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 43' ' ' LEU . 4.2 m -139.44 142.81 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.005 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.3 m -101.31 117.44 34.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.613 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 18.6 t -99.24 104.9 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.936 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 7.4 t -81.42 101.33 9.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.408 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 43.3 m-85 -89.27 103.08 15.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.43 -93.5 0.01 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.736 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mpm_? -119.05 30.93 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 m -156.46 114.5 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.715 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 5.7 ppt_? -105.03 151.81 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.316 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -146.47 145.89 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.093 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -87.74 141.38 28.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.756 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.5 t -129.31 95.25 31.03 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.211 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.82 116.1 2.48 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.68 2.253 . . . . 0.0 112.369 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -90.62 158.35 16.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.929 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.87 -63.53 2.83 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.645 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.21 -47.62 3.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.958 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.65 7.5 8.83 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.741 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -96.74 39.39 1.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.409 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 2.5 ttp -111.0 123.9 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.862 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.56 145.64 18.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.546 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 80' ' ' ASP . 98.6 t -49.36 -41.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.738 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.442 ' CB ' ' HB3' ' A' ' 78' ' ' LEU . 1.7 t80 -50.24 -42.59 52.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.409 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 3.1 m -70.85 -34.63 71.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.185 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.891 HD13 HD22 ' A' ' 82' ' ' LEU . 4.1 tp -67.89 -38.91 83.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.512 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.929 ' CG2' HG11 ' A' ' 65' ' ' VAL . 3.9 mt -65.1 -45.25 94.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.695 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -59.17 -39.82 83.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.728 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -65.79 -48.19 72.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.714 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -64.7 -48.65 73.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.914 HG21 HG21 ' A' ' 65' ' ' VAL . 67.1 t -54.03 -48.19 64.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.028 0.442 . . . . 0.0 110.765 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 83.9 m -57.12 -42.9 81.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.521 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.53 -33.05 74.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.779 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.583 ' O ' HG12 ' A' ' 55' ' ' VAL . 8.1 t80 -60.5 -56.7 18.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.647 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -43.49 85.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -72.01 -27.35 62.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.39 -39.74 31.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.181 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.3 p -85.67 4.3 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.61 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.56 52.78 2.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.81 0.338 . . . . 0.0 111.257 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HD2' HG11 ' A' ' 55' ' ' VAL . 72.3 mttt -116.71 -175.22 2.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.1 m-20 -145.86 171.0 7.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.73 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 34.2 Cg_endo -65.02 -7.43 15.29 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.425 2.083 . . . . 0.0 112.903 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -46.86 -37.43 8.79 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 111.446 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.826 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 5.9 p90 -104.56 152.59 22.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.09 154.24 25.69 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.827 0.346 . . . . 0.0 111.058 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.826 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 70.1 mt -142.78 111.0 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.849 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.488 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -106.95 107.18 18.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.929 HG11 ' CG2' ' A' ' 44' ' ' ILE . 4.2 t -83.44 98.89 5.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.011 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -55.26 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.264 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 ptt85 -163.54 -175.16 4.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD11 HG12 ' A' ' 44' ' ' ILE . 7.1 mt -126.87 152.27 47.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 111.023 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -141.51 132.79 26.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.88 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.62 ' CE1' HD21 ' A' ' 92' ' ' LEU . 11.5 m-70 -58.13 -46.85 84.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.1 -61.58 0.21 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.507 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -151.65 77.61 1.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.951 0.405 . . . . 0.0 110.835 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.96 39.45 1.41 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.43 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.634 ' O ' HD23 ' A' ' 76' ' ' LEU . . . -159.22 41.71 0.48 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 76' ' ' LEU . 10.6 mt -63.16 157.47 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 0.0 111.066 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.819 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -156.9 139.68 15.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 111.211 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -108.48 -163.12 0.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.731 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -98.75 71.61 1.94 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.827 0.346 . . . . 0.0 110.889 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.82 -43.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.931 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -72.25 135.02 45.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.736 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.775 ' O ' HG12 ' A' ' 85' ' ' VAL . 28.2 mm -53.1 155.94 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.158 0.504 . . . . 0.0 111.581 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.891 HD22 HD13 ' A' ' 43' ' ' LEU . 62.9 tp -70.88 -51.56 25.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.493 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.417 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . 31.0 p -71.62 -8.15 52.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.73 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.6 -38.34 10.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.641 0.257 . . . . 0.0 111.291 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.819 HG21 ' HB3' ' A' ' 76' ' ' LEU . 13.7 p -101.02 -33.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.882 0.372 . . . . 0.0 111.599 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.42 174.23 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.378 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.23 154.85 50.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.51 130.64 36.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 56.37 68.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -132.55 149.17 52.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -97.32 143.62 27.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.62 HD21 ' CE1' ' A' ' 70' ' ' HIS . 12.0 mt -142.86 145.37 33.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.903 0.383 . . . . 0.0 111.202 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.81 116.18 35.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.766 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.613 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -99.48 121.89 41.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.052 0.453 . . . . 0.0 111.716 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 t -109.03 126.79 66.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.34 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.576 ' HD2' HG23 ' A' ' 63' ' ' ILE . 1.6 p90 -151.41 -179.77 7.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.178 0.513 . . . . 0.0 111.611 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.66 156.66 28.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.077 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -155.93 134.38 11.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.727 0.299 . . . . 0.0 111.193 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 5.0 tt0 -99.06 67.87 1.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.5 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.836 -179.953 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 60.59 -177.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.641 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -76.12 159.57 30.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.737 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.23 120.46 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.044 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.52 HG21 HD21 ' A' ' 43' ' ' LEU . 3.3 m -132.8 143.13 40.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -96.12 114.89 26.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.12 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.654 ' CG1' ' HB2' ' A' ' 94' ' ' ALA . 20.0 t -104.43 104.31 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 14.5 t -86.66 101.8 13.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.082 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 44.7 m-85 -85.06 98.47 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.778 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.9 -79.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.357 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -138.19 31.32 2.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.822 0.344 . . . . 0.0 110.791 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.557 HG21 ' CD1' ' A' ' 51' ' ' TYR . 87.4 m -139.61 112.34 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -88.65 123.19 32.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 m -135.27 116.74 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.062 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.9 145.58 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.9 t -131.66 103.12 14.8 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.243 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.61 130.13 4.35 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.649 2.233 . . . . 0.0 112.294 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.64 131.42 47.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.03 -48.86 57.6 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.97 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -120.98 -46.07 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.31 11.69 9.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.675 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -97.76 35.02 1.75 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 110.622 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -109.94 118.73 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.811 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -54.52 149.96 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.616 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.908 HG23 ' O ' ' A' ' 80' ' ' ASP . 48.9 t -48.05 -43.81 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.008 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.482 ' CD2' ' HB3' ' A' ' 78' ' ' LEU . 1.8 t80 -50.38 -49.38 54.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.236 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.3 t -62.33 -35.96 80.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.397 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.799 HD13 HD21 ' A' ' 82' ' ' LEU . 6.0 tp -66.36 -33.99 76.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.568 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.868 ' CG2' HG11 ' A' ' 65' ' ' VAL . 5.3 mt -66.18 -51.18 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.814 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -35.11 72.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.002 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -68.67 -48.13 64.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.735 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -67.93 -47.08 69.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.366 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 44' ' ' ILE . 61.2 t -53.09 -53.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.842 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.5 m -56.96 -44.74 82.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -29.89 70.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.911 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.557 ' CD1' HG21 ' A' ' 27' ' ' THR . 4.1 t80 -65.58 -57.4 8.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.772 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HA ' HG12 ' A' ' 55' ' ' VAL . 8.9 ptt180 -58.8 -35.19 72.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.887 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 7.6 mmtt -72.6 -29.99 63.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.29 -33.66 25.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.426 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 55' ' ' VAL . 14.9 p -84.7 4.6 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.645 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.87 44.31 4.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 111.258 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -112.69 -174.76 2.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -147.59 176.29 2.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.742 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 18.7 Cg_exo -66.24 -9.29 23.15 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.826 2.35 . . . . 0.0 112.624 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -45.79 -39.4 8.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.714 0.292 . . . . 0.0 111.438 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.848 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 6.7 p90 -102.74 145.1 30.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.933 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -76.47 155.6 33.73 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.609 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.848 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 78.8 mt -142.95 110.97 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.887 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.489 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.2 OUTLIER -106.94 105.36 15.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.561 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.868 HG11 ' CG2' ' A' ' 44' ' ' ILE . 1.5 t -83.29 97.29 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.159 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -56.08 -74.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -167.66 178.12 5.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.786 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.545 ' HB2' HD12 ' A' ' 76' ' ' LEU . 1.1 mt -119.45 156.84 29.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 1.1 tt0 -138.66 147.01 42.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.962 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.775 ' HA ' HD23 ' A' ' 92' ' ' LEU . 4.7 m-70 -68.14 -64.54 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.89 -53.02 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.474 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.74 34.13 0.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.24 69.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.44 56.37 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.438 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 12.5 mt -62.49 153.38 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 111.099 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.938 HD11 HD22 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -129.0 114.18 16.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.794 179.69 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -163.39 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.17 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.665 HD23 HD12 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -113.54 36.5 3.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 0.0 110.773 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -148.29 26.88 0.95 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.908 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -131.64 134.28 45.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.882 0.372 . . . . 0.0 110.946 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 85' ' ' VAL . 29.1 mm -57.91 157.14 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.698 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.84 HD13 ' HB3' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -61.84 -56.13 22.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.626 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 34.7 m -71.19 -7.4 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.835 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.67 -37.46 15.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.574 0.226 . . . . 0.0 111.479 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 81' ' ' ILE . 8.5 m -114.9 -31.34 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.84 ' HB3' HD13 ' A' ' 82' ' ' LEU . . . -96.69 174.1 6.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 0.0 111.226 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.16 153.96 45.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.7 125.97 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.99 71.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -134.34 157.48 46.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.15 130.85 50.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.533 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.938 HD22 HD11 ' A' ' 76' ' ' LEU . 5.2 mt -138.62 132.7 31.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.354 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 69' ' ' GLU . 4.7 m -82.94 134.42 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.436 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.654 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . . . -109.86 117.01 32.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.947 0.403 . . . . 0.0 111.768 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.1 t -97.03 127.12 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.344 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.459 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -160.75 174.77 13.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.122 0.487 . . . . 0.0 111.707 -179.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.17 157.95 25.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.242 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 62' ' ' TRP . 9.7 pt-20 -155.23 135.0 12.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.046 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.476 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 2.3 tt0 -101.44 65.93 1.07 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.892 0.377 . . . . 0.0 111.008 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.956 179.895 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.945 0.402 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -96.94 -177.42 3.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.556 ' CE2' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -84.0 155.95 22.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.824 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -164.53 120.5 1.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.77 142.56 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.046 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.524 HG21 ' HD3' ' A' ' 28' ' ' ARG . 23.9 m -95.3 119.68 34.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 29' ' ' VAL . 21.3 t -98.97 107.55 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.022 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.86 101.59 14.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.479 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 43.6 m-85 -85.75 100.75 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.714 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.33 -78.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.294 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 tpm_? -141.84 31.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.729 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.0 m -137.66 125.48 22.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HD3' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -95.43 130.42 42.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 22' ' ' VAL . 6.7 m -135.35 127.11 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.043 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -74.98 143.22 43.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.986 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.3 t -140.72 92.62 8.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.145 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -84.65 123.03 2.8 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.757 2.305 . . . . 0.0 112.593 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.414 ' CB ' ' HB3' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -94.12 141.87 28.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.745 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.29 -81.79 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.881 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.24 -35.52 9.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 110.978 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.64 14.67 10.15 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.506 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 mtt-85 -98.6 28.46 4.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.941 0.4 . . . . 0.0 110.866 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.42 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 10.2 ttp -105.06 145.53 30.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.694 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.46 147.88 33.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 80' ' ' ASP . 59.1 t -48.83 -42.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.666 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -50.23 -38.8 42.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.42 ' CB ' ' HG2' ' A' ' 38' ' ' MET . 0.4 OUTLIER -73.86 -34.58 64.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.278 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.864 ' CD1' HD11 ' A' ' 82' ' ' LEU . 5.4 tt -70.15 -38.66 75.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.673 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.925 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.1 mt -66.09 -45.83 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.634 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -59.06 -40.62 85.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.709 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -67.9 -44.79 76.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.782 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -66.85 -37.77 85.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 44' ' ' ILE . 75.0 t -59.64 -54.11 39.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.412 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -55.86 -42.72 76.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.599 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -37.87 86.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.703 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 55' ' ' VAL . 56.4 t80 -58.98 -57.02 14.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.69 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -51.37 -47.74 62.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.96 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -72.28 -25.75 61.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.225 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.49 -38.56 55.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.197 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 55' ' ' VAL . 13.6 p -92.28 12.74 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.617 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 57.54 56.86 4.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.905 0.383 . . . . 0.0 111.307 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 61' ' ' TYR . 65.3 mttt -120.72 -175.39 3.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.468 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 1.6 m-20 -148.05 171.16 6.63 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.506 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' A' ' 58' ' ' ASP . 31.6 Cg_endo -64.19 -8.13 15.65 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.371 2.047 . . . . 0.0 112.916 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -46.35 -37.39 7.43 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.64 0.257 . . . . 0.0 111.521 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.838 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 6.0 p90 -104.8 156.13 18.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -85.03 153.79 22.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.164 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.838 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 76.6 mt -142.13 110.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.81 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -103.71 102.91 12.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.648 179.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.925 HG11 ' CG2' ' A' ' 44' ' ' ILE . 5.8 t -76.52 97.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -57.49 -78.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.0 -177.5 6.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.638 HD23 HD13 ' A' ' 44' ' ' ILE . 2.0 mm? -112.33 165.0 12.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -148.98 160.56 43.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.645 ' HA ' HD23 ' A' ' 92' ' ' LEU . 16.9 m-70 -94.61 -43.47 8.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.66 -88.39 0.14 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.41 33.02 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.769 0.318 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.45 108.12 0.99 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.4 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.09 95.28 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.403 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 76' ' ' LEU . 3.4 mm -93.19 155.26 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 76' ' ' LEU . 2.0 mp -133.54 118.02 17.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -95.17 -175.36 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.793 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.49 44.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.855 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.4 27.52 0.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.973 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.92 ' O ' HG23 ' A' ' 40' ' ' VAL . 9.3 m-20 -137.26 134.7 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.695 ' O ' HG22 ' A' ' 85' ' ' VAL . 31.7 mm -58.78 158.56 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.121 0.486 . . . . 0.0 111.586 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.864 HD11 ' CD1' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -58.0 -56.76 17.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.444 -179.433 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 68.9 m -70.66 -7.55 45.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.789 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.22 -30.97 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.678 0.275 . . . . 0.0 111.586 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 81' ' ' ILE . 2.4 m -120.06 -36.09 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.33 174.14 6.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.791 0.329 . . . . 0.0 111.338 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.55 150.52 47.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.752 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.61 132.72 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.01 60.32 2.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.732 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -138.97 134.85 33.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.38 151.2 26.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.763 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 70' ' ' HIS . 23.7 mt -146.13 150.85 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.007 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.25 114.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.758 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.449 ' HB2' HG13 ' A' ' 22' ' ' VAL . . . -95.27 128.1 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.751 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.93 137.15 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.32 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -167.88 163.32 13.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.129 0.49 . . . . 0.0 111.901 -179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -104.79 156.81 17.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.11 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -155.27 128.9 8.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.014 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.446 ' CB ' ' HD1' ' A' ' 62' ' ' TRP . 20.6 tt0 -86.53 66.85 9.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.036 0.446 . . . . 0.0 110.533 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.89 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.806 0.336 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -64.69 160.32 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.614 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -80.95 157.57 25.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -161.24 120.28 2.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.01 0.434 . . . . 0.0 111.061 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.698 HG21 HD21 ' A' ' 43' ' ' LEU . 4.1 m -132.9 142.9 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.926 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -100.43 118.59 36.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.529 HG13 HD21 ' A' ' 68' ' ' LEU . 31.4 t -97.75 109.59 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.758 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 t -88.3 101.68 14.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 55.7 m-85 -84.71 98.51 10.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.395 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.97 -85.42 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.333 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 24' ' ' PHE . 3.0 mmp_? -129.17 31.38 4.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.4 m -138.25 145.09 40.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -105.85 138.3 42.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.027 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.76 108.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.019 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -74.81 149.05 39.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG21 ' HB2' ' A' ' 47' ' ' ALA . 21.1 t -141.25 94.12 7.8 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.322 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.28 129.11 4.37 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.645 2.23 . . . . 0.0 112.391 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.6 m -99.66 140.04 34.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.768 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.69 -50.81 62.37 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.576 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -112.28 -29.91 7.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 111.066 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.68 14.24 53.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.523 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.81 35.91 2.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.731 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.2 ttp -104.17 137.61 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -69.77 150.14 47.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.53 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 80' ' ' ASP . 44.3 t -48.86 -42.08 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.968 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -50.17 -43.06 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.32 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -30.48 63.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.579 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.096 HD13 HD21 ' A' ' 82' ' ' LEU . 3.3 tp -71.38 -39.18 71.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.618 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.935 ' CG2' HG11 ' A' ' 65' ' ' VAL . 4.3 mt -67.81 -44.13 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.692 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.21 -38.43 86.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -68.79 -42.73 76.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.604 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' A' ' 31' ' ' VAL . . . -69.46 -40.77 76.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.296 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 44' ' ' ILE . 98.0 t -58.45 -51.84 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.72 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.9 m -58.18 -44.44 88.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.416 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -64.48 -29.93 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.802 ' O ' HG22 ' A' ' 55' ' ' VAL . 7.5 t80 -64.13 -57.88 8.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.656 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HG3' ' N ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -58.77 -32.66 69.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.641 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.42 ' N ' ' HG3' ' A' ' 52' ' ' ARG . 11.2 mmtt -72.52 -27.91 62.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.52 26.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.34 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 51' ' ' TYR . 2.8 m -93.99 18.98 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.583 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 55.16 28.97 11.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.562 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.64 ' HB2' HG23 ' A' ' 55' ' ' VAL . 10.0 mttt -94.54 -169.87 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.835 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m-20 -160.06 177.07 2.21 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.731 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 58' ' ' ASP . 33.0 Cg_exo -61.49 -12.13 22.99 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.663 2.242 . . . . 0.0 112.767 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -45.02 -53.1 8.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.815 0.341 . . . . 0.0 111.346 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.781 ' CZ ' HD11 ' A' ' 63' ' ' ILE . 3.7 p90 -90.44 148.68 22.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -79.71 155.49 27.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.79 0.328 . . . . 0.0 111.028 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 68.7 mt -142.46 111.02 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.759 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.482 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -104.65 105.33 15.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.651 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.935 HG11 ' CG2' ' A' ' 44' ' ' ILE . 1.4 t -83.02 97.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.133 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -53.56 -76.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -159.85 -176.97 6.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.991 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.529 HD21 HG13 ' A' ' 22' ' ' VAL . 10.0 mt -117.49 160.75 20.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.57 159.36 43.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.591 ' HA ' HD23 ' A' ' 92' ' ' LEU . 10.9 m-70 -85.23 -30.78 23.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.773 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.95 -53.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.406 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -156.72 73.01 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.996 0.427 . . . . 0.0 110.784 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.91 57.66 0.54 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.41 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.61 59.0 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.493 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 76' ' ' LEU . 7.2 mt -71.66 158.36 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.824 0.345 . . . . 0.0 111.187 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.991 HD11 HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -151.25 141.43 22.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.7 -162.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.707 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.01 43.49 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.886 0.374 . . . . 0.0 110.944 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.3 25.33 1.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.909 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.0 m-20 -133.13 132.99 42.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.993 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.612 ' O ' HG22 ' A' ' 85' ' ' VAL . 27.5 mm -56.02 158.38 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.038 0.447 . . . . 0.0 111.534 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.096 HD21 HD13 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -62.27 -57.55 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.625 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.3 t -67.76 -11.6 58.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.934 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.41 -47.28 11.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.586 0.231 . . . . 0.0 111.516 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 81' ' ' ILE . 6.3 m -103.9 -32.75 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.645 ' HB3' HD13 ' A' ' 82' ' ' LEU . . . -101.55 173.99 6.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.901 0.381 . . . . 0.0 111.213 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.87 154.44 49.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.766 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -54.34 124.03 14.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.09 70.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -140.21 144.55 36.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.024 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -92.86 148.97 21.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.796 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.991 HD22 HD11 ' A' ' 76' ' ' LEU . 1.6 mt -143.41 146.84 33.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.128 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.3 t -92.12 122.76 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.605 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.426 ' HB2' HG13 ' A' ' 22' ' ' VAL . . . -108.85 118.12 35.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.002 0.429 . . . . 0.0 111.822 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 t -103.31 128.18 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.149 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.582 ' HD2' HG23 ' A' ' 63' ' ' ILE . 2.1 p90 -153.31 -177.65 6.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.277 0.56 . . . . 0.0 111.718 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -118.06 157.27 27.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.856 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.17 132.15 9.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.745 0.307 . . . . 0.0 111.125 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.469 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 3.7 tt0 -92.05 73.42 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.05 0.452 . . . . 0.0 110.462 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 t70 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.927 -179.967 . . . . . . . . 0 0 . 1 stop_ save_